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Chapter 1 
1 Introduction 
1.1 G-Protein coupled receptors 
1.1.1 Classification and relevance of GPCRs 
G-protein coupled receptors (GPCRs), forming one of the largest protein family in the human 
proteome (Lander et al., 2001; Venter et al., 2001) and accounting for about 2% of the 
human genome (Fredriksson et al., 2003), are embedded in the plasma membrane and are 
the most important proteins for transferring signals from the extracellular medium to the 
cytoplasm. A huge variety of external stimuli are able to activate GPCRs, including photons, 
neurotransmitters, peptides, proteases, glycoprotein hormones, purine ligands and 
chemokines (Liapakis et al., 2012). In humans these ligands address more than 800 GPCRs 
with about 400 functional non-olfactory receptors (updated figures on the homepage of the 
International Union of Basic and Clinical Pharmacology, IUPHAR, http://www.iuphar-
db.org/index.jsp;(Sharman et al., 2013). By phylogenetic analysis they were classified in five 
groups: glutamate, rhodopsin, adhesion, frizzled/taste2 and secretin (GRAFS 
classification;(Fredriksson et al., 2003). The rhodopsin family, also referred to as class A 
GPCRs according to the A-F clan system, which covers all GPCRs in both vertebrates and 
invertebrates (Attwood and Findlay, 1994; Kolakowski, 1994), is by far the largest and most 
diverse family with about 700 receptor proteins (Lagerstrom and Schioth, 2008). It is 
subdivided into four groups (α, β, γ and δ) with the histamine receptor family located in the 
amine receptor cluster of the α-subgroup (Fredriksson et al., 2003). Class B (secretin and 
adhesion receptor families with 15 and 24 members, respectively) and class C (glutamate 
receptor family with 15 human proteins) receptors contain only a few GPCRs. Emphasizing 
their importance for drug discovery, GPCRs are associated with many physiological 
processes and diseases, such as asthma, cancer, inflammation, obesity, pain as well as 
cardiovascular, metabolic, gastrointestinal and CNS diseases (Pierce et al., 2002). 
Furthermore, genetic variations in GPCRs are responsible for more than 30 different human 
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diseases (Schöneberg et al., 2004). To date, about 30% of all drugs on the market address 
GPCRs (Overington et al., 2006). This includes top-selling drugs targeting α- and β-
adrenergic receptors, 5-HT receptors, dopamine receptors, histamine receptors and 
angiotensin receptors. However, only a small number of the superfamily of GPCRs is 
addressed by drugs at all (De los Frailes and Diez, 2009; Lappano and Maggiolini, 2011). 
Additionally, more than 100 GPCRs belong to the group of orphan receptors. This means 
that the corresponding endogenous ligands are still unknown (Chung et al., 2008). Thus, 
there is a great potential for the discovery of ‘new’ disease-related GPCRs. Taking into 
consideration the broad experience with established valuable GPCR addressing 
pharmacotherapeutics and the advances in structural biology in the past 13 years, GPCRs 
will continue to be in the focus of drug discovery (Salon et al., 2011). 
1.1.2 GPCR structure 
The sequence of GPCRs is characterized by seven stretches with mainly hydrophobic 
residues, forming the common architecture of seven α-helical segments (seven 
transmembrane domains, 7TM) permeating the lipid core of the plasma membrane (Figure 
1.1). At the intracellular surface GPCRs are able to interact with G-proteins (guanine 
nucleotide-binding proteins), transmitting the external stimuli to second messenger systems. 
However, the coupling of GPCRs to heterotrimeric G-proteins is just one possible signaling 
pathway (section 1.1.5). The notation 7TM receptor seems therefore more applicable 
(Kobilka, 2007). The seven TM domains are connected by three extra- and intracellular 
loops, respectively, being the most variable structures in GPCRs concerning length, 
sequence identity and flexibility (Kobilka and Schertler, 2008; Mirzadegan et al., 2003; 
Wheatley et al., 2012). In TMs several highly conserved motifs were recognized which are 
associated with specific functions in GPCRs, e.g. the D/ERY motif at the cytoplasmic end of 
TM3 which is part of the ionic lock, restraining the TM6 position close to TM3 by interactions 
with Glu6.30 (1) in the inactive receptor state of some GPCRs (Rovati et al., 2007; Vogel et al., 
2008), the CWxP motif inTM6 composed of Trp6.48 and Pro6.50, responsible for the rotamer 
toggle switch and the kink in TM6 (Shi et al., 2002), or the NPxxY(x)5,6F motif at the 
cytoplasmic part of TM7 which performs conformational changes during GPCR activation 
(Fritze et al., 2003; Scheerer et al., 2008). 
________________________________ 
(1)    Residues within TM domains are named according to the Ballesteros/Weinstein nomenclature; the most 
conserved residue in each TM is numbered as X.50 where X is the number of the respective TM domain 
(Ballesteros and Weinstein, 1995)
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These conserved structural features suggested a common mechanism of activation (Ahuja 
and Smith, 2009; Karnik et al., 2003; Nygaard et al., 2009; Schwartz et al., 2006). However, 
for a long time the activation of GPCRs remained unclear due to the lack of structural 
information. 
 
 
 
Figure 1.1: Model of a 7TM receptor embedded in a lipid bilayer 
Large green tubes represent the seven TM domains extending from the extracellular medium 
(top) to the cytoplasmic side of the membrane (lipid core with grey carbons). TMs are connected 
by extra- and intracellular loops (green lines). At the intracellular side helix 8 (short green tube) is 
positioned parallel to the membrane within the polar lipid head groups. 
 
 
First evidence for the 7TM structure of GPCRs was provided by electron microscopy studies 
of bacteriorhodopsin (Henderson and Unwin, 1975) and confirmed by a low resolution two-
dimensional projection map of rhodopsin (Schertler et al., 1993). A first 3D structure was 
published in 1995 with a resolution of about 9.5 Å, disclosing the overall shape of the 
rhodopsin molecule (Unger and Schertler, 1995). In the year 2000, the first high resolution X-
ray structure of a GPCR, bovine rhodopsin (Palczewski et al., 2000), was a breakthrough in 
structural biology. In the following years several rhodopsin crystal structures were resolved 
(Topiol and Sabio, 2009), which served as templates for molecular modeling studies of other 
GPCRs (Barton et al., 2007). However, rhodopsin is unique among the class A receptor 
family. In contrast to GPCRs such as aminergic receptors the ligand 11-cis-retinal is 
covalently bound to rhodopsin by a Schiff base with Lys2967.43 (Li et al., 2004). Furthermore, 
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the sequence is rather distant to that of other class A GPCRs. In later years, the X-ray 
structures of GPCRs (e.g. βARs and adenosine A2A receptor) proved that rhodopsin based 
homology models of GPCRs are too imprecise for drug design (Rosenbaum et al., 2009). It 
was not until 2007 that the first non-rhodopsin GPCR structure was resolved, the human 
β2AR (Cherezov et al., 2007; Rasmussen et al., 2007). The breakthrough was enabled by 
advances in GPCR crystallography (Venkatakrishnan et al., 2013). For instance, the 
stabilization of the highly flexible third cytoplasmic loop by binding a Fab antibody fragment or 
by generating a fusion protein (where T4 lysozyme was fused into ICL3 of the GPCR) 
resulted in more hydrophilic crystal contacts. This was as important as the insertion of point 
mutations in the protein to increase the thermostability of the receptor or the development of 
suitable crystallization matrices. Furthermore, using high affinity ligands with a slow rate of 
dissociation, receptors were locked in a single conformation and therefore stabilized during 
the crystallization (Tate, 2012). In the year 2008 even the first active receptor conformation of 
a GPCR, ligand free rhodopsin (opsin), was obtained (Park et al., 2008; Scheerer et al., 
2008). Attaching a G-protein fragment to opsin helped to restrain the receptor in an active 
conformation. The comparison of inactive and active state GPCR conformations allowed 
invaluable insights into activating switches of GPCRs (Trzaskowski et al., 2012). In 2011 
Kobilka and coworkers released the ternary complex of an agonist bound β2AR with the 
nucleotide-free Gs heterotrimer, capturing the moment the receptor is activated by a ligand 
and sending a signal into the cell – a further milestone in GPCR research (Rasmussen et al., 
2011). Recently, the three-dimensional structure of the human CXCR1 in liquid crystalline 
phospholipid bilayers under physiological conditions and without stabilizing mutations was 
determined using NMR spectroscopy for the first time (Park et al., 2012). All in all, since the 
year 2000, 20 different class A GPCRs have been determined (Venkatakrishnan et al., 2013; 
Wacker et al., 2013). Unfortunately, structural information about class B and class C GPCRs 
is limited, although the N-terminal ligand binding domain was already resolved for 
representative receptors of both classes. It is expected that whole protein structures of those 
GPCRs will be available within the next two years (Stevens et al., 2013); metabotropic 
glutamate receptors for example are already in the pipeline (GPCR Network, 
http://gpcr.scripps.edu). The crystallization of a frizzled (class F) G-protein coupled receptor, 
the smoothened (SMO) receptor, was reported lately (Wang et al., 2013). Also just recently 
the structure of active β-arrestin-1 bound to a carboxy-terminal G-protein coupled receptor 
phosphopeptide was published (Shukla et al., 2013). Besides G-proteins β-arrestins are 
alternative signal transducing molecule interacting with 7TM receptors (see 1.1.5;(Lefkowitz 
and Shenoy, 2005). 
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1.1.3 Ligand classification 
Ligands able to activate and/or stabilize active GPCR conformations and, thus, to mobilize 
intracellular downstream effectors like G-proteins are termed agonists (Figure 1.2 A). 
However, ligand free receptors are also able to adopt active conformations and to interact 
with, e.g. G-proteins. Constitutive activity is frequently observed in wild-type and mutated 
GPCRs. The isomerization of inactive receptor conformations to active ones occur 
spontaneously, thus increasing the basal G-protein activity (Seifert and Wenzel-Seifert, 
2002). In case of GPCRs exhibiting agonist-independent activity, inverse agonists can 
suppress basal activity. Such ligands stabilize receptor conformations which are not able to 
interact with intracellular signal transducers. According to the classical two state model 
(Figure 1.2 B), which assumes an inactive and active GPCR state (R and R*, respectively), 
partial agonists and partial inverse agonists are able to shift the equilibrium to a certain 
degree, resulting in a submaximal effect compared to full agonists and full inverse agonists, 
respectively. However, based on the theory of multiple receptor states with certain energies 
this concept could be rendered more precisely (see 1.1.6). Antagonists are bound to 
receptors without changing the equilibrium between inactive and active states, i.e. without 
changing the basal activity of the respective receptor. 
 
 
 
Figure 1.2: Classification of GPCR ligands and two state model of GPCR activation 
A, Classification of GPCR ligands, adapted from Tate et al. (2012); B, Two state model of GPCR 
activation, adapted from Seifert and Wenzel-Seifert (2002). R* and R, active and inactive receptor 
conformation, able to interact with signaling effectors (R*) or not (R). 
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6 1.1 G-Protein coupled receptors 
1.1.4 G-protein cycle 
The first intracellular signal transducers identified to be activated by 7TM receptors were 
heterotrimeric G-proteins, composed of three subunits, α, β and γ (Oldham and Hamm, 
2008). In total 21 Gα, 6 Gβ and 12 Gγ subunits are found in humans (Downes and Gautam, 
1999), whereas not all possible combinations of the three subunits are relevant for signal 
transduction (Denis et al., 2012). Both the Gα protein and the Gβγ-subunit are attached to 
the membrane (Chen and Manning, 2001; Dupre et al., 2009). Compared to the number and 
diversity of ligands at GPCRs (peptides, biogenic amines, lipids and a magnitude of synthetic 
chemicals) the number of heterotrimers is rather low. This is in accord with the higher 
sequence similarity at the cytoplasmic side of the TM bundle (Mirzadegan et al., 2003) which 
indicates a similar signal transduction mechanism of GPCRs. The heterotrimers are 
classified in four main classes based on the primary sequence of the Gα subunit and, in part, 
on the selectivity of effectors (Gαs, Gαi/o, Gαq/11 and Gα12/13;(Cabrera-Vera et al., 2003; 
Milligan and Kostenis, 2006). Most important effectors for Gα and Gβγ are shown in Figure 
1.3. Some GPCRs couple to more than one G-protein subtype (Hermans, 2003; Lefkowitz et 
al., 2002; Xiao, 2001).  
 
 
Figure 1.3: The G-protein cycle 
R and R*, receptor conformation able to interact with signaling downstream effectors (R*) or not 
(R); AC, adenylyl cyclase; PLC-β, phospholipase C beta; PKC, protein kinase C; RhoGEF, 
structural domain of guanine nucleotide exchange factors for Rho/Rac/Cdc42-like GTPases; PLD, 
phospholipase D. Adapted from Rasmussen et al. (2011); downstream effectors were taken from 
Cabrera-Vera et al. (2003). 
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In the G-protein cycle the heterotrimer with GDP bound to the α-subunit interacts with an 
active GPCR conformation. The activated GPCR serves as catalytic activator for the GDP-
GTP exchange of the α-subunit and thus conformational changes in Gα results in a break of 
the heterotrimeric complex in Gα and Gβγ and an adoption of subunit conformations capable 
of interacting with downstream effectors (Johnston and Siderovski, 2007). The GTPase 
activity of Gα cleaves off the third phosphate group from GTP. The resulting GDP bound α-
subunit recombines with the Gβγ subunit to return to the resting state (Figure 1.3). GTP 
hydrolysis can be accelerated by regulators of G-protein signaling (RGS) proteins of Gq and 
Gi/o proteins (Magalhaes et al., 2012). 
1.1.5 Alternative signaling pathways and functional selectivity 
Regardless of their role as ligand-regulated guanine nucleotide exchange factors for 
heterotrimeric G-proteins, GPCRs are capable of interacting with G-protein independent 
signal transduction pathways (Magalhaes et al., 2012). Following receptor activation, G-
protein coupled receptor kinases (GRKs) can phosphorylate serine and threonine residues in 
intracellular loops and C-terminus of GPCRs. As a consequence, β-arrestins bind to the 
modified receptor, preventing receptor–G-protein interactions and terminating GPCR 
signaling via heterotrimeric G-proteins (Kohout and Lefkowitz, 2003). For a long time, the 
recruitment of β-arrestin was considered necessary only for receptor desensitization, 
internalization and recycling of GPCRs (Lefkowitz, 1998; Lefkowitz and Shenoy, 2005). 
However, in the past decade evidence raised that GRKs and β-arrestins initiate G-protein 
independent pathways, such as the inhibition of nuclear factor κB (NF-κB)-targeted gene 
expression, scaffolding proteins of the mitogen-activated protein kinase (MAPK) signaling 
pathways and interactions with members of the c-Src family (Reiter et al., 2012; Shukla et al., 
2011). The different G-protein and/or β-arrestin dependent pathways are preferentially or 
specifically activated by some ligands. These biased ligands are assumed to stabilize distinct 
receptor conformations which are capable of interacting exclusively or preferably with 
downstream signaling pathways (functional selectivity). Accordingly, the cubic ternary 
complex model, a model for 7TM receptor activation considering complexes of ligand-
receptor, receptor-transducer and ligand-receptor-transducer for both, inactive and active 
GPCR conformations, has to be expanded to include receptor states interacting with different 
signal pathways (model of multiple signaling-component receptor conformations; Figure 
1.4;(Rajagopal et al., 2010). Both models consider inactive (not able to interact with signaling 
downstream effectors) and active (able to initiate e.g. the G-protein cycle) GPCR 
conformations, explain constitutive activity (RaT state: active receptor conformation without a 
ligand bound and linked to e.g. a signaling G-protein; cf. Figure 1.4), and the fact that also 
8 1.1 G-Protein coupled receptors 
inactive receptor states could couple to G-proteins without initiating the G-protein cycle 
(observed e.g. for opioid peptide receptors where antagonist bound inactive state 
conformations form GTP-sensitive, non-signaling ternary complexes, or for ligand free wild-
type cannabinoid CB1 receptors which sequester G-proteins – in the form of non-signaling 
ternary complexes – from other systems;(Kenakin, 2004). 
 
 
        
 
Figure 1.4: Receptor theory for GPCR activation 
A, Cubic ternary complex model; B, A new model of 
GPCR activation considering multiple signaling-
component receptor conformations (adapted 
from(Rajagopal et al., 2010). L, ligand; Ri, receptor 
in an inactive conformation which is not able to 
initiate the signaling of downstream effectors; Ra, 
active receptor conformation which could form 
signaling complexes with effectors; T, transducer, 
e.g. G-proteins or β-arrestins. 
 
        
 
 
1.1.6 GPCR activation 
GPCRs are dynamic, flexible molecules, capable of adopting specific receptor 
conformations, stabilized by functionally distinct ligands (Frauenfelder et al., 1991; Kobilka 
and Deupi, 2007). To explain the different structural and functional receptor states, e.g. 
during the activation of rhodopsin where several conformations with different functionality are 
passed through (Hofmann et al., 2009), it is not sufficient to consider a simple on-off switch 
model but to assume different conformations with distinct energies (Deupi and Kobilka, 
2010). Stable conformations with low energy such as the structures obtained from X-ray 
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crystallography are favored. The transition from one local minimum energy conformation to 
another is determined by the differences between the respective energies of these states 
and the activation energy barrier (energy landscape of the receptor;(Kobilka and Deupi, 
2007). Conformational switches from one state to another occurring during receptor 
activation can happen in two different ways, by the induced-fit mechanism or by 
conformational selection. The major differences between these mechanisms consist in the 
first stages of ligand-receptor interaction and activation (Deupi and Kobilka, 2010). According 
to the induced-fit mechanism the ligand binds to the GPCR in the inactive conformation and 
thereby changes the energy landscape of the (ligand bound) receptor. Consequently, the 
energy difference between the inactive and active state is reduced. Furthermore, ligand 
binding provides the necessary energy for overcoming the transition barrier to achieve the 
active state, and the ligand stabilizes the receptor in its active conformation. A representative 
example of that mechanism is rhodopsin, which is characterized by low energy in the inactive 
conformation (and therefore locking the receptor in this state), as well as by a high energy 
barrier between inactive and active conformation (Figure 1.5 A). Hence, rhodopsin is devoid 
of constitutive activity (Govardhan and Oprian, 1994). The isomerization of covalently bound 
retinal upon light absorption involves energy transfer to the receptor, inducing conformational 
changes and the ‘jump’ over the activation barrier. In contrast, for the β2AR, representing an 
example of the conformational selection mechanism (Figure 1.5 B), the ligand-free receptor 
adopts multiple conformations (Ghanouni et al., 2001; Peleg et al., 2001) probably not 
separated by high energy barriers. This allows for a switch to an active receptor state, 
elevating the basal (constitutive) activity of the β2AR (Seifert et al., 1998). In principle, the 
different conformational states can be stabilized by specific ligands, which in case of agonists 
lower the energy of the ligand-receptor complex LR* (ligand bound to an active receptor 
conformation). The increase in energy difference and barrier referred to R and LR hinders 
the transition to an inactive receptor state and therefore shifts the equilibrium of the receptor 
towards R*. In both mechanism G-protein binding further changes the energy landscape and 
shifts the equilibrium towards the active state of the receptor. To explain partial agonism two 
not-excluding theories are discussed. First, due to higher dissociation rates of partial 
agonists compared to full agonists not each ligand-receptor complex persists long enough to 
initiate the G-protein cycle. This results in a reduced effector response to ligand binding. 
Second, partial agonists are able to bind to receptor conformations which are not capable of 
interacting with downstream effectors in the same way as full agonists, but probably activate 
the G-protein only partially (Deupi and Kobilka, 2010). 
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Figure 1.5: Energy landscape of the activation mechanism of rhodopsin and the β2AR 
A, Energy landscape of rhodopsin (induced-fit mechanism); B, Energy landscape of the β2AR 
(conformational selection). G, G-protein; L, ligand. Adapted from Deupi and Kobilka (2010). 
 
 
1.2 The histamine H2R and the histamine receptor family 
1.2.1 Histamine receptor subtypes 
The biogenic amine histamine is synthesized in the cytosol via pyridoxal-5-phosphate 
dependent decarboxylation of histidine by L-histidine decarboxylase (HDC). The uptake of 
histamine in secretary granules is enabled by the vesicular monoamine transporter 2 
(VMAT2;(Kazumori et al., 2004). High concentrations of histamine are found in mast cells, 
blood basophil and blood platelets, the skin, connective tissue, the lung and the 
gastrointestinal tract including enterochromaffin-like (ECL) cells in the stomach (Parsons and 
Ganellin, 2006). In the brain histaminergic neurons are involved in the sleep-wake cycle, 
energy and endocrine homeostasis, synaptic plasticity and learning (Haas and Panula, 
2003). Histamine performs its actions as a local mediator and neurotransmitter via four 
histamine receptor subtypes (H1R, H2R, H3R and H4R), all belonging to aminergic class A 
GPCRs (Foord et al., 2005; Seifert et al., 2013). Despite binding the same endogenous 
ligand, a phylogenetic analysis (evolutionary ancestry based on sequence alignments) 
revealed that the histamine H2 receptor clusters with adrenergic, dopamine and serotonin 
receptor subtypes (Figure 1.6;(Vassilatis et al., 2003). Within the histamine receptor family, 
H3 and H4 receptors are most closely related, sharing an overall and TM sequence identity of 
about 41% and 52%, respectively (Table 1.1). 
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Sequence identity  
Table 1.1: Sequence identity of histamine 
receptor subtypes 
Sequence identities (in %) are based on a 
multiple sequence alignment of the human 
H1, H2, H3 and H4 receptor. The definition of 
TM domains was taken from a crystal 
structure of the hβ2AR (Cherezov et al., 
2007). 
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 H1R  26 28 22 
 
H2R 36  23 20 
 
H3R 32 30  41 
 
H4R 29 26 52  
 
 
 
 
Figure 1.6: Phylogenetic tree of aminergic class A GPCRs 
The ruler at the top indicates the horizontal distance equal to 10% sequence divergence. 
Adapted from Vassilatis et al. (2003).  
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The histamine H1 receptor 
The histamine H1R, a 487 amino acids containing GPCR, is widely expressed in the body, 
e.g., in nerve cells, most smooth muscles especially in airways, gastrointestinal tract, 
endothelial and epithelial cells, neutrophils, genitourinary system and the cardiovascular 
system (Hill et al., 1997). The H1R couples predominantly to Gq/11 proteins, initiating the 
phosphoinositide metabolism, resulting in inositol trisphosphate (IP3) and diacylglycerol (DG). 
Consequently, Ca2+ is released from intracellular stores and protein kinase C is activated 
(Smit et al., 1999). H1R antagonists (antihistamines) have been used for decades for the 
treatment of allergic disorders (e.g. allergic rhinitis, chronic urticarial and atopic dermatitis), 
nausea and vomiting, and sedation (Du Buske, 1996; Simons and Simons, 2011; Simons, 
2004). First generation antihistamines, like mepyramine or diphenhydramine, are highly 
lipophilic compounds which cross the blood brain barrier, block central H1 receptors and 
cause sedation. More polar H1R antagonists such as cetirizine were develop to reduce this 
undesired effect in the treatment of allergic diseases (‘non-sedative’ second generation of 
H1R blockers). Besides, H1R agonists such as the supra-/histaprodifens have been used as 
pharmacological tools to study H1R functions in cellular systems. Betahistine (Aquamen
®) is 
so far the only marketed H1R agonist; the drug is therapeutically used in the treatment of 
Menière`s disease (Barak, 2008; Seifert et al., 2003). 
 
A detailed description of the H2R and its ligands is given in sections 1.2.2 to 1.2.4.  
 
The histamine H3 receptor 
The histamine H3 receptor (containing 445 amino acids) was first proposed in 1983. 
Experiments with rat cerebral cortical slices revealed that histamine inhibited its own 
synthesis and release via presynaptic feedback mechanisms which could not be attributed to 
H1R or H2R activity (Arrang et al., 1983). The discovery of the agonist (R)-α-methylhistamine 
and the competitive antagonist thioperamide as well as cloning of the H3R in 1999 enabled 
the investigation of its (patho)physiological roles and its intracellular mechanism (Arrang et 
al., 1987; Lovenberg et al., 1999). The H3R is mostly expressed in the CNS and is important 
as a presynaptic auto- and heteroreceptor, controlling the release of histamine and other 
neurotransmitters such as dopamine, serotonin, noradrenalin and acetylcholine (Gemkow et 
al., 2009; Hill et al., 1997). The H3R is involved in the regulation of several central functions 
like locomotor activity, wakefulness, food intake, thermoregulation and memory (Bakker et 
al., 2004). In the periphery the H3R was detected in the cardiovascular system, the 
gastrointestinal tract and the airways (Bertaccini and Coruzzi, 1995; Delaunois et al., 1995; 
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Malinowska et al., 1998). The activation of H3Rs leads to a decrease in intracellular cAMP 
levels via coupling to Gi/o proteins and inhibition of the adenylyl cyclase. Besides, activation 
of phospholipase A2 (PLA2), MAPKs and phosphatidyl inositol-3 kinase, as well as inhibition 
of the Na+/H+ exchanger and modulation of intracellular calcium was demonstrated (Bongers 
et al., 2007; Leurs et al., 2005). Potential therapeutic applications for H3R inverse agonists, 
antagonists or agonists include the treatment of migraine, asthma, allergic rhinitis, 
nociception, neuralgia, ischaemic arrhythmias, insomnia, cognitive disorders, tremor and 
obesity (Berlin et al., 2011; Wijtmans et al., 2007). Recently, the H3R inverse agonist 
pitolisant was the first H3R ligand to be introduced in the clinics for the treatment of 
narcolepsy (Schwartz, 2011). 
 
The histamine H4 receptor 
The latest member of the histamine receptor family is the H4R, comprising 390 amino acids. 
Although proposed 1994 (Raible et al.) it was not until the year 2000 that the H4R was 
identified by several research groups due to its sequence homology with the H3R (Liu et al., 
2001; Morse et al., 2001; Nakamura et al., 2000; Nguyen et al., 2001; Oda et al., 2000; Zhu 
et al., 2001). The H4R is mainly expressed in cells of hematopoietic origin like neutrophils, 
mast cells, eosinophils, basophils, dendritic cells, monocytes and T cells as well as the CNS 
(Connelly et al., 2009; Leurs et al., 2009). The location of H4Rs in these cells suggested an 
important role in the modulation of immune and inflammatory responses, such as eosinophil 
chemotaxis, mast cell chemotaxis and chronic inﬂammation, dendritic cell activation and T 
cell differentiation, airway inﬂammation and allergy, chronic pruritus and autoimmune 
disorders (Thurmond et al., 2008; Zampeli and Tiligada, 2009). The H4R is coupled to 
pertussis toxin (PTX) sensitive Gi/o proteins and thus inhibits adenylyl cyclase (Leurs et al., 
2009). Additionally, the H4R can activate the MAPK pathway via PTX sensitive mechanisms 
(Morse et al., 2001) and induce calcium mobilization in mast cells and eosinophils, possibly 
initiated by the dissociated Gβγ subunit and PLC activation (de Esch et al., 2005; Hofstra et 
al., 2003). Besides coupling to G-proteins, recently, the activation of β-arrestin by several 
H4R ligands was reported (Nijmeijer et al., 2012; Seifert et al., 2011). The H4R represents an 
interesting target for the treatment of diseases like pruritus, atopic dermatitis, asthma and 
allergic rhinitis (Walter et al., 2011). Some H4R ligands already entered into clinical studies, 
e.g. UR-63325, the first H4R antagonist from which clinical data has been reported 
(Lazewska and Kiec-Kononowicz, 2012), ZPL-38937887 (formerly PF-03893787) and JNJ-
39758979 (Salcedo et al., 2013). 
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1.2.2 Characterization of the H2R 
Effects of histamine at receptors different from those targeted by the classical antihistamines, 
were first detected at the stomach (acid secretion; 1941), the uterus (inhibition of the 
contraction in rats; 1946) and the heart (positive chronotrop; 1960). Ash and Schild (1966) 
noticed that these effects could not be blocked by histamine receptor antagonists such as 
mepyramine (later disclosed to be a H1R selective antagonist) and therefore proposed an 
additional histamine receptor subtype. In 1972, this receptor was defined as the H2R by 
pharmacological experiments using burimamide, the first antagonist at the H2R (Black et al., 
1972). H2Rs were found in gastric parietal cells, cardiac tissue, lung parenchyma, smooth 
muscles in airway, uterine and vascular smooth muscle and cells of the immune system 
(basophils, mast cells and lymphocytes) (Del Valle and Gantz, 1997; Hill et al., 1997). 
Besides, the H2R is widely distributed in the brain, e.g. the basal ganglia, hippocampus, 
amygdala and cerebral cortex (Traiffort et al., 1992). An important physiological H2R-
mediated effect of histamine is the stimulation of parietal cells leading to acid secretion. 
Histamine is released from enterochromaffin-like cells upon stimulation of cholecystokinin 
CCK2 receptors by gastrin. Coupling of the H2R to Gαs proteins results in stimulation of 
cAMP production, initiating the fusion and activation of the H+/K+-ATPase (Schubert and 
Peura, 2008). Moreover, mobilisation of intracellular Ca2+ was reported (Delvalle et al., 
1992). Blocking the H2R by antagonists such as cimetidine and ranitidine presented a 
breakthrough in the treatment of peptic ulcer disease (Malfertheiner et al., 2009; Yeomans, 
2002), offered new approaches to the pharmacotherapy of gastro-esophageal reflux disease 
(Katz and Tutuian, 2001) and Zollinger-Ellison syndrome (Wilcox and Hirschowitz, 2009) 
and, later on, proved to be useful in the triple therapy for helicobacter pylori eradication 
(Graham et al., 2003). It should be noted, that nowadays H2R antagonists are mostly 
replaced by proton pump inhibitors (PPI). The positive chronotropic and inotropic response 
on atrial and ventricular tissues and the vasodilatory effect via H2R stimulation are mediated 
by an increase in cAMP production. In the heart the cAMP response results in both an 
increase in contractility and relaxation (positive lusitropic effect) (Levi and Alloatti, 1988). 
Besides, important roles of the H2R in inflammation and modulation of the immune system 
were reported. H2R activation leads to suppression of inflammatory functions by decreasing 
chemotaxis of eosinophils and neutrophils as well as inhibition of neutrophil activation, 
superoxide formation and degranulation. Suppression of immune response is mediated by 
reducing T cell proliferation and modulating cytokine production (Akdis and Simons, 2006; 
Schneider et al., 2002). In the early 1990s the first H2Rs were cloned, i.e. canine H2R (Gantz 
et al., 1991b), human H2R (Gantz et al., 1991a) rat H2R (Ruat et al., 1991) and guinea pig 
H2R (Traiffort et al., 1995). The sequence of the human H2R is composed of 359 amino acids 
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with seven stretches of mainly hydrophobic residues typical for 7TM receptors. Cloning of 
H2R species and transfection in various cell lines and membranes enabled the detection of 
additional intracellular signaling mechanisms of the H2R. Activation of the inositol 1,4,5-
trisphosphate signal pathway via Gαq-proteins and phospholipase C (Kuhn et al., 1996; 
Leopoldt et al., 1997; Wang et al., 1996) results in an increase in the intracellular Ca2+ 
concentration. This could contribute to the positive inotropic effects in cardiac myocytes 
(Wellner-Kienitz et al., 2003). Agonistic stimulation of H2Rs led to β-arrestin, dynamin and 
clathrin dependent desensitization and internalization (Fernandez et al., 2008). H2R 
desensitization was dependent on regulators of G-protein signaling (RGS) and G-protein 
coupled receptor kinase 2 (GRK2) without phosphorylation of the H2R. However, GRK2 
kinase activity was necessary for receptor internalization and the subsequent resensitization 
(Fernandez et al., 2011). 
1.2.3 H2R ligands 
Metiamide (Black et al., 1973), chemically derived from burimamide, was the first orally 
available H2R antagonist which entered controlled trials in humans (Pounder et al., 1975). 
Due to cases of agranulocytosis, a severe adverse effect, metiamide had to be withdrawn 
(Burland et al., 1975), whereas cimetidine (trademark Tagamet), the cyanoguanidine 
analogue of the thiourea metiamide, was developed and launched onto the market in 1976 
(Brimblecombe et al., 1975; Molinder, 1994). Cimetidine revolutionized the treatment of 
peptic ulcer and became one of the first blockbuster drugs in history (sales of $1 billion 
annually). Stimulated by the proof of principle, additional H2R antagonists were marketed as 
drugs, such as ranitidine or famotidine, and other compounds were developed as 
pharmacological tools to characterize the H2R, e.g. tiotidine (Figure 1.7;(Ganellin, 1992). 
Among a huge number of H2R antagonists described in the literature, zolantidine is unique, 
as it was designed as a CNS-penetrating pharmacological tool for the investigation of H2Rs 
in the brain (Calcutt et al., 1988; Young et al., 1988). Later on, most of the classical H2R 
antagonists were characterized as inverse agonists (Monczor et al., 1998; Smit et al., 1996). 
With the discovery of the proton pump inhibitors, which irreversibly block the H+/K+-ATPase 
located in parietal cells of the gastric mucosa, the relevance of H2R antagonists as drugs for 
the treatment of gastric acid related diseases has substantially declined (Fellenius et al., 
1981; Sachs et al., 2007). The treatment of chronic heart failure has been explored as a 
potential indication for H2R antagonists (Kim et al., 2006; Takahama et al., 2010). 
In contrast to H2R antagonists, agonists at the H2R have not been routinely used in therapy. 
The potential therapeutic value of H2R agonists as inotropic vasodilators in severe 
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congestive heart failure, demonstrated in patients using impromidine, stimulated the search 
for ‘cardiohistaminergics’ with improved pharmacological properties (Baumann et al., 1984; 
Buschauer, 1989; Buschauer and Baumann, 1991; Felix et al., 1991). Moreover, one may 
speculate about H2R agonists as anti-inflammatory agents (Burde et al., 1990; Burde et al., 
1989). In 2005 histamine dihydrochloride (Ceplene®) was approved by the EMA (European 
Medicines Agency) in combination with interleukin-2 for maintenance treatment in adults with 
acute myeloid leukemia, AML (Yang and Perry, 2011). Besides, H2R agonists are important 
pharmacological tools to study the physiological and pathophysiological role of this histamine 
receptor (Birnkammer et al., 2012; Coruzzi et al., 1993). 4-Methylhistamine (5-
methylhistamine according to the IUPAC rules of chemical nomenclature) was used by Black 
et al. (1972) as a selective agonist to define the H2R; it should be noted that 30 years later 
the compound turned out to be much more potent as a H4R agonist. Impromidine was 
described as the first highly potent H2R agonist, exhibiting 50-fold higher potency than 
histamine regarding the positive chronotropic response at the isolated, spontaneously 
beating guinea pig right atrium (Durant et al., 1978). Numerous impromidine analogues and 
amine-type compounds such as amthamine and dimaprit have been synthesized and 
evaluated for H2 agonism (for a review, cf.(Dove et al., 2004). In terms of drug-like properties, 
the major disadvantage of the basic N-[3-(1H-imidazol-4-yl)propyl]guanidines (pKa ~ 12) is 
the lack of oral bioavailability (and CNS penetration). The insertion of a carbonyl next to the 
guanidine moiety decrease the basicity by 4-5 orders of magnitude and improved the 
pharmacokinetic properties of these acylguanidine-type agonists so that they were absorbed 
from the gut of mice and detectable in the brain (Ghorai et al., 2008). After the discovery of 
the H3R and the H4R, the imidazolylpropylguanidines, regardless of being acylated or not, 
turned out to possess considerably high affinity to histamine receptors other than H2R. This 
problem was solved by a bioisosteric approach: replacement of the imidazolyl ring by a 2-
amino-4-methylthiazol-5-yl moiety (cf. structure of amthamine) resulted in highly potent and 
selective guanidine-type H2R agonists (Figure 1.7, cf. compounds AK24 and AK470;(Ghorai 
et al., 2008; Kraus et al., 2009). Remarkably, both guanidines and acylguanidines show 
higher potencies at guinea pig H2Rs than at the human orthologue. An aspartate in the 
gpH2R in position 7.36 (alanine in the hH2R) was shown to contribute to the distinct 
interaction of H2R species isoforms with acyl-/guanidines (Birnkammer et al., 2012; Burde et 
al., 1990; Buschauer, 1989; Kelley et al., 2001; Preuss et al., 2007). Recently synthesized 
bivalent compound exhibited a similar preference for the guinea pig compared to the human 
H2R orthologue. 
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Figure 1.7: Structures of H2R ligands 
Selectivity data (pEC50) for AK24 and AK470 were determined in the GTPase activity assay (Ghorai et 
al., 2008; Kraus et al., 2009). 
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1.2.4 Bivalent ligands for the H2 receptor 
Bivalent ligands consist of two pharmacophores, separated by an appropriate spacer to 
define their distance and, if necessary, an additional linker to connect the pharmacophoric 
units and the spacer (Shonberg et al., 2011). At first developed by Portoghese et al. in the 
1980s for opioid receptors (Portoghese et al., 1986), bivalent ligands are now widely used in 
targeting GPCRs and have been reported, e.g., for the CXCR4 (Tanaka et al., 2010), 
dopamine D2 receptor (Kühhorn et al., 2011), β2-adrenergic and adenosine A1 receptors 
(Karellas et al., 2008), serotonin receptors (Halazy et al., 1996) and histamine receptors 
(Birnkammer et al., 2012).  
Compared to the corresponding monovalent parent compound, bivalent ligands can have 
increased potency, intrinsic activity and receptor subtype selectivity, and the pharmacokinetic 
properties can be improved (Halazy, 1999). With regards to the study of ligand-GPCR 
interactions, bivalent ligands have been of special interest as pharmacological tools to 
explore putative receptor homo- and heterodimers, for instance, in case of adrenergic 
receptors (Angers et al., 2000; Xu et al., 2003), opioid receptors (Portoghese, 2001; Ramsay 
et al., 2002), muscarinic receptors (Hern et al., 2010; Zeng and Wess, 2000), dopamine 
receptors (Lukasiewicz et al., 2010; Scarselli et al., 2001) and histamine receptors 
(Fukushima et al., 1997; van Rijn et al., 2006). However, it is extremely challenging to 
determine the ligand-receptor stoichiometry and to get insight into the molecular binding 
mode as a crystal structure of such a GPCR dimer in complex with a bivalent ligand is not yet 
available. As a conceivable alternative to simultaneous binding to the orthosteric binding 
sites of dimerizing receptor protomers, interactions with two binding sites at the same 
protomer should be taken into account, i.e., one pharmacophoric moiety could bind to the 
orthosteric site and the second pharmacophoric moiety to an additional (allosteric) site 
(Halazy, 1999; May et al., 2007; Messer, 2004; Perez et al., 1998; Valant et al., 2009). For 
‘bridging’ of dimerizing receptor protomers, the distance between the pharmacophoric units is 
a critical issue. Although the ideal spacer length varies between 18 and 25 atoms for several 
GPCRs studied, the optimal length has to be elucidated empirically (Berque-Bestel et al., 
2008). Molecular modeling of opioid receptors suggested a distance of ~ 27 Å between two 
recognition sites of neighboring receptors with a TM5/TM6 interface (Portoghese, 2001). This 
corresponds to an extended alkyl chain with 20 methylene groups.  
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Figure 1.8: Potencies of bivalent acylguanidine-type H2R agonists compared to their 
monovalent congeners and dependence on their spacer length 
A, Structures of selected mono- and bivalent acylguanidine-type agonists. B, pEC50 values of 
monovalent (grey) and bivalent (black) acylguanidine-type agonists at the human (left) and guinea 
pig (right) H2R determined in the GTPase assay (Birnkammer, 2011; Birnkammer et al., 2012). C - 
E, Potencies of bivalent acylguanidine-type agonists 5 (C), 4 (D) and 3 (E) with increasing spacer 
length n at the human (●) and guinea pig () H2R in the GTPase assay (Birnkammer et al., 2012). 
Cpd. 4 with 20 methylene groups in the spacer showed no agonistic activity at the hH2R (D). 
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Recently reported bivalent H2R agonists, hetarylpropylguanidines connected by dialkanoyl 
spacers attached to the guanidine moiety (Figure 1.8 A;(Birnkammer, 2011; Birnkammer et 
al., 2012), were more potent than their monovalent parent compounds (Figure 1.8 B) and 
revealed highest potencies at spacer lengths of 6 to 8 methylene groups (~ 9 Å to 11.5 Å; 
Figure 1.8 C-E). Obviously, the distance of < 12 Å between the pharmacophores is 
insufficient to bind simultaneously to the orthosteric sites of dimerizing GPCRs. Instead, the 
increase in potency might be caused by interaction of the second acylguanidine moiety with 
an additional recognition site at the same receptor protomer. This hypothesis was 
investigated by site-directed mutagenesis experiments at the gpH2R presented in chapter 7 
of this thesis. 
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Chapter 2 
2 Scope and Objectives 
G-protein coupled receptors, membrane spanning proteins transferring extracellular signals 
across the cell membrane to the intracellular side, are fundamental for most physiological 
processes and are the targets of about 30% of all drugs on the market (Katritch et al., 2012; 
Stevens et al., 2013). Ligand binding to GPCRs stabilizes different, active or inactive states 
of the receptor. Active states couple to effectors of cytosolic signaling pathways, like 
heterotrimeric G-proteins and arrestins. However, the molecular basis for GPCR activation 
remained unclear for a long time. In 2000 the first crystal structure of a GPCR was obtained, 
bovine rhodopsin (Palczewski et al., 2000), and since 2007 several other GPCRs in their 
inactive state were crystallized. The recent resolution of active state GPCRs, namely 
activated opsin, the β2AR and the adenosine A2A receptor (Lebon et al., 2011; Park et al., 
2008; Rasmussen et al., 2011b) has been the basis for more detailed investigations on 
GPCR activation mechanisms. Relatedness of the βARs to the histamine H2 receptor 
(Vassilatis et al., 2003) make the latter an interesting GPCR for structural analysis. Results of 
such experimental and theoretical studies may advance the development of potent and 
selective H2R ligands in our group, including bivalent hetarylpropylguanidines which showed 
an increased potency compared to their monovalent congeners (Birnkammer et al., 2012; 
Kraus et al., 2009). 
In the first part of this thesis, the aim was to investigate the structural differences between 
inactive and active hH2R states. Homology models had to be constructed based on the 
inactive tβ1AR state (Warne et al., 2008) and on the active hβ2AR state (Rasmussen et al., 
2011a). Additionally, in a multiple template approach another active hH2R state variant was 
to be generated using the structures of the tβ1AR and opsin (Scheerer et al., 2008). The 
intention was to compare different models of active hH2R states with respect to reliability and 
to select the ‘best’ model (chapter 3). 
Subsequently, it was intended to embed hH2R models of both states into a natural 
environment consisting of a 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bilayer and 
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water molecules as solvent, and to subject the models to 80 ns molecular dynamics (MD) 
simulations with the MD package GROMACS (Van Der Spoel et al., 2005). This should 
further validate the hH2R models, prove their relatively stable existence in a natural, dynamic 
environment and allow the investigation of the impact of conformational flexibility on the 
process of receptor activation (chapter 4).  
The analysis of the results of the MD simulations should be performed with two novel 
routines extending the capabilities of GROMACS (chapter 5). They had to systematically 
calculate direct and water mediated H-bonds as well as van der Waals contacts in MD 
simulation systems. Major goals were a user-friendly setup of the analysis, a rapid 
calculation and a suitable output format. Additionally, to assure the quality of the simulated 
proteins, it was planned to write a program that is able to analyze the stereochemistry at Cα 
atoms as well as the planarity of aromatic side chains, delocalized π-electron systems and 
peptide bonds. The program should also measure backbone Φ/Ψ dihedral angles and side 
chain torsions and compare them to experimental reference values (Lovell et al., 2000). 
In the second part of this thesis, site-directed mutagenesis studies were to study the 
influence of amino acids in the hH2R and the gpH2R on receptor activation. In the first 
project, Tyr1825.38 suggested to contribute to ligand binding (Nederkoorn et al., 1996) should 
be mutated in the hH2R to Phe (chapter 6). After expression in Sf9 cells using 
bacculoviruses, membranes containing the recombinant protein should be obtained, and 
several ligands were planned to be investigated at the wild-type and mutant hH2Rs in the 
GTPase and GTPγS assay. 
In a further project a putative second binding site for bivalent hetarylpropylguanidine-type 
agonists should be identified in order to explore their higher potency at the H2R compared to 
monovalent compounds (chapter 7). Receptor mutants of the gpH2R should be generated 
and, after expression in Sf9 cells, ligands should be tested in the GPTγS assay at the wild-
type and mutated gpH2Rs. 
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Chapter 3 
3 Homology Models of Inactive and Active Human 
Histamine H2 Receptor States 
3.1 Introduction 
Since the first crystallization of a G-protein coupled receptor in the year 2000, bovine 
rhodopsin (Palczewski et al., 2000), several Class A GPCR structures have been resolved. 
Until 2007 all obtained structures adopted an inactive receptor conformation (Katritch et al., 
2012). Advances in protein engineering and crystallography allowed the resolution of the first 
crystal structure of an active state GPCR in 2008, activated opsin (Park et al., 2008; 
Scheerer et al., 2008). This enabled invaluable insights into GPCR structure and function. 
For the histamine H2 receptor no structural data from crystallography or NMR spectroscopy 
exist so far. In such cases the technique of homology modeling may be used to better 
understand structure-function relationships of these receptors (Costanzi, 2012). Some 
inactive state models of the H2R were already described, based on crystal structures of 
rhodopsin (Kelley et al., 2001; Kim et al., 2006; Preuss, 2007), the β2-adrenoceptor (Ghorai 
et al., 2008) and the adenosine A2A receptor (Zhang et al., 2012). However, to date no 
receptor conformations of the H2R in its putative active state were constructed and compared 
to the inactive state. 
In order to unveil the structural determinants which keep the hH2R in its inactive and active 
conformation, respectively, and to analyze possible key structural elements for the transition 
from the inactive to the active state, homology models of both receptor states were 
constructed and examined. Because of differences in the template structures, two 
comparative models of the active receptor conformation were created. The coupling of the 
activated hH2R with a protein fragment of the C-terminal part of the Gsα-protein further 
enabled the exploration of a part of the receptor–G-protein interface at an atomic level. 
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3.2 Materials and methods 
3.2.1 Sequence alignment 
All sequences were received from the UniProt Knowledgebase (UniProtKB;(Consortium, 
2012). The multiple sequence alignment (MSA) of the hH2R and the GPCRs resolved so far 
was performed with ClustalW2 (Goujon et al., 2010; Larkin et al., 2007). To achieve a correct 
alignment especially for the sequences following the intracellular loop 3 (ICL3; very variable 
in length), the MSA was performed with about 330 other GPCR sequences. The alignment 
was modified to attain a gap-free alignment in the region of the transmembrane domains 
(T s). The lengths of the α-helices were calculated after assigning the secondary structure 
to the proteins with the DSSP (Define Secondary Structure of Proteins) algorithm (Kabsch 
and Sander, 1983) included in Sybyl-X 1.3 (Tripos, St. Louis, MO, USA), using the inactive 
state crystal structures listed in Table 3.1. All 15 GPCR structures were superimposed by 
aligning their common alpha helical regions (Figure 3.1). This structural superimposition was 
used to refine and control the initial multiple sequence alignment. The conservation score of 
amino acids at identic positions in the hH2R and the respective template sequence was 
calculated with ClustalX 2.1 (Larkin et al., 2007; Thompson et al., 1997), using the Gonnet 
PAM250 matrix (Gonnet et al., 1992) and a score plot scale of 5. The conservation score, 
ranging from 0 to 100, is an indication for the quality of the alignment, in which a high score 
indicates a well-conserved amino acid pair. 
3.2.2 Generation of 3D structures 
3.2.2.1 Generation of the inactive state hH2R model 
For the generation of the homology model of the hH2R in the inactive receptor conformation 
(hH2Ri) a crystal structure of the turkey β1-adrenoceptor (tβ1AR) was selected as template 
(PDB ID 2VT4, chain B;(Warne et al., 2008b). The coordinates for the hH2R from TM1 to the 
N-terminus of ECL2 (Ala161.30 to Asn162), from the C-terminal part of ECL2 to TM5 (Ser165 
to Ala2135.69), from TM6 (Arg2286.29 to Leu2596.60), TM7 (Glu2677.32 to Tyr2887.53) and helix 8 
with a few C-terminal amino acids (Leu291 to Cys305) were taken from the template. In the 
tβ1AR this corresponds to Gln39
1.30 to Pro187, Leu190 to Ile2385.69, Arg2846.29 to Phe3156.60, 
Asp3227.32 to Tyr3437.53, and Ser346 to Phe359, respectively. The α-helix present in ECL2 of 
the tβ1AR was preserved in the model. The e2 loop of the tβ1AR is two amino acids longer 
than that of the hH2R. Thus, Asp186 to Ala189 of the tβ1AR were deleted and Glu163 and 
Thr164 of the hH2R were inserted using the loop search application included in Sybyl-X 1.3.
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Table 3.1: GPCR crystal structures of inactive states considered on homology modeling of the 
hH2R 
GPCR UniprotKB 
entry 
PDB ID Resolution 
[Å] 
Publication 
date 
     
Turkey β1-adrenergic receptor 
(tβ1AR)
1
 
P07700 2VT4 2.7 2008 
Human β2-adrenergic receptor 
(hβ2AR)
2
 
P07550 2RH1 2.4 2007 
Human adenosine A2A receptor 
(hA2AAR)
3
 
P29274 3EML 2.6 2008 
Bovine rhodopsin  
(bovRhod)
4
 
P02699 1U19 2.2 2004 
Squid rhodopsin  
(squidRhod)
5
 
P31356 2Z73 2.5 2007 
Human histamine H1 receptor 
(hH1R)
6
 
P35367 3RZE 3.1 2010 
Human D3 dopamine receptor 
(hD3R)
7
 
P35462 3PBL 2.89 2010 
Human muscarinic acetylcholine 
receptor M2 (hmAChRM2)
8
 
P08172 3UON 3.0 2011 
Rat muscarinic acetylcholine 
receptor M3 (rmAChRM3)
9
 
P08483 4DAJ 3.4 2012 
Human C-X-C chemokine receptor 
type 4 (hCXCR4)
10
 
P61073 3ODU 2.5 2010 
Human sphingosine 1-phosphate 
receptor 1 (hS1PR1)
11
 
P21453 3V2W 3.35 2011 
Mouse delta-type opioid receptor 
(mOPRD)
12
 
P32300 4EL4 3.4 2012 
Human kappa-type opioid receptor 
(hOPRK)
13
 
P41145 4DJH 2.9 2012 
Mouse mu-type opioid receptor 
(mOPRM)
14
 
P42866 4DKL 2.8 2012 
Human nociceptin receptor 
(hNOPR)
15
 
P41146 4EA3 3.01 2012 
1
 (Warne et al., 2008b), chain B; 
2
 (Cherezov et al., 2007); 
3
 (Jaakola et al., 2008); 
4
 (Okada et al., 
2004), chain A; 
5
 (Murakami and Kouyama, 2008), chain A; 
6
 (Shimamura et al., 2011); 
7
 (Chien et al., 
2010), chain B; 
8
 (Haga et al., 2012); 
9
 (Kruse et al., 2012), chain D; 
10
 (Wu et al., 2010), chain A; 
11
 
(Hanson et al., 2012); 
12
 (Granier et al., 2012); 
13
 (Wu et al., 2012), chain B; 
14
 (Manglik et al., 2012); 
15
 
(Thompson et al., 2012), chain A. 
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This approach scans for loop fragments contained in a protein database (a subset of the 
Protein Data Bank, PDB;(Bernstein et al., 1977). Loops of appropriate residue lengths and 
with terminal residues well fitting the anchor regions of the modeled protein are then chosen 
(Rossi et al., 2007). ICL3 (Lys214 to Ile227) which is not resolved in the template structure 
and ECL3 (Arg260 to Asn266) were also constructed with loop searches. The junction of 
TM7 to H8 is one amino acid longer in the hH2R sequence than in the tβ1AR. Therefore, 
Cys344 and Arg345 were deleted in the template and a loop search was performed with Ala-
Ala-Leu (Ala289 to Leu291) to close the gap. N- and C-terminal amino acids were not 
present in the template structure. Predictions about these peptide sequences in the hH2R 
would be highly speculative and they were therefore not modeled. 
3.2.2.2 Generation of the active state hH2R models 
The first homology model of the hH2R in the active receptor conformation (hH2Ra1) was 
constructed by a multiple template approach using the crystal structure of the tβ1AR (PDB ID 
2VT4, chain B;(Warne et al., 2008b) and the crystal structure of opsin in its G-protein-
interacting conformation (PDB ID 3DQB;(Scheerer et al., 2008). To locate appropriate 
alignments of hH2R domains with the templates, the structures of the tβ1AR and opsin were 
superimposed based on their common TM domains and helix 8. TM1 of the hH2R (Ala16
1.30 
to Leu451.59) was constructed by mutating the corresponding TM1 of the tβ1AR (Gln39
1.30 to 
Ser681.59). The result was aligned to 20 N-terminal amino acids of TM1 of the tβ1AR 
(Gln391.30 to Gly581.49) and 2 C-terminal amino acids of TM1 of opsin (Val631.58 and 
Gln641.59). Accordingly, TM2 of the hH2R (Leu52
2.38 to Ser812.67) was based on mutation of 
tβ1AR-TM2 (Leu75
2.38 to Arg1042.67) and superimposed with 4 N-terminal amino acids of TM2 
of opsin (Leu722.39 to Ile752.42) and 4 C-terminal amino acids of TM2 of the tβ1AR (Leu101
2.64 
to Arg1042.67). The coordinates from ECL1 to TM4 (Cys822.68 to His1554.62) were directly 
adopted from the tβ1AR (Gly105
2.68 to Met1784.62). TM5 of the hH2R (Glu180
5.36 to Ala2135.69) 
was generated by mutation of tβ1AR-TM5 (Arg205
5.36 to Ile2385.69) and fitted to 13 N-terminal 
amino acids of TM5 of the tβ1AR (Arg205
5.36 to Tyr2175.48) and 8 C-terminal amino acids of 
TM5 of opsin (Leu2265.61 to Ala2335.68). TM6 of the hH2R (Glu229
6.30 to Gly2586.59) was also 
based on the tβ1AR (Glu285
6.30 to Val3146.59). It was superimposed to TM6 of opsin 
considering the common α-helical domains (tβ1AR, Glu285
6.30 to Asn3136.58; opsin, Glu2476.30 
to Ile2756.58). TM7 and helix 8 of the hH2R (Glu270
7.35 to Ala308) were constructed by 
mutating opsin (Met2887.35 to Asn326). ICL1 (Asn46 to Asn51) was adopted from opsin 
(His65 to Thr70), and ECL2 (Leu156 to Asn179) from the inactive hH2R state model 
described above. Atoms at the junction of the inserted ICL1 and the adjacent TMs 1 and 2, 
as well as at ECL2 and its surrounding residues were carefully modified to obtain an 
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appropriate geometry of the connecting bonds (e.g. planarity of peptide omega angles). ICL3 
(Lys214 to Arg228) and ECL3 (Leu259 to Leu269) were modeled with loop searches. N- and 
C-terminal amino acids were not included in the homology model due to the low sequence 
identity to the template opsin (N-terminus) and because they were not resolved in the 
template structures (C-terminus), respectively. 
For the construction of the second homology model of the hH2R in the active receptor 
conformation (hH2Ra2) the crystal structure of the nanobody-stabilized active state of the 
β2AR (PDB ID 3P0G;(Rasmussen et al., 2011a) was used as template. The coordinates of a 
few amino acids preceding TM1 till the N-terminus of ECL2 (Ser8 to Asn162), of most of 
ECL2 till TM5 (Ser165 to Arg2105.66), of TM6 (Ile2276.28 to Arg2606.61), of TM7 (Glu2677.32 to 
Ala2897.54) and of helix 8 with some C-terminal amino acids (Asn292 to Leu307) were taken 
from the template. In the template β2AR this corresponds to Asp23 to Thr177, Ile182 to 
Lys2275.66, Leu2666.28 to Gln2996.61, Lys3057.32 to Cys3277.54, and Ser329 to Arg344, 
respectively. Due to a two amino acids longer ECL2 in the hβ2AR, Glu163 and Thr164 of the 
hH2R replacing His178 to Ala181 in the hβ2AR were inserted with a loop search. ICL3 which 
is not resolved in the template structure was also constructed with a loop search (Asp211 to 
Thr226). The junction between TM7 and H8 of the hH2R is one amino acid longer than in the 
hβ2AR. Therefore Arg328 was deleted in the template, and a loop search was performed with 
Ala290 and Leu291 to close the gap. Most of the N- and C-terminal amino acids are not 
present in the template structure and were therefore not modeled for the hH2R. 
3.2.2.3 Structural refinement of the homology models 
Side chain conformations of identical amino acids in corresponding positions of the hH2R and 
the template were not changed. All other amino acids were mutated into the appropriate 
hH2R residue. Conformations were adjusted with respect to corresponding side chain torsion 
angles in the template in order to reproduce contacts between adjacent amino acids. 
Additionally, the agreement with frequently occurring rotamer states provided by Lovell et al. 
(2000) was ensured, and the structures were checked for bumps between neighboring amino 
acids. From 15 conserved water molecules identified by Angel et al. (2009), 10 were inserted 
in the homology models of the hH2R. If necessary, the positions were manually adjusted to 
enable similar hydrogen bonds as suggested from the analysis of crystal structures (Angel et 
al., 2009). Amber-FF99 charges were assigned to the protein and to the water molecules. 
Finally, all three homology models were energy-minimized (100 iterations) with the steepest 
descent method, using the Amber-FF99 force field and a dielectric constant of 4. 
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3.2.2.4 Insertion of the C-terminal part of the Gsα-protein and docking of histamine 
Both active state models were completed by insertion of the carboxy terminus of the α-
subunit of the Gs-protein (GαCT). It was constructed as described in the supplementary 
information of Scheerer et al. (2008). The 11 amino acid synthetic peptide (ILENLKDCGLF) 
derived from the C-terminus of the transducin Gαt subunit which was co-crystallized in the 
structure of opsin in its G-protein-interacting conformation (PDB ID 3DQB;(Scheerer et al., 
2008), was mutated to the sequence of the short isoform of the Gα subunit of the guanine 
nucleotide-binding protein Gs, GsαS (384-QRMHLRQYELL-394). The backbone of the 4 N-
terminal amino acids (QRMH) was rebuilt to obtain the geometry of an ideal α-helix 
(Φ = -57°, Ψ = -47°;(CBN, 1970). Thr369 to Ile383 of GsαS were likewise constructed, and 
finally both peptide chains were connected, resulting in a 26 amino acid containing C-
terminal fragment of GsαS (GαCT). The active state model based on the crystal structures of 
the tβ1AR and opsin (hH2Ra1) was superimposed with opsin, regarding all common TM 
domains. The active state model based on the crystal structure of the active hβ2AR state 
(hH2Ra2) was superimposed with opsin, considering only TM5 and TM6. The newly 
constructed GαCT peptide was aligned to Gαt of the opsin-Gαt-complex and inserted in each 
of the two active state models. If necessary, side chain torsions were modified at the 
interface between the receptor and GαCT to avoid too close van der Waals contacts.  
Histamine was manually docked into the active state models in an energy-minimum 
conformation, interacting with Asp983.32 and Asp1865.42 (Gantz et al., 1992). Gasteiger-
Hückel charges were assigned to the ligand, and the active state homology models were 
energy-minimized again as described above. 
3.2.3 Structure validation 
For validation of the hH2R models, the planarity of peptide bonds, aromatic side chains and 
polar side chain groups containing a planar π-electron system were checked. Furthermore, 
the distribution of the peptide backbone dihedral angles phi (Φ) and psi (Ψ) (Ramachandran 
plot) and the side chain rotamers were measured and compared to experimental values 
(Lovell et al., 2000). All parameters were analyzed with the program gro_validation described 
in chapter 5. Main chain bond angles and lengths, as well as bad contacts within the protein 
were controlled using PROCHECK (Laskowski et al., 1993). 
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3.3 Results and discussion 
3.3.1 Template selection 
The first step in homology modeling is the selection of an appropriate template. In the last 
years several GPCRs were successfully crystallized (Katritch et al., 2012). GPCRs available 
to date for homology modeling of inactive state receptors are given in Table 3.1 and shown in 
Figure 3.1. Sequence identity, conservation of amino acids, and structural features like the 
distribution of prolines in transmembrane domains and cysteins forming disulfide bridges are 
crucial for the selection of an appropriate template (Worth et al., 2009). As some structural 
features of the target GPCR are probably distributed over different crystal structures, the 
application of multiple templates may often improve the quality of the final model (Mobarec et 
al., 2009; Yarnitzky et al., 2010).  
The tβ1AR (33%), the hβ2AR (32%) and the hD3R (29%) display the highest sequence 
identity with the hH2R. However, since a GPCR homology model is mainly based on TM 
domains of the template protein, TM sequence identity is of special importance (Table 3.2). 
For TM1 to 7, again the tβ1AR (44%), the hD3R (42%) and the hβ2AR (38%) share the 
highest sequence identity with the hH2R. Mostly this is also the case when analyzing single 
TMs. Possible alternative templates are for TM1 the histamine H1 receptor, for TM2 the 
adenosine A2A receptor, for TM3 and TM7 the -type opioid receptor, for TM4 the 
sphingosine 1-phosphate receptor 1, and for TM5 the muscarinic acetylcholine receptor M3.  
In contrast to sequence identity which can only be true (1) for identical or false (0) for 
different amino acids at the same position, the conservation score distinguishes between the 
types of amino acids compared. Higher values are assigned for conservative exchanges as 
valine → isoleucine (65) and lower for non-conservative exchanges like valine → threonine 
(28). Thus, conservation scores enable a refined comparison of protein sequences. In case 
of the hH2R, sequence identity and similarity analyses lead to comparable results. The 
tβ1AR, the hβ2AR and the hD3R show the highest conservation scores for the sequence as a 
whole (53, 54 and 49, respectively), as well as the TM domains 1 to 7 (64, 61 and 64, 
respectively) (Table 3.3). Regarding conservation, alternative possible templates to model 
the hH2R are for TM1, TM2, TM5 and TM7 the histamine H1 receptor, for TM2 the adenosine 
A2A receptor, for TM4 the -type opioid receptor, and for TM5 the muscarinic acetylcholine 
receptor M3. 
Concerning sequence identity and conservation, a multiple template approach using TM 
coordinates from different templates is possible. However, this approach is only appropriate if 
the target receptor shares low sequence identity with the templates (Yarnitzky et al., 2010). 
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Since the tβ1AR, the hβ2AR and the hD3R show adequate sequence identity and 
conservation with the hH2R, the use of only one template for the modeling process is 
suitable. 
Proline kinks in the α-helices of the 7 transmembrane receptors appear in the tβ1AR (Warne 
et al., 2008b), the hβ2AR (Cherezov et al., 2007) and the hD3R (Chien et al., 2010) next to 
conserved prolines in all TMs except 1 and 3. Apart from TM4, these prolines are also 
present in the hH2R (Figure 3.2), indicating that helical kinks exist in its 3D structure, too. A 
proline in position 4.59 or 4.60 is present in 14 of the 15 crystallized GPCRs. The kinks in 
TM4 of the tβ1AR, the hβ2AR and the hD3R are rather weak and located at the extracellular 
end. 
 
 
Figure 3.1: Alignment of inactive state GPCR structures considered on homology 
modeling of the hH2R  
Side view of the Cα trace of the 15 GPCR crystal structures given in Table 3.1. All structures 
were superimposed with the β2AR as reference structure using their shared α-helical regions. 
Stabilizing proteins (e.g. the T4 lysozyme protein) and co-crystallized ligands are omitted. 
TM2
TM1
TM3
TM4
TM5
TM6
TM7
H8
 Chapter 3: Homology models of inactive and active hH2R states 43 
However, the -type opioid receptor without one of these prolines contains an even more 
pronounced kink in TM4. Recent studies revealed that only 33% to 38% of the kinks in TM 
domains of GPCRs are associated with proline (Hall et al., 2009; Huang and Chen, 2012; 
Langelaan et al., 2010). According to an evolutionary hypothesis, a mutation to proline 
initially induces a kink in a helix, and the resulting packing defects are subsequently repaired 
by further mutations, thereby locking the kink in the structure (Yohannan et al., 2004). 
Therefore, the introduction of a helical kink in TM4 of the hH2R despite the missing proline is 
reasonable. 
 
Table 3.2: Sequence identity between the hH2R and GPCRs with available crystal structure 
The numbers are the percentage sequence identity with the hH2R for the complete receptor sequence 
(all), each single TM and TM1 to 7. The values were calculated as the amount of identical amino acids 
at the same position divided by the number of positions analyzed. The three highest identity scores 
are highlighted in decreasing grey-scales (dark grey, highest score). 
GPCR  all   TM1  TM2  TM3  TM4  TM5  TM6  TM7  TM1-7 
                      
                      
tβ1AR  33   34  57  47  33  35  42  57   44  
                      
hβ2AR  32   27  53  46  25  39  41  33   38  
                      
hA2AAR  23   33  46  30  21  29  25  32   31  
                      
bovRhod  15   10  20  21  11  29  28  17   19  
                      
squidRhod  16   16  25  33  21  18  12  16   20  
                      
hH1R  24   38  42  37  13  31  40  45   35  
                      
hD3R  29   43  41  59  30  27  45  48   42  
                      
hmAChRM2  24   29  31  41  17  27  37  40   32  
                      
rmAChRM3  22   28  30  36  27  36  38  36   33  
                      
hCXCR4  18   27  17  34  10  18  25  25   22  
                      
hS1PR1  17   21  32  18  29  23  26  38   27  
                      
mOPRD  22   26  33  38  16  21  31  46   30  
                      
hOPRK  20   27  30  46  28  13  24  52   31  
                      
mOPRM  18   20  30  39  21  15  24  46   28  
                      
hNOPR  18   20  30  29  12  17  19  46   25  
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Table 3.3: Conservation scores between the hH2R and GPCRs with available crystal structures 
The numbers are the conservation scores between the hH2R and the respective template GPCR for 
the complete receptor sequence (all), each single TM and TM1 to 7, calculated as described in section 
3.2. The three highest scores are highlighted in decreasing grey-scales (dark grey, highest score). 
GPCR  all   TM1  TM2  TM3  TM4  TM5  TM6  TM7  TM1-7 
                      
                      
tβ1AR  53   63  72  66  55  63  60  69   64  
                      
hβ2AR  54   55  68  65  56  65  60  60   61  
                      
hA2AAR  43   55  68  54  51  47  44  53   53  
                      
bovRhod  38   36  46  49  46  53  44  47   46  
                      
squidRhod  38   42  45  55  49  46  33  45   45  
                      
hH1R  45   60  69  60  42  56  56  66   58  
                      
hD3R  49   61  63  78  62  53  62  68   64  
                      
hmAChRM2  45   57  61  63  37  53  54  58   55  
                      
rmAChRM3  41   53  60  62  43  56  55  56   55  
                      
hCXCR4  38   54  45  55  37  39  43  42   45  
                      
hS1PR1  37   48  50  47  52  38  45  55   48  
                      
mOPRD  42   50  51  58  47  45  52  65   52  
                      
hOPRK  39   52  53  62  55  39  47  65   53  
                      
mOPRM  38   47  49  58  47  42  45  64   50  
                      
hNOPR  36   43  49  52  40  44  38  59   46  
                      
 
 
 
A conserved disulfide bond between Cys3.25 of TM3 and Cys5.30 of ECL2 is present in all 15 
GPCR structures except the sphingosine 1-phosphate receptor 1. It fixes the second half of 
ECL2 to TM3 and thereby limits its mobility. This restraint probably occurs also in the hH2R 
between the corresponding Cys913.25 and Cys174ECL2. Further disulfide bonds observed in 
GPCR crystal structures (Figure 3.2) are absent in the hH2R structure because of missing 
cysteine residues in the respective positions. 
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Figure 3.2: Multiple sequence alignment of the hH2R and 15 GPCRs 
N-term
hH2R - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M A P N G T A S S - - - - - - - - - - - - - - - - - - - - - - - -
tβ1AR - - - - - - - - - - - - - - - - - - - - - - M G D G W L P P D C G P H N R S G G G G A T A A P - - - - - - - - - - - - - - - - - - - - T G S
hβ2AR - - - - - - - - - - - - - - - - - - - - - - M G Q - - - - P G N G S A F L L A P N G S H A P - - - - - - - - - - - - - - - - - - - - - - - D
hA2AAR - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M P - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
bovRhod - - - - - - - - - - - - - - - - - - - - - - - M N G T E G P N F Y V P F S N K T G V V R S P F - - - - - - - - - - - - - - - - - - - - - - -
squidRhod - - - - - - - - - - - - - - - - - - - - - - - - M G R D L R D N E T W W Y N P S I V V H P H W R - - - - - - - - - - - - - - - - - - - - - -
hH1R - - - - - - - - - - - - - - - - - - - - - - - - - - M S L P N S S C L L E D K M C E G N K T T - - - - - - - - - - - - - - - - - - - - - - -
hD3R - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M A S L S Q L S S H L N Y - - - - - - - - - - - - - - - - - - - - T C G
hmAChRM2 - - - - - - - - - - - - - - - - - - - M N N S T N S - - - - - - - - - - - - - - S N N S L A L - - - - - - - - - - - - - - - - - - - - - - T
rmAChRM3 - - - - - - - - - - - - - - - - M T L H S N S T T S P L F P N I S S S W V H S P S E A G L P L G T V T Q L G S Y N I S Q E T G N F S S N D T
hCXCR4 - - - - - - - - - - - - - - - - - - - - - - - - M E G I S I Y T S D N Y T E E M G S G D Y D S - - - - - - - - - - - - - - - - - - - - - M K
hS1PR1 - - - - - - - - - - - - - - - - M G P T S V P L V K A H R S S V S D Y V N Y D I I V R H Y N Y - - - - - - - - - - - - - - - - - - - - - - T
mOPRD M E L V P S - - - - - - - - - - - A R A E L Q S S P - - L V N L S D A F P S A F P S A G A N A S G S - - - - - - - - - - - - - - - P G A R -
hOPRK M D S P I Q I F R G E - - - - - - P G P T C A P S A C L P P N S S A W F P G - - - W A E P D S N G S - - - - - - - - - - - - - - - A G S E D
mOPRM M D S S A G P G N I S D C S D P L A P A S C S P A P G S W L N L S H V D G N Q S D P C G P N R T G L - - - - - - - - - - - - - - - G G S H S
hNOPR M E P L F P - - - - - - - - - - A P F W E V I Y G S H L Q G N L S L L S P N - - H S L L P P H L L L - - - - - - - - - - - - - - - N A S H G
TM1 ICL1 TM2
hH2R - - - - F C L D S T A C K I T I T V V L A V L I L I T V A G N V V V C L A V G L N R R L R N L T N C F I V S L A I T D L L L G L L V L P F S
tβ1AR R Q V S A E L L S Q Q W E A G M S L L M A L V V L L I V A G N V L V I A A I G R T Q R L Q T L T N L F I T S L A C A D L V M G L L V V P F G
hβ2AR H D V T Q E R - D E V W V V G M G I V M S L I V L A I V F G N V L V I T A I A K F E R L Q T V T N Y F I T S L A C A D L V M G L A V V P F G
hA2AAR - - - I M G S - - - - - - S V Y I T V E L A I A V L A I L G N V L V C W A V W L N S N L Q N V T N Y F V V S L A A A D I A V G V L A I P F A
bovRhod E A P Q Y Y L A E P W Q F S M L A A Y M F L L I M L G F P I N F L T L Y V T V Q H K K L R T P L N Y I L L N L A V A D L F M V F G G F T T T
squidRhod - - - E F D Q V P D A V Y Y S L G I F I G I C G I I G C G G N G I V I Y L F T K T K S L Q T P A N M F I I N L A F S D F T F S L V N G F P L
hH1R - - - - - - - M A S P Q L M P L V V V L S T I C L V T V G L N L L V L Y A V R S E R K L H T V G N L Y I V S L S V A D L I V G A V V M P M N
hD3R A E N S T G A S Q A R P H A Y Y A L S Y C A L I L A I V F G N G L V C M A V L K E R A L Q T T T N Y L V V S L A V A D L L V A T L V M P W V
hmAChRM2 S P - - - - - Y K T F E V V F I V L V A G S L S L V T I I G N I L V M V S I K V N R H L Q T V N N Y F L F S L A C A D L I I G V F S M N L Y
rmAChRM3 S S D P L G G H T I W Q V V F I A F L T G F L A L V T I I G N I L V I V A F K V N K Q L K T V N N Y F L L S L A C A D L I I G V I S M N L F
hCXCR4 E P C F R E E N A N F N K I F L P T I Y S I I F L T G I V G N G L V I L V M G Y Q K K L R S M T D K Y R L H L S V A D L L F V I T L P F W A
hS1PR1 G K L N I S A D K E N S I K L T S V V F I L I C C F I I L E N I F V L L T I W K T K K F H R P M Y Y F I G N L A L S D L L A G V A Y T A N L
mOPRD - - - - - S A S S L A L A I A I T A L Y S A V C A V G L L G N V L V M F G I V R Y T K L K T A T N I Y I F N L A L A D A L A T S T L P F Q S
hOPRK A Q L E P A H I S P A I P V I I T A V Y S V V F V V G L V G N S L V M F V I I R Y T K M K T A T N I Y I F N L A L A D A L V T T T M P F Q S
mOPRM L C P Q T G S P S M V T A I T I M A L Y S I V C V V G L F G N F L V M Y V I V R Y T K M K T A T N I Y I F N L A L A D A L A T S T L P F Q S
hNOPR A F L - - - - - P L G L K V T I V G L Y L A V C V G G L L G N C L V M Y V I L R H T K M K T A T N I Y I F N L A L A D T L V L L T L P F Q G
ECL1 TM3 ICL2
hH2R A I Y Q L S C - K W S F G K V F C N I Y T S L D V M L C T A S I L N L F M I S L D R Y C A V M D P - L R Y P V L - - - V T P V R V A I S L V
tβ1AR A T L V V R G - T W L W G S F L C E C W T S L D V L C V T A S I E T L C V I A I D R Y L A I T S P - F R Y Q S L - - - M T R A R A K V I I C
hβ2AR A A H I L M K - M W T F G N F W C E F W T S I D V L C V T A S I E T L C V I A V D R Y F A I T S P - F K Y Q S L - - - L T K N K A R V I I L
hA2AAR I T I S T G - - - F C A A C H G C L F I A C F V L V L T Q S S I F S L L A I A I D R Y I A I R I P - L R Y N G - - - L V T G T R A K G I I A
bovRhod L Y T S L H G - Y F V F G P T G C N L E G F F A T L G G E I A L W S L V V L A I E R Y V V V C K P M S N F R - - - - - F G E N H A I M G V A
squidRhod M T I S C F L K K W I F G F A A C K V Y G F I G G I F G F M S I M T M A M I S I D R Y N V I G R P M A A S K - - - - K M S H R R A F I M I I
hH1R I L Y L L M S K - W S L G R P L C L F W L S M D Y V A S T A S I F S V F I L C I D R Y R S V Q Q P - L R Y L - - K Y R T - K T R A S A T I L
hD3R V Y L E V T G G V W N F S R I C C D V F V T L D V M M C T A S I L N L C A I S I D R Y T A V V M P - V H Y Q H G T G Q S S C R R V A L M I T
hmAChRM2 T L Y T V I G Y - W P L G P V V C D L W L A L D Y V V S N A S V M N L L I I S F D R Y F C V T K P - L T Y P - - V K R T - T K M A G M M I A
rmAChRM3 T T Y I I M N R - W A L G N L A C D L W L S I D Y V A S N A S V M N L L V I S F D R Y F S I T R P - L T Y R - - A K R T - T K R A G V M I G
hCXCR4 V D A V - A N - - W Y F G N F L C K A V H V I Y T V N L Y S S V L I L A F I S L D R Y L A I V H A T N S - - - - Q R P R K L L A E K V V Y V
hS1PR1 L L S G A T T - - Y K L T P A Q W F L R E G S M F V A L S A S V F S L L A I A I E R Y I T M L K M K L H N G - - - - - S N N F R L F L L I S
mOPRD A K Y L M - E - T W P F G E L L C K A V L S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V K A L D F R - - - - T P A K A K L I N I
hOPRK T V Y L M - N - S W P F G D V L C K I V I S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V K A L D F R - - - - T P L K A K I I N I
mOPRM V N Y L M - G - T W P F G N I L C K I V I S I D Y Y N M F T S I F T L C T M S V D R Y I A V C H P V K A L D F R - - - - T P R N A K I V N V
hNOPR T D I L L - G - F W P F G N A L C K T V I A I D Y Y N M F T S T F T L T A M S V D R Y V A I C H P I R A L D V R - - - - T S S K A Q A V N V
TM4 ECL2 TM5
hH2R L I W V I S I T L S F L S I H L G W N S R - - - - - - - - - N E T S K G N H T T S K C K V Q V N E V Y G L V D G L V T F Y L P L L I M C I T
tβ1AR T V W A I S A L V S F L P I M M H W W R D E - - - - - - - D P Q A L K C Y Q D P G C C D F V T N R A Y A I A S S I I S F Y I P L L I M I F V
hβ2AR M V W I V S G L T S F L P I Q M H W Y R A T - - - - - - - H Q E A I N C Y A N E T C C D F F T N Q A Y A I A S S I V S F Y V P L V I M V F V
hA2AAR I C W V L S F A I G L T P M L G W N N C G Q P K E G K N H S Q G C G E G Q V A C L F E D V V P M N Y M V Y F N F F A C V L V P L L L M L G V
bovRhod F T W V M A L A C A A P P L V G W S R Y I P E G - - - - - - M Q C S C G I D Y Y T P H E E T N N E S F V I Y M F V V H F I I P L I V I F F C
squidRhod F V W L W S V L W A I G P I F G W G A Y T L E G - - - - - - - - V L C N C S F D Y I S R D S T T R S N I L C M F I L G F F G P I L I I F F C
hH1R G A W F L S F L W V I P I L G W N H F M Q Q T S V - - - - - - - - - - R R E D K C E T D F Y D V T W F K V M T A I I N F Y L P T L L M L W F
hD3R A V W V L A F A V S C P L L F G F N T T - - - - - - - - - - - - - - - G D P T - - V C S I S N - P D F V I Y S S V V S F Y L P F G V T V L V
hmAChRM2 A A W V L S F I L W A P A I L F W Q F I V G V R T - - - - - - - - - - V E D G E C Y I Q F F S N A A V T F G T A I A A F Y L P V I I M T V L
rmAChRM3 L A W V I S F V L W A P A I L F W Q Y F V G K R T - - - - - - - - - - V P P G E C F I Q F L S E P T I T F G T A I A A F Y M P V T I M T I L
hCXCR4 G V W I P A L L L T I P D F I F A N V S - - - - - - - - - - E A D D R Y I C D R F Y P N D L W V V V F Q F Q H I M V G L I L P G I V I L S C
hS1PR1 A C W V I S L I L G G L P I M G W N C I S - - - - - - - - - - - - - - A L S S C S T V L P L Y H K H Y I L F C T T V F T L L L L S I V I L Y
mOPRD C I W V L A S G V G V P I M V M A V T Q P R D G A - - - - - - - V V C M L Q F P S P - S W Y W D T V T K I C V F L F A F V V P I L I I T V C
hOPRK C I W L L S S S V G I S A I V L G G T K V R E D V D - - - - - V I E C S L Q F P D D D Y S W W D L F M K I C V F I F A F V I P V L I I I V C
mOPRM C N W I L S S A I G L P V M F M A T T K Y R Q G S - - - - - - - I D C T L T F S H P - T W Y W E N L L K I C V F I F A F I M P V L I I T V C
hNOPR A I W A L A S V V G V P V A I M G S A Q V E D E E - - - - - - - I E C L V E I P T P - Q D Y W G P V F A I C I F L F S F I V P V L V I S V C
ICL3 TM6
hH2R Y Y R I F K V A R D Q A K R I N H I S S W K A A T I R - - - - - - - - - - E H K A T V T L A A V M G A F I I C W F P Y F T A F V Y R G L R -
tβ1AR Y L R V Y R E A K E Q I R K I D R C E G R F Y G S Q E - - - - - - - - - R E H K A L K T L G I I M G V F T L C W L P F F L V N I V N V F N R
hβ2AR Y S R V F Q E A K R Q L Q K I D K S E G R F H V Q N L - - - - - - - - - K E H K A L K T L G I I M G T F T L C W L P F F I V N I V H V I Q D
hA2AAR Y L R I F L A A R R Q L K Q M E S Q P L P G E R A R - - - - - - S T L Q K E V H A A K S L A I I V G L F A L C W L P L H I I N C F T F F C P
bovRhod Y G Q L V F T V K E A A A Q Q Q E S A - - - - - - - - - - - - - T T Q K A E K E V T R M V I I M V I A F L I C W L P Y A G V A F Y I F T H Q
squidRhod Y F N I V M S V S N H E K E M A A M A K R L N A K E - L R K A Q A G A N A E M R L A K I S I V I V S Q F L L S W S P Y A V V A L L A Q F G P
hH1R Y A K I Y K A V R Q H C Q H R E L I N R S L P S F S E Q Y V S G L H M N R E R K A A K Q L G F I M A A F I L C W I P Y F I F F M V I A F C -
hD3R Y A R I Y V V L K Q R R R K R I L T R Q N S - - - Q C P L Q P R G V P L R E K K A T Q M V A I V L G A F I V C W L P F F L T H V L N T H C Q
hmAChRM2 Y W H I S R A S K S R I K K D K K E P V A N Q D P V S A K K K P P - P S R E K K V T R T I L A I L L A F I I T W A P Y N V M V L I N T F - C
rmAChRM3 Y W R I Y K E T E K R T K E L A G L Q A S G T E A E A T K R K R M S L I K E K K A A Q T L S A I L L A F I I T W T P Y N I M V L V N T - F C
hCXCR4 Y C I I I S K L S H S K - - - - - - - - - - - - - - - - - - - - - - G H Q K R K A L K T T V I L I L A F F A C W L P Y Y I G I S I D S F I L
hS1PR1 C R I Y S L V R T R S R R L T F R K N I S K A S R S S - - - - - - - - - K S L A L L K T V I I V L S V F I A C W A P L F I L L L L D V G C K
mOPRD Y G L M L L R L R S V R L L S G S K E K D R S - - - - - - - - - - - - - - L R R I T R M V L V V V G A F V V C W A P I H I F V I V W T L V D
hOPRK Y T L M I L R L K S V R L L S G S R E K D R N - - - - - - - - - - - - - - L R R I T R L V L V V V A V F V V C W T P I H I F I L V E A L G S
mOPRM Y G L M I L R L K S V R M L S G S K E K D - - - - - - - - - - - - - - R N L R R I T R M V L V V V A V F I V C W T P I H I Y V I I K A L I T
hNOPR Y S L M I R R L R G V R L L S G S - - - - - - - - - - - - - - R E K D R N L R R I T R L V L V V V A V F V G C W T P V Q V F V L A Q G L G V
ECL3 TM7 H8 C-term
hH2R - - - - - - - - G D D A I N E V L E A I V L W L G Y A N S A L N P I L Y A A L N R D F R T G Y Q Q L F C C R L A N R N - - - - - - - - - - -
tβ1AR - - - - - - - - - - D L V P D W L F V F F N W L G Y A N S A F N P I I Y - C R S P D F R K A F K R L L C F P R K A D - - - - - - - - - - - -
hβ2AR - - - - - - - - - - N L I R K E V Y I L L N W I G Y V N S G F N P L I Y - C R S P D F R I A F Q E L L C L R R S S L - - - - - - - - - - - -
hA2AAR D C S - - - - - - - - H A P L W L M Y L A I V L S H T N S V V N P F I Y A Y R I R E F R Q T F R K I I R S H V L R Q Q E P F K A A G - - - -
bovRhod G S - - - - - - - - - D F G P I F M T I P A F F A K T S A V Y N P V I Y I M M N K Q F R N C M V T T L C C G K N P L G - - - - - - - - - - -
squidRhod - - - - - - - - - L E W V T P Y A A Q L P V M F A K A S A I H N P M I Y S V S H P K F R E A I S Q T F P W V L T C C Q F D D K E T E D D - -
hH1R K N - - - - - - - - C C N E H L - H M F T I W L G Y I N S T L N P L I Y P L C N E N F K K T F K R I L H I R S - - - - - - - - - - - - - - -
hD3R T - - - - - - - - - C H V S P E L Y S A T T W L G Y V N S A L N P V I Y T T F N I E F R K A F L K I L S C - - - - - - - - - - - - - - - - -
hmAChRM2 A P - - - - - - - - C I P - N T V W T I G Y W L C Y I N S T I N P A C Y A L C N A T F K K T F K H L L M C H Y K N I G A T R - - - - - - - -
rmAChRM3 D S - - - - - - - - C I P - K T Y W N L G Y W L C Y I N S T V N P V C Y A L C N K T F R T T F K T L L L C Q C D K R K R R K Q Q Y Q Q R Q S
hCXCR4 L E I I K Q G C E F E N T V H K W I S I T E A L A F F H C C L N P I L Y A F L G A K F K T S A Q H A L T S V S R G S S - - - - - - - - - - -
hS1PR1 V K - - - - - - - - T C D I L F R A E Y F L V L A V L N S G T N P I I Y T L T N K E M R R A F I R I M S C C K C P S G - - - - - - - - - - -
mOPRD I N R - - - - - - R D P L V V A A L H L C I A L G Y A N S S L N P V L Y A F L D E N F K R C F R Q L C R T P C G R Q E P G S - - - - - - - -
hOPRK T S - - - - - - - H S T A A L S S Y Y F C I A L G Y T N S S L N P I L Y A F L D E N F K R C F R D F C F P L K M R M E R Q S - - - - - - - -
mOPRM I P - - - - - - - E T T F Q T V S W H F C I A L G Y T N S C L N P V L Y A F L D E N F K R C F R E F C I P T S S T I E Q Q N - - - - - - - -
hNOPR Q P - - - - - - - S S E T A V A I L R F C T A L G Y V N S C L N P I L Y A F L D E N F K A C F R K F C C A S A L R R D V Q V - - - - - - - -
46 3.3 Results and discussion 
The multiple sequence alignment was performed as described in section 3.2. The most conserved 
residue of each TM is shown in a white character on black background. Cysteines forming disulfide 
bridges are highlighted in yellow. The conservation score of amino acids of the respective GPCR with 
the hH2R was calculated as described in section 3.2 and is shown in grey scales (dark grey, high 
conservation; bright grey, low conservation). The α-helical domains are indicated with black lines 
above the sequence. For reasons of clarity, in some sequences (tβ1AR, hβ2AR, hH1R, hD3R, 
hmAChRM2, rmAChRM3 and hS1PR1) amino acids of ICL3 are omitted (indicated by |). The 
sequences following helix 8 are truncated. 
 
 
 
The tβ1AR shows the highest sequence identity and conservation score with the hH2R. 
Furthermore, its structural features, i.e. kinks and disulfide bonds, are also expected in the 
hH2R. Consequently, the tβ1AR was considered to be an appropriate template for an inactive 
state model of the hH2R. 
Recently, structures of some active state GPCRs were published, namely opsin (Park et al., 
2008; Scheerer et al., 2008), rhodopsin (Choe et al., 2011; Deupi et al., 2012a; Standfuss et 
al., 2011), the adenosine A2A receptor (Lebon et al., 2011; Xu et al., 2011) and the β2-
adrenergic receptor bound to an agonist and stabilized by a heterotrimeric Gs-protein 
(Rasmussen et al., 2011b) or by a nanobody (Rasmussen et al., 2011a).  
The first model of the hH2R in the active state (hH2Ra1) was created at a point of time when 
only 3D structures of opsin (PDB IDs 3DQB and 3CAP) were available as active state 
templates. However, opsin has a low overall and TM sequence identity with the hH2R (15% 
and 19%, respectively; Table 3.2). Therefore, a multiple template approach using opsin (PDB 
ID 3DQB) and the template for the inactive state hH2R, the tβ1AR, was applied, resulting in a 
chimeric protein (Figure 3.3). This approach is not only suitable to combine structural 
properties which are distributed over more than one template, but also to insert 
characteristics of active GPCR states (Schneider et al., 2010).  
Since the β2AR is one of the GPCRs exhibiting highest sequence identity and conservation 
with the hH2R, a second active state model of the hH2R (hH2Ra2) was created using the 
nanobody bound hβ2AR as template (Rasmussen et al., 2011a). Its overall structure is very 
similar to the Gs-protein bound β2AR (Rasmussen et al., 2011b) released afterwards (Figure 
3.4). Thus, the use of either structure as template will not lead to significantly different target 
models.  
 
 
 Chapter 3: Homology models of inactive and active hH2R states 47 
 
 
Figure 3.3: Comparison of the TM domains of the tβ1AR, opsin and the hH2Ra1 model 
Extracellular (A) and intracellular (B) view into the tβ1AR (PDB ID 2VT4, chain B; ), opsin (PDB 
ID 3DQB; ) and the hH2Ra1 model () after superposition of their common TM domains. TMs 
are shown as ribbons. Extra- and intracellular loops are omitted for reasons of clarity. 
 
The active state structures of the adenosine A2A receptor diverge from those of rhodopsin 
and the β2AR (Lebon et al., 2011; Xu et al., 2011). The relocation of TM6 is much smaller 
(3-4 Å vs. 8 Å), partially occluding the G-protein binding site. The adenosine A2A receptor 
structures rather represent an intermediate conformation between the inactive and active 
state, and thus were disqualified as appropriate templates for the construction of an active 
state hH2R homology model. 
 
  
Figure 3.4: Comparison of the active state structures of the hβ2AR 
Structures of the nanobody-stabilized active state of the hβ2AR (PDB ID 3P0G; ) and the 
hβ2AR-Gs complex (PDB ID 3SN6; ) after superimposing their common TM domains. View from 
the extracellular (A) and the intracellular (B) side. 
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3.3.2 Stereochemical quality of the models 
3.3.2.1 Omega backbone angles 
The planarity of the peptide bond is one of the major constraints forcing protein 
configurations (Edison, 2001). However, in experimentally derived peptide and protein 
structures, peptide bonds have significant deviations from planarity (MacArthur and 
Thornton, 1996). The mean (± SD) of the hH2Ri, hH2Ra1 and hH2Ra2 were 178.7° (± 5.8°), 
176.7° (± 6.2°) and 177.0° (± 6.1°), respectively. This is in good agreement with the mean  
values reported in literature (MacArthur and Thornton, 1996; Morris et al., 1992). Most of the 
coordinates of the backbone atoms defining the amide bonds were directly taken from the 
templates or the protein fragments derived from loop searches, and they were only 
marginally changed by energy minimization. In the hH2Ri, hH2Ra1 and hH2Ra2 models, 27 out 
of 289 (9.3%), 40 out of 314 (12.7%), and 38 out of 324 (11.7%)  angles deviated more 
than 10° from planarity (180°), respectively (Figure 3.5). Only two (hH2Ri and hH2Ra2) and 
three (hH2Ra1) of these angles were introduced by connecting TMs with protein fragments 
received from loop searches, or by connecting parts of the receptor obtained from different 
templates. 
 
 
 
Figure 3.5: Distribution of the backbone dihedral angle  in the hH2R models 
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3.3.2.2 Ramachandran plot 
The backbone dihedral angles Φ (phi) and Ψ (psi) were generally found in the favored 
conformational regions (Figure 3.6, Table 3.4). In total, for the hH2Ri, hH2Ra1 and hH2Ra2 
models, only two, four and one amino acid, respectively, were located in disallowed regions. 
5 out of these 7 amino acids were obtained from protein crystal structures, either from the 
templates tβ1AR and opsin, or from a protein fragment of the Protein Data Bank received by 
a loop search. The two remaining backbone angles of Asn266 in the hH2Ri and Leu269 in the 
hH2Ra1 model are located at the junction of ECL3 (obtained by a loop search) and TM7 
(taken from a template GPCR). 
 
 
Table 3.4: Ramachandran analysis 
Residue Region
3
 hH2Ri hH2Ra1 hH2Ra2 
General
1
 favored 95.4% (249/261) 88.8% (253/285) 91.9% (271/295) 
 allowed 3.8% (10/261) 9.8% (28/285) 7.8% (23/295) 
 outlier 0.8% (2/261) 1.4% (4/285) 0.3% (1/295) 
     
Glycine favored 100% (13/13) 100% (13/13) 84.6% (11/13) 
 allowed 0% (0/13) 0% (0/13) 15.4% (2/13) 
 outlier 0% (0/13) 0% (0/13) 0% (0/13) 
     
Proline favored 100% (7/7) 85.7% (6/7) 85.7% (6/7) 
 allowed 0% (0/7) 14.3% (1/7) 14.3% (1/7) 
 outlier 0% (0/7) 0% (0/7) 0% (0/7) 
     
Pre-proline
2
 favored 100% (7/7) 85.7% (6/7) 100% (7/7) 
 allowed 0% (0/7) 14.3% (1/7) 0% (0/7) 
 outlier 0% (0/7) 0% (0/7) 0% (0/7) 
     
     
Summary favored 95.8% (276/288) 89.1% (278/312) 91.6% (295/322) 
 allowed 3.5% (10/288) 9.6% (30/312) 8.1% (26/322) 
 outlier 0.7% (2/288) 1.3% (4/312) 0.3% (1/322) 
1
  All amino acids except glycine, proline and residues preceding proline. 
2
  Amino acids preceding proline. 
3
  For the definition of the regions favored, allowed and outlier see chapter 5. 
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Figure 3.6: Ramachandran plots of hH2R models 
Ramachandran plots of the hH2Ri (A), hH2Ra1 (B) and hH2Ra2 (C) model. Plots are shown for (1) all 
amino acids except glycine, proline and residues preceding proline, (2) glycine, (3) proline and (4) 
pre-proline (amino acid before proline). Red fields, most favored regions; yellow fields, additionally 
allowed regions; grey fields, disallowed regions. Outliers are labeled. Ramachandran analysis was 
performed as described in chapter 5.  
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3.3.2.3 Side chain dihedral angles 
Since the TM sequence identity between the templates and the hH2R is below 50%, more 
than every second dihedral angle had to be manually adjusted. As the dihedral angles affect 
the positions of side chains and the contacts to amino acids of neighboring TMs, accurately 
checking for reasonable torsions is feasible. The majority of amino acid side chains adopt 
dihedral angles frequently occurring in protein crystal structures. Only 2.0% (hH2Ri), 2.2% 
(hH2Ra1) and 3.2% (hH2Ra2) of these torsions are found in unfavorable regions (Table 3.5). 
These uncommon side chains were either directly adopted from a template structure, 
adjusted to point in the same direction as the respective side chain in the template, or 
generated to avoid clashes with neighboring amino acids. 
 
 
Table 3.5: Side chain dihedral angles 
Region
1
 hH2Ri hH2Ra1 hH2Ra2 
Favored 94.3% (232/246) 92.6% (252/272) 94.0% (265/282) 
Allowed 3.7% (9/246) 5.1% (14/272) 2.8% (8/282) 
Disallowed 2.0% (5/246) 2.2% (6/272) 3.2% (9/282) 
 
   
Outlier reason 
Same side chain 
dihedrals angle as the 
respective amino acid in 
the template 
Trp158
ECL2
 Ser150
4.57
 
Trp158
ECL2
 
Asn179
ECL2
 
Leu30
1.44
  
Asn217
ICL3
 
Leu129
ICL2
 
Thr131
ICL2
 
Leu152
4.59
 
Trp158
ECL2
 
Arg296
H8
 
    
Adjusted to occupy the 
same area as in the 
template and/ or to 
interact with 
neighboring amino 
acids 
Tyr94
3.28 
 
Asn159
ECL2
 
Asn162
ECL2
 
Arg50
ICL1
  
Leu52
2.38
 
Asn159
ECL2
 
Phe110
3.44
 
Asn159
ECL2
 
    
Adjusted to avoid an 
overlap with proximate 
amino acids 
Tyr202
5.58
 
  
1
 The definition of the regions for amino acid side chains (favored, allowed and disallowed) is  
given in chapter 5. 
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3.3.2.4 Planarity of aromatic groups and delocalized π-electron systems in amino acid side 
chains 
The dihedral angles of one (hH2Ri) and ten (hH2Ra1 and hH2Ra2, respectively) amino acids 
with aromatic groups or delocalized π-electron system deviate between 10° and 30° from 
planarity (Figure 3.7). An unnatural deformation of originally planar moieties of amino acids 
could therefore be excluded. 
 
  
Figure 3.7: Planarity check of aromatic groups and delocalized  
π-electron systems in amino acid side chains 
  
 
3.3.2.5 Main chain bond lengths, bond angles and bad contacts 
Main chain bond lengths and angles are in acceptable limits (Table 3.6). A bad contact in the 
hH2Ra2 was detected with PROCHECK for Ala224
6.25 near ICL3. However, a bump was 
neither observed visually nor was the energy of that residue conspicuously higher than for 
other amino acids. 
 
Table 3.6: PROCHECK analysis of main chain parameters and bad contacts 
Parameter hH2Ri hH2Ra1 hH2Ra2 
Main chain bond lengths within limits 100% 100% 100% 
Main chain bond angles within limits 96.1% 93.6% 91.6% 
Bad contacts 0 0 1 
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3.3.3 Comparison of inactive and active hH2R receptor states 
3.3.3.1 Overall topology of the protein backbone 
After superimposing the backbone atoms of the shared TM domains 1 to 7 of the hH2Ri, 
hH2Ra1 and hH2Ra2 models, root mean square deviations (RMSD) of 1.81 Å for hH2Ri vs. 
hH2Ra1, 2.66 Å for hH2Ri vs. hH2Ra2, and 1.74 Å for hH2Ra1 vs. hH2Ra2 were calculated. The 
RMSD values for all backbone atoms, i.e. TMs and loops, were only slightly higher (1.93 Å, 
2.91 Å and 2.07 Å, respectively). Figure 3.8 depicts the RMSD values of backbone and side 
chain atoms as a function of the residue number. 
Comparing hH2Ri and hH2Ra1, high backbone RMSD values (ca. > 4 Å) were only observed 
in intracellular parts, namely around ICL1, from the end of TM5 via ICL3 to the intracellular 
part of TM6, as well as the end of TM7 and H8 (Figure 3.8 A and Figure 3.9 D). In relation to 
the hH2R in the inactive state, the hH2Ra1 model is characterized by outward movements of 
TM6 and of the cytoplasmic ends of TM1 and TM2, including ICL1, as well as by the inward 
move of TM7 and helix 8. In hH2Ra1 this results in an increase of the distance between TM6 
and TM2 (by 4.7 Å), TM3 (by 2.1 Å) and TM7 (by 1.2 Å), respectively (Table 3.7). The inward 
position of TM7 in the hH2Ra1 model also leads to a decreased cytoplasmic distance between 
TM2 and TM7 (by 1.0 Å) as well as TM3 and TM7 (by 2.9 Å). Remaining parts differ only 
slightly between both models, since their backbone coordinates were either directly taken 
from the tβ1AR in each case (the protein fragment from ECL1 till the beginning of ECL2), 
since domains of hH2Ra1 were adapted to the template tβ1AR of the hH2Ri model 
(extracellular parts of TM1, TM2 and TM5), or since fragments were generated the same way 
in both models (ECL2 and ECL3). 
Although the hH2Ra2 model was derived from a different template than hH2Ri and the hH2Ra1, 
the extracellular parts of the three models fit very well. Exceptions occur at the N-terminus of 
TM1, which is facing more outwards in the hH2Ra2 model (Figure 3.10 A), and loop ECL3 
which was generated by a special loop search (individual anchor regions at the extracellular 
ends of TM6 and TM7 in the hH2Ra2 model). Compared to hH2Ri and hH2Ra1, the distance 
between TM1 and TM7 decreased in hH2Ra2 by 1.9 Å and 2.2 Å, respectively. Major changes 
occurred at the intracellular part. TM1 of the hH2Ra2 model was even further away from helix 
8 of the inactive state than TM1 of hH2Ra1, because helix 8 of hH2Ra2 moved further inwards 
compared to the other models (Figure 3.9 D). However, ICL1, the cytoplasmic part of TM2 
and the end of TM7 overlap very well in both active state hH2Rs (Figure 3.8 C). In the hH2Ra2 
model, the backbone coordinates at the cytoplasmic ends of TM3 and TM4 deviate slightly 
from those of the other two models. TM3 is moderately shifted to the center of the receptor, 
and TM4 moves outwards in the hH2Ra2 model (Figure 3.10 C). Whereas the intracellular 
54 3.3 Results and discussion 
distances between TM2 and TM3 as well as TM3 and TM7 are the smallest in the hH2Ra2 
model (9.9 Å and 13.3 Å, respectively), the distance between TM3 and TM5 is increased by 
1.2 Å and 1.6 Å compared to hH2Ri and hH2Ra1, respectively. This increase is caused by the 
intracellular parts of TM5 and TM6 of hH2Ra2, located more outwards than in the other 
models (Figure 3.9 D). In the hH2Ra2 model, the distances of TM6 to TM2, TM3 and TM7 are 
4.8 Å, 2.6 Å and 1.2 Å greater, respectively, than in the hH2Ri model.  
 
Figure 3.8: Root mean square deviations between inactive and active hH2R states 
Shown is the RMSD of each residue for backbone atoms (N, Cα, C, O; black line) and side chain 
heavy atoms (all side chain atoms except hydrogens; grey line) for hH2Ri vs. hH2Ra1 (A), hH2Ri vs. 
hH2Ra2 (B), and hH2Ra1 vs. hH2Ra2 (C). The RMSD was calculated after superimposition of the 
shared α-helical region of the hH2Ri, hH2Ra1 and hH2Ra2. 
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Figure 3.9: Cartoon representation of the hH2R homology models 
Comparison of the hH2Ri, hH2Ra1 and hH2Ra2 after superimposing their shared TM domains. A, 
view from the extracellular side; B, C, side view; D, view from the intracellular side. 
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Figure 3.10: Planes parallel to the membrane at the extra- and intracellular side of the hH2R 
models used for the calculation of TM distances 
After superimposition of the shared TM domains of the hH2Ri (), hH2Ra1 () and hH2Ra2 () (B, side 
view), the least extending α-helix at the extracellular and intracellular side, respectively, was 
determined. Geometric centers of the heavy backbone atoms of the terminal four amino acids were 
defined for both TMs. Planes parallel to the plasma membrane were constructed through these 
centers. The intersections of the planes with the other TMs were used to define four amino acids in the 
other six α-helices at their extra- and intracellular ends, respectively. The geometric centers of the 
heavy backbone atoms of these amino acids were used for the calculation of pairwise distances 
(Table 3.7). For each receptor model, the calculations were based on the same amino acids. A, View 
from the extracellular side; C, View from the intracellular side. Loop regions and termini were not 
shown for reasons of clarity. 
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Some slight anomalies are also observed in T 4 and T 5. The α-helix of TM4 has a 
marginally different course compared to the other models (Figure 3.9 C), and in TM5 a bulge 
is present near the orthosteric binding site (Figure 3.9 A). Taken together, the 
rearrangements of TM domains in the active hH2R state models are very similar to evident 
changes when comparing the inactive and active states of rhodopsin/opsin (Okada et al., 
2004; Scheerer et al., 2008) and of the β2AR (Cherezov et al., 2007; Rasmussen et al., 
2011a). 
 
 
Table 3.7: Distances of TM domains at the extra- and intracellular side of the hH2R models 
The distances (Å) were calculated between the center of the backbone atoms (N, Cα, C, O) of 4 
consecutive residues of each TM at the extra- and intracellular side as explained in Figure 3.10. 
Shown are TM couples where at least one interaction occurs as described in Figure 3.16 and Table 
3.9. Numbers in brackets indicate that there is no interaction between the respective TMs. 
 TM contact 
Extracellular side  Intracellular side 
hH2Ri hH2Ra1 hH2Ra2 
 hH2Ri hH2Ra1 hH2Ra2 
        
        
TM1 – TM2 10.8 11.0 10.6  9.4 10.1 9.5 
TM1 – TM7 16.0 (16.3) 14.1  10.8 11.7 11.3 
TM2 – TM3 11.8 11.7 12.3  10.9 11.6 9.9 
TM2 – TM4 (21.4) (21.3) (21.4)  11.5 10.6 11.3 
TM2 – TM6 (21.6) (22.3) (21.8)  13.9 (18.6) (18.7) 
TM2 – TM7 12.7 13.2 12.5  12.3 11.3 10.8 
TM3 – TM4 9.8 9.8 9.4  11.7 11.7 11.9 
TM3 – TM5 17.2 17.4 17.2  9.6 9.2 10.8 
TM3 – TM6 19.6 20.2 20.1  11.2 13.3 13.8 
TM3 – TM7 (16.9) 17.0 (17.3)  (17.5) 14.6 13.3 
TM4 – TM5 13.9 14.2 14.8  (20.5) (20.2) (21.2) 
TM5 – TM6 10.2 10.2 9.8  11.9 11.0 11.7 
TM6 – TM7 11.3 11.8 11.5  10.2 11.4 11.4 
 
 
Notably, T  domains with highly conserved prolines introducing kinks in the α-helical 
structure differ from the inactive state in the hH2Ra2 model (TM2 and TM6) or in both active 
state models (TM7). The latter could be a general characteristic and be part of the 
rearrangement of the cytoplasmic end of TM7 (Table 3.8).  
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Table 3.8: Proline kinks (in degree) in transmembrane domains of  
inactive and active hH2R states 
TM hH2Ri hH2Ra1 hH2Ra2 
2 29.8 30.1 26.8 
5 12.0 12.2 13.4 
6 33.3 32.3 29.1 
7 40.2 32.5 36.1 
 
 
3.3.3.2 Activation of the hH2R 
The alterations of the relative positions of TM domains during receptor activation are 
accompanied by conformational changes (molecular switches) which were proposed to be 
responsible for activation and signal transduction from the ligand binding site to the G-protein 
interacting surface at the intracellular part of the receptor (Trzaskowski et al., 2012). 
The so-called rotamer toggle switch was previously suggested to be part of the signal 
transduction in GPCRs (Shi et al., 2002). According to this hypothesis, conformational 
changes of amino acid side chains located close to the orthosteric binding site 
(Cys/Ser/Thr6.47, Trp6.48 and Phe6.52) modulate the proline kink in TM6 (Kobilka and Deupi, 
2007), thereby leading to the outward move of its cytoplasmic part. In this way, the rotamer 
toggle switch was supposed to transfer the signal from the ligand binding site to the 
intracellular side. However, in the active state structures of rhodopsin (Park et al., 2008), the 
adenosine A2A receptor (Xu et al., 2011) and the β2AR (Rasmussen et al., 2011a), Trp
6.48 
does not show the predicted rotamer transition. Relocation of Trp6.48, as part of the so-called 
transmission switch (Deupi and Standfuss, 2011), is only indicated in the crystal structure of 
opsin (Scheerer et al., 2008) and therefore also present in the hH2Ra1 model. Summarizing 
data from active state structures, a rearrangement of amino acids in TM3, TM5 and TM6 
(Ile3.40, Pro5.50, Leu5.51, Phe6.44 and Trp6.48) may be responsible for signal transmission 
including TM6 movement. 
In the hH2Ra1 model, changes of amino acids touching the orthosteric binding site are 
observed for Tyr2506.51 and Phe2546.55. Both side chains are located deeper in the binding 
pocket compared to the inactive state. Consequently, Trp2476.48 turns down, stacks with 
Phe2516.52 and forces Phe2436.44 in a new position closer to Leu1955.51 (Figure 3.11 A). 
These changes resemble those of the respective amino acids in the transition from rhodopsin 
to opsin. The modification of the side chains of Trp2476.48 and Tyr2506.51, which were 
reported to contribute to the stabilization of inactive state conformations (Deupi et al., 2012b), 
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results in a break of interactions with amino acids of TM7 (Figure 3.16 B1), partly impairing 
the hydrogen bond network around TM7 (see below). To avoid an overlap of Phe2436.44 with 
Leu1955.51 and other clashes with TM5, TM6 rotates horizontally outwards. Furthermore, the 
new position of the Phe2546.55 side chain results in a movement of Phe2516.52, breaking the 
π-π-interactions with Phe1915.47 and forming a new aromatic interaction with Tyr1925.48. 
Since the position of Phe1915.47 in the inactive state partly overlaps with Phe2516.52 in the 
hH2Ra1 model, Phe191
5.47 is relocated, enabling the Trp2476.48 movement towards the 
position of Phe2436.44 in the inactive state. Hence, the crucial move of Phe2436.44 is initiated 
by Tyr2506.51 and Phe2546.55 near the binding pocket. TM3 is only slightly affected by this 
rearrangement. Solely the χ2 dihedral angle of Ile1063.40 is changed to enable the new 
Phe2436.44 position. Caused by the construction of the hH2Ra1 model, where TM6 was 
adapted to the structure of opsin, the mechanism is comparable to the rhodopsin activation 
(Figure 3.11 A). 
The activation mechanism suggested from the hH2Ra2 model is similar to that described for 
the β2AR (Deupi and Standfuss, 2011; Rasmussen et al., 2011a). The hH2Ra2 binding site is 
contracted, leading to a 2.1 Å inward shift of the Cα atom of Thr190
5.46 compared to the 
inactive state. The inward movement of TM5 is relayed up to the highly conserved Pro1945.50. 
 
 
Figure 3.11: Signal transduction from the ligand binding site to the motion of TM6 in the 
active hH2R states 
Superimposed structures of hH2Ri (blue ribbons for TMs, carbon atoms in cyan) with hH2Ra1 (A, 
green ribbons for TMs, carbon atoms in orange) and hH2Ra2 (B, orange ribbons for TMs, carbon 
atoms in green). The movements of amino acid side chains by receptor activation are indicated 
with thin black arrays. The moves of transmembrane domains are shown with grey arrays. 
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To avoid an overlap of TM5 with Ile1063.40, this residue changes its conformation, pointing 
towards TM7 in its new position and enabling the side chain movement of Phe2436.44 into the 
former Ile1063.40 position. As in the hH2Ra1 model and in the active state crystal structures, 
the new position of Phe2436.44 requires the outward motion of TM6. Thus, Phe6.44 seems to 
be a key amino acid in receptor activation (Figure 3.11 B). 
The motion of TM6 affects a further highly conserved motif. Concluded from biochemical 
studies, Arg3.50 of the D/ERY motif and Glu6.30 are in close contact forming a salt bridge. This 
so-called ionic lock was discussed to be a key structural element for restraining GPCRs in an 
inactive receptor conformation (Angelova et al., 2002; Ballesteros et al., 2001; Greasley et 
al., 2002; Shapiro et al., 2002). In the crystal structures of rhodopsin (Palczewski et al., 
2000), the dopamine D3 receptor (Chien et al., 2010) and some antagonist bound adenosine 
A2A receptors (Dore et al., 2011) the ionic lock is observed, but all other crystallized inactive 
states of GPCRs do not contain this restraint. For the β2AR an equilibrium of conformations 
with and without the lock was suggested (Dror et al., 2009), and the relatively high basal 
activity and structural instability of the β2AR was discussed as reason (Rasmussen et al., 
2007). Furthermore, high crystallographic B-values in the structure of rhodopsin (Palczewski 
et al., 2000) indicated that the side chains of Arg3.50 and Glu6.30 may adopt different 
conformations. The salt bridge between these amino acids is not present in the hH2Ri model 
(Figure 3.12 A). The distance between the closest heteroatoms of Arg1163.50 and Glu2296.30 
is 5.9 Å. Similar to the tβ1AR (Warne et al., 2008b), Glu229
6.30 points towards the cytoplasm. 
The close contact of Asp1153.49 and Arg1163.50 enables a salt bridge between them. 
Asp1153.49 is furthermore hydrogen bonded to Tyr126ICL2, possibly restraining the α-helical 
conformation of ICL2. Both the tyrosine residue and the α-helix of ICL2 were discussed to be 
important for G-protein coupling (Warne et al., 2008b). The side chain of Arg1163.50 is 
additionally retained in its position by interacting with the hydrophobic amino acids Ile1123.46, 
Ile2055.61 and Leu2366.37. However, by torsion of the side chain of Glu2296.30, a closer contact 
to Arg1163.50 is possible (distance between the closest heteroatoms ~ 3.5 Å). Therefore, an 
equilibrium as suggested for the β2AR cannot be ruled out. In the hH2Ra1 model Glu229
6.30 
moves towards TM5 and interacts with Arg2105.66 (salt bridge) and Thr2336.34 (hydrogen 
bond), restraining the cytoplasmic ends of TM5 and TM6 in their close contact (Figure 3.12 
B). The ionic interaction between Asp1153.49 and Arg1163.50 is broken. The aspartate moves 
towards T 4 and is close to Tyr391 of GαCT. Arg1163.50 is flanked by the hydrophobic side 
chains of Ile1123.46, Tyr2025.58, Ile2055.61 and Leu2366.37, filling a part of the newly created 
gap between TM3 and TM6. Additionally, Arg1163.50 interacts with Tyr391 and Leu393 of 
GαCT. The side chain positions are in agreement with the structure of opsin (Scheerer et al., 
2008). In the hH2Ra2 model Glu229
6.30 is also linked to Arg2105.66 (salt bridge). Similar to the 
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inactive state, Asp1153.49 is hydrogen bonded to Tyr126ICL2, and additionally to Thr532.39. 
Arg1163.50 is surrounded by the hydrophobic side chains of Thr532.39 and Ile1123.46. It further 
contacts Tyr391 and Leu393 (van der Waals interactions) as well as Glu392 (salt bridge) of 
GαCT (Figure 3.12 C). The ionic interaction with the G-protein is enabled by the more inward 
position of TM3 in the hH2Ra2 model compared to hH2Ra1 (Figure 3.9 D).  
The differences of the D/ERY motif in the hH2R models are in agreement with a previous 
study on the rat histamine H2 receptor, where the aspartate and arginine residues were 
separately replaced by Ala or Asn (Alewijnse et al., 2000). Mutation of the aspartate resulted 
in receptors with high constitutive activity, increased agonist affinity and increased signaling 
properties. On the atomic level, the substitution of Asp3.49 releases Arg3.50 from its 
constrained ‘inactive’ position. 
 
 
 Figure 3.12: Rearrangement of the DRY 
motif in the hH2R 
Side view of hH2Ri (A, blue ribbons), 
hH2Ra1 (B, green ribbons) and hH2Ra2 (C, 
orange ribbons). Shown are amino acids 
(sticks) close to Asp115
3.49
, Arg116
3.50
 and 
Glu229
6.30
. Hydrogen bonds are indicated 
with yellow dashed lines. Not all TMs are 
shown for reasons of clarity. 
  
  
L236
I112
I205
R116
Y126
D115
E229
ICL2
TM5
TM7
TM3
TM6
I205
I112
Y202
R116
Y391
D115
E229
R210
T233
L236
L393
GαCT
ICL2
TM5
TM3
TM6
I112
R116
Y391
D115
E229
R210
E392L393
GαCT
Y126
T53
TM5
TM3
TM6
TM2
B                                                                      C 
A                
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The putative ionic lock with Glu6.30 is then impossible, since Arg3.50 is not fixed in the 
appropriate position. Furthermore, Arg3.50 is free to fill the gap between TM3 and TM6, to 
interact with the G-protein and therefore to stabilize an active receptor conformation with 
increased affinity for agonists (Lefkowitz et al., 1993; Rasmussen et al., 2011a). The 
mutation of the arginine also led to an increased agonist affinity, but decreased signal 
transduction properties. Again, the potential disruption of the (possibly temporary) ionic lock 
could cause a shift towards an active receptor conformation, characterized by higher agonist 
affinity. Because Arg3.50 contributes to the receptor-G-protein interaction, replacing this 
residue could result in decreased signaling properties of the receptor as identified by the 
rH2R mutant. 
Both active state models indicate that the hydrophobic interface of TM2/TM6 and TM3/TM6 
is broken up on receptor activation. In the inactive state, amino acids of TM2, TM3 and TM6 
are packed in the middle of the TM bundle, resulting in smaller distances in the intracellular 
part of the inactive state receptor (TM2-TM6, 13.9 Å; TM3-TM6, 11.2 Å; Table 3.7) compared 
to hH2Ra1 (TM2-TM6, 18.6 Å; TM3-TM6, 13.3 Å) and hH2Ra2 (TM2-TM6, 18.7 Å; TM3-TM6, 
13.8 Å). Only in the inactive conformation van der Waals interactions between TM2 
(Thr532.39, Ile572.43, Leu602.46) and TM6 (Leu2366.37, Val2396.40), as well as TM3 (Ile1123.46, 
Ser1133.47) and TM6 (Leu2366.37, Val2396.40, Met2406.41) are present (Figure 3.13 A). These 
amino acids correspond partly with those of rhodopsin (Leu762.43, Leu792.46, Leu1283.43, 
Leu1313.46, Met2536.36, Met2576.40), forming the so called hydrophobic barrier. This barrier 
separates the water-mediated hydrogen bond network around TM2 and TM7 from the D/ERY 
motif (Li et al., 2004; Standfuss et al., 2011). In the active receptor conformation this 
hydrophobic cluster is broken by the rotation of TM6 (Figure 3.13 B). Instead, in the core of 
the receptor amino acids of TM3, TM5 and TM7 approach each other. Tyr2887.53 is linked to 
Leu1093.43 and Ile1123.46, as well as Ser1053.39 to Asn2847.49 in the hH2Ra1 model (water-
mediated hydrogen bond) and Leu1093.43 to Asn2847.49 in the hH2Ra2 model (van der Waals 
interaction). Furthermore, Tyr2025.58 is extended by a conformational switch into the gap 
between TM3 and TM6, being in close contact to Tyr2887.53 of the NPxxY(x)5,6F motif.  
The motion of TM6 at the cytoplasmic part of the receptor enables the rearrangement of the 
highly conserved NPxxY(x)5,6F motif at the end of TM7 and helix 8. In the inactive state 
Tyr2887.53 points towards T 2, similar as in the structures of the β1AR (Warne et al., 2008b), 
the β2AR (Cherezov et al., 2007), squid rhodopsin (Murakami and Kouyama, 2008), the 
adenosine A2A receptor (Jaakola et al., 2008) and the dopamine D3 receptor (Chien et al., 
2010).  
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Figure 3.13: Disruption of the hydrophobic barrier by activation of the hH2R  
Cytoplasmic view of the superimposed structures of hH2Ri (blue ribbons) and hH2Ra2 (orange 
ribbons). Black arrays indicate the movement of TMs 2, 6 and 7 on receptor activation. Amino 
acids of the hydrophobic barrier are shown in spheres surrounded by a mesh. Additionally drawn 
residues (sticks) are either in close contact to Tyr288
7.53
 or fill the gap between TM3 and TM6. 
Amino acids are from hH2Ri (A) and hH2Ra2 (B), respectively (hH2Ra1 is not shown since, in the 
analyzed region, the positions of TM domains and side chains do not significantly differ in both 
active state models). 
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Whereas van der Waals interactions with Ile572.43, Val2396.40, Asn2847.49 and Leu2877.52 do 
also occur in both active hH2R state models, the ‘inactive’ position of Tyr288
7.53 is stabilized 
by hydrophobic contacts with Val391.53 and Thr2356.36 as well as with Phe295 and Tyr299 of 
helix 8 (Figure 3.13 A). In the hH2Ri model, a conserved water molecule placed between 
TM2 and TM7 connects the side chain hydroxyl group of Tyr2887.53 to the backbone oxygen 
of Ile572.43 and the side chain of Asn2847.49 via hydrogen bonds (Figure 3.14 A). In contrast, 
in the active state models Tyr2887.53 is switched into the newly created gap between TM3 
and TM6 (Figure 3.13 B). This orientation is also present in the active state structures of the 
β2AR (Rasmussen et al., 2011a; Rasmussen et al., 2011b) and opsin (Scheerer et al., 2008). 
Furthermore, Tyr2887.53 approaches Tyr2025.58, which changes its place with Met2406.41 on 
receptor activation and extends into the gap between TM3 and TM6. The water mediated 
hydrogen bonds of Tyr2887.53 are broken, and new interactions are formed with Leu602.46, 
Leu1093.43 and Ile1123.46 (Figure 3.13 B). In rhodopsin the disruption of the Tyr-Phe 
interaction within the NPxxY(x)5,6F motif (alanine replacement mutation) results in a partly 
activated receptor (metarhodopsin II). However, replacement of Tyr7.53 led to decreased 
activation rate of the G-protein compared to the wild-type (determined from GTPγS uptake by 
Gt), suggesting that Tyr
7.53 is not only important for stabilizing an inactive receptor state but 
also for efficient G-protein coupling (Fritze et al., 2003). Indeed, the position of Tyr7.53 in 
active GPCR states seems to keep TM6 away from moving inwards and to maintain the 
crevice at the intracellular surface (Scheerer et al., 2008). 
The rearrangement of TM7 around Tyr2887.53 and the motion of TM6 change the hydrogen 
bond network at the cytoplasmic part of the receptor, affecting TM1, TM2, TM3, TM6 and 
TM7. In the hH2Ri model, a water molecule connects the backbone oxygen of Val239
6.40 to 
the side chains of Asn2807.45 and Asn2847.49 (Figure 3.14 A). This water molecule was 
derived from the structure of the hβ2AR (Cherezov et al., 2007), connecting the respective 
amino acids Ile2956.40, Asn3187.45 and Asn3227.49. In the active state models of the hH2R 
these contacts are unclosed (Figure 3.14 B, C). The distances between the corresponding 
heteroatoms are raised by 1.5 Å to 2.7 Å. The outward move of TM6 and, as a consequence, 
the partial disintegration of the water network, could be a trigger for the modification of the 
NPxxY(x)5,6F motif. Asn284
7.49 and the subsequent part of TM 7 up to helix 8 are rearranged 
in the active state hH2R models, and the proline kink in TM7 is modified, too. Direct hydrogen 
bonds to other amino acids are formed by the side chains of Asn2807.45 (hH2Ra1) and 
Asp642.50 (hH2Ra2).  
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 Figure 3.14: Hydrogen bond network at 
the intracellular part of the hH2R  
Side view of hH2Ri (A), hH2Ra1 (B) and 
hH2Ra2 (C). All TM domains except TM4 and 
TM5 are shown as tubes. Amino acids 
(sticks) with grey carbon atoms contribute to 
the hydrogen bond network of the respective 
hH2R model. Amino acids with black carbon 
atoms are not part of the network. The water 
molecules were inserted as described in 
section 3.2.2. Hydrogen bonds are indicated 
with yellow dashed lines (maximum distance 
of 3.5 Å between corresponding 
heteroatoms, hydrogen bond angle of at 
least 120°). 
  
  
 
In the hH2Ra1 model the inward position of the intracellular end of TM7 enables a water 
mediated hydrogen bond between Ser1053.39 and the side chains of Asp642.50 and 
Asn2847.49. In the hH2Ra2 model Ser105
3.39 is connected by direct hydrogen bonds to 
Thr632.49 and Asp642.50, and additionally by a water molecule to Gly2777.42 and the side chain 
of Trp2476.48 which is also part of the hydrogen bond network in the inactive state. This 
connection is absent in hH2Ra1 due to the motion of Trp247
6.48 towards Phe2436.44, indicating 
that the interruption of the hydrogen bond network near Trp2476.48 could be a further link from 
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the rearrangements below the ligand binding site to the modifications around Tyr2887.49 of 
the NPxxY(x)5,6F motif. Similar observations were reported for a constitutively active 
rhodopsin mutant. The movement of the side chain of Trp6.48, following the TM6 motion, 
disrupts the water mediated hydrogen bond with Ser7.45. This results in a reorganization of 
the hydrogen bond network, including highly conserved amino acids in TM1, TM2 and in the 
NPxxY(x)5,6F motif (Standfuss et al., 2011). 
In rhodopsin the linkage of the amino acids in position 3.28 and 7.43 are of special 
importance for the activation mechanism. Concomitant with the metarhodopsin II formation, 
the Schiff base nitrogen of Lys2967.43 is deprotonated and the Glu1133.28/Lys2967.43 salt 
bridge is broken. This so called 3-7 lock switch was discussed to be the fundamental trigger 
for receptor activation (Kim et al., 2004). However, in the nanobody and Gs-protein stabilized 
active state structures of the β2AR (Rasmussen et al., 2011a; Rasmussen et al., 2011b), the 
respective amino acids in TM3 and TM7 are still in close contact to each other. Thus, the 
switch in TM3/TM7 seems not to be a common element required for GPCR activation. 
Accordingly, in the inactive and active state hH2R models the respective heteroatoms of 
Tyr943.28, Asp983.32 and Tyr2787.43 were in close contact (distances of heteroatoms below 3.9 
Å). Only in the hH2Ra1 model hydrogen bonds from Tyr278
7.43 to Tyr943.28 and Asp983.32 were 
detected (Figure 3.16 B1, Table 3.9). 
3.3.3.3 Analysis of inter-TM domain contacts 
Besides molecular switches of highly conserved motifs, the types and counts of interactions 
(salt bridges, direct and water mediated hydrogen bonds, van der Waals contacts) between 
neighboring TMs were systematically analyzed in order to identify structural features crucial 
for the inactive and active hH2R states (Figure 3.16, Table 3.9). Most of the contacts are of 
the van der Waals type, taking into account that about 65% of all amino acids in the α-helical 
region of the hH2R are hydrophobic. The majority of the differences of inter-TM contacts 
between inactive and active hH2R states apply to molecular switches around highly 
conserved motifs described in the previous section. 
The relatively slight differences of TM domains at the extracellular part (Figure 3.8) indicate 
analogous interactions in all three receptor models. Indeed, remarkable anomalies occur only 
in the hH2Ra1 model with respect to TM6 and TM7 (Figure 3.16 B1). The reason is the 
adjustment of TM6 and some amino acid side chains to the active structure of opsin. The 
reduced number of interactions in the TM1-TM7 and TM2-TM7 interfaces of hH2Ra1 is 
caused by the adaption of the side chain conformation of Trp2757.40 to the respective amino 
acid of opsin (Scheerer et al., 2008). In contrast to rhodopsin, where the side chain of the 
corresponding Phe2937.40 is located in the interface between TM1-TM2-TM7 (Okada et al., 
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2004), in opsin it points towards the plasma membrane. Therefore, van der Waals 
interactions from Trp2757.40 to TM1 and TM2 were broken. Receptor activation is not affected 
by this modification. The adaption of Trp2476.48 and Phe2506.51 to the respective positions of 
Trp6.48 and Phe6.51 in opsin, respectively, results in a break of contacts to TM7 (see above). 
The reduced number of interactions in the TM5-TM6 interface is caused by the alignment of 
T 6 of the tβ1AR to the respective TM of opsin during model generation. Consequently, the 
suggested activation mechanism of hH2Ra1 differs from that of hH2Ra2 (cf. section 3.3.3.2). 
Major changes occur at the intracellular side. The cytoplasmic outward movement of TM6 
and the rearrangement and inward movement of TM7 have the greatest impact. In general, 
the contacts of TM6 to TM2, TM3, TM5 and TM7, respectively, and the contacts between 
TM3 and TM7 are modified by receptor activation (Figure 3.16 A2, B2, C2). The differences 
between TM2 and TM6, TM3 and TM6 as well as TM3 and TM7 were already described in 
context with the hydrophobic barrier. The rearrangement of TM7 including the change of the 
NPxxY(x)5,6F motif and the water mediated hydrogen bond network affecting the TM6-TM7 
interface was also discussed above. Although the TM5-TM6 distance is only slightly reduced 
from 11.9 Å in the hH2Ri to 11.0 Å in the hH2Ra1 and 11.7 Å in the hH2Ra2 model, the number 
of interactions increases from 8 (inactive) to 16 in both active state models (Figure 3.15).  
 
 
 
Figure 3.15: Interface between TM5 and TM6 at the intracellular side of the hH2R 
View from the intracellular side. In hH2Ri (A, TMs as blue ribbons) Phe206
5.62
, Arg210
5.66
, 
Ala225
6.26
, Glu229
6.30
, Leu236
6.37
, Val239
6.40
 and Phe243
6.44
 do not contribute to the TM5-TM6 
interaction observed in both active hH2R states. In hH2Ra1 (B, TMs as green ribbons) Ile219
5.75
, 
Lys223
6.24
, Ala237
6.38
 and Ile244
6.45
, connecting TM5 and TM6 in the inactive state, do not point to 
the other TM domain, respectively.  
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Table 3.9: Counts and types of contacts between TM domains of the hH2R states 
Given are the counts of interactions at the extra- and intracellular part of the three receptor states for a 
specific TM-TM contact. In brackets: counts of ionic interactions (distance of charged heteroatoms 
below 5 Å), hydrogen bonds (distance of heteroatoms below 3.5 Å, angle of heteroatom 1, hydrogen 
and heteroatom 2 at least 120°), water mediated hydrogen bonds and van der Waals interactions 
(distance of hydrophobic heavy atoms below 5 Å). Repulsive ionic interactions between neighboring 
TMs were not observed. 
 TM contact hH2Ri hH2Ra1 hH2Ra2 
     
     
E
x
tr
a
c
e
ll
u
la
r 
s
id
e
 
TM1 - TM2 9 (0, 0, 0, 9) 8 (0, 0, 0, 8) 9 (0, 0, 0, 9) 
TM1 - TM7 2 (0, 0, 0, 2) 0 (0, 0, 0, 0) 3 (0, 0, 0, 3) 
TM2 - TM3 9 (0, 0, 0, 9) 10 (0, 0, 0, 10) 8 (0, 1, 0, 7) 
TM2 - TM7 9 (0, 1, 1, 7) 3 (0, 0, 0, 3) 7 (0, 0, 1, 6) 
TM3 - TM4 10 (0, 1, 0, 9) 10 (0, 1, 0, 9) 11 (0, 0, 0, 11) 
TM3 - TM5 2 (0, 0, 0, 2) 3 (0, 0, 0, 3) 3 (0, 0, 0, 3) 
TM3 - TM6 2 (0, 0, 0, 2) 1 (0, 0, 0, 1) 1 (0, 0, 0, 1) 
TM3 - TM7 0 (0, 0, 0, 0) 2 (0, 2, 0, 0) 0 (0, 0, 0, 0) 
TM4 - TM5 8 (0, 0, 4, 4) 6 (0, 0, 2, 4) 7 (0, 0, 3, 4) 
TM5 - TM6 14 (0, 1, 0, 13) 9 (0, 1, 0, 8) 13 (0, 1, 0, 12) 
TM6 - TM7 19 (1, 1, 4, 13) 11 (1, 1, 0, 9) 18 (2, 0, 3, 13) 
 total 84 (1, 4, 9, 70) 63 (1, 5, 2, 55) 80 (2, 2, 7, 69) 
     
     
In
tr
a
c
e
ll
u
la
r 
s
id
e
 
TM1 - TM2 12 (0, 0, 1, 11) 9 (0, 0, 1, 8) 13 (0, 0, 1, 12) 
TM1 - TM7 9 (0, 1, 1, 7) 5 (0, 1, 0, 4) 7 (0, 1, 0, 6) 
TM2 - TM3 14 (0, 2, 0, 12) 11 (0, 1, 1, 9) 17 (0, 4, 0, 13) 
TM2 - TM4 12 (0, 1, 0, 11) 13 (0, 1, 0, 12) 13 (0, 1, 0, 12) 
TM2 - TM6 3 (0, 0, 0, 3) 0 (0, 0, 0, 0) 0 (0, 0, 0, 0) 
TM2 - TM7 7 (0, 1, 4, 2) 6 (0, 0, 2, 4) 8 (0, 1, 2, 5) 
TM3 - TM4 7 (0, 0, 0, 7) 8 (0, 0, 0, 8) 10 (0, 0, 0, 10) 
TM3 - TM5 19 (0, 0, 0, 19) 21 (0, 0, 0, 21) 17 (0, 1, 0, 16) 
TM3 - TM6 9 (0, 0, 0, 9) 3 (0, 0, 0, 3) 2 (0, 0, 0, 2) 
TM3 - TM7 0 (0, 0, 0, 0) 3 (0, 0, 1, 2) 3 (0, 0, 0, 3) 
TM5 - TM6 8 (0, 0, 0, 8) 16 (1, 1, 0, 14) 16 (1, 0, 0, 15) 
TM6 - TM7 9 (0, 0, 2, 7) 3 (0, 0, 0, 3) 6 (0, 0, 0, 6) 
 total 96 (0, 5, 8, 96) 98 (1, 4, 5, 88) 112 (1, 8, 3, 100) 
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Figure 3.16: Contacts between TM domains at the extra- and intracellular part of the hH2R 
states 
The total number of interactions (salt bridge, hydrogen bond, water mediated hydrogen bond, van 
der Waals contacts; for definition cf. Table 3.9) between TM domains at the extracellular (1) and 
the intracellular (2) part of hH2Ri (A), hH2Ra1 (B) and hH2Ra2 (C). The border between the extra- 
and intracellular side is the middle between the planes shown in Figure 3.10.  
TM4
TM5
TM3
TM2
TM1
TM7
TM6
Inactive
2
9
9
10
8
14
19
9
2
2
TM4
TM5
TM3
TM2
TM1
TM7
TM6
12
9
14
12
7
7
19
9
8
9
Inactive
3
TM4
TM5
TM3
TM2
TM1
TM7
TM6
Active-1
10
3
10
6
9
11
3
2 8
1
TM4
TM5
TM3
TM2
TM1
TM7
TM6
9
5
11
13
6
21
3
16
Active-1
3
8
3
TM4
TM5
TM3
TM2
TM1
TM7
TM6
Active-2
3
8
7
11
7
13
18
9
1
3
TM4
TM5
TM3
TM2
TM1
TM7
TM6
13
7
17
13
8
17
2
16
Active-2
3
10
6
A1                                                                    A2 
B1                                                                    B2 
C1                                                                    C2 
70 3.3 Results and discussion 
Moreover, since the TM5-TM6 interface changes upon the outward move of TM6, none of 
the 8 hydrophobic contacts in hH2Ri is retained in hH2Ra1 and only one in hH2Ra2. However, 
some of the amino acids connecting TM5 and TM6 in the hH2Ri model form new contacts to 
the other TM. Ile2195.75, Lys2236.24, Ala2376.38 and Ile2446.45 only contribute to the interface in 
the hH2Ri. In the active state models these amino acids do not point towards TM5 but face 
the lipid bilayer or the solvent (Figure 3.15 B). Phe2065.62, Arg2105.66, Ala2256.26, Glu2296.30, 
Leu2366.37, Val2396.40 and Phe2436.44 are part of the TM5-TM6 interface only in both active 
state conformations. In the inactive state they are displayed towards the plasma membrane 
or the cytoplasm (amino acids of TM5), or towards the core of the receptor (amino acids of 
TM6). 
3.3.3.4 Contacts of extra- and intracellular loops 
In the active state models the backbones of ICL1, which fit very well among each other 
(Figure 3.8 C), are placed away from TM7 as well as H8 and located more outwards than in 
hH2Ri (Figure 3.9 D). This allows the inward motion of the cytoplasmic part of TM7 and helix 
8, also observed in opsin and the activated β2AR, followed by the rearrangement around the 
NPxxY(x)5,6F motif (Cherezov et al., 2007; Okada et al., 2004; Rasmussen et al., 2011b; 
Scheerer et al., 2008). Interactions are formed with TM1, TM2 and H8, but they do not 
significantly differ between the inactive and active hH2R states. This is also the case for 
ECL1, whose shape is very similar in the three models (Figure 3.9 A). Contacts are mainly 
formed with the adjacent TMs 2 and 3, as well as with the backbone of ECL2 (Figure 3.9 A). 
For the hH2Ri and hH2Ra1 models, ICL2 and its neighbors TM3 and TM4 were taken from the 
same template, the tβ1AR. Therefore, the backbone geometry, the position of the side chains 
and their interactions are almost identical (Figure 3.8 A). ICL2 of the hH2Ra2 model is slightly 
shifted due to the more inward position of TM3 and the more outward position of TM4 at their 
cytoplasmic ends, respectively (Figure 3.9 D). Besides intra-loop interactions, contacts are 
formed mainly with terminal residues of TM3 and TM4. Additionally two hydrophobic 
interactions with Leu522.38 are obvious. In the active states, side chains in ICL2 contact 
residues of GαCT (section 3.3.4.2). ECL2 of the hH2Ri and hH2Ra1 models was constructed 
in the same way (section 3.2.2). Therefore, backbones and side chains overlap well in both 
models. Despite using another template for ECL2 in the hH2Ra2 model, the deviation from the 
other two models is only marginal (Figure 3.9 A). Merely around the solvent exposed Glu163, 
ECL2 is positioned closer to ECL3 resulting in higher RMSD values for Asn162 and Glu163 
(Figure 3.8 B, C). Interactions of ECL2 are similar in all hH2R models, and the loops are 
mainly stabilized by intra-loop contacts. Contacts are formed with ECL1, ECL3 (hH2Ri and 
hH2Ra1), as well as with the termini of TMs 4 and 5. Furthermore, the close distance to TM3 
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enables in all three models a highly conserved disulfide bridge of Cys174 with Cys913.25, a 
hydrogen bond of Asn168 with Lys883.22 and hydrophobic interactions of Thr171 with 
Gly873.21 and Lys883.22, Cys174 with Tyr943.28, and Val176 with Thr953.29. In the hH2Ra1 
model, Val176 contacts histamine (section 3.3.4.1). Since the α-helices of TM5 and TM6 
extend far at their cytoplasmic ends, interactions of the modeled parts of ICL3 are rare. Only 
some contacts to TM5 and TM6 as well as to GαCT in the hH2Ra2 were detected (section 
3.3.4.2). Like ECL2, ECL3 of the hH2Ri and hH2Ra1 models was constructed in the same 
way, resulting in a similar course in both models (Figure 3.9 A) as well as in identical 
interactions to nearby domains. Since ECL3 of hH2Ra2 was generated by another loop 
search, the backbone and the side chains deviate from the other two models (Figure 
3.8 B, C). 
3.3.3.5 Interactions of helix 8 
The region surrounding helix 8 is characterized by changes in the active state models, 
namely the inward movement of TM7 and H8 itself, and the outward shifts of TM1 and TM2 
compared to the inactive state (Figure 3.9 D). Despite these changes, the interaction of H8 
with the cytoplasmic part of TM1 is similar in the three models, consisting of about 10 
hydrophobic interactions. Furthermore, ICL1 is connected to H8 in the same way in all 
models (Arg48 to Asp294, and Leu49 to Asp294 and Phe295). Besides TM1 and ICL1, also 
TM7 stabilizes H8 in its position by interactions of the aromatic side chains of Phe295 and 
Tyr299 with TM7. The contact of Tyr2887.53 to Phe295 and Tyr299 observed in hH2Ri is 
broken in both active state models due to the rearrangement of the cytoplasmic part of TM7 
(section 3.3.3.1). Instead of that, Phe295 interacts with Ala2897.54, Ile572.43 and Asn542.40 (the 
latter only in hH2Ra1). A hydrogen bond of the side chain of Arg296 to the backbone oxygens 
of Ala2907.55 and Leu2917.56 is present in the hH2Ri and the hH2Ra1 models. This is also 
observed for the respective amino acids in the crystal structures of the tβ1AR and opsin. In 
the hH2Ra2 model and its template, the hβ2AR, this contact is missing, but Asp294 is 
hydrogen bonded to Asn292 at the junction of TM7 and H8. In the hH2Ri model Asn292 is 
hydrogen bonded to Thr2356.36, possibly contributing to the inward position of TM6 in the 
inactive state. 
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3.3.4 Ligand and GαCT interactions with the active hH2R states 
3.3.4.1 Histamine binding 
The interactions of the endogenous agonist histamine with the orthosteric binding site of the 
hH2R are similar in both active state models (Figure 3.17). Salt bridges and/or charge-
assisted hydrogen bonds are formed with Asp983.32 and Asp1865.42. This docking is in 
agreement with mutational data received at the canine H2R (Gantz et al., 1992). Van der 
Waals contacts occur with Val993.33, Tyr2506.51 and Phe2546.55 in both models. These amino 
acids were reported to contribute to ligand binding in several GPCRs (Cherezov et al., 2007; 
Shi and Javitch, 2002; Warne et al., 2008b; Wieland et al., 1999; Wieland et al., 1996). 
Additionally, Tyr1825.38 is in close contact to the ligand, however, without being hydrogen 
bonded to the imidazole moiety of histamine as supposed formerly (Nederkoorn et al., 
1996a; Nederkoorn et al., 1996b). To test this hypothesis a Tyr182Phe hH2R mutant was 
generated and pharmacologically characterized (chapter 6).  
 
 
 
Figure 3.17: Histamine binding in the orthosteric binding site of the hH2R 
Side view of the hH2Ra1 (A) and the hH2Ra2 (B) model in complex with histamine. The orthosteric 
binding site is shown from TM7. ECL3 and TM7 are omitted for reasons of clarity. Histamine 
(carbon atoms in brown (A) and green (B), respectively) was manually docked into the putative 
binding pocket. Amino acid side chains in a sphere of 5 Å radius around histamine are displayed 
in sticks and are surrounded by a grey surface. Hydrogen bonds are indicated with yellow dashed 
lines. 
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In the hH2Ra2 model Phe251
6.52 contacts histamine at the same position as Phe1915.47 in the 
hH2Ra1 model. In hH2Ra2 the ligand is located somewhat deeper in the binding pocket due to 
the more downward position of Tyr2506.51 and Phe2546.55. Compared to hH2Ra1, TM5 to TM7 
are slightly shifted to the cytoplasm, whereas TM3 is moved to the extracellular side (Figure 
3.9). Therefore, only in the hH2Ra1 model the ligand is able to contact Val176 in ECL2 at the 
top of the binding pocket. A further remarkable difference between both active state models 
is the position of TM5. The distance calculated between the corresponding Cα atoms of TM5 
(Thr1905.46) and TM3 (Thr1033.37), TM6 (Trp2476.48) and TM7 (Gly2777.42) is decreased in the 
hH2Ra2 model by 0.52 Å, 0.47 Å, and 1.18 Å, respectively. Accordingly, in the template for the 
hH2Ra2 model, the hβ2AR, a similar compression is observed (Rasmussen et al., 2011a). 
3.3.4.2 Receptor – G-Protein interaction 
After superimposing the active state models, the docked C-terminal part of the Gsα-protein 
(GαCT) is apparently closer to ICL3 and T 6 in the hH2Ra2 model (Figure 3.18 A, B). This is 
due to a different docking procedure of GαCT in both models. Since the cytoplasmic parts of 
TM5 and TM6 of hH2Ra2 were more protruding and outwards shifted than in hH2Ra1 (Figure 
3.9 D), GαCT was docked closer to ICL3 and T 6 in the hH2Ra2 model in order to enable 
adequate interactions with this region of the receptor. However, the C-terminal ends of GαCT 
fit well in both models. Several van der Waals contacts of GαCT are formed with the crevice 
between TM2, TM3, ICL2 and the junction TM7-H8. Additionally, the helices of TM5 and 
TM6, which both expand farthest into the cytoplasm, contact the Gsα-subunit. Most of the 
interactions are also present in the crystal structure of opsin in its G-protein-interacting 
conformation and in the structure of the β2AR-Gs complex (Table 3.10). In general, more 
interactions are formed in the hH2Ra1 model (Figure 3.18 C, D).  
 
Table 3.10: Van der Waals contacts between GαCT and active state hH2R models 
domain hH2Ra1 hH2Ra2 
TM2 2 (T53
1
, N54) 0 
TM3 6 (D115, R116
1,2
, A119
1,2
, V120
1,2
) 6 (R116, A119, V120) 
ICL2 4 (P123
2
, Y126
2
) 1 (P123) 
TM5 3 (I205
1,2
, Q212
1,2
, I219) 1 (I216
2
) 
TM6 5 (R228
1
, A232
1,2
, T235
2
, L236
2
) 4 (A232, T235, V239) 
TM7/H8 1 (N292
1
) 1 (N292) 
total 21 13 
1,2
 Hydrophobic interactions are also observed for the respective amino acid in the crystal 
structure of opsin (
1
;(Scheerer et al., 2008) and in the β2AR (
2
;(Rasmussen et al., 2011b), 
respectively. 
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Figure 3.18: Interactions of the cytoplasmic part of the hH2R with the Gsα-protein 
A, B, Side view (A) and cytoplasmic view (B) of the interaction of the C-terminus of the Gsα-protein 
(GαCT) with the (aligned) hH2Ra1 () and hH2Ra2 () models, shown in ribbons. C, D, 
Cytoplasmic view on amino acid side chains (shown in sticks) of hH2Ra1 (C, Cα trace in green) and 
hH2Ra2 (D, Cα trace in orange) which interact with GαCT (transparent blue surface). Docking of 
GαCT was performed as described in section 3.2.2 
 
 
Apart from these hydrophobic interactions some polar contacts occur. In the hH2Ra1 model a 
hydrogen bond between Asn542.40 and Glu392 (GαCT) and a salt bridge between Arg293 in 
H8 and the charged C-terminus of GαCT, Leu394, are observed. In the hH2Ra2 model 
hydrogen bonds between Ser221ICL3 and Asp381 (GαCT), Asn292 (TM7-H8) and Glu392 
(GαCT), as well as an ionic interaction between Arg1163.50 and Glu392 (GαCT) are formed. 
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3.4 Summary and conclusion 
3.4.1 Template selection and quality of the models 
Homology models of the hH2R in its inactive and active state were generated. At the time of 
creation of the inactive state model only bovine and squid rhodopsin, the tβ1AR, the hβ2AR 
and the adenosine A2A receptor were available as templates. However, the retrospective 
analysis of all GPCR structures resolved till the end of 2012 confirmed that using the tβ1AR 
(Warne et al., 2008a) was most appropriate. A phylogenetic analysis of class 1 aminergic 
GPCRs indicated that the H2R is closest related to the 5-HT4R and the βARs, whereas the 
H1R, of which a crystal structure is available (Shimamura et al., 2011), is distant from the H2R 
and more related to muscarinic acetylcholine receptors (Vassilatis et al., 2003). For the 
active hH2R state, two models were generated. At first the crystal structure of the tβ1AR was 
used in a multiple template approach, inserting the structural changes crucial for receptor 
activation by adaption to the structure of opsin (Scheerer et al., 2008). This was attained by 
the partly adaption of the intracellular segments of the TMs of hH2Ra1 to opsin in order to 
mimic the shift of the helices observed for the transition from rhodopsin to opsin, including 
opening of the cytoplasmic crevice enabling interaction with the C-terminal part of the G-
protein. Therefore, most of the TMs in hH2Ra1 could be taken from the tβ1AR. However, TM7 
of opsin shows a different helical turn compared to the inactive conformation of rhodopsin 
(Okada et al., 2004). In the active state, Tyr3067.53 is directed towards the core of the 
receptor, keeping TM6 away from moving inward. This is the case in the hβ2AR, too. The 
corresponding Tyr3267.53 moves to the center of the receptor upon activation and keeps TM6 
in the outward position (Cherezov et al., 2007; Rasmussen et al., 2011a). In order to 
preserve this structural feature, TM7 and helix 8 were directly taken from opsin. Taking only 
the latter as whole template for the hH2R seemed inappropriate since in a previous MD 
simulation of the hH2R based on the structure of rhodopsin distance restraints had to be 
applied to maintain α-helical elements of the receptor (Preuss, 2007). For the second model 
the structure of the nanobody-stabilized active state of the hβ2AR was used (Rasmussen et 
al., 2011a), because of its close relatedness to the hH2R and the exclusion of remaining 
active state GPCR crystal structures, such as the adenosine A2A receptor (Lebon et al., 2011; 
Xu et al., 2011). The stereochemical quality of the hH2R homology models was confirmed by 
analyzing the planarity of the peptide bond, aromatic side chains and delocalized π-electron 
systems in amino acid side chains. The stability of naturally planar moieties during energy 
minimization is a good measure for the integrity of the receptor with proper side chain 
conformations. Generally, the deviation from planarity was only marginal. The analysis of 
backbone dihedral angles (Φ and Ψ) as well as side chain torsions of the models showed a 
76 3.4 Summary and conclusion 
good agreement with experimental values (Lovell et al., 2000). The majority of residues with 
dihedral angles located in disallowed regions of the conformational space were obtained 
from the templates or from protein fragments of the Protein Data Bank received by a loop 
search. The good stereochemical quality of the models was a prerequisite for the analysis 
and comparison of hH2R states.  
3.4.2 Comparison of hH2R states 
The overall topology (i.e. the relative positions of TM domains) of both active state models 
was very similar. Differences between the active hH2R states occurred at the bottom of the 
binding site which linked the binding pocket to the rearrangement of TM6. In the hH2Ra1 the 
activation mechanism resembled that of rhodopsin/opsin, whereas in hH2Ra2 it was similar to 
the β2AR. The rigid body fitting of tβ1AR-TM6 to TM6 of opsin in hH2Ra1 resulted in close 
contacts especially between TM5 and TM6 in the middle of the receptor which required the 
adjustment of side chain torsions. Furthermore, due to the close relatedness of the hH2R with 
the βARs, the hH2Ra2 seemed to be a more suitable model for the active hH2R state. In 
comparison to the inactive state, the crucial rearrangements especially of the cytoplasmic 
part of TM6 and TM7 were in accordance with changes observed for the transition of 
rhodopsin in the ground state to activated opsin (Okada et al., 2004; Scheerer et al., 2008) 
and of the inactive to the active hβ2AR (Cherezov et al., 2007; Rasmussen et al., 2011a). 
These major changes were accompanied by altered distances of nearby TM domains, mainly 
in the intracellular part of the receptor, and by a different number and kind of interactions 
between them. Most of the differences of inter-TM contacts were caused by conformational 
changes around highly conserved motifs. These molecular switches, connected to each 
other, are suggested to be essential for receptor activation and present in at least six regions 
of the hH2R models. A modification of the TM5 position and of side chain orientations, mainly 
in TM3 and TM6, linked the ligand binding site to the critical outward movement of TM6. A 
concomitant rearrangement of amino acids contributing to the ionic lock in some inactive 
state structures contributed to stabilization of the active hH2R state and to the binding of the 
G-protein fragment. Further changes during hH2R activation are: reordering of the water 
mediated hydrogen bond network around TM7, rearrangement of the highly conserved 
NPxxY(x)5,6F motif, disruption of a hydrophobic barrier in the center of the TM bundle and an 
altered TM5-TM6 interface. Most of these changes correspond to those resulting from 
comparison of inactive and active states of resolved GPCR structures. 
 Chapter 3: Homology models of inactive and active hH2R states 77 
3.4.3 Conclusion 
The homology models of the hH2R enabled valuable insights into the differences between 
inactive and active hH2R states. However, molecular dynamics simulations are necessary to 
further validate the inactive and active hH2R state models. In particular, their relatively stable 
existences in a natural, dynamic environment and the impact of conformational flexibility on 
the process of receptor activation have to be analyzed. 
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Chapter 4 
4 Molecular Dynamics Simulations of Inactive and 
Active Human Histamine H2 Receptor States 
4.1 Introduction 
Advances in crystallization techniques enabled the resolution of several 3D structures of G-
protein coupled receptors in the last years (Venkatakrishnan et al., 2013). In TM domains the 
sequences as well as the structures fit quite well between these receptors (Figure 3.1). In the 
terminal segments of TMs and especially in the extra- and intracellular loops, sequence 
identity is reduced. Accordingly, backbone courses of crystallized GPCRs deviate most is 
these regions, resulting in characteristic structures of each receptor. Only GPCRs with high 
sequence identity adopt nearly identical structures, e.g. the tβ1AR and the hβ2AR with an 
overall and TM sequence identity of about 54% and 70%, respectively, and a backbone 
RMSD of 1.4 Å (Cherezov et al., 2007; Warne et al., 2008). Since GPCRs with rather low 
sequence similarities possess different 3D structures, homology models based on templates 
with a moderate sequence identity – such as models of the H2R derived from the β-
adrenoceptors (TM sequence identity of 40% to 45%; cf. chapter 3) – are too close to the 
template from which the TM domains are mostly directly taken. Although the technique of 
energy minimization is able to relax the protein structure and reduce unfavorable contacts, it 
is not able to find alternative conformations of amino acid side chains and TM positions. 
Furthermore, artificial restraints from, e.g., lattice contacts or metal ions present in crystal 
structures are directly transferred into homology models. Also the protein environment 
composed of detergents during the crystallization is of impact on the conformation, and 
structures obtained with x-ray crystallography are of low energy and adopt stable geometries 
(Deupi and Kobilka, 2010). Thus, it is important to embed the protein into a natural 
environment, to allow the protein to relax and to enable the adoption of different backbone 
and side chain conformations. In molecular dynamics (MD) simulations atoms or groups of 
atoms are able to interact with each other based on forces and potential energies obtained 
from a molecular mechanics force field. Solving Newton's equations of motion, atoms are 
capable to move within a distinct time step (Van Der Spoel et al., 2005). MD simulation is an 
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established computational method to investigate the conformational dynamics of membrane 
proteins and has been successfully used for studying the structure, activation and 
dimerization of GPCRs (Taddese et al., 2012; Vanni and Rothlisberger, 2012). 
In the present study the putative inactive and active receptor states of the human H2R (hH2Ri 
and hH2Ra2; cf. chapter 3) were embedded in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC) bilayers (Figure 4.1) to simulate a natural environment for the membrane proteins, 
and subsequently subjected to MD simulations, consisting of 20 ns equilibration phases and 
80 ns production runs. The systems were hydrated with water molecules, and counter ions 
were added to attain a final system charge of zero. The purpose of this study was to 
characterize the structure and function of the hH2R in an inactive and active state and to 
check and upgrade the results obtained from analyzing hH2R homology models (chapter 3). 
4.2 Materials and methods 
4.2.1 Materials 
MD simulations were performed with the software package GROMACS 4.0.7 (GROningen 
MAchine for Chemical Simulations;(Hess et al., 2008; Van Der Spoel et al., 2005). The pre-
equilibrated lipid bilayer consisting of 128 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
molecules (Figure 4.1) including the respective parameters of the GROMOS96 53a6 force 
field was obtained from Kukol (2009). Visual inspections of the simulation systems were 
performed with VMD (Visual Molecular Dynamics;(Humphrey et al., 1996). For structure 
validation of the proteins the program described in chapter 5 was used (gro_validation). 
Analysis of the simulation runs was performed with tools included in GROMACS or with the 
programs gro_hbonds and gro_contacts described in chapter 5 for the calculation of 
hydrogen bonds and van der Waals contacts, respectively. Interactions between residues 
were assigned by using cut-off values for ionic interactions (distance of charged heteroatoms 
below 5 Å), hydrogen bonds (distance of heteroatoms below 3.5 Å, angle of heteroatom 1, 
hydrogen and heteroatom 2 at least 120°) and van der Waals interactions (distance of 
hydrophobic heavy atoms below 5 Å). The area per lipid was calculated with the program 
InflateGRO described by Kandt et al. (2007) and provided at the homepage of the Life and 
Medical Science Center of the University of Bonn, Germany. 
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Figure 4.1: Structure of DPPC and numbering of the acyl chains sn-1 and sn-2 
 
 
4.2.2 Parameters of the MD simulations 
All MD simulations were performed applying the GROMOS96 53a6 force field (Oostenbrink 
et al., 2004). In order to allow a larger time step of 2 fs the LINCS (LINear Constraint Solver) 
algorithm (Hess, 2007; Hess et al., 1997) with constraints on all bonds was used. Cut-off 
values for the generation of the short-range neighbor list for calculating van der Waals 
interactions, the Lennard-Jones interactions, and the long-range electrostatic interactions 
were set to 1.4 nm. The latter were calculated with the Particle Mesh Ewald method (Darden 
et al., 1993; Essmann et al., 1995). The neighbor list was updated every 10th step of the 
calculation, and the frequency to write coordinates, velocities, forces and energies to output 
files was set to 500 steps (corresponding to 1 ps). Periodic boundary conditions were applied 
in all directions of the simulation box. Deviations of the system temperature (323 K) were 
corrected using the Berendsen algorithm (Berendsen, 1991) with a coupling constant of 0.1 
ps. To enable the NPT ensemble, i.e. constant number of particles (N), conserved system 
pressure (P) and temperature (T), the Berendsen barostat (Berendsen et al., 1984) was used 
with a semi-isotropic pressure coupling in the x-y plane parallel to the membrane and the z-
dimension. A complete list of parameters for MD simulations is provided in the Appendix 
(section 9.1). 
4.2.3 Construction of the hH2R-DPPC-water systems 
The energy optimized homology models hH2Ri and hH2Ra2 (refer to chapter 3 for a 
description) were transferred to the GROMACS file format (gro), including the generation of 
an appropriate topology file with parameters of the GROMOS96 53a6 force field, defining 
atom types, bond angels and lengths, as well as dihedral angles and constraints. The 
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parameters for the ligand histamine, present in the binding pocket of hh2Ra2, were adapted to 
the parameters of the GROMOS96 53a6 force field (a listing of all parameters used for 
histamine is given in the Appendix, section 9.2). The receptor models including ten 
conserved water molecules, respectively, and in case of hH2Ra2 histamine and the C-terminal 
part of the GsαS-subunit (GαCT), were energy minimized in two steps with the steepest 
descent method. In the first minimization backbone atoms were restrained (force constant 
1,000 kJ mol-1 nm-2) and in the second one all atoms were able to move freely until the 
maximum force was below 10 kJ mol-1 nm-1 or the maximum number of minimization steps 
was reached (50,000). Then the models were inserted in a lipid bilayer consisting of 128 
DPPC molecules (Kukol, 2009). This bilayer was built with standard parameters of the 
GROMOS96 53a6 force ﬁeld and was equilibrated by Kukol in a 40 ns MD simulation using 
the software package GROMACS. The embedding of the protein in the membrane was 
performed according to a method described by Kandt et al. (2007). Accordingly, the lipid 
molecules of the pre-equilibrated bilayer were scaled in their x and y direction parallel to the 
membrane with a factor of 4. The protein was inserted in the middle of the widened bilayer, 
and DPPC molecules overlapping with the receptor were deleted manually, taking care that 
at the extra- and intracellular side of the membrane the same amount of lipid molecules 
remained. In iterative steps the bilayer was scaled with a factor of 0.95 and energy-
minimized with the protein positions restrained (force constant 100,000 kJ mol-1 nm-2), 
respectively, until the area per lipid converged to the reference value for a DPPC bilayer at 
50 °C of about 60 to 64 Å² (Kucerka et al., 2008; Kucerka et al., 2011; Nagle, 1993; Nagle 
and Tristram-Nagle, 2000b). In the next step water molecules (Simple Point Charge water, 
SPC) were added to the system in an automated procedure, inserting water molecules into 
every position of the box so that the distance between any atom of the solute molecules 
(protein, lipid and ligand) and any atom of the solvent molecule was less than the sum of the 
van der Waals radii of both atoms (command genbox). To ensure that water molecules were 
not included within the bilayer or the hydrophobic interface between the protein and the lipid 
tails, carbon atoms (common radius of 1.5 Å) in the DPPC acyl chains were replaced by 
fluorine atoms (not present in the system) and a radius of 3.5 Å was assigned. In order to 
enable a hydration of the polar head groups of DPPC, the carbonyl carbon atom and the two 
carbon atoms next to the carbonyl group were not exchanged by fluorine atoms (carbon 
atoms 1 to 3 according to the numbering in Figure 4.1). After addition of water molecules, 
fluorine atoms were replaced again by the original carbon atoms. Both systems were 
checked visually, and water molecules were deleted if appropriate. Finally, Cl- ions were 
added to the system to achieve a total charge of zero (command genion). The two systems 
were energy-minimized in four steps with the steepest descend method, applying decreasing 
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position restraints on the system (first step: protein, histamine in case of the hH2Ra2, 
conserved water molecules, DPPC; second step: protein, histamine in case of the hH2Ra2, 
conserved water molecules; third step: protein backbone; fourth step: no restraints). 
Thereafter, the equilibration of the systems was performed in four steps, each with 5 ns 
duration. In steps one to three position restraints (force constant 1,000 kJ mol-1 nm-2) were 
imposed (1) on the complete protein and the conserved water molecules, (2) on the protein 
backbone (Cα, C, N), and (3) on the backbone atoms of the TM domains. In the fourth step all 
atoms were able to move without restrictions. Subsequently, the hH2R systems were 
subjected to 80 ns production runs. 
4.3 Results 
4.3.1 Size and composition of the simulation systems 
The dimension of the simulation box with the hH2Ri was 7.28 x 7.30 x 10.00 nm and 
consisted of 39,904 atoms or sites (united atoms), respectively, with 292 residues of the 
hH2R, 120 DPPC molecules, ten conserved water molecules, 10,305 water molecules as 
solvent and 11 chloride ions to attain a total charge of zero (Figure 4.2 A). The system of the 
hH2Ra2 was larger in the z-dimension because of the additional GαCT docked at the 
cytoplasmic side of the hH2Ra2 (7.28 x 7.30 x 11.00 nm; Figure 4.2 B). Accordingly, the box 
contained 44,800 atoms or sites, respectively, with 292 residues of the hH2R, 28 residues of 
GαCT, the ligand histamine, 120 DPPC molecules, ten conserved water molecules, 11,828 
water molecules as solvent and 13 chloride ions. The number of positively charged moieties 
in the hH2Ra2 was increased because of the protonated amine function of histamine (Eriks et 
al., 1993) and the uncharged Asp1153.49, which was proposed for active GPCR states (Dror 
et al., 2011; Ghanouni et al., 2000; Vogel et al., 2008). 
4.3.2 Equilibration of the hH2R-DPPC-water systems 
The analysis of system parameters and the inspection of the lipid bilayer during the 
equilibration phase are crucial since the quality and suitability of an MD simulation depends 
considerably on the accurateness of the input structures. Furthermore, comparisons with 
experimental reference values can prove a bilayer structure to be appropriate. 
 
 
88 4.3 Results 
                                  hH2Ri                                 hH2Ra2 
 
  
Figure 4.2: Structures of hH2R models embedded in a solvated DPPC bilayer after 20 ns 
equilibration 
The backbone of the hH2Ri (blue ribbon and tubes) and hH2Ra2 (orange ribbon and tubes) is 
shown within the DPPC bilayer (carbon atoms in grey sticks). Chloride ions are highlighted in 
green spheres. 
 
 
4.3.2.1 System parameters 
In order to assure the quality of the simulation system, convergence of parameters such as 
energy, temperature, pressure, box dimensions and density were checked (Figure 4.3). The 
total energy of the system is the sum of the potential and the kinetic energy. The latter 
remained stable during the equilibration (mean ± SD for hH2Ri and hH2Ra2: 107 x 10
3 ± 381 
kJ mol-1 and 120 x 103 ± 404 kJ mol-1) since it is based on the temperature of the system 
which was restricted by coupling to an external thermostat. The potential energy is the sum 
of terms related to internal coordinates and non-bonded energy contributions between pairs 
of atoms and is constant in an equilibrated system. Because of position restraints applied 
during the equilibration phase it decreased slightly in both systems, mainly at points in time 
when the constraints were released. However, potential energies nearly converged to a 
stable value until the end of the respective equilibration period (final values for hH2Ri and 
hH2Ra2: -589 x 10
3 kJ mol-1 and -655 x 103 kJ mol-1). Density remained unchanged in both 
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systems (mean ± SD for hH2Ri and hH2Ra2: 990 ± 1.8 kg m
-3 and 990 ± 1.7 kg m-3), as well as 
the pressure which was restricted by the berendsen barostat.  
 
                  hH2Ri          hH2Ra2 
 
  
 
  
 
      
Figure 4.3: System parameters of the 20 ns equilibration phase 
Potential energy (A), density (B) and box dimensions (C) in x- (black line) and z-direction (grey 
line) for the system of the hH2Ri and hH2Ra2, respectively. The y-vector was similar to the x-vector 
(semiisotropic pressure coupling) and is not shown. Every 10
th
 frame (10 ps interval) was 
analyzed. 
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90 4.3 Results 
The box size decreased slightly in the plane parallel to the membrane (x- and y-direction) 
and increased in the z-dimension, primarily in the hH2Ra2 system when all position restraints 
were released (15 ps). However, the box dimensions stabilized quickly.  
To avoid ‘edge effects’ at the border of the simulation box, periodic boundary conditions were 
applied to the MD simulations, i.e. one box is surrounded by copies of itself in all three 
dimensions. However, also the periodicity can cause artifacts in the calculation if a molecule 
in a box and its periodic image in a neighboring box approach each other by less than 1.4 
nm. Thus, the distance of the proteins to their nearest periodic images were analyzed. During 
the 20 ns equilibration phase of the hH2Ri and the hH2Ra2 this distance was above the cut-off 
value for the calculation of long-range interactions (1.4 nm) at any time, respectively (Figure 
4.4). 
 
                   hH2Ri          hH2Ra2 
 
  
Figure 4.4: Distance of the protein to its nearest periodic image 
The red dashed line indicates the cut-off value for non-bonded long range interactions (1.4 nm). 
Every 10
th
 frame was analyzed (10 ps interval). 
 
 
4.3.2.2 Lipid bilayer 
Hydrophobic, polar and charged amino acids are distributed over GPCRs depending on their 
exposure to the extra- and intracellular solvent or the lipid membrane (Rees et al., 1989; 
Wallin et al., 1997). Whereas at the extra- and intracellular surface charged residues 
accumulate, at the receptor surface which is exposed to the membrane hydrophobic amino 
acids predominate. The protein was inserted into the lipid bilayer to enable an alignment of 
the amino acids of this so called hydrophobic belt with the lipophilic tails of the DPPC 
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molecules (Figure 4.5). Charged amino acids faced the solvent or the lipid head groups 
(Ballesteros et al., 2001).  
 
 
hH2Ri                                 hH2Ra2 
 
  
Figure 4.5: Embedding of the hH2R models in the DPPC bilayer 
Side view of the hH2Ri and hH2Ra2 in surface representation within the lipid bilayer (sticks). 
Hydrophobic amino acids (alanine, glycine, isoleucine, leucine, methionine, phenylalanine, 
proline and valine) are highlighted in green and charged amino acids (arginine, aspartate, 
glutamate and lysine) in blue. 
 
 
An appropriate solvation of the bilayer is confirmed by a close contact of water molecules 
with polar and charged atoms of the lipid head groups (N, O, P). Thus, the radial distribution 
functions (RDFs) of water oxygens and the carbonyl oxygen atoms, phosphorus atoms and 
nitrogen atoms of DPPC, respectively, were calculated (Figure 4.6). The integration of the 
first peaks gives the average number of water molecules within the respective radius around 
the atoms (Pandey and Roy, 2011; Poger and Mark, 2010). Based on the calculation of the 
last 2.5 ns of the equilibration, nitrogen atoms were solvated best (in hH2Ri and hH2Ra2 on 
average 14.8 and 13.7 water molecules within a radius of 6.2 Å and 6.1 Å, respectively, 
around the nitrogen atoms; Table 4.1). In a radius of 4.6 Å around phosphorous atoms an 
average number of about 3.5 water molecules were found in both simulation systems. The 
oxygen atoms of the carbonyl functions were solvated least because of the shielding effects 
of the choline moieties of DPPC. 
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Figure 4.6: Radial distribution functions for clustering of water oxygens with head group 
nitrogen, phosphorus and carbonyl oxygens 
The radial distribution functions are shown for the oxygen atoms of water molecules and the 
nitrogen (blue), phosphorous (orange), carbonyl oxygen of the sn-1 (brown) and sn-2 (red) chain 
of DPPC, respectively. The data shown is the average over time (last 2.5 ns of the equilibration 
phase) and DPPC molecules. 
 
 
Table 4.1: Average number of water molecules around the lipid head groups of DPPC 
Shown is the average number of water molecules received from integrating the radial distribution 
functions (Figure 4.6). The radiuses around the heteroatoms of DPPC are given in brackets [Å]. 
 hH2Ri hH2Ra2 
Nitrogen 14.8 (6.2) 13.7 (6.1) 
Phosphorous 3.5 (4.6) 3.5 (4.6) 
Oxygen (sn-1 chain) 1.5 (3.4) 1.5 (3.5) 
Oxygen (sn-2 chain) 0.7 (3.4) 0.7 (3.4) 
 
The dynamics of the carbon chains of bilayers strongly depends on the temperature. For MD 
simulations a temperature about ten degree above the phase transition temperature of the 
lipid is generally used. In case of the DPPC bilayer, this temperature was determined at 
314.4 K (De Young and Dill, 1988; Lewis et al., 1987), and therefore for MD simulations 323 
K is commonly used (Patra et al., 2003; Prates Ramalho et al., 2011). A measure for the 
dynamics of carbon chains is the time-averaged mobility of a particular C-D bond (carbon-
deuterium bond) within a lipid molecule, the deuterium order parameters SCD (Vermeer et al., 
2007). Experimental values are obtained from deuterium NMR quadrupole splittings. The 
values calculated for both simulation systems are in good agreement with values reported in 
literature (Figure 4.7). 
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Figure 4.7: Deuterium order parameters for the carbon chains of DPPC 
Deuterium order parameters are shown for the sn-1 (▲) and sn-2 () chain for the systems with 
the hH2Ri and with the hH2Ra2. Experimental SCD values are from Douliez et al. (1995); blue line), 
Leftin and Brown (2011); purple line) and Petrache et al. (2000); green line). 
 
The orientation of the lipid head groups was calculated as probability distribution of the angle 
between the P→N dipole and the bilayer normal and compared with experimental data, too. 
In neutron diffraction studies the P→N vector was shown to be nearly parallel to the 
membrane (Buldt et al., 1978). The peak of the distribution, averaged over the last 2.5 ns of 
the equilibration phase and all lipid molecules, was at about 79° and 77° for the system with 
the hH2Ri and with the hH2Ra2, respectively (Figure 4.8). Published values ranged from 60° to 
90° (Jambeck and Lyubartsev, 2012; Poger and Mark, 2010; Ulmschneider and 
Ulmschneider, 2009) indicating a good agreement with data from the MD simulations. 
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Figure 4.8: Distribution of the angle between the P→N dipole of the DPPC head groups 
and the normal of the membrane in the last 2.5 ns of the equilibration phase 
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To further validate the simulated bilayer, the membrane thickness was compared with data 
from X-ray scattering experiments. The distance between the peaks in the electron density 
proﬁle, corresponding to the distance between the lipid head group phosphates, is a good 
estimation of the bilayer thickness (Kucerka et al., 2011). For a DPPC bilayer at 50 °C, 38.0 
Å were measured (Kucerka et al., 2008). The thickness calculated during the equilibration 
phase was below that value for both systems (mean ± SD for hH2Ri and hH2Ra2: 33.6 ± 1.5 Å 
and 34.7 ± 1.8 Å; Figure 4.9). However, at the end of the last equilibration step of hH2Ra2 the 
thickness converged to the reference value, probably caused by a slight contraction of the 
simulation box in the x-y plane and an expansion in z-dimension, i.e. the normal of the 
bilayer (Figure 4.3 C). 
 
                 hH2Ri            hH2Ra2 
 
 
Figure 4.9: Thickness of the DPPC bilayer measured as the average distance between the 
phosphates of DPPC 
The thickness was measured as the average distances between the phosphates of DPPC every 
10
th
 frame (10 ps interval). The red line indicates the experimentally determined thickness of a 
DPPC bilayer at 50 °C.  
 
 
Finally, the area per lipid was analyzed. In a simulation system consisting only of lipid and 
water molecules this is just the area of the plane parallel to the membrane divided by the 
number of lipids in one layer. If a membrane protein is embedded the required area of the 
protein has to be estimated and subtracted from the membrane plane (Allen et al., 2009). 
Values for the area per lipid derived from experiments (X-ray methods, NMR and neutron 
diffraction) and simulations vary considerably. Measured areas per lipid of a DPPC bilayer at 
about 323 K range from 50 to 72 Å² (Nagle and Tristram-Nagle, 2000a; Poger and Mark, 
2010). The values obtained from both simulations with the hH2R are in the range of data 
received from literature (Figure 4.10). Comparable to other parameters, values changed after 
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releasing constraints from simulation components and converged to constant values at the 
end of the respective equilibration step. The decrease in the area per lipid observed in both 
simulations, most pronounced at the 4th step of the hH2Ra2 system, correlated with the 
alterations in the box dimensions (Figure 4.3 C). 
 
               hH2Ri        hH2Ra2 
 
 
Figure 4.10: Area per lipid of the DPPC bilayer during the equilibration phase 
The area per lipid was calculated with InlateGRO every 100
th
 ps. Blue line, DPPC monolayer at 
the extracellular side; Green line, DPPC monolayer at the intracellular side; Red dashed line, 
Lower and upper limits (50 Å² and 72 Å², respectively) received from literature for the area per 
lipid of DPPC at 50 °C. 
 
 
In summary, the convergence of system parameters to stable values and the agreement of 
the DPPC bilayer structure with experimental data proved both simulation systems to be 
appropriate for starting productive 80 ns MD simulations which will be analyzed in the 
following sections. 
4.3.3 Analysis of system parameters 
The potential energy (mean ± SD for hH2Ri and hH2Ra2: -589 x 10
3 ± 608 kJ mol-1 and -657 x 
103 ± 619 kJ mol-1) and the density (mean ± SD for hH2Ri and hH2Ra2: 991 ± 1.1 kg m
-3 and 
991 ± 1.0 kg m-3) of both simulation systems remained constant during the 80 ns production 
runs (Figure 4.11 A, B). However, the simulation box of the hH2Ri was contracted slightly in 
the plane of the membrane and raised in the z-dimension at the beginning of the simulation 
and at 35 to 40 ns (about 2%; Figure 4.11 C). The box dimensions of the hH2Ra2 system 
remained stable. 
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Figure 4.11: System parameters of the 80 ns production run 
Shown are the potential energy (A), the density (B) and the box dimensions (C) in the x- (black 
line) and z-direction (grey line) for the system of the hH2Ri and hH2Ra2, respectively. The y-vector 
was similar to the x-vector (semiisotropic pressure coupling) and is not shown. Every 10
th
 frame 
(10 ps interval) was analyzed. 
 
The distance of the hH2Ri to its nearest periodic image was below the cut-off value for 
calculating long-range interactions (1.4 nm) in about 0.4% of all time points analyzed. The 
side chains of Arg215 and Asn217 in ICL3 approach Cys304 and Cys305 in the C-terminus, 
respectively (Figure 4.12). However, this long range interaction in the x-y plane was only 
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temporary, and no artifacts were expected from that. The hH2Ra2 was in a proper distance to 
its periodic images during the whole simulation. 
 
             hH2Ri         hH2Ra2 
 
  
 
 
Figure 4.12: Distance and position of the hH2R to its periodic images 
A, Distance of the hH2Ri and hH2Ra2 to its nearest periodic image. The red dashed line indicates 
the cut-off value for the calculation of non-bonded long range interactions (1.4 nm). Every 10
th
 
frame was analyzed (10 ps interval). B, The hH2Ri in the middle (orange ribbon and tubes) and 
its eight periodic images (green ribbon and tubes) in the x-y plane, viewed from the intracellular 
side. Amino acids closer than 1.4 nm in 0.4% of all time points are highlighted with cyan spheres. 
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98 4.3 Results 
4.3.4 Structural analysis of the DPPC bilayer 
Analogously to the equilibration phase of the hH2Ri and hH2Ra2 the corresponding 
parameters of the DPPC bilayer were analyzed during the 80 ns productive MD simulations. 
The deuterium order parameters (Figure 4.13 A) of the sn-1 and sn-2 chains of both 
simulation systems were in very good agreement with the values provided by Douliez (1995). 
The orientations of the lipid head groups, represented by the frequency distributions of the 
angle formed by the P→N vector and the bilayer normal (peaks at 81° for both hH2Ri and 
hH2Ra2; Figure 4.13 B) were in good agreement to experimental values, too. The bilayer 
thickness remained nearly constant in the simulation systems (mean ± SD for hH2Ri and 
hH2Ra2: 37.9 ± 1.6 Å and 38.1 ± 1.4 Å) and was in excellent agreement to the values 
obtained from experiments (Figure 4.13 C). As demonstrated (Figure 4.10), the area per lipid 
for DPPC decreased in both systems during the equilibration phase by about 10 Å². This was 
in correlation with the alterations of the box dimensions which were compressed in the plane 
of the membrane and expanded in the direction parallel to the normal of the membrane in the 
hH2Ri and hH2Ra2 system, respectively. During the production run (Figure 4.13 D) a slight, 
continuous decrease of the area per lipid was obvious in the hH2Ri system. In both systems, 
the values were still above the lowest limit of the experimental reference values, and the 
standard deviations were small (mean ± SD for hH2Ri and hH2Ra2: 54.3 ± 1.7 Å² and 53.6 ± 
1.4 Å²).  
The alignment of the hydrophobic belt of the hH2Ri and hH2Ra2 with the lipophilic DPPC 
chains was assessed by calculating the fraction of time points in which a hydrophobic moiety 
of an amino acid was in close distance to the carbon chains of the membrane lipids (distance 
of hydrophobic heavy atoms < 5 Å). Figure 4.14 shows that most amino acids of the GPCR 
core were in close contact to the lipids during the entire simulation.  
The absence of water molecules within the lipid tails of DPPC during the MD simulations of 
hH2Ri and hH2Ra2 was checked visually and by calculating the density profile of water 
molecules along the normal of the membrane (Figure 4.15). The density curve of the hH2Ra2 
system was shifted to the right due to the space filling GαCT below the intracellular part. No 
water molecules diffused into the hydrophobic core of the bilayer within the 80 ns MD 
simulations. 
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Figure 4.13: Bilayer parameters of the 80 ns MD simulation of the hH2Ri and hH2Ra2 
The deuterium order parameters (A), the orientation of the P→N vector of the lipid head groups 
in relation to the bilayer normal (B), the bilayer thickness (C) and the area per lipid (D) were 
determined and compared to reference values as described in Figure 4.7, Figure 4.8, Figure 4.9 
and Figure 4.10, respectively. 
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                                hH2Ri   hH2Ra2 
Hydrophobic contacts 
 
Figure 4.14: Contact of the hH2R states to the lipophilic tails of DPPC 
For each amino acid of the hH2Ri and hH2Ra2, respectively, the frequency of hydrophobic 
contacts to the lipophilic tails of DPPC (carbon atom 2 to 16 of the sn-1 and sn-2 chain, 
respectively, as defined in Figure 4.1) were calculated. The surface of the final structures (after 
80 ns MD simulations) of the two receptor states were colored according to these frequencies 
(rainbow coloring from blue to red corresponding to 0% to 100% frequency). 
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Figure 4.15: Density profile of the water molecules in the simulation boxes of the hH2Ri 
and hH2Ra2 along the normal of the membrane 
 
4.3.5 Protein structure validation 
The quality of the proteins was assessed every 10th picosecond during the entire 80 ns MD 
simulations of the hH2Ri and the hH2Ra2, respectively, resulting in 8,000 time points. All data 
were obtained with the program gro_validation and the tool for analyzing the frequency of H-
bonds of each heteroatom of a protein included in gro_hbonds. Both programs are described 
in chapter 5. 
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4.3.5.1 Stereochemistry and planarity 
Stereochemical errors in MD simulations may dramatically influence results (Schreiner et al., 
2011). The analysis of correct configurations at Cα atoms of amino acids is therefore a 
fundamental task for proving the quality of an MD approach. In our simulations, the 
stereochemistry at Cα atoms was correct for all amino acids of the hH2Ri, hH2Ra2 and GαCT. 
All dihedral angles (more than 2.21 and 2.42 million in hH2Ri and hH2Ra2-GαCT, respectively) 
used for testing stereochemistry were within the range of 15° to 47° (Figure 4.16 A), with a 
mean (and mode) of the distributions of all angles of 32° to 33° (Figure 4.16 B). For 
proteinogenic L-amino acids with an ideal tetrahedral configuration around the Cα atom this 
angle is about 35°. 
 
                 hH2Ri              hH2Ra2-GαCT 
  
 
  
  
  
Figure 4.16: Control of the stereochemistry at Cα atoms 
A, Frequency distribution of the dihedral angle Cα-N-C-Cβ used to check the stereochemistry at 
the Cα atom of all amino acids of the respective protein over all time points analyzed. B, Mean 
(black point) ± SD (grey line) of the dihedral angle Cα-N-C-Cβ of every residue. The break of the 
graph in hH2Ra2-GαCT separates hH2Ra2 and GαCT. 
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102 4.3 Results 
Aromatic side chains (of His, Phe, Trp and Tyr) as well as polar side chains (of Arg, Asn, 
Asp, Gln and Glu) containing a delocalized π-electron system are putative planar moieties in 
proteins. In accurate MD systems their planarity is retained throughout the simulation. To 
investigate the deviation from planarity, suitable dihedral angles (chapter 5) were measured 
in the hH2Ri and hH2Ra2-GαCT. 
 
                 hH2Ri               hH2Ra2-GαCT 
  
  
  
  
  
  
Figure 4.17: Analysis of naturally planar moieties in amino acid side chains 
A, Frequency distribution of all dihedral angles used to measure planarity of aromatic side chains 
(His, Phe, Trp and Tyr) and planar delocalized π-electron systems (Arg, Asn, Asp, Gln and Glu) of 
amino acid side chains. B, Mean of all dihedral angles used to measure planarity of one specific 
residue. C, Mean of each analyzed dihedral angle. The break of the graph in hH2Ra2-GαCT 
separates hH2Ra2 and GαCT. 
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In both simulations only 13 angles (of a total of more than 4.75 and 5.20 million angles 
analyzed in hH2Ri and hH2Ra2-GαCT, respectively) deviated more than 30° from planarity 
(Figure 4.17 A). The mean dihedral angle of each residue with a planar moiety, composed of 
up to 20 single dihedral angles (e.g. for the side chain of tryptophan), was within ± 4° in both 
systems (Figure 4.17 B). The mean of each measured dihedral angle was within ± 8° (Figure 
4.17 C). 
 
In order to assess the geometry of the peptide bond of the proteins in both MD simulations, 
the omega angle between the planes Oi-Ci-Ni+1 and Ci-Ni+1-Hi+1 was measured (chapter 5). 
This angle is 180° in case of a planar trans configuration of the atoms at the amide bond Ci-
Ni+1.  
 
                hH2Ri                   hH2Ra2-GαCT 
  
  
  
  
Figure 4.18: Analysis of the peptide dihedral angle 
A, Frequency distribution of the omega dihedral angles of all amino acids over all time points 
analyzed. B, Mean (black point) ± SD (grey line) of the omega angle of each residue of the hH2Ri 
and hH2Ra2-GαCT, respectively. The break of the graph in hH2Ra2-GαCT separates hH2Ra2 and 
GαCT. 
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104 4.3 Results 
Figure 4.18 shows the distribution of all omega angles of the hH2Ri and the hH2Ra2 systems 
(2.32 and 2.52 million, respectively) as well as the mean omega angles of each residue. The 
mean of all angles was ~ 177°. This is in good agreement with values obtained from 
literature of about 179° (MacArthur and Thornton, 1996; Morris et al., 1992). However, the 
width of the distribution was smaller for experimentally derived omega angles, having the 
majority of values within 170° to 190° (Edison, 2001). Thus, parameters of the GROMOS96 
53a6 force field affecting the amide bond Ci-Ni+1 should be defined more strictly. 
4.3.5.2 Ramachandran analysis 
The majority of residues of the hH2Ri and hH2Ra2 exhibited backbone Φ/Ψ (phi/psi) 
combinations located either in favored or allowed regions of the conformational space during 
the entire simulations (Figure 4.19). Only eleven and eight amino acids in hH2Ri and hH2Ra2-
GαCT, respectively, possessed dihedral angles not frequently occurring in proteins in more 
than 20% of all time points. Ramachandran plots of residues which have disallowed values in 
more than 50% of the time points are shown in Figure 4.20. Strikingly, all of these amino 
acids except Ser963.30 resided in flexible parts of the proteins, namely in loops or at the 
border of TMs. 
 
 
    hH2Ri              hH2Ra2-GαCT 
  
  
Figure 4.19: Ramachandran analysis of hH2Ri and hH2Ra2-GαCT in 80 ns MD simulations 
For each residue the frequency of Φ/Ψ dihedral combinations located in favored (blue), allowed 
(yellow) and disallowed (red) regions (as defined in chapter 5) of the Ramachandran plot is 
shown. The break of the graph in hH2Ra2-GαCT separates hH2Ra2 and GαCT. 
 
 
 
0.0
0.2
0.4
0.6
0.8
1.0
15 65 115 165 215 265
F
re
q
u
e
n
c
y
Residue number
0.0
0.2
0.4
0.6
0.8
1.0
15 65 115 165 215 265
F
re
q
u
e
n
c
y
Residue number
369
 Chapter 4: Molecular dynamics simulations of hH2R states 105 
 
h
H
2
R
i 
        Leu52
2.38
       Ser96
3.30
      Lys88
3.22
 
   
    
    
 0 ns              Φ/Ψ               80 ns 0 ns              Φ/Ψ               80 ns 0 ns              Φ/Ψ               80 ns 
    
                                          Cys171.31                               Trp158ECL2 
 
 
  
             
 0 ns              Φ/Ψ               80 ns          0 ns              Φ/Ψ               80 ns 
     
h
H
2
R
a
2
-G
α
C
T
 
        Lys88
3.22
       Ala16
1.30
     Glu392
GαCT
 
   
    
    
 0 ns              Φ/Ψ               80 ns 0 ns              Φ/Ψ               80 ns 0 ns              Φ/Ψ               80 ns 
 
Figure 4.20: Ramachandran plots of residues with a high proportion of time points in 
which an outlier region was occupied 
Ramachandran plots for amino acids of the hH2Ri and hH2Ra2 (including GαCT) with more 
than 50% of their Φ/Ψ dihedral angles in the outlier region. Below each Ramachandran plot 
the time dependent distribution of Φ/Ψ pairs is given. The analysis was performed as 
described in chapter 5. Red, favored region; yellow, allowed region; grey, disallowed region. 
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106 4.3 Results 
4.3.5.3 Side chain rotamers 
Frequently occurring side chain conformations (rotamers) of amino acids are accessible from 
protein crystal structures and were analyzed previously (Lovell et al., 2003; Lovell et al., 
2000). The agreement of rotamers obtained in MD simulations with these experimentally 
derived low-energy conformations accounts for the reliability of the MD results. The majority 
of residues of the hH2Ri, hH2Ra2 and GαCT had side chain dihedral angles or combinations of 
dihedral angles (in case of residues with more than one rotatable bond in the side chain), 
respectively, during the 80 ns MD simulation which are frequently occurring in protein crystal 
structures (Figure 4.21). In both simulation systems just two amino acids possessed in more 
than 20% of the simulations improbable conformations. In hH2Ri the rotamers of His230
6.31 
and Glu1805.36 had in 26.2% and 25.4% of the simulation, respectively, disallowed dihedral 
angles. The side chain torsions of Met1003.34 of the hH2Ra2 were in 24.8% of the simulation in 
outlier regions, and of Glu370 (GαCT) in 22.5%. 
 
       hH2Ri       hH2Ra2-GαCT 
  
   
Figure 4.21: Rotamer analysis 
For the 80 ns simulation for each residue of the hH2Ri and hH2Ra2 (including GαCT) the number of 
side chain dihedral angles located in favored (blue), allowed (yellow) and disallowed (red) regions 
(as defined in chapter 5) is shown. The break of the graph in hH2Ra2-GαCT separates hH2Ra2 and 
GαCT. 
 
4.3.5.4 Saturation of heteroatoms with H-bonds 
The control of unsatisfied buried H-bond donors and acceptors in protein structures is a 
common tool in molecular modeling (Vriend, 1990). The saturation of heteroatoms with H-
bonds was checked with the program gro_hbonds described in chapter 5. The majority of 
heteroatoms of hH2Ri and hH2Ra2-GαCT were H-bonded for most of the simulation time 
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(Figure 4.22 A, B). Furthermore, most of the side chains of polar amino acids located in TM 
domains were well H-bonded (Figure 4.22 C, D). The average saturation of polar side chains 
in TM domains was 96.7% and 94.8% for the simulation of the hH2Ri and hH2Ra2, 
respectively.  
 
  
  
  
 
  
Figure 4.22: Saturation of protein heteroatoms with H-bonds 
A, B, Frequency distribution of protein heteroatoms with respect to their fraction of being H-
bonded for the hH2Ri (A) and hH2Ra2-GαCT (B). C, D, Frequency of side chains of polar amino 
acids within the TM segments of the hH2Ri (C) and hH2Ra2 (D) involved in H-bonds. The grey 
background indicates the maximal TM domains of hH2Ri and hH2Ra2. 
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Tyr1925.48 was least saturated with H-bonds in the hH2Ri (26%) and hH2Ra2 (30%), 
respectively. In both receptor states the side chain of Tyr1925.48 was mainly connected to the 
backbone oxygen of Phe2516.52. This is similar to the structures of the β1AR and the β2AR, in 
which the corresponding Tyr2175.48 and Tyr2095.48 are close to the backbone oxygen of 
Phe3076.52 and Phe2906.52, respectively (Cherezov et al., 2007; Warne et al., 2008). In both 
structures this oxygen is the only heteroatom in a radius of 4 Å around the Tyr5.48 hydroxyl 
group which is capable of forming H-bonds. 
4.3.6 Secondary structure of hH2R states 
The stability of the α-helical structure of TM domains of the hH2Ri and hH2Ra2 was checked 
with the DSSP (Define Secondary Structure of Proteins) algorithm (Kabsch and Sander, 
1983). The prolines in position 2.59 and 5.50 caused an interruption in the α-helix of the two 
hH2Rs (Figure 4.23). Additional deviations from an ideal α-helix occurred in TM3, TM4 and 
TM7 of hH2Ri and in TM4, TM6 and TM7 of hH2Ra2. However, the secondary structure of 
these TMs was retained throughout the simulation (Table 4.2).  
 
  hH2Ri hH2Ra2 
 
 
Figure 4.23: DSSP plot of the hH2Ri and hH2Ra2 
DSSP plot illustrating the dynamics of secondary structure elements of the hH2R models during 
the 80 ns MD simulation. Blue, α-helix; red, β-strands; yellow, turn; green, bend; white, coil. 
 
 
The distortion of the α-helix in T 4 is located around position 4.57. The templates tβ1AR and 
hβ2AR of the hH2Ri and hH2Ra2, respectively, contain a proline kink based on Pro
4.60 (chapter 
3). Distortions of α-helices in TM domains three amino acids before a proline are typical 
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when analyzing the secondary structure with the DSSP algorithm and were observed for 
T 2 and T 5, too. The temporary interruption of the α-helix at His2306.31 in hH2Ra2 is located 
at the cytoplasmic end of TM6 which belongs to the most flexible parts of TM domains 
(Figure 4.27).  
 
 
Table 4.2: Secondary structure analysis of critical residues in TMs of the hH2Rs 
hH2Ri 
 hH2Ra2 
Residue H
a
 DSSP
b
  Residue H
a
 DSSP
b
 
Thr95
3.29
 62  
 Leu149
4.56
 51  
Ser96
3.30
 61  
 Ser150
4.57
 9  
Leu149
4.56
 68  
 Phe151
4.58
 54  
Ser150
4.57
 26  
 Glu229
6.30
 78  
Phe151
4.58
 51  
 His230
6.31
 10  
Tyr278
7.43
 49  
 Ala279
7.44
 72  
Ala279
7.44
 14  
    
a 
Percentage of time points the respective amino acid is α-helical. 
b
 Each bar represents the whole 80 ns simulation, black color indicates the presence of an  
α-helix. 
 
 
Most secondary structure elements were retained during the simulations of the hH2Ri and 
hH2Ra2. However, in both cases the α-helical part of ECL2 was already disrupted during the 
equilibration phase. By contrast, the α-helix of ICL2 was stable until the end of the 
simulations. Disorganization of the secondary structure was also observed in the hH2Ri at the 
cytoplasmic ends of TM5 and TM6. In the initial model ICL3 was constructed by a loop 
search (chapter 3), resulting in an elongation of the α-helical segments of TM5 and TM6 into 
the solvent. Without the stabilizing effect of GαCT in the active hH2R these segments are 
obviously instable (Figure 4.24). Only small α-helical fragments separated from TM6 were 
temporarily present. 
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Ile205
5.61 
 
 
 
Met240
6.41
 
 
                             
Figure 4.24: Disruption of the cytoplasmic ends of TM5 and TM6 in hH2Ri 
A, Snapshots of the MD simulation of hH2Ri before the equilibration and at time points 0, 20, 40, 60 
and 80 ns. B, DSSP plot from the end of TM5 to the beginning of TM6 (Ile205
5.61
 to Met240
6.41
); a 
black line indicates the presence of an α-helix. 
 
 
Kinks in the α-helical segments of the hH2R states were present in TM2, TM5, TM6 and TM7 
(Figure 4.25). The kink in TM2 of hH2Ri was constant throughout the simulation (mean ± SD: 
27.9 ± 2.3°) and comparable to that in the initial model (29.8°; cf. Table 3.8). In hH2Ra2 the 
kink rose in the first 10 ns of the simulation from about 30° to 33°. The kink in the initial 
hH2Ra2 model was only 26.8°. The marginal increase of the kink angle could not be ascribed 
to changes around Pro732.59 or the extra- and intracellular positions of TM2. The kinks in 
TM5 of hH2Ri and hH2Ra2 fluctuated least and were comparable to the kinks in the initial 
models (mean ± SD for hH2Ri: 14.5 ± 1.6° vs. 12.0°; mean ± SD for hH2Ra2: 11.8 ± 1.4° vs. 
13.4°).  
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                         hH2Ri            hH2Ra2 
 
   
 
  
   
 
  
   
 
  
    
 
 
Figure 4.25: Proline kinks of hH2R states in TM2, TM5, TM6 and TM7 
Left, Superimposed TM domains of the hH2Ri () and hH2Ra2 (), using the average structures 
of the 80 ns MD simulation, respectively (cf. Figure 4.30). Cα atoms of proline are shown as 
spheres. The numbers on the left are the respective backbone RMSDs. Right, Proline kinks of 
TM2, TM5, TM6 and TM7. The mean kink is shown with the red dashed line. The kink was 
calculated every 10
th
 picosecond. 
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The proline kinks of TM6 in hH2Ra2 and of TM7 in hH2Ri remained stable and were similar to 
those in the initial models (31.7 ± 2.5° vs. 29.1° and 42.3 ± 2.7° vs. 40.2°, respectively). The 
TM6 kink in hH2Ri rose in the first 10 ns of the simulation from about 38° to 42°, caused by 
the slight movement of the highly flexible cytoplasmic part of TM6 towards TM7. At 65 ns the 
kink decreased by about 7°, probably due to the release of a water molecule near Pro2496.50 
(section 4.3.8.1). The kink in TM7 of hH2Ra2 was higher at the beginning of the simulation 
(~ 44°) compared to the initial model (36.1°) and decreased in the first 25 ns to about 36°. 
The determination of this kink was not quite accurate for the hH2Ra2 since the α-helix of TM7 
was permanently present only until Leu2877.52, just two amino acids after Pro2857.50 (from 
Tyr2887.53 to Leu2917.56, α-helical structures occurred in < 10% of time points). Remarkably, 
the proline kink was not responsible for the inward move of TM7 at the cytoplasmic part 
during receptor activation. Accordingly, the average TM7 domains of hH2Ri and hH2Ra2 fitted 
quite well (backbone based RMSD 1.5 Å; Figure 4.25). However, the complete TM7 was 
shifted, resulting in a more inwards position of its cytoplasmic end. Nevertheless, the change 
of the kink at the beginning of the hH2Ra2 simulation was the result of the distorted α-helix 
following Pro2857.50. The backbone of Ala2897.54 was shifted towards TM1. Whereas H-bonds 
between the backbone nitrogen of Ala2897.54 and the backbone oxygen of Asn2847.49 
became less frequent, the H-bond frequency between the oxygen of Ala2897.54 and the 
backbone nitrogen of Asn2927.57 increased. Furthermore, van der Waals contacts between 
Ala2897.54 and Pro2857.50 occurred more frequently (Figure 4.26). 
 
 
  
Figure 4.26: Contacts of Ala289
7.54
 in hH2Ra2 
A, H-bond frequency between the backbone nitrogen of Ala289
7.54
 and the backbone oxygen of 
Asn284
7.49
 (grey line) as well as between the backbone oxygen of Ala289
7.54
 and the backbone 
nitrogen of Asn292
7.57
 (black line). B, Frequency of van der Waals contact between Ala289
7.54
 
and Pro285
7.50
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In summary, changes of the kinks in TM domains caused by highly conserved prolines seem 
not to be necessary for the transmission from the inactive to the active hH2R state. Moreover, 
the kinks were well comparable when superimposing the respective TM domains of the hH2Ri 
and hH2Ra2 (Figure 4.25). Instead, receptor activation of the hH2R is accompanied with 
movements of complete TMs. 
4.3.7 Flexibility of the proteins and comparison of the backbone positions of hH2R 
states 
The root mean square fluctuation (RMSF) is a measure for the deviation of a special residue 
or particle averaged over time. It is therefore suitable to determine the mobility of a protein 
during a simulation (Figure 4.27). Not surprisingly, extra- and intracellular loops, as well as 
the N- and C-terminus were most flexible. RMSF values based on side chain atoms were 
generally slightly higher than values based on backbone atoms. A similar curve is presented 
in Figure 7.1, which shows the crystallographic temperature factors (B-factors; an indicator of 
the mobility) of an active GPCR conformation of the hβ2AR (Rasmussen et al., 2011a). 
 
           hH2Ri       hH2Ra2 
 
  
  
Figure 4.27: Root mean square fluctuation (RMSF) of the hH2Ri and hH2Ra2 during 80 ns of 
MD simulation 
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Remarkably, ECL2, ICL3 and ECL3 were more flexible in the hH2Ri than in the active 
receptor conformation. Despite similar courses of ECL2 and ECL3, respectively, in the initial 
models of the hH2Ri and hH2Ra2 (Figure 3.9), during the MD simulation of hH2Ra2 constant 
interactions between ECL2 and ECL3 occurred (section 4.3.9.3), restricting the mobility of 
ECL3. In the hH2Ri, ECL3 moved outwards already during the equilibration phase and 
retained in that position in the production run, broadening the access to the binding site 
between ECL2 and ECL3 (cf. section 4.3.9.3). In the hH2Ra2, the intracellular ends of TM5 
and TM6 as well as ICL3 were stabilized by the parallel arrangement of TM5 and TM6 and 
contacts to GαCT. In hH2Ri, the respective parts were able to move freely in the intracellular 
solvent and therefore exhibited higher mobility. 
Analyzing the deviation from the input structure of the MD simulation based on the complete 
protein backbone, in hH2Ri stable RMSD values were only obtained temporarily between 20 
ns and 40 ns (~ 3.0 Å) and after 45 ns (~ 3.5 Å), respectively (Figure 4.28 A). If only the TM 
domains are considered, a quite stable RMSD value of about 2.0 Å was reached after 15 ns. 
However, RMSD values were always lower in the hH2Ra2 simulation. The hH2Ra2 converged 
after 15 ns to stable values of about 2.0 Å and 1.2 Å in the case of all backbone atoms and 
the TM-backbone, respectively (Figure 4.28 B). The higher displacement in the hH2Ri 
simulation was possibly caused by different interactions of extracellular loops (section 
4.3.9.3), the insertion of the G-protein fragment GαCT in hH2Ra2 and by the stabilizing effects 
of histamine in the binding site of hH2Ra2, connecting TM domains at the extracellular part by 
generating stable contacts to TM3, TM5, TM6 and TM7 (section 4.3.10). 
 
              hH2Ri           hH2Ra2 
 
 
Figure 4.28: Root mean square deviation of the backbone of the hH2Ri and hH2Ra2 from the 
input structures during 80 ns of simulation time 
Root mean square deviations based on backbone atoms (black line) and on TM-backbone atoms 
(grey line) of the hH2Ri and hH2Ra2. 
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In the hH2Ri, largest displacements of TM domains compared to the input structure of the 
simulation occurred in TM5 (Figure 4.29). The extracellular part before the kink caused by 
Pro1945.50 (backbone RMSD up to 3.1 Å) moved away from TM4 (~ 1 Å; measured between 
the Cα atoms of Ile154
4.61 and Asp1865.42). Thus, the number of interactions at the TM4-TM5 
interface was very low (cf. section 4.3.9.2). Instead, hydrophobic amino acids (Leu1494.56, 
Ile1544.61, Val1855.41 and Val1895.45) were in close contact to the lipophilic tails of DPPC. 
Furthermore, Trp158ECL2 interacted with residues at the top of TM4 and TM5 (Ser1534.60, 
Ile1544.61, Val1855.41 and Val1895.45). The center of TM5 (Thr1905.46 to Ile2055.61) remained 
quite stable in its position (RMSD ~ 1.7 Å). The intracellular part of TM5 extending into the 
cytoplasmic solvent moved away from TM6 (~ 1.5 Å; measured between the Cα atoms of 
Tyr2025.58 and Ala2376.38; RMSD up to 5.3 Å). Together with the disruption of the cytoplasmic 
end of TM6 this resulted in a reduction of contacts between the cytoplasmic parts of TM5 and 
TM6. In the hH2Ra2 the protruding position of TM6 enabled a parallel positioning of both TMs 
and thus a high number of interactions (Figure 4.47). TM3 of hh2Ri moved as a whole slightly 
into the cytoplasm and at its extracellular part further towards TM6 (by 1.7 Å; measured 
between the Cα atoms of Val99
3.33 and Phe2516.52), which also moved towards TM3. Highest 
RMSD values (~ 2.1 Å) were obtained for amino acids facing the center of the receptor, 
namely Phe903.24, Tyr943.28 and Asp983.32. Such as TM3, also TM4 moved slightly towards 
the cytoplasm (average RMSD 2.2 Å). 
In the hH2Ra2 minor changes occurred. At the extracellular part of the receptor TM1 was 
displaced most (average RMSD 4.6 Å). The α-helix of Thr201.34 to Val231.37 was slightly 
disrupted during the last equilibration step. However, an ideal 1,4 α-helix was quickly 
restored in the production run. Furthermore, TM1 and TM2 were separated at their 
extracellular ends by about 1 Å. The new position of TM1 was closer to the middle of the 
TM2-TM7 interface and even further away from TM1 in hH2Ri after superimposing the two 
hH2R states (Figure 4.30). ICL3 and the intracellular ends of TM5 and TM6, which both 
extended into the solvent (Asp2115.67 to Val2346.35), moved inwards following the shift of 
GαCT (section 4.3.10.2) to retain the close interaction between the receptor and the G-
protein fragment. Finally, H8 further approached TM1. Comparing the first and the last 
quarter of the simulation, the frequency of van der Waals contacts rose for Val381.52-Phe295 
(39% → 100%), Val381.52-Leu302 (7% → 63%), Leu411.55-Leu302 (41% → 97%), Ala421.56-
Gly298 (19% → 99%), Ala421.56-Leu302 (65% → 86%) and Val431.57-Asp294 (7% → 96%). 
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B 
 
Figure 4.29: Displacement of the backbone of hH2Ri and hH2Ra2 during the 80 ns MD 
simulation 
A, Comparison of the structure at the start of the simulation, the final snapshot after 80 ns and the 
average structure (average coordinates) of the hH2Ri and hH2Ra2, respectively. B, Residue based 
RMSD of all snapshots (8,000 in total) with respect to the structure at the beginning of the 
simulation. 
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Based on the superposition of backbone atoms of the common TM domains of the hH2Ri and 
hH2Ra2, respectively (Figure 4.30 and Figure 4.31), major differences occurred at the extra- 
and intracellular end of TM1, which in hH2Ra2 was shifted more towards TM7 and located 
more outwards due to the inwards movement of TM7 and helix 8, respectively. At the 
intracellular side of the hH2Ra2, TM3 was closer to the core of the receptor and TM4 moved 
away from TM2, which adopts an outward position in hH2Ra2 to allow the inward movement 
of T 7 and the interaction with GαCT. Furthermore, at the intracellular side the protein 
fragment from the end of TM5 to the beginning of TM6 was located more outwards in the 
hH2Ra2 as already resulting from the comparison of the initial hH2R models (chapter 3). At the 
extracellular side minor changes occurred. TM5 of hH2Ri was more separated from TM4, and 
TM6 followed this shift and moved slightly towards TM7. However, the highly flexible loops, 
especially ECL2, ICL3 and ECL3, deviated most between hH2R states. 
 
 
Extracellular view Intracellular view 
 
 
Figure 4.30: Superimposition of the average structures of the hH2Ri and hH2Ra2 
The average backbone coordinates of the hH2Ri () and hH2Ra2 (), respectively, were 
calculated after superimposing every 10
th
 coordinate file (8,000 in total) of the respective MD 
simulation to the input structure of the simulation, based on backbone atoms (using g_rmsf of 
GROMACS). The resulting average structures of the two hH2R states were then superimposed 
based on their common TM domains. Loops are not shown for reasons of clarity. 
 
 
 
TM3
TM4
TM5
TM6
TM7
TM2
TM1 TM3
TM4
TM5 TM6
TM7
TM2
TM1
H8
118 4.3 Results 
  
Figure 4.31: Backbone based root mean square deviation of hH2R states 
The structures of the hH2Ri and hH2Ra2 at different simulation times were superimposed based 
on backbone atoms of their common TM domains. The grey background indicates the common 
TM domains of the two hH2R states. 
 
 
4.3.8 Internal water molecules 
4.3.8.1 Stability of putatively conserved water molecules inserted into the initial hH2Rs  
In the initial homology models of the hH2Ri and hH2Ra2, ten putatively conserved water 
molecules were inserted (Angel et al., 2009), respectively. Their stability within the TM 
bundle during the MD simulations was assessed by calculating their distance to the center of 
mass of the receptor and their hydrogen bonding to the receptor. These two measurements 
were in good agreement to each other (see example in Figure 4.32 A, B). In the hH2Ri none 
of the ten water molecules remained stable in its position during the whole 80 ns simulation 
period. The water molecule received from the crystal structure of the hβ2AR (Cherezov et al., 
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2007) mediates the contacts between Cys2466.47, Tyr2506.51 and Val2737.38. It was present in 
its original position between TM6 and TM7 until 67 ns. Then it moved to the extracellular 
solvent. Strikingly, this was exactly the time the angle of the proline kink of TM6 decreased 
from about 40° to 36° (Figure 4.25). The missing water molecule led to the formation of an H-
bond between the backbone atoms of Cys2466.47 and Tyr2506.51, bringing these residues into 
closer distance (Figure 4.32 C, D). However, an impact of this conformational change on 
receptor activation was not obvious. 
 
  
  
  
Figure 4.32: Conserved water molecule between TM6 and TM7 
A, Frequency of hydrogen bonding of the water molecule inserted near Cys246
6.47
, Tyr250
6.51
 
and Val273
7.38
 to the protein; B, Distance of this water molecule to the center of mass of the 
receptor. C, Frequency of H-bonds between the backbone oxygen of Cys246
6.47
 and the 
backbone nitrogen of Tyr250
6.51
. D, Distance of the backbone oxygen of Cys246
6.47
 and the 
backbone nitrogen of Tyr250
6.51
. 
 
 
Water molecules connecting the side chains of Asn361.50 and Asp642.50 in the initial hH2Ri 
model, as well as Val2396.40, Asn2807.45 and Asn2847.49 were stable until 20 and 10 ns, 
respectively. They were part of the H-bond network between TM1, TM2, TM3 and TM7 just 
like five further water molecules leaving the hH2Ri within the first 3 ns of the simulation. All of 
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them were replaced by other water molecules from the solvent during the MD simulation. The 
water molecule inserted between TM4 and TM5 near the orthosteric binding site, obtained 
from the structure of the tβ1AR (Warne et al., 2008), was not stable in the receptor and was 
not replaced. In its initial position it stabilized the kink in TM4 which was introduced by the 
template tβ1AR (section 3.3.1). Instead, backbone oxygen atoms of Leu149
4.56 and Ser1505.57 
were saturated by forming direct H-bonds to the side chain (frequency of 90%) or backbone 
(55%) of Ser1534.60. The remaining water molecule in the initial hH2Ri model (again obtained 
from the structure of the hβ2AR) connected the side chains of Ser75
2.61 and Trp2757.40 near 
the extracellular surface. However, diffusion of water molecules from the solvent displaced 
this molecule and the connection was broken, too. Subsequently the side chains of Ser752.61 
(direct H-bonds to Tyr943.28 and Tyr2787.43 with a frequency of 83% and 92%, respectively) 
and Trp2757.40 (water mediated H-bond to Gln792.65 in 66% of the simulation time) formed 
new and stable interactions. 
In general conserved water molecules added to the initial model of the hH2Ra2 were more 
stable in their positions. The water molecule between the backbone atoms of Cys2466.47, 
Tyr2506.51 and Val2737.38 remained in its position until 59 ns. After that point a direct H-bond 
was formed, however, without affecting the kink angle at Pro2496.50 such as in the inactive 
state. Remarkably, from 68 ns until the end of the simulation another water molecule from 
the solvent was present in the respective position, indicating the importance of a water 
molecule at this site. The connection between TM6 (Cys2466.47 and Tyr2506.51) and TM7 
(Val2737.38) mediated by these water molecules was weak but stable during the simulation 
(frequency of ~ 30%). Corresponding to the hH2Ri, the water molecule added between 
Ser752.61 and Trp2757.40 was quickly replaced by other water molecules from the extracellular 
solvent, and the side chains did not interact until the end of the simulation. Instead, the two 
residues formed stable H-bonds with Tyr943.28 (frequency of 90%) and Tyr2787.43 (98%) as 
well as Gln792.65 (95%), respectively. The water molecule near the kink of TM4, saturating 
mainly the backbone oxygen atoms of Leu1494.56 and Ser1505.57 was replaced after 25 ns by 
other water molecules. Stable water mediated H-bonds including the backbone and side 
chain atoms of Ser1534.60 stabilized the kink. The water molecules within the H-bond network 
of TM1, TM2 and TM7 were stable in their positions at least until 25 ns. All water molecules 
were subsequently replaced by solvent water, except of two which remained stable in their 
position until the end of the MD simulation (Figure 4.33). They mediated the contact between 
Asn361.50 and Asp502.50 and stabilized the intracellular end of TM7 by connecting the 
backbone nitrogen of Ala2897.54 to the H-bond network. 
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Figure 4.33: Stable conserved water molecules in hH2Ra2 
 
 
Taken together, the majority of the water molecules inserted in the initial hH2R models were 
not stable during the MD simulations. However, most of them were replaced by water 
molecules from the solvent, suggesting that these putatively conserved water molecules 
were appropriately placed in the homology models hH2Ri and hH2Ra2, and that there is a 
pronounced exchange between water molecules located within and outside the receptor, 
indicating the permeation of the inter-TM region with water molecules from the solvent. 
4.3.8.2 Solvation of polar amino acid side chains within TMs 
The permeation of the core of the receptor with water from the solvent was analyzed by 
calculating the average solvation of amino acids, i.e. the H-bond frequency of each residue 
with water molecules. Apart from the extra- and intracellular loops, especially residues of 
TM3, TM5, TM6 and TM7 were solvated despite their location between TM domains (Figure 
4.34 A, B), taking into account the space filling orthosteric binding site and the H-bond 
network around TM7. Of special interest was the solvation of polar amino acid side chains 
located in TM domains. Their average solvation was similar for the two hH2R states (70.5% 
in hH2Ri and 69.1% in hH2Ra2). However, not all polar side chains were in contact to water 
molecules during the simulation (Figure 4.34 C, D). Least solvated in the hH2Ri were side 
chains of Thr221.36 (0.7%), Ser963.30 (2.3%), Thr1033.37 (1.2%), Ser1504.57 (4.7%), His1554.62 
(2.0%) and Tyr1925.48 (0.0%). However, all of these buried residues were well saturated with 
H-bond acceptors and donors of neighboring amino acids (in more than 70% of the 
simulation H-bonds were detected), except Tyr1925.48, whose hydroxyl moiety was H-bonded 
in just 26% of all time points analyzed (cf. section 4.3.5.4). In hH2Ra2 Thr20
1.34 (1.2%), 
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Thr221.36 (1.3%), Thr321.46 (0.4%), Ser963.30 (0.5%), Thr1033.37 (3.1%), Ser1464.53 (0.0%), 
Tyr1925.48 (1.0%) and Thr2526.53 (1.5%) were the most buried residues. Saturation of a polar 
side chain with H-bonds was again minimal for Tyr1925.48 (30%; cf. section 4.3.5.4). All other 
polar side chains were sufficiently H-bonded as in the case of the hH2Ri. 
 
 
 
 
 
  
Figure 4.34: Solvation of amino acids in hH2Ri and hH2Ra2-GαCT 
A, B, H-bond frequency of amino acids of the hH2Ri (A) and hH2Ra2-GαCT (B) to water 
molecules. The grey background indicates the TM domains. The break of the graph in hH2Ra2-
GαCT separates hH2Ra2 and GαCT. C, D, Fraction of H-bonds of polar amino acid side chains 
(Arg, Asn, Asp, Gln, Glu, His, Lys, Ser, Thr, Tyr) to water molecules during the 80 ns MD 
simulations of the hH2Ri (C) and hH2Ra2 (D). The grey background indicates the maximal TM 
regions. 
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Thus, not only parts of the receptor exposed to the extra- and intracellular solvent were 
surrounded by water molecules, but also residues within TM domains, predominantly polar 
amino acid side chains. An H-bond network including polar side chains and water molecules 
was recently reported to be part of the activation mechanism of a constitutively active 
rhodopsin mutant (Standfuss et al., 2011). 
4.3.8.3 Solvation of polar side chains near the H-bond network around TM7 
In general, amino acids located between TM1, TM2, TM3 and TM7 and containing a polar 
side chain such as Thr321.46, Asn361.50, Thr632.49, Asp642.50, Ser1053.39, Asn2807.45, 
Ser2817.46 and Asn2847.49 are potential candidates to contribute to the H-bond network 
located at the cytoplasmic part of TM7. In the initial models of hH2Ri and hH2Ra2 this network 
was extended by seven conserved water molecules. However, single receptor conformations 
do not consider the flexibility related to water mediated H-bonds. Moreover, the interface 
between TM1, TM2, TM3 and TM7 was able to accept even more water molecules, enabling 
an extensive hydration of polar amino acid side chains. This solvation, calculated as the 
frequency of H-bonds between side chains and water molecules, is shown in Figure 4.35. 
 
 
               hH2Ri                 hH2Ra2 
 
   
Figure 4.35: Solvation of buried polar amino acid side chains 
A, B, Hydrogen bonds of the side chain heteroatoms of amino acids indicated at the abscissa to 
water molecules during the 80 ns MD simulations of the hH2Ri and hH2Ra2. Shown is the H-bond 
frequency for the period 0-20 ns (black bar), 20-40 ns (dark grey bar), 40-60 ns (bright grey bar) 
and 60-80 ns (white bar). 
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Least solvated in the hH2Ri were Thr32
1.46 and Ser2817.46, in the hH2Ra2 Thr32
1.46, Thr632.49 
and Ser1053.39. During the whole simulation, in the hH2Ri 194 and in the hH2Ra2 29 water 
molecules contributed to the H-bond network of these eight amino acid side chains, 
indicating a higher water diffusion in the inactive hH2R. The average number of water 
molecules in the network was slightly higher in the inactive state. In a radius of about ~ 10 Å 
around the side chain heteroatoms of Asn361.50, Asp642.50, Ser1053.39 and Asn2807.45 in the 
hH2Ri and hH2Ra2 there were on average 10.0 and 8.6 water molecules, respectively, hence 
in both hH2R states more than in the initial models. 
 
  
  
 
 
Figure 4.36: Path of water molecule 737 through the hH2Ri 
A, B, View from the intracellular side of the hH2Ri at time points 47,575 ps (A) and 47,576 ps (B). 
The water molecule 737 is shown in green. C, All water molecules partly contributing to the H-
bond network around TM7 were checked for penetrating the hH2Ri and the hH2Ra2, respectively, 
by analyzing their z-coordinates. The z-coordinates of water molecule 737 in the hH2Ri are 
shown. D, Superimposition of the average structures (for a description cf. Figure 4.30) of the 
hH2Ri (blue ribbons) and hH2Ra2 (orange ribbons). The average distances (hH2Ri vs. hH2Ra2; in 
Å) during the 80 ns MD simulations are shown for TM2-TM6 and TM3-TM6 (in red) as well as 
TM2-TM7 and TM3-TM7 (in cyan). The distances were calculated as described in Figure 3.10. 
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The close contact between TM3 and TM7 at the cytoplasmic part of the hH2Ra2 (12.7 Å vs. 
17.9 Å in the hH2Ri) prevented a diffusion of water molecules from the extra- to the 
intracellular solvent and vice versa. In the hH2Ri 26 water molecules which contributed to the 
H-bond network crossed the receptor from one side of the membrane to the other. An 
example is shown in Figure 4.36. The water molecule migrated from the extra- to the 
intracellular side of the receptor between Leu602.46, Ile1123.46, Leu2366.37 and Tyr2887.53. 
4.3.9 Molecular differences between the inactive and active hH2R state 
4.3.9.1 Detailed analysis of molecular switches and amino acid interactions 
Changes occurring during receptor activation of the hH2R are all directly or indirectly 
connected to differences in the conformation of the orthosteric binding site between hH2Ri 
and hH2Ra2. Whereas the initial homology models described in chapter 3 suggested how the 
signal is transferred from the binding site to the intracellular part of the receptor, the result of 
the 80 ns MD simulation of the hH2Ri and hH2Ra2 proved interactions to be stable, only 
transient or arising during the simulation. 
The crucial difference between the ‘inactive’ and ‘active’ binding site occurred at its bottom 
(Figure 4.37). In the hH2Ri the side chain of Cys102
3.36 fills the gap between Phe1915.47, 
Phe2436.44 and Phe2516.52. This was already the case in the initial hH2Ri model. The 80 ns 
simulation proved this interaction to be stable (frequency of van der Waals contacts 73%, 
92% and 61%, respectively). Cys1023.36 prevented the contacts of Ile1063.40 with Phe2516.52 
and Trp2476.48. In the active state Cys1023.36 points towards TM7, forming a water mediated 
H-bond with the backbone of Gly2777.42 (continuously during the simulation with a frequency 
of 35%), an interaction lacking in the initial hH2Ra2 model, which did not contain a water 
molecule in that position. This contact is a first link between the H-bond network and the 
altered binding site of the active state (see below). A connection between the corresponding 
residues in the β2AR (Val117
3.36 and Gly3157.42;(Rasmussen et al., 2011a) and opsin 
(Gly1213.36 and Ala2957.42;(Scheerer et al., 2008) was not observed. However, in the crystal 
structure of the partly activated human adenosine A2A receptor a water molecule is co-
crystallized between Thr883.36 and Ser2777.42 (PDB ID 2YDO;(Lebon et al., 2011). 
Furthermore, the side chain switch of Cys1023.36 enabled the approximation of Ile1063.40 to 
Phe2516.52 and Trp2476.48 (van der Waals contact frequencies of 100%) below the binding 
site of hH2Ra2. The latter two residues keep Ile106
3.40 in a position towards TM6. This allowed 
the change of the side chain orientations of Ile1063.40 and Phe2436.44, recently identified to be 
an important transition step in some GPCRs (Rasmussen et al., 2011a; Valentin-Hansen et 
al., 2012b). After receptor activation, Phe2436.44 was close to TM5 (van der Waals contact 
126 4.3 Results 
frequency to Pro1945.50 of 64%). Instead, in hH2Ri Ile106
3.40 was close to TM5 (van der Waals 
contacts to Leu1955.51 and Met1985.54 with a frequency of 86% and 98%, respectively), and 
Phe2436.44 was packed between Trp2476.48, Ser1053.39 and Ile1063.40 (frequency > 94%, 
respectively).  
 
 
  
Figure 4.37: Conformational differences below the orthosteric binding site of hH2R states 
Shown are the final snapshots (at 80 ns) of the hH2Ri (A) and hH2Ra2 (B). 
 
 
Furthermore, in hH2Ri Phe243
6.44 was able to contact TM7, forcing the side chain of 
Asn2807.45 by van der Waals contacts (frequency of 85%) towards TM2. By this, the H-bond 
network at the cytoplasmic part of the receptor is affected, too. In the initial hH2Ri model 
Asn2807.45 pointed towards TM6. Due to the switch of Phe2436.44 in hH2Ra2 towards TM5, the 
van der Waals contacts to Ser1053.39 (frequency of 94% in hH2Ri) and Asn280
7.45 
disappeared. Hence, both residues were able to form new interactions influencing the H-
bond network. Instead, in direction TM2/TM7 Leu1093.43 flanked Phe2436.44, contributing to 
restrain it in its ‘active’ position. Furthermore, in both hH2R states Phe243
6.44 is in close 
contact to Leu1955.51. However, the switch of Phe2436.44 forced the break of the 
Ile1063.40/Leu1955.51 contact (frequency of 86% in the inactive vs. 0% in the active state) and 
a separation of TM3 and TM5 in hH2Ra2 to enable the new side chain position of Phe243
6.44. 
The distance between the Cα atoms of Ile106
3.40 and Leu1955.51 increased on average from 
6.8 Å in hH2Ri to 9.8 Å in hH2Ra2. Between the inactive and active β2AR conformation, the 
respective increase was about 1.5 Å. To avoid an overlap of the Phe2436.44 side chain with 
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Ile1063.40, Phe1915.47, Pro1945.50 and Leu1955.51, the outward position of TM6 is inevitable. 
Phe2436.44 is just the anchor below which the outward movement of TM6 and deviations 
between hH2Ri and hH2Ra2 became obvious (increasing RMSD values; Figure 4.31). 
Additionally, the separation of T 3 from T 5 enabled an ‘upward’ shift of  et1985.54, just 
below the phenyl moiety of Phe2436.44. Met2406.41 moved upwards too and interacted with 
Met1985.54 (van der Waals contacts frequency of 100%). The Met1985.54-Met2406.41 contact 
contributed to keep TM6 in an outward position. The contact between Met2406.41 and 
Leu1093.43 (frequency 90% in hH2Ri) disappeared in hH2Ra2 (increased distance between 
TM3 and TM6). The changes of Met1985.54 and Met2406.41 were closely linked to the side 
chain switch of Tyr2025.58 (Figure 4.38).  
 
 
 
Figure 4.38: The interface between TM5 and TM6 of hH2Ri and hH2Ra2 
Shown are the final snapshots (at 80 ns) of hH2Ri (A) and hH2Ra2 (B). Tyr202
5.58
 and Met240
6.41
 
which exchange their position during receptor activation are shown as sticks, as well as 
Thr233
6.34
 in hH2Ri which helps to maintain Tyr202
5.58
 in its ‘inactive’ position.  
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First, the upward shift of Met2406.41 enabled that Tyr2025.58 may occupy the gap between 
TM3 and TM6 below Phe2436.44, and second, the upward move of Met1985.54 was necessary 
for the new position of the Tyr2025.58 side chain in hH2Ra2 where it contacted Ser113
3.47 (H-
bond frequency of 66%), Arg1163.50 of the DRY motif (direct and water mediated H-bond 
frequency 79%) and Tyr2887.53 of the NPxxY(x)5,6F motif (water mediated H-bond frequency 
53%; Figure 4.39). 
These interactions maintained the position of TM6, disrupted the ionic lock and the 
hydrophobic barrier and stabilized the inward position of TM7. In mutational studies at the 
β2AR Tyr223
5.58 was shown to play a role in stabilizing the active receptor conformation 
(Valentin-Hansen et al., 2012a), and in rhodopsin, the mutation of Tyr2235.58 to phenylalanine 
decreases the lifetime of the Meta II intermediate (Goncalves et al., 2010). 
 
  
Figure 4.39: Contacts of Tyr202
5.58
 to Arg116
3.50
 and Tyr288
7.53
 in hH2Ra2 
A, Summarized H-bond frequency (direct and water mediated) between the side chains of 
Tyr202
5.58
 and Arg116
3.50
; B, Water mediated H-bond frequency between the side chains of 
Tyr202
5.58
 and Tyr288
7.53
. 
 
 
An inward shift of TM5 as observed in the initial hH2Ra2 model and the structure of the active 
β2AR (Rasmussen et al., 2011a) seemed not to be important for the activation mechanism. 
Furthermore, a rotamer switch of Trp2476.48 which was proposed for some GPCRs (Shi et al., 
2002) and which was not observed in the initial hH2R model did also not occur during the 80 
ns MD simulation. Only slight differences were observed (mean ± SD for the 1 and 2 
dihedral angle: -70.8° ± 7.3° and 95.4° ± 11.8° in hH2Ri and -61.3° ± 9.2° and 106.1° ± 11.7° 
in hH2Ra2; Figure 4.40). Taken together, a rotamer change of Trp247
6.48 probably does not 
contribute to receptor activation of the hH2R. 
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            hH2Ri           hH2Ra2 
 
 
Figure 4.40: Dihedral angles of Trp247
6.48 
1 (black line) and 2 (grey line) dihedral angle of Trp247
6.48
 of the hH2Ri and hH2Ra2. 
 
 
The stable position during the 80 ns simulation of a downwards extended TM6 in hH2Ra2 
enabled a slightly closer distance between TMs 5 and 6 (~ 0.5 Å), a parallel alignment of 
both helices and a reordering of the TM5-TM6 interface, leading to more contacts between 
the two TMs than in hH2Ri (Figure 4.38 and cf. section 4.3.9.2). Due to the flexibility of TM5 
and TM6 during the MD simulation, even more residues were part of the TM5-TM6 interface 
than in the initial homology model of hH2Ra2. Overall 26 amino acids belonged to the 
interface in hH2Ra2, among which Ala209
5.65, Gln2125.68, Ile2165.72, Asn2175.73, Arg2286.29, 
Val2346.35, Ala2376.38 and Ile2446.45 were not identified in the initial model. Most of the 
contacts were hydrophobic interactions. Polar contacts occurred between Arg2105.66 and 
Thr2336.34 (H-bond between the side chains in 46% of the simulation), Gln2125.68 and 
Arg2286.29 (direct and water mediated H-bond between the side chains in 27% and 24% of 
the simulation, respectively) and between Glu2296.30 and Arg1163.50 (see below). In contrast, 
in hH2Ri only 14 amino acids of TM5 and TM6 contribute to the interface. All contacts were 
hydrophobic, except the H-bond between the side chains of Tyr2025.61 and Thr2336.34 
(frequency of 54%) which contributed to keep Tyr2025.61 in its ‘inactive’ position. 
Strikingly, the ionic lock which is composed of Asp1153.49 and Arg1163.50 of the highly 
conserved D/ERY motif and Glu2296.30 located at the cytoplasmic end of TM6 (Vogel et al., 
2008) showed a relevant change during the simulation of the hH2Ri (Figure 4.41). Unlike in 
the initial model indicating an open ionic lock such as observed in the template, the tβ1AR 
(Warne et al., 2008), the contact between Arg1163.50 and Glu2296.30 was temporarily present 
during the simulation. A hydrogen bond from the side chain of Arg1163.50 to the backbone of 
Glu2296.30 occurred in 40.7% of the simulation (Figure 4.42 A). The distance between the 
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charged side chain of Arg1163.50 and Glu2296.30 was in 22% of the simulation smaller than 5 
Å, indicating a moderate ionic interaction. In the period from 15 to 35 ns, the distance was 
increased (Figure 4.42 B). Furthermore, the side chain methylene groups of both amino 
acids were in close contact to each other in 25% of the simulation (Figure 4.42 C). The 
temporary presence of the ionic lock already supposed in chapter 3 is in accordance to 
experimental results from a rH2R mutant (see chapter 3;(Alewijnse et al., 2000) and is also 
discussed for the β2AR (Dror et al., 2009). In the inactive state further interactions of the 
Arg1163.50 side chain to amino acids of TM6 occurred, namely van der Waals contacts with 
Thr2336.34 and Leu2366.37 (frequency of 67% and 84%, respectively; the latter was already 
present in the initial model) and direct and water mediated H-bonds to the backbone of 
Ala2326.33 (frequency of 20%) and the side chain of Thr2356.36 (20%). In summary, the 
interactions of Arg1163.50 did essentially contribute to the strong TM3-TM6 contact in the 
inactive state (cf. Figure 4.47 in section 4.3.9.2). 
 
 
 
Figure 4.41: The ionic lock in hH2Ri and its disruption in hH2Ra2 
Amino acids forming the ionic lock and their neighboring residues are shown in the hH2Ri (A; blue 
ribbons) and hH2Ra2 (B; orange ribbons with GαCT in blue ribbons). H-bonds, water mediated H-
bonds and ionic interactions are indicated with yellow, cyan and green dashed lines, respectively. 
Amino acids performing polar contacts are shown in sticks and residues contributing to van der 
Waals interactions in spheres. 
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In contrast, in hH2Ra2 the distance between Arg116
3.50 and Glu2296.30 was too large during 
the entire simulation (about 20 Å between the positively charged side chain moieties; Figure 
4.42 D). In hH2Ra2 Arg116
3.50 interacted with the C-terminal fragment of the GsαS protein 
(section 4.3.10.2), Tyr2022.38 (Figure 4.39), the backbone of Leu2877.52 (H-bond frequency of 
70%) and Tyr2887.53 (see below). Thus, in the hH2Ra2 Arg116
3.50 played an important role in 
connecting TM3 and TM7 as well as bridging TM5 with TM7, both keeping TM6 in an 
outward position. The contacts to TM7 were not observed in the initial model.  
 
 
   
  
   
Figure 4.42: Ionic lock – contacts between Arg116
3.50
 and Glu229
6.30
 
A-C, MD simulation of the hH2Ri; A, H-bond frequency between the side chain of Arg116
3.50
 and 
the backbone of Glu229
6.30
. B, Distance between the closest charged side chain heteroatoms of 
Arg116
3.50
 and Glu229
6.30
. C, Distance between hydrophobic side chain atoms of Arg116
3.50
 and 
Glu229
6.30
; the distance calculation between hydrophobic sites was truncated at 10 Å. D, 
Distance between closest side chain heteroatoms of Arg116
3.50
 and Glu229
6.30
 in the MD 
simulation of the hH2Ra2. 
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Besides Arg1163.50 also the neighboring Asp1153.49 had a specific function in hH2Ri. As 
already obvious in the initial models, it was connected to Arg1163.50 via a salt bridge 
(frequency of 87%) as well as via direct and water mediated H-bonds (in 20% and 54% of the 
simulation, respectively), keeping Arg1163.50 in its ‘inactive’ position. In both receptor states 
contacts to TM2 were formed (H-bond to Thr532.39 in hH2Ri and van der Waals contact to 
Phe562.42 in hH2Ra2 in 92% and 84% of the simulation, respectively). Furthermore, the 
contact to Tyr126ICL2 was retained in both hH2R states (H-bond frequency > 98%). 
In hH2Ri, Glu229
6.30 was not only involved in the ionic lock. It formed additional contacts with 
TM3 (van der Waals interactions with Ala1193.53 and Val1203.54 in 54% and 84% of the 
simulation, respectively) and with the neighboring Ala2256.26, Thr2266.27, Ile2276.28 and 
Arg2286.29, maintaining the side chain in an appropriate position to interact with Arg1163.50. In 
contrast, in hH2Ra2 Glu229
6.30 exclusively interacted with TM5. Polar contacts were formed 
with Arg2105.66 (frequency of 73%, in 50% of the simulation an ionic interaction between the 
two side chains occurred as already observed in the initial hH2Ra2 model), Lys214
5.70 
(frequency of 64%, in 58% ionic interactions), Asn2175.73 (frequency of direct and water 
mediated H-bonds of 50%), and van der Waals contacts with Ala2135.69 (93%). Thus, 
whereas Glu2296.30 was a key amino acid in hH2Ri for connecting TM3 and TM6, it was one 
of the key residues for the strong TM5-TM6 contact in hH2Ra2 (cf. Figure 4.47 in section 
4.3.9.2). 
The disruption of the packing of hydrophobic amino acids of TM2, TM3 and TM6 in the core 
of the receptor (the so called hydrophobic barrier;(Li et al., 2004; Standfuss et al., 2011) 
upon receptor activation was already observed by comparing the initial homology models 
hH2Ri and hH2Ra2. Like the cleavage of the ionic lock, it was the result of the TM6 movement. 
The average distance, e.g. between Cα atoms of Leu109
3.43 and Leu2366.37, increased from 
7.8 Å in hH2Ri to 13.1 Å in hH2Ra2. During the 80 ns MD simulation the hydrophobic barrier 
was composed of Leu602.46, Leu1093.43, Ile1123.46, Ser1133.47, Leu2366.37, Val2396.40 and 
Met2406.41 (Figure 4.43). In hH2Ri, van der Waals contacts were formed by Leu60
2.46 with 
Val2396.40 (frequency of 80%), by Leu1093.43 with Leu2366.37, Val2396.40 and Met2406.41 
(frequency of 77%, 94% and 90%, respectively), and by Leu2366.37 with Ile1123.46 and 
Ser1133.47 (frequency of 99% and 66%, respectively). The contact between Leu2366.37, 
Thr532.39 and Ile572.43 described in chapter 3 was not stable. In hH2Ra2, the contacts between 
TM3 and TM7 were closer than in hH2Ri. Interactions were formed between Leu60
2.46 and 
Asn2847.49 (van der Waals interaction in 92% of the simulation), Leu1093.43 and Asn2847.49 as 
well as Tyr2887.53 (39% and 100%, respectively), Ile1123.46 and Tyr2887.53 (100%), and 
between Ser1133.47 and Tyr2887.53 (68%; additionally direct and water mediated H-bonds 
between the side chains). Thus, all residues of TM2 and TM3 being part of the hydrophobic 
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barrier in hH2Ri were connected to Asn284
7.49 and/or Tyr2887.53 in the active state. They 
contributed to keep T 7 in its ‘active’, inward position. Furthermore, Leu2366.37 interacted 
with GαCT (section 4.3.10.2) and amplified the interaction with TM5 by a hydrophobic 
contact to Phe2065.62 (frequency of 69%). Also other exclusive interactions of TM6 residues 
being part of the hydrophobic barrier in hH2Ri strengthened the TM5-TM6 contact in hH2Ra2, 
e.g. Val2396.40 approached Tyr2025.58 (van der Waals contact in 79% of the simulation) and 
Met2406.41 Leu1955.51 (72%). 
 
 
Figure 4.43: Hydrophobic barrier and the interface between TM6 and TM7 at the cytoplasmic 
part of hH2R states 
Side view of the hH2Ri (A; blue ribbons) and view from the cytoplasm of the hH2Ra2 (B; orange 
ribbons). Amino acids of the hydrophobic barrier are shown as spheres, and remaining residues 
connecting TM6 and TM7 (A) or TM5, TM6 and TM7 (B), respectively, are shown as sticks. 
 
 
The relative positions of TM6 and TM7 in hH2Ri were stabilized by the van der Waals 
contacts between Val2346.35 and Leu2917.56, Thr2356.36 and Tyr2887.53, Thr2356.36 and 
Asn2927.57, Ala2386.39 and Leu2917.56 as well as Val2396.40 and Asn2847.49 (in 69%, 99%, 
85%, 88% and 60% of the simulation, respectively). The water mediated H-bonds from the 
backbone of Val2396.40 to Asn2807.45 and Asn2847.49 were only temporarily but present until 
the end of the 80 ns simulation (26% and 39%, respectively). All these TM6-TM7 contacts 
occurred only in hH2Ri. In hH2Ra2, the opening of the TM3-TM6 contact enabled the inward 
position of TM7. Tyr2887.53 is of special importance as reported for several GPCRs (Ahuja 
and Smith, 2009; Rasmussen et al., 2011a; Scheerer et al., 2008; Vanni et al., 2010; Wess 
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et al., 2008). In both hH2R states, the position of Tyr288
7.53 is stabilized by hydrophobic 
contacts to Ile572.43, Leu602.46, Val2396.40, Asn2847.49 and Leu2877.52. However, the different 
arrangement of TM7 at the cytoplasmic part of the receptors led to unique interactions mainly 
with TM1 and H8 in the hH2Ri, as well as TM3 in the hH2Ra2. In the inactive state, the side 
chain position of Tyr2887.53 close to TM1 enabled a stable interaction with Val391.53 (van der 
Waals contact in 99% of the simulation). Additionally, a van der Waals contact to Ala612.47 
and a water mediated H-bond to the side chain of Asp642.50 were present in about 20% of the 
simulation. A hydrophobic interaction with Thr2356.36 was stable (99%). Crucial for the 
‘inactive’ position of Tyr2887.53 in hH2Ri were the contacts to Phe295
H8 (π-π interaction, 
frequency of 100%) and Tyr299H8 (75%), as well as the interactions with Pro2857.50 and 
Asn2927.57 (frequency of 50% and 28%, respectively). In the hH2Ra2, van der Waals contacts 
to Leu1093.43 (frequency of 100%), Ile1123.46 (100%), Ser1133.47 (68%) and Arg1163.50 (63%) 
were formed. Furthermore, the hydroxyl group of Tyr2887.53 formed direct and water 
mediated H-bonds to the side chain of Ser1133.47 (frequency of 28% and 14%, respectively), 
as well as water mediated H-bonds to the side chains of Arg1163.50 (37%) and Tyr2025.38 
(57%) and to the backbone of Val2396.40 (45%). Thus, the rearrangement of Tyr2887.53 during 
receptor activation, already observed in the initial hH2Ra2 model, was proved to be stable 
during the 80 ns MD simulations. In hH2Ra2 it was crucial for the TM3-TM7 contact at the 
intracellular side of the receptor and contributed to maintain the outward position of TM6 by 
contacts to Tyr2025.38 and Arg1163.50. In hH2Ri, Tyr288
7.53 was linked to the H-bond network 
between TM1, TM2, TM3 and TM7. Water mediated H-bonds were formed by the hydroxyl 
group of Tyr2887.53 with the side chains of Asp642.50 and Asn2847.49 (frequency of 18% in 
both cases). Despite the low frequency, these contacts were often formed during the 
simulation (Figure 4.44). Thus, the H-bond network around TM7 accounted for the outwards 
position of TM7 in hH2Ri by directing the side chain of Tyr288
7.53 towards TM2. 
 
                          Tyr288
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                          Tyr288
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Figure 4.44: Water mediated H-bonds from Tyr288
7.53
 to Asp64
2.50
 and Asn284
7.49
 in hH2Ri 
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The H-bond network (Figure 4.45) is furthermore directly influenced by amino acids below 
the orthosteric binding site of the hH2Ra2. Besides the interaction between Cys102
3.36 and 
Gly2777.42 (cf. Figure 4.37), Ser1053.39 was able to contact Asn2807.45, Ser2817.46 and 
Asn2847.49 in overall 58% of the simulation (direct and water mediated H-bonds). Therefore, 
Cys1023.36 and Ser1053.39 were able to pull the cytoplasmic part of TM7 towards TM3. In 
hH2Ri, the conformation of Asn280
7.45, adjusted by the side chain position of Phe2436.44 
below the binding site, was stabilized in its ‘inactive’ position by direct H-bonds of the side 
chain to Asp642.50 (frequency of 53%) and to its own backbone (34%). In contrast, in hH2Ra2 
Asn2807.45 is released from this constraint and formed H-bonds with Ser1053.39 (18%, mainly 
in the second part of the simulation), Cys2466.47 (17%, decreasing in the second part of the 
simulation) and Asn2847.49 (direct and water mediated H-bond in 46% and 87% of the 
simulation, respectively). The side chain of Asn2847.49 is thereby kept in its close position to 
TM3 (water mediated H-bond to Ser1053.39 in 20% of the simulation). Thus, Asn2807.45 
seemed to be a further trigger for tearing T 7 in its ‘active’, inward position. Whereas the 
extracellular part of TM7 fitted quite well between hH2Ri and hH2Ra2, the shift of TM7 towards 
TM3 in hH2Ra2 ‘started’ at Asn280
7.45 (cf. Figure 4.37). The crucial role of Asn2807.45 and the 
impact of the bottom of the orthosteric binding site became not clear from the initial homology 
models of hH2Ri and hH2Ra2. 
 
 
Figure 4.45: H-bond network between TM1, TM2, TM3 and TM7 
Most important amino acids of the H-bond network around TM7 are shown in the final snapshot 
(80 ns) of hH2Ri (A) and hH2Ra2 (B). TM1, TM2 and TM6 (A, blue ribbons; B, orange ribbons) are 
not shown completely and TM4 and TM5 are omitted for reasons of clarity. H-bonds and water 
mediated H-bonds are indicated with yellow and cyan dashed lines, respectively.  
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In the hH2Ra2, the side chains of Asp64
2.50 and Ser1053.39 were linked by a direct H-bond 
(frequency of 62%; in hH2Ri only by a water mediated H-bond in 63% of the simulation), 
leading to a shift of the side chain of Asp642.50 towards TM3. As a consequence, Asn2847.49 
which was well H-bonded to Asp642.50 in hH2Ri and hH2Ra2 (frequency of 79% and 95%, 
respectively) followed this shift and thus possibly contributed to the more inward position of 
the cytoplasmic part of TM7 in the hH2Ra2 (Figure 4.45). The movement was further 
facilitated by the strong interaction between Asp642.50 and Ser2817.46 in the hH2Ra2 
(frequency of 92% vs. 29% in hH2Ri). In hH2Ri, the hydroxyl group of Ser281
7.46 formed an 
additional water mediated H-bond to the side chain of Asn2807.45 (frequency of 24%). 
However, these contacts of Ser2817.46 decreased from the first 20 ns to the last 20 ns of the 
simulation from 65% to 2% and from 55% to 1%, respectively. Instead, Ser2817.46 developed 
a direct H-bond to the backbone oxygen of Tyr2787.43 (frequency increase from 30% to 78%). 
This stabilized the kink in T 7 and is similar to other GPCRs, e.g. the inactive β2AR state 
(Cherezov et al., 2007), where the hydroxyl group of the corresponding Ser3197.46 is in close 
distance to the backbone oxygen of Tyr3167.43 (3.1 Å). By contrast, in the hH2Ra2 the hydroxyl 
group of Ser2817.46 is continuously H-bonded to the carboxyl group of Asp642.50 (frequency of 
92%), as well as by water mediated H-bonds to the side chains of Ser1053.39 (24%) and 
Asn2807.45 (42%) and to the backbone of Gly2777.42 (32%). Thus, in the active hH2R state 
Ser2817.46 fulfills an important role in connecting TM7 to TM2 and TM3 at the cytoplasmic 
part (Figure 4.47).  
Thr632.49 had only a minor role in the H-bond network. Its side chain pointed towards TM3 
and is averted from the interface with TM7. Thus, it contributes to the connection TM2-TM3 
by H-bonds to Ser1053.39 (frequency of about 34% in the two hH2R states) and Asn108
3.42 
(32%, only in hH2Ra2) and stabilizes the side chain of Asp64
2.50 by water mediated H-bonds 
(68% and 29% in hH2Ri and hH2Ra2, respectively). The backbone oxygen of Ser281
7.46 is 
connected to the side chain of Asn361.50 (about 80% of the simulation in both states). Thus, 
Asn361.50 stabilized the kink in TM7. Furthermore, in both receptor states Asn361.50 stabilized 
the side chain of Asp642.50 in its respective position by water mediated H-bonds (in 72% and 
94% of the hH2Ri and hH2Ra2 simulation, respectively). In the inactive state, Asn36
1.50 helps 
to restrain Asn2847.49 in a more downward position by direct and water mediated H-bonds 
(12% and 19%, respectively), decreasing the H-bond frequency with Asp642.50 (see above).   
In both hH2R states the side chain of Thr32
1.46 did not contribute to the stabilization of other 
polar side chains in the interface and to bridging TM domains. In both hH2R states it is mainly 
H-bonded to the backbone of Leu281.42 (frequency of 40% and 58%, respectively). 
Nevertheless, according to the multiple sequence alignment analysis described in chapter 7, 
in 60% of the aminergic GPCRs in position 1.46 a threonine is present. The role of a polar 
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side chain in this region of the hH2R remains unclear from the 80 ns MD simulations. Only 
the backbone oxygen is important for adjusting the side chain position of Asn361.50 via H-
bonds in about 90% of the simulations of both hH2R states. 
4.3.9.2 Analysis of TM-TM contacts 
The analysis of contacts between TMs is meaningful for detecting differences in hH2R states 
(cf. chapter 3). Differences in the number of interactions at the extracellular part of the 
receptor were obvious around TM7 (in the active state stronger interactions with TM1, TM2 
and TM3, and weaker contacts with TM6), between TM4 and TM5 (weak in hH2Ri) as well as 
TM2 and TM3 (weaker in hH2Ra2). In general, more changes occurred at the intracellular 
side. The majority of deviations between hH2Ri and hH2Ra2 could be ascribed to molecular 
switches occurring during hH2R activation (Table 4.3). These switches described above are 
important for rhodopsin and the β2AR, too (Trzaskowski et al., 2012). In the active state the 
contact of TM3 with TM5 and TM6 is weaker and with TM4 and TM7 stronger than in hH2Ri. 
TM7 is more attached to TM2 and less connected to TM6 in the active state, where also the 
TM5-TM6 link is closer. Most TM-TM contacts remained stable during the 80 ns MD 
simulations of both states. 
 
Extracellular part 
One of the most striking differences at the extracellular side of hH2Ri and hH2Ra2 is the 
position of T 1. Caused by the hβ2AR as template, TM1 of hH2Ra2 is closer to TM7 than in 
hH2Ri (Figure 4.30). During the MD simulation TM1 of hH2Ra2 further moves towards TM7 
(section 4.3.7). The different TM1-TM2 interface and the closer distance to TM7 (about 2 Å at 
the extracellular ends) resulted in additional contacts. However, the majority of interactions 
(hydrophobic and van der Waals contacts) occurred between identical residues in both hH2R 
states. Some contacts in hH2Ra2 were more stable during the 80 ns simulation than in hH2Ri, 
e.g. in the TM1-TM7 interface the hydrophobic contacts between Leu281.42 and Trp2757.40 
(frequency of 98% vs. 22%), Leu281.42 and Ala2827.47 (53% vs. 24%) as well as between 
Ile291.43 and Trp2757.40 (97% vs. 18%). Only in the hH2Ra2, Leu28
1.42 interacted with 
Ala2797.44 (frequency of 65%). The type and the number of interactions are similar at the 
TM2-TM7 interface in the extracellular part of the hH2Ri and hH2Ra2 (Figure 4.47). 
Differences concerned mainly the side chain orientation of Gln792.65, which was more flexible 
in hH2Ri and positioned towards the backbone of Ala271
7.36 enabling an H-bond (frequency 
of 29%). In contrast, in the active state an H-bond to the side chain of Trp2757.40 which was 
less frequent in hH2Ri (66% vs. 95%) restrained Gln79
2.65 in a more downward position, 
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resulting in an interaction with the hydroxyl group of Tyr2787.43 via a water mediated H-bond 
(frequency of 36%). The average distance between Cα atoms of Gln79
2.65 and Tyr2787.43 is 
smaller for the hH2Ra2 (12.7 Å vs. 14.2 Å). The ‘downward’ shift of Gln79
2.65 in hH2Ra2 is 
probably a reason for the larger kink in TM2 and may stabilize the rearrangement of the 
cytoplasmic part of TM7. Additional interactions between TM3 and TM7 in hH2Ra2 (2.8 vs. 0.9 
in hH2Ri) were mainly caused by the side chain switch of Cys102
3.36, enabling the interaction 
with Gly2777.42 (Figure 4.37) and the H-bond between Asp983.32 and Tyr2787.43 (frequency of 
100%). Presumably, the latter was enabled by the more inward position of the extracellular 
part of TM2 (larger proline kink, Figure 4.25) which forced the side chain of Tyr2787.43 closer 
to TM3. 
The TM2-TM3 interface at the extracellular side is characterized by a crossing of the TM 
segments, amplified by the proline kink of TM2 (Figure 4.30) which is more pronounced in 
the hH2Ra2 (Figure 4.25). Moreover, TM3 of hH2Ri moved towards the core of the receptor 
during the simulation. Together with a slightly closer distance between TM2 and TM3 this 
enabled more contacts between TM2 and TM3 in hH2Ri (Figure 4.47). Apart from a direct H-
bond from the side chain of Ser752.61 and a water mediated H-bond from the side chain of 
Gln792.65, respectively, to the hydroxyl group of Tyr943.28 (present in hH2Ri and hH2Ra2 with a 
frequency of more than 83% and 49%, respectively), all contacts occurred between 
hydrophobic side chains of TM2 and TM3. The shift of TM3 in hH2Ri strengthened the 
contacts near the extracellular surface (the average number of interactions increased from 
1.2 in the first quarter of the simulation to 5.2 in the last quarter), as obvious for the 
hydrophobic contacts between Phe742.60 and Ile933.27 (frequency rising from 53% to 100%), 
Phe742.60 and Leu973.31 (11% to 60%), Ile772.63 and Phe903.24 (18% to 100%), Tyr782.64 and 
Phe903.24 (25% to 100%) as well as Tyr782.64 and Cys913.25 (0% to 44%), all absent in 
hH2Ra2. These interactions stabilized the ‘inactive’ position of T 3 and therefore contributed 
to the crucial differences between both hH2R states. The striking difference of the TM4-TM5 
interface is related to the movement of TM5 in hH2Ri. Instead of direct contacts between the 
two TMs in hH2Ri they were mainly stabilized by close contacts to DPPC molecules (section 
4.3.7). Although the TM5-TM6 interfaces also varied because of the altered TM5 position, no 
implications on receptor activation were evident. 
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Intracellular part 
The difference of the TM1-TM2 interfaces between hH2Ri and hH2Ra2 becomes obvious by 
the more outward position of TM1 in the active state (Figure 4.30). However, most 
interactions occurred between the same pairs of amino acids. In hH2Ra2, an additional van 
der Waals contact between Cys401.54 and Leu652.51 (frequency of 47%) and a stronger 
contact between Val391.53 and Ile572.43 (98% vs. 31% in hH2Ri) was observed. They 
contribute to stabilize the intracellular part of T 1 in the ‘active’ position, which allowed the 
inward move of TM7 upon receptor activation. Instead, in hH2Ri Cys40
1.54 is close to Val582.44 
(van der Waals contact frequency of 86%), and a direct H-bond from the backbone of 
Val431.57 to the side chain of Asn542.40 (frequency of 88%) stabilized both TMs in their relative 
positions. Asn542.40 formed additional polar contacts to ICL1 (Arg50 and Asn51) and helix 8 
(Asp294). The outward move of TM1 at the TM1-TM7 interface in hH2Ra2 was compensated 
by the inward move of TM7, thus resulting in similar contacts between the two receptor 
states. A crucial difference occurred for Val391.53. In the inactive state it was linked to 
Tyr2887.53, helping to lock it in its ‘inactive’ position (van der Waals contact frequency of 
99%), whereas in hH2Ra2 the inward position of TM7 allowed a contact to Ala289
7.54 
(frequency of 99%). 
The TM2-TM3 interface was nearly identical in both hH2R states. Only the interaction 
between Thr532.36 and Asp1153.49 was not possible in hH2Ra2 (cf. section 4.3.9.1, ionic lock), 
and the contact between Phe562.42 and Asn1083.42 was more pronounced in hH2Ri (van der 
Waals contact frequency 66% vs. 19% in hH2Ra2) due to the shift of TM3 towards the 
cytoplasm. The closer distance between TM2 and TM4 in hH2Ri (Figure 4.30) led to the 
stabilization of the H-bond between Ser592.45 and Trp1434.50 (frequency of 97% vs. 33%) and 
of the van der Waals contact between Leu662.52 and Trp1434.50 (frequency of 83% vs. 45%). 
Both interactions contributed to the more outward position of TM2 in hH2Ri and allowed the 
inward move of TM2 during receptor activation, presumably necessary for the interaction with 
the G-protein. 
The interaction between TM2 and TM6 at the intracellular part of the hH2Ri was caused by 
the packing of hydrophobic side chains in the center of the receptor (hydrophobic barrier, 
contact of Leu602.46 with Val2396.40). The stronger contact between TM2 and TM7 in hH2Ra2 
was also caused by Leu602.46, which was released from the hydrophobic barrier, and 
additionally by the van der Waals contact Ile572.43-Ala2897.54 (frequency of 87%) enabled by 
the inward position of TM7. Additional differences occurred in the H-bond network. Thus, the 
interfaces TM2-TM6 and TM2-TM7 were mainly affected by alterations in the well-known 
switches of the hydrophobic barrier and the H-bond network.  
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Table 4.3: Links between molecular switches and differences in the TM-TM interfaces at the 
intracellular parts of the hH2Ri and hH2Ra2 
Molecular switch Affected TM-TM interface 
Binding site TM3-TM6, TM3-TM7 
Tyr202
5.58
 TM5-TM7 
TM6 outward position TM3-TM6, TM5-TM6, TM6-TM7 
Ionic lock TM3-TM6, TM5-TM6 
Hydrophobic barrier 
TM2-TM6, TM2-TM7, TM3-TM6, TM3-TM7, TM5-TM6, 
TM6-TM7 
H-bond network TM2-TM7, TM3-TM7, TM6-TM7 
TM7 rearrangement with Tyr288
7.53
 TM1-TM7, TM3-TM7, TM5-TM7, TM6-TM7 
 
 
The stronger contact between TM3 and 
TM4 in hH2Ra2 was the result of a 
different side chain conformation of 
Arg1344.41. Whereas in hH2Ri it pointed 
to the lipid head groups, in hH2Ra2 the 
side chain was only flanked by lipids 
and additionally pointed to Met1113.45, 
Leu1143.48 and Cys1183.52. In all cases 
water mediated H-bonds were formed 
(summarized frequency of 72%; Figure 
4.46).  
 
 
Figure 4.46: Frequency of water mediated 
H-bonds of Arg134
4.41
 to TM3 
Ser1133.47 played different roles in the two receptor states. In hH2Ri it contributed to the TM3-
TM5 connection by direct and water mediated H-bonds (frequency of 86%) as well as by van 
der Waals contacts (frequency of 62%) to Thr2015.57 and was furthermore close to Ile2055.61 
(van der Waals frequency of 81%). Instead, in hH2Ra2 Ser113
3.47 performed an H-bond to the 
hydroxyl group of Tyr2025.58 (frequency of 66%), keeping the Tyr2025.58 side chain in its 
position between TM3 and TM6. Furthermore, Ser1133.47 was close to Met1985.54 (H-bond 
and van der Waals frequency of 34% and 93%, respectively). The position of Met1985.54 was 
important for keeping TM6 in the outward position. The higher number of TM3-TM5 
interactions in hH2Ri was due to the differences below the binding site (Ile106
3.40 and 
Leu1093.43) and a closer contact between TM3 and TM5 at their intracellular ends (~ 3 Å). 
The majority of contacts between TM3 and TM6 was already described in section 4.3.9.1 (cf. 
changes below the binding site, the hydrophobic barrier and the ionic lock). Additionally, 
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Ala1193.53 and Val1203.34 contacted residues in hH2Ri belonging to the intracellular end of 
TM6 (Ala2256.26, Arg2286.29, Glu2296.30and His2306.31). The contacts between TM3 and TM7 
in hH2Ra2 and their role – cleavage of the hydrophobic barrier and rearrangement of TM7 
including the switch of Tyr2887.53 – were also described in section 4.3.9.1. The difference of 
the TM5-TM6 interface at the cytoplasmic part between hH2Ri and hH2Ra2 during the 80 ns 
MD simulation was related to the outward position of TM6 in hH2Ra2 (Figure 4.38). Due to the 
high flexibility of TM5 and TM6 at their cytoplasmic ends in hH2Ri (Figure 4.27), the average 
number of contacts during the MD simulation between the two domains varied between 13.9 
and 17.7. The single contact between TM5 and TM7 in hH2Ra2 refers to the water mediated 
H-bond between Tyr2025.58 and Tyr2887.53. The differences of the TM6-TM7 interface 
between hH2Ri and hH2Ra2 were also described in section 4.3.9.1 (cf. hydrophobic barrier). 
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Figure 4.47: Contacts between TM domains at the extra- and intracellular part of the 
hH2R states during 80 ns MD simulations 
Average number of interactions (salt bridge, hydrogen bond, water mediated hydrogen bond, 
van der Waals contacts; for definition cf. section 4.2) between TM domains at the extracellular 
and the intracellular part of hH2Ri and hH2Ra2, respectively (for definition of extra- and 
intracellular parts of the hH2R states, cf. Figure 3.16). 
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4.3.9.3 Loops and helix 8 
The number of interactions of extracellular loops with neighboring domains was generally 
higher in hH2Ra2 (Table 4.4). In contrast, the ECLs of hH2Ri were more flexible (Figure 4.27) 
and more displaced compared to the input structure of the simulation (Figure 4.28). The 
higher number of interaction in hH2Ra2 correlated with the restraining of loops in the active 
hH2R state. Furthermore, the solvent accessible surface area (SASA, Figure 4.48) was 
slightly higher in hH2Ri, indicating that less residues were in contact to the rest of the protein 
and more residues were exposed to the solvent.  
 
 
Table 4.4: Average number of contacts to extra- and intracellular loops 
Extracellular side  Intracellular side 
ECL domain hH2Ri hH2Ra2  ICL domain hH2Ri hH2Ra2 
ECL1 TM2 6.0 5.9  ICL1 TM1 4.0 5.3 
 TM3 4.5 7.4   TM2 2.4 5.0 
 ECL2 4.9 6.0   ICL2 0.6 0.3 
ECL2 TM2 4.0 4.8   H8 7.9 6.6 
 TM3 10.2 8.2  ICL2 TM2 3.4 3.4 
 TM4 4.9 7.2   TM3 7.8 9.0 
 TM5 13.0 10.3   TM4 6.4 6.6 
 TM6 3.8 5.3   TM5 1.5 0.0 
 ECL3 0.2 6.9   ICL3 4.0 0.0 
 TM7 1.0 3.0   TM6 0.7 0.0 
ECL3 TM5 0.4 0.0  ICL3 TM5 4.9 4.7 
 TM6 1.9 6.0   TM6 2.6 5.4 
 TM7 3.6 4.1      
         
         
Helix8 TM1 9.5 9.3   TM6 1.3 0.0 
 TM2 1.1 2.7   TM7 6.2 2.9 
For the definition of interactions (salt bridge, hydrogen bond, water mediated hydrogen bond and 
van der Waals contacts) cf. section 4.2. 
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Figure 4.48: Solvent 
accessible surface 
area (SASA) for the 
loops of hH2Ri and 
hH2Ra2 
The SASA was 
calculated for the same 
residues of all loops in 
hH2Ri and hH2Ra2. 
 
 
ECL1 of hH2Ra2 was better attached to TM3 and ECL2 than in hH2Ri (Table 4.4). Van der 
Waals interactions of Trp84ECL1 with Phe903.24, Cys913.25 and Tyr943.28 were more stable in 
hH2Ra2 (frequency in hH2Ra2 of 94%, 99% and 99% vs. 14%, 20% and 20% in hH2Ri, 
respectively). The higher number of interactions between ECL1 and ECL2 in hH2Ra2 was 
mainly caused by stronger van der Waals contacts between Cys82ECL1 and Lys173ECL2 
(frequency of 61% in hH2Ra2 vs. 0% in hH2Ri), Trp84
ECL1 and Thr170ECL2 (76% vs. 0%), 
Trp84ECL1 and Cys174ECL2 (100% vs. 20%), as well as Gly87ECL1 and Thr170ECL2 (68% vs. 
42%). However, the ECL1 course was only slightly different between the two receptor states 
(Figure 4.49), as also indicated by the backbone RMSD values of corresponding residues 
(Figure 4.31). The most remarkable difference in ECL2 occurred in the N-terminal part until 
Cys174ECL2, connected to Cys913.25 by a disulfide bridge. Whereas in hH2Ri this part of ECL2 
moved more into the extracellular solvent, it was rather located above the C-terminal part of 
ECL2 in hH2Ra2 (beginning with Cys174
ECL2) and thus able to contact ECL3 and keep it in an 
inward position. However, due to the high flexibility of the side chains of ECL2 and ECL3 
(Figure 4.27), the average frequency of interactions between pairs of residues was below 
30%. Direct and water mediated H-bonds, salt bridges and van der Waals contacts occurred 
for Arg161, Thr164, Lys166, Lys173, Val176, Gln177 and Val178 (ECL2) as well as Arg260, 
Gly261, Asp263, Asp262 and Ile265 (ECL3). Instead, in hH2Ri ECL3 moved outwards, 
opened the crevice between ECL2 and ECL3 and thus possibly enabled the accession of 
ligands to the orthosteric binding site. Not surprisingly, the differences of ECL2 and ECL3 
between hH2Ri and hH2Ra2 belonged to the most prominent ones during the simulation (see 
RMSD values in Figure 4.31). Comparing the crystal structures of inactive and active β2AR 
states, the differences at the extracellular side were lower (Cherezov et al., 2007; 
Rasmussen et al., 2011b). However, the courses of loops in GPCR crystals should generally 
interpreted with caution because of possible interfering lattice contacts with adjacent 
molecules (Warne et al., 2008).  
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Figure 4.49: Extra- and intracellular loops of hH2Ri and hH2Ra2 
The average simulation structures of the hH2Ri and hH2Ra2 are shown (for the determination refer 
to Figure 4.30). 
 
 
The generally higher SASA of the extracellular loops of hH2Ri may facilitate the adhesion of 
approaching ligands. This remarkable difference was not obvious in the initial hH2Ri and 
hH2Ra2 models. The course of both ECL2 and ECL3 in the two receptor states was quite 
similar (Figure 3.8). Moreover, an ionic interaction occurred between Glu163ECL2 and 
Arg260ECL3 in hH2Ri (distance of the closest side chain heteroatoms 3.2 Å vs. 15.6 Å in 
hH2Ra2). 
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The different contacts of intracellular loops in hH2Ri and hH2Ra2 were due to the 
rearrangements of T 6 and T 7 and to the docking of GαCT into hH2Ra2. Due to the 
interaction with GαCT the SASA of all intracellular loops was lower in hH2Ra2 (Figure 4.48). 
The position of ICL1 was already distant in the initial hH2R models (Figure 3.8). This distance 
was even increased in the simulations, since helix 8 of hH2Ra2 further approached TM1 and 
ICL1. Thus, the RMSD between corresponding residues of hH2Ri and hH2Ra2 rose until about 
10 ns. This was one of the most remarkable differences between the two receptor states 
(Figure 4.31). Different interactions with TM1, TM2 and ICL2 could not be attributed to 
receptor activation. However, the van der Waals contact between Leu49ICL1 and Phe295H8 
only present in hH2Ri (frequency of 97%) is crucial for the ‘inactive’ position of Phe295
H8 and 
thus for the stabilizing contact to Tyr2887.53 (π-π-stacking). The higher distances from ICL2 to 
ICL3, TM5 and TM6 did not allow an interaction of ICL2 with these domains in hH2Ra2. 
Furthermore, the presence of GαCT prevented a direct contact. Instead, ICL2 of hH2Ra2 was 
able to interact with the G-protein fragment (section 4.3.10.2). In hH2Ri, the H-bond between 
Asp122ICL2 and Trp222ICL3 (frequency of 58%) and the van der Waals contacts between 
Pro123ICL2 and Trp222ICL3, Pro123ICL2 and Lys223ICL3, Leu124ICL2 and Trp222ICL3 as well as 
Leu124ICL2 and Lys223ICL3 (frequency of 64%, 54%, 65% and 41%, respectively) contributed 
to the inward position of TM5, ICL3, and TM6 and to the prevention of G-protein binding. In 
hH2Ra2, the strong interaction of ICL3 with GαCT (average number of interactions ~ 12) 
probably caused the reduced flexibility (Figure 4.27) and the less replacement from its initial 
position (Figure 4.28). Contacts of ICL2 to TM5 and TM6 in hH2Ri were not consistent during 
the simulation (Asp122ICL2, Pro123ICL2, Lys2145.70, Ala2256.25 and Als2256.26). 
Aromatic residues at the end of TM7 and helix 8 were connected to each other and 
performed conformational changes during receptor activation. In hH2Ri, Tyr288
7.53 and 
Phe295H8 (both part of the NPxxY(x)5,6F motif) were arranged parallel and established 
aromatic π-π interactions during the entire simulation. This strong interaction restrained the 
side chain of Tyr2887.53 in its ‘inactive’ conformation (Figure 4.50 A). Phe295H8 was packed 
between the hydrophobic side chains of Val391.53, Ala421.56, Val431.57, Leu49ICL1 and Ile572.43 
(contact frequency of 92%, 59%, 100%, 97% and 99%, respectively). It was furthermore in 
close contact to Thr2356.36 (frequency of 71%), thus contributing to keep TM6 in its inward 
position. Phe295H8 forced Asn2927.57 (van der Waals contact frequency 100%) to show 
towards TM6 and to interact with Val2346.35 (van der Waals contact frequency 26%) and 
Thr2356.36 (water mediated H-bond and van der Waals contacts in 13% and 85% of the 
simulation, respectively), again linking TM6 to TM7. The side chain of Arg2286.29 was 
connected to the side chain of Asp294H8 by a salt bridge and a water mediated H-bond in 
22% and 17% of the simulation, respectively. Tyr2887.53 and Phe295H8, both pointing towards 
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TM2 (resulting in higher distances of TM2 to TM7 and H8; cf. Figure 4.49), were key amino 
acids for keeping TM7 in its outward position in hH2Ri. 
In hH2Ra2, the Tyr288
7.53-Phe295H8 contact was broken, which has been suggested to be 
necessary for GPCR activation (Fritze et al., 2003; Prioleau et al., 2002; Scheerer et al., 
2008). Tyr2887.53 switched towards the TM3-TM6 interface (Figure 4.43), and Phe295H8 
underwent a conformational change and pointed towards the second half of H8. Therefore, 
the side chain positions of Tyr2887.53 and Phe295H8 in hH2Ra2 allowed the approximation of 
TM7 to TM2 and TM3. Similar to Phe295H8, Tyr299H8 rotated away from the TM1-TM7 
interface, resulting in a parallel arrangement of Phe295H8, Tyr299H8 and Phe303 (van der 
Waals contacts > 99%; Figure 4.50 B). Residues stabilizing Phe295H8 were Val381.52, 
Val391.53, Ala421.56, Val431.57, Ala2897.54, Ala2907.55 and Asn2927.57 (van der Waals contact 
frequency of 84%, 100%, 100%, 100%, 99%, 88% and 91%, respectively). In hH2Ri, the 
switch of Phe295H8 was prevented by Tyr299H8, which was packed between Val381.52, 
Val391.53, Ala421.56, Pro2857.50, Ala2897.54 and Gly298H8 (van der Waals contact frequency of 
99%, 81%, 83%, 47%, 100% and 91%, respectively). Furthermore, Tyr299H8 was close to 
Tyr2887.53 and performed H-bonds with its hydroxyl group to the backbone of Pro2857.50 and 
Ala2897.54 (frequency of 70% and 53%, respectively). The higher number of interactions 
between TM7 and H8 in hH2Ri was mainly caused by the side chain positions of Phe295
H8 
and Tyr299H8. In hH2Ra2, amino acids of helix 8 were part of the interaction site of GαCT 
(section 4.3.10.2). 
 
  
Figure 4.50: The role of helix 8 in hH2R activation 
Residues of the hH2Ri (A; blue ribbons) and hH2Ra2 (B; orange ribbons with GαCT in green 
surface representation) which contributed to the interactions of the aromatic amino acids 
Tyr288
7.53
, Phe295, Tyr299 and Phe303 (green sticks). Residues interacting with GαCT in 
hH2Ra2 are shown in brown sticks. 
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4.3.10 Ligand and GαCT interactions with the active hH2R state 
4.3.10.1 Interactions of histamine with the hH2R binding pocket 
Histamine remained stable in its position in the orthosteric binding site (average RMSD 1.12 
Å), indicating proper docking of the ligand in the initial hH2Ra2 model (chapter 3). The well-
known contacts to Asp983.32 and Asp1865.42 (Gantz et al., 1992), which were presumed for 
docking histamine were retained (Figure 4.51). The charge assisted H-bond from Asp983.32 to 
the positively charged side chain amine of histamine and the H-bond from Asp1865.42 to Nτ of 
the imidazole moiety were present in 95% and 99% of the simulation, respectively. Van der 
Waals contacts to Val993.33, Tyr2506.51, Phe2516.52 and Phe2546.55 already observed in the 
initial hH2Ra2 model were preserved during the complete simulation (frequency of 100% for 
all residues).  
Furthermore, histamine was linked to Tyr1825.38 in 77% of the simulation (hydrophobic 
contact of the imidazole moiety and the phenyl ring). Additionally, a water mediated H-bond 
between the hydroxyl moiety of Tyr1825.38 and Nπ of the imidazole moiety of histamine 
(frequency of 30%) was observed. However, this interaction is probably not essential. The 
data obtained at an hH2R mutant in which Tyr182 was replaced by Phe (chapter 6) indicated 
a minor impact of the hydroxyl group of Tyr1825.38 on histamine activity, contrary to previous 
suggestions (Nederkoorn et al., 1996a; Nederkoorn et al., 1996b). Instead, the hydroxyl 
group of Tyr1825.38 was mainly H-bonded to Asp1865.42 (frequency of 85%), adjusting a 
proper side chain conformation of the latter. The Nπ nitrogen of the imidazole moiety of 
histamine was primarily connected to Tyr2506.51 by a direct H-bond (frequency of 91%). 
Nevertheless, Tyr1825.38 seemed to play a more important role in histamine binding than 
Thr1905.46, which was also suggested to contribute to binding (Gantz et al., 1992) but was not 
connected to histamine during the whole MD simulation.  
Polar contacts occurred also between the amine nitrogen of histamine and Cys1023.36 (direct 
H-bond in 78% of the simulation) as well as the backbone oxygen of Leu2747.39 (frequency of 
37%). In several GPCRs, ECL2 is part of the ligand binding site (Avlani et al., 2007; Jaakola 
et al., 2008; Klco et al., 2005; Scarselli et al., 2007; Shi and Javitch, 2002). However, for 
histamine binding ECL2 seems to be less important. The Nπ nitrogen of the imidazole moiety 
of histamine and Lys175ECL2 were connected via a water mediated H-bond in only 16% of the 
simulation of hH2Ra2. Finally, van der Waals contacts of histamine not present in the initial 
hH2Ra2 model were formed with Thr103
3.37, Ile1063.40, Trp2476.48 and Tyr2787.43 (frequency of 
98%, 49%, 99% and 26%, respectively). 
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Figure 4.51: Histamine in the orthosteric binding site of the hH2Ra2 
Histamine (green carbon atoms) in the binding site of the hH2Ra2 (TMs in orange ribbons) after 
80 ns MD simulation. All residues which interacted with histamine during the MD simulation are 
shown (sticks with grey transparent surface). 
 
 
4.3.10.2 Receptor – GαCT interaction 
The C-terminal fragment of the GsαS-protein, GαCT, interacted with the most flexible parts of 
hH2Ra2, the cytoplasmic surface which forms an aligned pocket. Amino acids of all 
intracellular loops, the intracellular ends of TM2, TM3, TM5, TM6 and TM7 as well as helix 8 
were part of the receptor-GαCT interface (30 amino acids in total). Thus, all residues of the 
cytoplasmic crevice which was formed by the outward move of TM6 were part of the 
interaction site (Figure 4.52 A). However, the high flexibility of the hH2Ra2 in this region and of 
parts of GαCT led to varying pairs of interacting residues. All in all 67 contacts with an 
average frequency of 66% were detected. Compared to the hH2Ra1-GαCT complex (chapter 
3), the number of interactions between the initial hH2Ra2 and GαCT was lower, but rose 
significantly during the 80 ns simulation (Figure 4.52 B). GαCT moved towards helix 8 and 
ICL1, implying a concomitant shift of the cytoplasmic ends of TM5 and TM6 (Figure 4.52 C).  
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Figure 4.52: Interactions between hH2Ra2 and GαCT 
A, Interaction between hH2Ra2 and GαCT (green transparent surface representation). All 
residues (in spheres) of the hH2Ra2 (TMs in orange ribbons) which contributed to the binding of 
the G-protein fragment are shown, except Asp115
3.49
, Gln212
5.68
, Ser221
ICL3
 and Asn292
7.57
 (not 
visible). B, Average number of interactions between hH2Ra2 and GαCT. C, Superposition of the 
hH2Ra2 at the start and the end of the 80 ns MD simulation.  
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Among the interactions, several polar contacts were obvious, for the most frequent see Table 
4.5. The salt bridge between the side chains of Arg1163.50 and Glu392 described in chapter 3 
was present in 41% throughout the simulation. Additionally, several hydrophobic contacts 
linked the GαCT protein to the hH2Ra2. The most frequent contacts are listed in Table 4.6. 
Also repulsive ionic interactions between amino acids of the hH2Ra2 and GαCT occurred 
(Arg293H8-Arg389, frequency of 18%; Asp294H8-Glu392, 88%; Arg296H8-Arg389, 19%; 
Lys223ICL3-Arg385, 35%). 
 
 
Table 4.5: Polar contacts between hH2Ra2 and GαCT 
hH2Ra2 Type
1
 
 
GαCT Type
1
 
  
Contact
2
 Frequency [%]  
Thr53
2.39
 sc  Glu392 sc   H-bond 63  
Arg116
3.50
 sc 
 
Glu392 bb   SOL 49 
4, 5 
Ser220
ICL3
 sc 
 
Asn377 sc   H-bond 55 
5 
Ser221
ICL3
 sc 
 
Asp381 sc   H-bond
3
 71 
5 
Trp222
ICL3
 bb  Asp381 sc   H-bond 64  
Lys223
ICL3
 bb  Asp381 sc   H-bond 73  
Ala224
6.25
 bb  Asp381 sc   H-bond 79  
Arg228
6.29
 sc  Gln384 sc   H-bond 69  
Asn292
7.57
 sc  Glu392 sc   H-bond
3
 94  
Arg293
H8
 bb  Glu392 sc   H-bond 80  
Arg293
H8
 sc  Glu392 sc   Ionic 78  
Asp294
H8
 sc 
 
Glu392 sc   SOL 57 
4 
Arg296
H8
 sc  Leu394 bb   Ionic 93  
1 
sc, side chain; bb, backbone. 
2
 SOL, water mediated H-bond. 
3
 This H-bond was already present in the initial hH2Ra2-GαCT complex (cf. chapter 3). 
4
 The corresponding residue of opsin interacts with the GαCT peptide in the crystal structure 
of opsin (Scheerer et al., 2008). 
5
 The corresponding residue of the hβ2AR interacts with the G-protein in the crystal structure  
of the β2 adrenergic receptor–Gs protein complex (Rasmussen et al., 2011b). 
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Table 4.6: Frequency of van der Waals contacts between hH2Ra2 and GαCT 
hH2Ra2 GαCT F [%] 
 
 hH2Ra2 GαCT F [%] 
 
Arg116
3.50
 Leu393 50 
1, 2 
 
Lys223
ICL3
 Arg385 81 
 
Ala119
3.53
 Tyr391 97 
1, 2 
 
Ala224
6.25
 Asp381 76 
1 
Val120
3.54
 Leu388 54 
1, 2 
 
Ala224
6.25
 Gln384 77 
1 
Val120
3.54
 Leu393 96 
1, 2 
 
Ala224
6.25
 Arg385 51 
1 
Pro123
ICL2
 His387 97 
2 
 
Ile227
6.28
 Arg385 81 
 
Pro123
ICL2
 Tyr391 100 
2 
 
Ile227
6.28
 Leu388 74 
 
Tyr126
ICL2
 Tyr391 95 
2 
 
Ile227
6.28
 Leu394 95 
 
Ile216
5.72
 Phe376 87 
 
 
Arg228
6.29
 Leu388 87 
1 
Ile216
5.72
 Arg380 63 
 
 
Lys231
6.32
 Leu394 68 
 
Ile216
5.72
 Gln384 43 
 
 
Ala232
6.33
 Leu388 80 
1, 2 
Ile219
ICL3
 Ile372 54 
 
 
Ala232
6.33
 Leu393 75 
1, 2 
Ile219
ICL3
 Phe376 76 
 
 
Ala232
6.33
 Leu394 52 
1, 2 
Ser220
ICL3
 Phe376 66 
 
 
Leu236
6.37
 Leu393 91 
2 
Ser220
ICL3
 Asn377 38 
 
 
Leu291
7.56
 Leu393 59 
 
Trp222
ICL3
 Asn377 42 
 
 
Arg293
H8
 Glu392 70 
 
Trp222
ICL3
 Asp381 51 
 
 
   
 
1
 The corresponding residue of opsin interacts with the GαCT peptide in the crystal  
structure of opsin (Scheerer et al., 2008). 
2
 The corresponding residue of the hβ2AR interacts with the G-protein in the crystal 
structure of the β2 adrenergic receptor–Gs protein complex (Rasmussen et al., 2011b). 
 
 
4.4 Discussion 
4.4.1 Quality of the MD simulations 
The analysis of system parameters during the 20 ns equilibration phase and the 80 ns 
production run of the hH2Ri and hH2Ra2 showed that the parameters attained stable values as 
expected for accurate MD simulation systems. Highest variability was measured for the box 
dimensions. In both simulation systems the plane parallel to the membrane was contracted 
and the z-dimension expanded. The reason is possibly related to the bilayer (see below). 
However, in the 80 ns simulation period the box vectors converged. The distance of the 
hH2Ri to its nearest periodic image was in a marginal fraction of the simulation below the cut-
off value for long-range interactions (1.4 nm). Therefore, during these phases the protein 
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could manipulate itself resulting in artifacts of the simulation. However, no bad effects were 
observed. The structure of the DPPC bilayer was generally in very good agreement to 
experimentally characterized bilayers. Only the area per lipid was slightly above the lowest 
reference value. However, the quality of a lipid bilayer does not only depend on this 
parameter (Poger and Mark, 2010). The reduction of the area per lipid correlated with the 
alterations of the box vectors. The insertion of the protein with the tool InflateGRO (Kandt et 
al., 2007) in the DPPC bilayer was performed as recommended (refer to the website of the 
Life and Medical Science Center of the University of Bonn, http://www.csb.bit.uni-
bonn.de/inflategro.html). Furthermore, parameters potentially influencing the box dimensions 
such as the pressure coupling were adapted to previous simulations with the same lipid 
parameters (Kukol, 2009). Thus, possibly the estimation of the protein size performed by 
InflateGRO was critical since this is a well-known challenge in MD system preparations 
(Allen et al., 2009). Nevertheless, the area per lipid was still in accordance to reference 
values in both simulation systems. 
The quality of the proteins hH2Ri, hH2Ra2 and GαCT were extensively examined with the 
program gro_validation described in chapter 5. Stereochemistry at Cα atoms and planarity of 
aromatic side chains and delocalized π-electron systems in polar side chains were as 
expected for accurate amino acids, substantiating the quality of the initial hH2R models and 
of the force field used. Errors of the stereochemistry could originate from inappropriate 
protein structures or from wrong force fields parameters. However, the distribution of the 
peptide dihedral angle ω was broadened compared to experimentally derived data (Edison, 
2001). The correspondence of the dihedral angles Φ and Ψ of the protein backbone to 
values obtained from protein crystal structures (Lovell et al., 2000) was very good. The same 
applied to the side chain dihedral angles. They were in very good agreement to frequently 
occurring rotamer states. The correctness of stereochemical parameters and the 
reproducibility of experimental values of the proteins were the prerequisite of using the data 
obtained from these MD simulations to draw reliable conclusions on the conformational 
differences between inactive and active hH2R states and thus activation of the hH2R. 
4.4.2 Activation of the hH2R 
In general two different mechanisms for the activation of GPCRs are discussed (Deupi and 
Kobilka, 2010; Trzaskowski et al., 2012). According to the ‘induced fit’ theory, ligand binding 
is accompanied with an energy transfer inducing a conformational change of the protein. 
Thus, the ligands had to bind to the receptor with high affinity in order to provide enough 
energy to enable the ‘jump’ of the GPCR over the first, high energy barrier. In rhodopsin, the 
isomerization of the light sensitive and (via a protonated Schiff base with Lys2967.43) 
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covalently bound chromophore 11-cis-retinal to all-trans retinal after light absorption (Li et al., 
2004) provides such high energy. In contrast, relatively low binding affinities and fast 
dissociation rates, e.g. of β2AR agonists (Gether et al., 1995), are not in agreement with an 
induced fit mechanism. Furthermore, several crystal structures of the putative inactive state 
of the β1AR and β2AR (Hanson et al., 2008; Rasmussen et al., 2007; Rosenbaum et al., 
2007; Warne et al., 2008) suggest that the internal flexibility allows the receptor to explore 
different conformations (Ghanouni et al., 2001; Peleg et al., 2001). Thus, in case of the βARs 
and probably also of the related hH2R, the mechanism of ‘conformational selection’ is 
preferred, in which a ligand binds to a suitable receptor conformation (e.g. an agonist to an 
active receptor conformation) which is then stabilized (Deupi and Kobilka, 2010). 
Accordingly, in the hH2R the activation process is not necessarily started at the orthosteric 
binding site and then transferred to the intracellular surface of the receptor via subsequent or 
parallel steps, enabling the interaction with the G-protein. Most likely, different conformations 
exist in equilibrium and are stabilized by different ligands. Therefore, the activation 
mechanism of the hH2R may be analyzed by the comparison of inactive and active receptor 
states based on the systematic calculation of ionic interactions, H-bonds, water mediated H-
bonds and van der Waals contacts. The examination of helical contacts was of special 
interest since the relative positions of TMs deviated between hH2Ri and hH2Ra2, similar to the 
differences between the inactive and active state of rhodopsin (Okada et al., 2004; Scheerer 
et al., 2008) and the β2AR (Cherezov et al., 2007; Rasmussen et al., 2011b). Residues with 
different interaction partners in hH2Ri and hH2Ra2 or changed positions during the MD 
simulations were especially important. Most of the deviations between the hH2R states 
occurred around molecular switches already described in chapter 3. However, the 80 ns MD 
simulations of hH2Ri and hH2Ra2 allowed a more detailed analysis of dynamic interactions 
and the detection of linkages between switches. A lot of contacts were not obvious in the 
initial homology models but emerged during the simulations, or they were unstable at the 
beginning and more stable at the end of the MD simulations. 
The pivotal difference between hH2R states was the outward position of the cytoplasmic part 
of T 6, adopted from the template hβ2AR (Rasmussen et al., 2011a) and previously 
described in literature to be a key alteration during GPCR activation (Altenbach et al., 2008; 
Farrens et al., 1996). This change was connected to all other molecular switches, namely the 
parallel arrangement of TM5 and TM6 (stable during the simulation of hH2Ra2) including the 
conformational switch of Tyr2025.58, the cleavage of the ionic lock and the hydrophobic 
barrier, the inward move of TM7 with the change of Tyr2887.53, the rearrangement of the H-
bond network between TM1, TM2, TM3 and TM7, and the alterations at the bottom of the 
binding site which was linked by the key amino acid Phe2436.44 to the movement of TM6. 
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Phe2436.44 was close to some residues of the orthosteric binding site (Cys1023.36, Ile1063.40, 
Trp2476.48 and Phe2516.52). By transition from the inactive to the active receptor 
conformation, Phe2436.44 was released from amino acids of TM3 and TM7 (Cys1023.36, 
Ser1053.39 and Asn2807.45) and turned towards TM5, residing in a pocket of several 
hydrophobic amino acids (Ile1063.40, Leu1093.43, Phe1915.47, Pro1945.50, Leu1955.51 and 
Met1985.54). Thereby it changed its position with Ile1063.40. This switch was first observed for 
corresponding amino acids in the crystal structure of the nanobody-stabilized active state of 
the β2AR (Rasmussen et al., 2011a). In a recent study, Phe
6.44Ala mutants of the ghrelin 
receptor, GPR119, the β2AR and the NK1 tachykinin receptor, respectively, showed strongly 
impaired or no spontaneous and/or agonist-mediated signaling (Valentin-Hansen et al., 
2012b). It was suggested that an aromatic ‘microswitch’ of Phe6.44 stabilizes the outward 
conformation of TM6 by sliding of the side chain into a hydrophobic pocket between TM3 and 
TM5, whereas the residue in position 3.40 is the gate for this transition. Furthermore, in the 
hH2R Phe243
6.44 affected the H-bond network around TM7. After Phe2436.44 approached 
TM5 in the active hH2R conformation, Ser105
3.39 was able to interact with the NPxxY(x)5,6F 
motif, and Asn2807.45 was released from its position towards TM2. Experimental 
investigations, e.g. on mutants, would be worthwhile for confirming the pivotal role of 
Phe2436.44 in the hH2R and would furthermore extend the knowledge about this ‘microswitch’ 
in GPCRs. Besides Phe2436.44, amino acids near the intracellular surface of the hH2R 
performed crucial conformational changes, most prominent in the case of Tyr2025.58, 
Arg1163.50 and Tyr2887.73. The switch of Tyr2025.58, first observed in the crystal structures of 
opsin and the active β2AR (Rasmussen et al., 2011a; Scheerer et al., 2008), led to sticking 
between TM3 and TM6. In the active hH2R state, Tyr202
5.58 interacted with Arg1163.50 and 
Tyr2887.73. The interaction with Arg3.50 was not possible in the β2AR (distance between side 
chain heteroatoms > 9 Å). Tyr2195.58 of the β2AR probably plays a role in stabilizing the 
active receptor conformation since a Tyr5.58Ala mutant showed a loss of Gs-signaling, arrestin 
mobilization and receptor internalization (Valentin-Hansen et al., 2012a). Also in rhodopsin, 
the analogous Tyr2235.58 was shown to be necessary for Gt-activation (Elgeti et al., 2011). 
Again mutants of Tyr2025.58 at the hH2R are suitable to further explore the importance of this 
residue. Apart from these key amino acids in hH2R activation, several other residues were 
part of maintaining the receptor in its inactive and active state, respectively. A schematic 
overview is given in Figure 4.53. 
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Figure 4.53: Schematic representation of the hH2R activation based on 80 ns MD 
simulations of inactive and active hH2R states 
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4.4.3 Conclusion 
Homology models of the hH2R in its inactive and active state were investigated by MD 
simulations, explicitly considering the natural environment consisting of a lipid bilayer (DPPC) 
and water molecules. Comparison of the simulated membrane structure with parameters 
derived from experiments, as well as the structure validation of the proteins (hH2Ri, hH2Ra2 
and GαCT) during the entire simulations with the program described in chapter 5 
(gro_validation) ensured the quality and reliability of the MD simulations and of the results 
which proved the initial homology models of the hH2Ri and hH2Ra2 to be stable and 
reasonable. In addition to the confirmation of rotamer states and interactions already 
observed in the initial models (chapter 3), the MD simulations enabled to identify new 
contacts, the linkage of several molecular switches important for receptor activation of the 
hH2R and the role of water molecules in connecting residues. This analysis was possible by 
the systematic exploration of polar and hydrophobic contacts in the hH2R states, calculated 
with the programs gro_hbonds and gro_contacts provided in chapter 5. The MD simulations 
confirmed the importance of ‘microswitches’ during hH2R activation, such as the 
rearrangement below the orthosteric binding site with Phe2436.44 as a key amino acid, the 
cleavage of the ionic lock and the hydrophobic barrier, conformational changes of Tyr2025.58 
and Tyr2887.53, rearrangement of the H-bond network between TM1, TM2, TM3 and TM7 as 
well as the inward move of the cytoplasmic part of TM7. All changes were related to the 
pivotal outward move of the cytoplasmic part of TM6 upon receptor activation. The results of 
these theoretical investigations have to be confirmed by experimental methods such as in-
vitro site-directed mutagenesis studies. 
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Chapter 5 
5 Computational Tools for Analyzing Molecular 
Dynamics Simulations 
5.1 Introduction 
Depending on the duration of a molecular dynamics (MD) simulation and the time step, the 
amount of data can rise tremendously since coordinates, velocities, forces, etc. are saved to 
hard disc. The simulation itself is time-consuming, and the analysis of the generated data is 
challenging for the user. With a time step of 2 fs and a frequency of 500 steps for writing data 
to the output files, a 80 ns simulation of a protein in a natural environment (consisting of a 
lipid bilayer and water molecules) as described in chapter 4, produces 80,000 coordinate 
sets with about 3.2 billion coordinates. This corresponds to files with more than 100 GB of 
data. It is of course not possible to examine every single time point visually in order to detect 
changes in the system. Furthermore, focusing on special contacts in a protein observed in 
the starting structure of the simulation or on expected interactions could result in ignoring 
interactions or changes arising during the simulation. Therefore it is essential to analyze MD 
simulations systematically, i.e. to measure all possible interactions of a residue or even atom 
over the whole duration of the simulation. Programs are necessary which are able to handle 
a huge amount of data and to produce output in a user friendly format which is easily 
understandable. 
In section 5.3 the program gro_hbonds is introduced which systematically calculates 
hydrogen bonds. H-bonds in proteins belong to the most important types of interactions, 
stabilizing the secondary and tertiary structure and enabling contacts to small molecules 
interacting with the proteins (Panigrahi and Desiraju, 2007). Besides direct H-bonds, it is also 
important to analyze water mediated H-bonds. For example, in GPCRs conserved water 
mediated H-bond networks could play an important role in receptor activation (Nygaard et al., 
2010). According to the IUPAC Recommendation of 2011 (Arunan et al., 2011) six criteria 
are capable of assigning H-bonds. For molecular modeling, criteria are necessary which are 
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directly or indirectly available from the output of coordinate files. The hydrogen bond angle 
X–H···Y (X and Y, heteroatoms; – covalent bond; ··· hydrogen bond) and the distance 
between participating atoms fit best to this requirement. In molecular modeling software there 
are different limits (cut-off values) of angles and distances for assigning an H-bond (Table 
5.1). 
 
Table 5.1: Default cut-off values for assigning H-bonds in molecular modeling software 
Software Distance cutoff [Å]
1
 Angle cutoff [°]
2
 
Sybyl
3
  2.8
4
 > 120 
VMD
5
 3.0 > 160 
GROMACS
6
 3.5 <  30
7
 
Amber
8
 3.0 > 135 
Charmm
9
 4.5 > 90 
Chimera
10
 4.0 > 160 
1 
Distance between participating heteroatoms. 
2
 Angle between heteroatom 1 – hydrogen atom – heteroatom 2. 
3
 Sybyl-X 1.3 (Tripos, St. Louis, MO, USA). 
4
 Sybyl measures the length of the H-bond itself (distance between the heteroatom and the   
hydrogen bonded H-atom). 
5
 VMD User's Guide (Humphrey et al., 1996). 
6
 GROMACS User Manual (Hess et al., 2008). 
7 
GROMACS defines the angle in a different way (cf. Figure 5.1).  
8 
AmberTools12 Manual (Salomon-Ferrer et al., 2013). 
9 
Charmm documentation (Brooks et al., 2009). 
10
Chimera User Guide (Pettersen et al., 2004). 
 
 
The molecular dynamics software GROMACS (Hess et al., 2008; Van Der Spoel et al., 2005) 
provides an opportunity to calculate H-bonds (command g_hbond). However, compared to 
other molecular modeling programs the angle calculated for assigning H-bonds is not X-H-Y, 
but Y-X-H (Figure 5.1). Furthermore, g_hbond is not able to perform a systematic calculation, 
and water mediated H-bonds are not considered in a convenient way. The speed of the 
calculation and the format of the output are further drawbacks of this tool. 
Hydrophobic contacts between amino acid side chains are a major factor for folding proteins 
and the packing of α-helices (Kellis et al., 1988; Matthews, 2001). Hydrophobic interactions 
could be analyzed with the program g_mdmat of GROMACS. Unfortunately, the output is 
inadequate for an intensive and effective analysis (cf. Figure 5.7 in section 5.4.1). Using this 
tool of GROMACS as a basis, the output is transformed and analyzed with the program 
gro_contacts described in section 5.4. 
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Figure 5.1: Definition of the angles used for the calculation of H-bonds 
 
For single protein structures, the verification of the stereochemical quality is performed with 
tools like PROCHECK (Laskowski et al., 1993). It proves the availability of the model and 
checks its comparability with experimentally determined protein structures. Conformations 
generated during MD simulations originate from artificial systems. Simple interaction models, 
e.g. Hooke's law for the calculation of bond lengths, are used. With respect to accurateness, 
force field methods (molecular mechanics) are not comparable to time-consuming ab initio 
quantum mechanics calculations. Nevertheless, reliable structures must be produced by the 
simulation for drawing authentic conclusions from the results. The examination of the protein 
structures during a complete MD simulation is performed with the program gro_validation 
described in section 5.5. It analyzes important parameters such as stereochemistry of amino 
acids, geometry of the peptide bond and planarity of aromatic side chains and of delocalized 
π-electron systems in side chains. Additionally, backbone (Φ and Ψ angles) and side chain 
dihedral angles (rotamers) are measured and compared to experimentally derived values. 
5.2 Materials and methods 
The analysis was performed with data obtained from MD simulations using the software 
package GROMACS 4.0.7 (Van Der Spoel et al., 2005) and the GROMOS96 53a6 force field 
(Oostenbrink et al., 2004). The programs were composed of shell scripts and subroutines 
written in the computer language C. All calculations were performed on a DELL Precision 
T3500 (Intel® Xeon® Processor W3565, 3.2 GHz and 6 GB RAM) with the operating system 
CentOS 5.6. Figures were created with Microsoft® Excel® 2010. 
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5.3 Systematic calculation of direct and water mediated H-bonds: 
gro_hbonds 
5.3.1 Skills of the program 
5.3.1.1 Systematic calculation of hydrogen bonds 
The program is able to calculate H-bonds from each heteroatom of a MD simulation system 
to all remaining heteroatoms at any time. The criteria for assigning an H-bond are the 
distance between two heteroatoms and the angle formed by the first heteroatom, a hydrogen 
atom (bonded to one of the two heteroatoms) and the second heteroatom. Default values 
(maximum distance of 3.5 Å and an angle of at least 120°) may be adjusted in the parameter 
file (parameters var-cutoffdist and var-cutoffang; Table 5.2). To save computation time and 
avoid repeats in the output files, only interactions of a specific heteroatom to subsequent 
heteroatoms (to heteroatoms with a higher atom number) in the molecular structure file of 
GROMACS are calculated. If there are more than one hydrogen atom part of an H-bond at 
different time points, these interactions are not treated separately but summarized to one 
result. For example, H-bonds of the side chain of lysine are not classified for each hydrogen 
atom at the amine nitrogen. The calculation is performed for each heteroatom starting at 
residue number one until the residue number corresponds to the value of the variable 
residues defined in the parameter file (Table 5.2). The program also allows the determination 
of H-bonds which are mediated by one water molecule. Every water molecule is separately 
checked for being H-bonded to two heteroatoms at the same time. Interactions between the 
same couple of heteroatoms mediated by different water molecules at different time points 
are combined to one result. So far, every proteinogenic amino acid listed in the residue 
topology file of the GROMOS96 53a6 force field (ffG53a6.rtp) is included in the program. 
Additionally considered are the residues for blocking the N- and C-terminus (ACE and NH2, 
respectively), the phospholipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 
histamine, SPC (Simple Point Charge) water and chloride ions. To include more residues, 
see Figure 5.2 for an example. 
5.3.1.2 Analysis of helical structures 
As an alternative to the DSSP (Define Secondary Structure of Proteins) algorithm (Kabsch 
and Sander, 1983), the helical structure analysis tool may be used to test if assumed α-
helical parts of proteins such as TM segments of GPCRs are really helical according to the 
IUPAC definition using H-bonds (rule 6.3;(CBN, 1970). Each backbone oxygen atom is 
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tested if it is hydrogen bonded to the backbone nitrogen localized four residues farther in the 
sequence (i+4 → i hydrogen bonding). Additionally, the secondary structure can be checked 
for a 310 helix (the backbone nitrogen of an amino acid forms an H-bond with the backbone 
oxygen of the amino acid three residues before, corresponding to a i+3 → i hydrogen 
bonding) and a π-helix (i+5 → i hydrogen bonding). 
5.3.1.3 Structure validation of H-bonds 
To validate a protein structure, it is useful to check for unoccupied buried H-bond donors and 
acceptors like performed by the molecular modeling package WHATIF (Vriend, 1990). The 
frequency of any heteroatom (nitrogen, oxygen or sulfur) being H-bonded during a MD 
simulation as well as the time course of the H-bonds are calculated. 
5.3.1.4 Detailed analysis of specific hydrogen bonds 
For specific interactions, a detailed output can be generated with time dependent distances 
between heteroatoms and angles of the respective H-bond during the entire simulation, as 
well as a time-resolved graph of the hydrogen bond presence (jpg format). 
5.3.2 Structure of the program 
For the calculation of H-bonds three files are necessary. The shell script gro_hbonds.sh 
organizes the analysis of H-bonds. It extracts variables from the parameter file (gro_hbonds-
para.txt) which is necessary to provide information from the simulation and enables to adjust 
the program by the user. Table 5.2 lists all parameters with a short description of the 
meaning. An exemplary parameter file is shown in the Appendix (section 9.3.1). Furthermore, 
the script transfers computationally intensive calculations to the C program gro_hbonds-calc. 
The shell script and the C program are divided in different sections and functions, 
respectively (Table 5.3). The source code of the programs is also shown in the Appendix 
(sections 9.3.2 and 9.3.3). The program is started with the command ./gro_hbonds.sh. 
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Table 5.2: Content of the parameter file for calculating H-bonds 
Parameter name Description 
var-sim Name of the simulation (all output files start with this term). 
var-filename 
Name of the gro, tpr and xtc file of the MD simulation. All three files 
must have the same name. Otherwise the respective lines in the shell 
script have to be adjusted. 
var-duration The duration of the simulation in picoseconds. 
var-timestep 
The time step of the analysis in picoseconds. E.g. a value of 10 means 
that the analysis is performed every 10
th
 ps. 
var-residues 
Last residue of which H-bonds to the rest of the system should be 
calculated. 
var-cutoffdist 
Cut-off value for the distance heteroatom 1 – heteroatom 2 for H-bonds 
in picometer (integer). 
var-cutoffang 
Cut-off value for the angle (in degree) heteroatom 1 – hydrogen – 
heteroatom 2 for H-bonds (integer). 
var-histo 
The number of data points (time points) to be summarized in one 
average value for the frequency distribution in the output file (integer). 
Assuming a value of 50 for var-histo and a time step of 10 ps, one data 
point in the output is the average of 500 ps. 
 
 
5.3.3 Adjusting the program 
The C program gro_hbonds-calc.c can be adjusted to allow the H-bond calculation for more 
than the residues mentioned in section 5.3.1.1. To add a molecule or residue, the array 
AAname (line 43 ff.) containing all residue names has to be supplemented. The variable 
no_def_res (line 11) indicating the number of molecules/residues which can be analyzed by 
the program has to be raised by one. Furthermore, a description of the newly added 
residue/molecule has to be assigned in AAcode (line 87 ff.). An example for the usage is 
shown for the amino acid arginine in Figure 5.2. 
For the H-bond calculation of charged N- and C-terminal amino acids, the program has to be 
adjusted. In contrast to the residue topology file of GROMACS (ffG53a6.rtp) such residues 
contain an additional atom. For example, in the MD simulation of the hH2Ra2 (chapter 4) the 
G-protein fragment GαCT contains at its C-terminus a charged leucine (residue number 319). 
In this case an additional entry in AAcode has to be made and the number of residues the 
program can handle has to be raised by one (variable no_def_res). Furthermore, three 
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sections (lines 266, 282 and 979) of the source code have to be changed. In case of more 
than one charged terminal residue corresponding lines have to be added to the respective 
section of the program. All parts of the program which have to be adjusted are identified 
easily by the term charge_termini. 
 
 
Table 5.3: Sections of the shell script gro_hbonds.sh 
Section Description 
1 
The variables are received from the parameter file and a list with the residue 
sequence is generated. 
2 
Calculation of H-bonds. A file containing the coordinates of 1,000 time points of the 
whole MD system is created from the binary xtc file (compressed version of the 
trajectory of the MD simulation with time, coordinates and box vectors) using the 
command trjconv. This file is used to calculate H-bonds with gro_hbonds-calc 
(function 1). Subsequently, all these subfiles containing the H-bond information of 
1,000 frames are combined (function 2 of gro_hbonds-calc) to one results file 
(hbond-Het_int.txt). This file contains all information necessary for subsequent 
analysis (sections 3, 4, 5 and 7). Five further files are created (cf. section 5.3.4) using 
function 4 of the C program which summarizes type (backbone and side chain) and 
residue based interactions from the heteroatom based input file (for a description see 
Table 5.5). 
3 
Calculation of water mediated H-bonds. Extract all data from hbond-Het_int.txt where 
a water molecule is part of the H-bond. Uses the function 3 of gro_hbonds-calc. Six 
files are written. 
4 
Helix analysis. All records containing interactions between backbone atoms are 
extracted from hbond-Het_int.txt. With gro_hbonds-calc (function 5) it is checked if an 
H-bond occurs between the carbonyl oxygen atom of an amino acid and the nitrogen 
atom three, four or five amino acids further in the sequence, respectively. Six files are 
created. 
5 
Calculation of the fraction of time points of the MD simulation a specific heteroatom 
(N, O and S) is hydrogen bonded (function 6 of gro_hbonds-calc). Using 
hbond-Het_int.txt as input, two output files are generated. 
6 
Detailed output (distance and angle over time) for one specific H-bond (function 8 of 
gro_hbonds-calc). This section could be used separately from the rest of the script. 
The atom numbers (of the gro file) of the heteroatoms and the hydrogens are needed. 
One file is written. 
7 
Graph of the presence of one H-bond during the entire simulation. The H-bonding 
data are received from one record in hbond-Het_int.txt (corresponds to one H-bond 
between two heteroatoms). Using the function 9 of the C program, an xpm file is 
produced which is then converted to a jpg picture. 
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[ ARG ] 
 [ atoms ] 
    N     N    -0.31000     0 
    H     H     0.31000     0 
   CA   CH1     0.00000     1 
   CB   CH2     0.00000     1 
   CG   CH2     0.00000     1 
   CD   CH2     0.09000     2 
   NE    NE    -0.11000     2 
   HE     H     0.24000     2 
   CZ     C     0.34000     2 
  NH1    NZ    -0.26000     2 
 HH11     H     0.24000     2 
 HH12     H     0.24000     2 
  NH2    NZ    -0.26000     2 
 HH21     H     0.24000     2 
 HH22     H     0.24000     2 
    C     C       0.450     3 
    O     O      -0.450     3 
 
Code for arginine in AAcode of gro_hbonds-calc.c: {17,5,0,1,6,1,9,2,12,2,16,0} 
   
Parameter Atom name Description 
17 - Number of atoms/sites of the residue. 
5 N, NE, NH1, NH2, O Number of heteroatoms. 
0 N 
Position of the first heteroatom in the residue topology file 
(rtp) of GROMACS, starting with zero. 
1 H 
Number of hydrogen atoms bonded to the preceding 
heteroatom. 
6 NE Position of the second heteroatom. 
1 HE 
Number of hydrogen atoms bonded to the preceding 
heteroatom. 
9 NH1 Position of the third heteroatom. 
2 HH11, HH12 
Number of hydrogen atoms bonded to the preceding 
heteroatom. 
12 NH2 Position of the fourth heteroatom. 
2 HH21, HH22 
Number of hydrogen atoms bonded to the preceding 
heteroatom. 
16 O Position of the 5
th
 heteroatom. 
0 - 
Number of hydrogen atoms bonded to the preceding 
heteroatom. 
Figure 5.2: Code for H-bond calculation of arginine 
Arginine with labeled atom names and the atom definition section such as listed in the residue 
topology file of the GROMOS96 53a6 force field (ffG53a6.rtp) is shown. The parameters of the 
variable AAcode used for the calculation of H-bonds with arginine are explained in the table. 
N 
H 
CA 
C 
O 
CB 
CG 
CD 
NE 
HE 
CZ 
NH2 
HH21 HH22 
NH1 
HH12 
HH11 
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5.3.4 Output files 
5.3.4.1 Types of output 
Two folders are created to store the output data (text files). In output_sum (Table 5.4), all 
files contain line by line a specific H-bond pair, the percentage of the simulation this H-bond 
was present as well as the time-resolved H-bond information (frequency distribution). The 
results for direct and water mediated H-bonds are given in three different ways, depending 
on the precision of the output (Table 5.5). 
 
 
Table 5.4: Files created for analyzing H-bonds 
File Description 
hbond-Het_-SOL.txt
1
 
hbond-type_-SOL.txt
2
 
hbond-res_-SOL.txt
3
 
Direct H-bonds
4
. 
hbond_SOL-Het.txt
1
 
hbond_SOL-type.txt
2
 
hbond_SOL-res.txt
3
 
Water mediated H-bonds. 
hbond-helix-1-3-res.txt
5
 
hbond-helix-1-4-res.txt
5
 
hbond-helix-1-5-res.txt
5
 
Helix analysis. Each line contains the data of one residue 
pair. Columns one to three: residue numbers of the two 
amino acids and fraction of time points an H-bond occurs. 
Column 4 ff.: data for the frequency distribution. 
hbonds-amount.txt 
Fraction of time points a specific heteroatom is hydrogen 
bonded. Column one to four: amino acid number, heteroatom 
number in that amino acid, backbone (0) or side chain (1) 
heteroatom and fraction of time points the heteroatom is H-
bonded. Column 5 ff.: data for the frequency distribution. 
hbond-dist-ang-het1-het2-H.txt 
Distance and angle information of a specific H-bond for each 
time point (in lines). 
hbond-existance_example.jpg 
A black line indicates the presence of an H-bond, using the 
cut-off values for H-bond distance and angle in the parameter 
file. 
1 
Heteroatom based information, cf. Table 5.5. 
2 
Type based information, cf. Table 5.5. 
3 
Residue based information, cf. Table 5.5. 
4 
The three files provided contains all hydrogen bonding data except those where water  
molecules are part of the H-bond (term –SOL) in order to reduce the size of the output files. 
5 
H-bonds from Oi to Ni+3, Oi to Ni+4 and Oi to Ni+5, respectively.  
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Table 5.5: Different types of output files for direct and water mediated H-bonds 
Term: Het  type  res 
      
      
Description: 
Heteroatom based H-
bond information:  
H-bond between two 
heteroatoms 
 
Type based H-bond 
information:  
H-bonds between one 
side chain or backbone 
and another side chain 
or backbone are 
summarized 
 
Residue based H-bond 
information:  
H-bonds between 
residues are 
summarized 
Example: 
Investigate which 
heteroatom of a ligand is 
H-bonded to the protein 
 
To analyze if an H-bond 
occurs between an 
amino acid side chain 
and the backbone of 
another amino acid 
 
Analyze if two residues 
are connected via H-
bonds 
C
o
lu
m
n
 i
n
 t
h
e
 o
u
tp
u
t 
fi
le
 
1 
Number of the residue 
which contains the first 
heteroatom 
 
Number of the residue 
which contains the first 
(couple of) heteroatom(s) 
 First residue 
2 
Number of the residue 
which contains the 
second heteroatom 
 
Number of the residue 
which contains the 
second (couple of) 
heteroatom(s) 
 Second residue 
3 
Code for the first 
heteroatom which 
indicates its location 
‡
 
 
Code for the first (couple 
of) heteroatom(s) which 
indicates its location 
‡
 
 
Fraction of time points a 
H-bond occurs between 
the respective residues 
4 
Code for the second 
heteroatom which 
indicates its location 
‡
 
 
Code for the second 
(couple of) 
heteroatom(s) which 
indicates its location 
‡
 
 
Frequency distribution of 
the H-bond(s) over time 
5 
Number of the first 
heteroatom in the 
respective residue 
 Fraction of time points a 
H-bond occurs between 
the respective parts of a 
residue 
 
6 
Number of the second 
heteroatom in the 
respective residue 
 
Frequency distribution of 
the H-bond(s) over time 
 
7 
Atom number in the gro 
file of the first 
heteroatom 
  
8 
Atom number in the gro 
file of the second 
heteroatom 
  
9 
Fraction of time points a 
H-bond occurs between 
the heteroatoms 
  
10 - 
end 
Frequency distribution of 
the H-bond over time 
  
‡
 0, backbone; 1, side chain; 2, terminus ACE or NH2; 3, lipid; 4, water; 5, ion; 6, ligand 
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Each line record starts with two to eight numbers which identify the heteroatoms or groups of 
heteroatoms which contribute to this respective contact and could be used for extracting 
information about specific interaction partners. All numbers are separated by tabulators. 
Furthermore, in the folder output_detail the complete data as obtained from the H-bond 
calculation are provided (with the term _int), listing every time point (in picoseconds) an H-
bond occurs without summing up like in the frequency distribution. These files could be used 
for a detailed and further analysis. 
5.3.4.2 Direct and water mediated H-bonds 
An example of the output for direct H-bonds is shown in Figure 5.3. In 78.4% of the 
simulation of the inactive hH2R state (chapter 4) an H-bond between Thr226
6.27 and 
Glu2296.30 occurred (Figure 5.3 A). This data is obtained from the file hbond-res_-SOL.txt. 
The contact could be split into the interaction of the backbone atoms of both residues, of the 
backbone of Thr2266.27 with the side chain of Glu2296.30 and of the side chains of both amino 
acids (14.5%, 77.4% and 48.4%, respectively; Figure 5.3 B-D). This information was 
extracted from hbond-type_-SOL.txt. The latter two interactions could again be split 
depending on the carboxyl oxygen of the Glu2296.30 side chain which is part of the H-bond 
(file hbond-Het_-SOL.txt, Figure 5.3 E, F). Water mediated H-bonds could be analyzed 
equivalent, using the data from the files hbond_SOL-Het.txt, hbond_SOL-type.txt and 
hbond_SOL-res.txt, respectively. 
5.3.4.3 Helix analysis 
Figure 5.4 shows an example for the analysis of α-helices from the simulation of hH2Ri 
(chapter 4). The data provided in the output files could be used to investigate the stability of 
TM domains. Furthermore, the existence of a special H-bond could be observed over time. 
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Figure 5.3: Example of the output for analyzing direct H-bonds 
Interaction between Thr226
6.27
 and Glu229
6.30
 during the MD simulation of hH2Ri (chapter 4). A, 
H-bond frequency between both residues; B, H-bond from the backbone of Thr226
6.27
 to the 
backbone of Glu229
6.30
; C, H-bond from the backbone of Thr226
6.27
 to the side chain of 
Glu229
6.30
; D, H-bond between the side chains of both residues; E, H-bond from the backbone 
oxygen of Thr226
6.27
 to the carboxyl oxygen atoms of Glu229
6.30
 (OE1, blue line; OE2, black 
line); F, H-bond from the side chain oxygen of Thr226
6.27
 to the carboxyl oxygen atoms of 
Glu229
6.30
 (OE1, blue line; OE2, black line). 
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Figure 5.4: Helix analysis 
A, H-bond frequency between Oi and Ni+4 in TM2 of hH2Ri during the 80 ns MD simulation 
(chapter 4); B, The reduced helicity of residue 59 is analyzed in detail. 
 
 
5.3.4.4 Structure validation of H-bonds 
The output file hbonds-amount.txt contains line by line the data for the heteroatoms of the 
simulation system, i.e., the fraction of time points the respective heteroatom is H-bonded and 
the time course (Figure 5.5). 
 
  
Figure 5.5: Saturation of H-bond donors and acceptors 
A, Average frequency heteroatoms of hH2Ri are H-bonded during the 80 ns MD simulation 
described in chapter 4. It is also possible to analyze the frequency distribution over time for one 
specific heteroatom. B, Percentage of heteroatoms which are H-bonded in the fraction of time 
points given on the abscissa during the whole MD simulation. 
 
0.0
0.2
0.4
0.6
0.8
1.0
47 57 67 77
H
-b
o
n
d
 f
re
q
u
e
n
c
y
Residue number
0.0
0.2
0.4
0.6
0.8
1.0
0 20 40 60 80
H
-b
o
n
d
 f
re
q
u
e
n
c
y
Time [ns]
0.0
0.2
0.4
0.6
0.8
1.0
0 20 40 60 80
H
-b
o
n
d
 f
re
q
u
e
n
c
y
Time [ns]
0
5
10
15
0.0 0.2 0.4 0.6 0.8 1.0
H
e
te
ro
a
to
m
s
 [
%
]
H-bond frequency
 A                                                           B 
 A                            B 
176  5.3 Systematic calculation of direct and water mediated H-bonds: gro_hbonds 
5.3.4.5 Detailed output for a specific interaction 
An example for a detailed H-bond analysis is shown in Figure 5.6. 
 
 
Figure 5.6: Detailed analysis of hydrogen bonds 
H-bond angle (blue) and heteroatom distance (grey) between the backbone oxygen of Thr226
6.27
 
and the nitrogen of Glu229
6.30
 during the MD simulation of hH2Ri (chapter 4). The black dashed 
lines at 120° and 0.35 nm indicate the cut-off values for the H-bond calculation. Above: 
Associated H-bond existence map (jpg file). Different grey tones indicate, from dark to light, 
higher and lower frequency of H-bonds, respectively. 
 
 
5.3.5 Performance 
The 80 ns MD simulation of the hH2Ri embedded in a DPPC bilayer and solubilized with 
water molecules (chapter 4) was used for testing the H-bonds analysis program. The 
simulation system contains about 1,750 heteroatoms of the protein and the lipid, and 
additionally about 10,300 oxygen atoms of the water molecules. Thus, calculating H-bonds 
for just one time point includes the analysis of more than 12,000 heteroatoms and 
coordinates, respectively. Consequently, for more than 19.4 million possibly interacting 
heteroatoms distances have to be measured. In case of the 80 ns MD simulation where 
every 10th picosecond was analyzed (corresponding to 8,000 frames in total) this results in 
more than 155 billion comparisons which were performed by the function 1 of gro_hbonds-
calc. The analysis of the hH2Ri simulation ran for about 3:30 hours. Most time-consuming are 
the transformation of the binary xtc file into the gro file using the tool trjconv of GROMACS 
and the calculations performed with the function 1 of gro_hbonds-calc. 
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5.4 Analysis of hydrophobic interactions: gro_contacts 
5.4.1 Skills of the program 
The tool g_mdmat of GROMACS analyzes the contacts between residues of a MD 
simulation. However, the output is rather useful for visual inspections than for a detailed 
analysis of interactions. The investigation of hydrophobic contacts in the 80 ns MD simulation 
of the hH2Ri (chapter 4) at every 10
th picosecond in the analysis (i.e. 8,000 coordinate sets in 
total) results in an xpm image file with a size of more than 1.39 GB. This file is divided into 
8,000 parts, each representing a contact map for a specific time point (Figure 5.7). Every 
pixel of such map denotes an interaction between two residues (distance between the 
closest atoms of two residues), encoded by an alphabetic letter in the file. Depending on the 
parameters submitted with the command g_mdmat e.g. these letters range from ‘A’ (distance 
smaller than 0.2 Å; white color in the picture) to ‘y’ (distance more than 10 Å; black color in 
the picture). This kind of data is not suitable for a systematic and fast graphical analysis. 
 
 
 
 
 
 
Figure 5.7: Hydrophobic contact map for one specific time point created by g_mdmat 
For reason of clarity deviating from the original output of g_mdmat the colors (decreasing grey 
scale) are inverted (black, close distance; white, distance more than 10 Å). 
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Thus, after a short modification, the xpm file containing all contact data is read with the C 
program gro_contacts-calc and analyzed for pairs of residues which are at least at one time 
point closer than the cut-off value defined in the parameter file (var-cutoff; Table 5.6). For 
these interaction pairs the time dependent distances as well as the fraction of time points the 
contact is closer than the cut-off value are printed to the output file. The generation of an 
appropriate index file for the command g_mdmat allows the selection of atoms (e.g. 
hydrophobic atoms) which should be considered for the contact analysis of each residue 
type. An example which was used for analysis of the MD simulations in chapter 4 is given in 
the Appendix (section 9.4.2). 
5.4.2 Structure of the program 
The program gro_contacts is composed of a shell script (gro_contacts.sh; cf. section 9.4.3) 
receiving information from the parameter file gro_contacts-para.txt (Table 5.6). It creates an 
index file with the atom numbers of a specific MD simulation, considering a reference file 
contacts-atoms.txt which contains in each line a residue and atom name. In the analysis of 
residue-residue contacts only the atoms given in the index file are considered. If the 
definition of atoms to be included in the calculation has to be modified, line 96 of the C 
program must be adjusted (cf. section 9.4.4). The variable AAcode contains a number 
indicating if the respective residue is included in the analysis. So far all proteinogenic amino 
acids of the GROMOS96 53a6 force field are listed in the file. Furthermore, it contains atom 
definitions of the phospholipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and of 
histamine. 
 
Table 5.6: Content of the parameter file for the calculation of hydrophobic contacts 
Parameter name Description 
var-sim Name of the simulation (all output files start with this term). 
var-filename 
Name of the gro, tpr and xtc files which must have the same name. 
Otherwise the respective lines in the shell script have to be changed. 
var-duration The duration of the simulation in picoseconds. 
var-timestep 
The time step of the analysis in picoseconds. E.g. a value of 10 means 
that the analysis is performed every 10
th
 ps. 
var-cutoff 
Cut-off value for contacts of two residues in picometer (the number has 
to be divided by 10 without a rest). 
var-last Last residue to be analyzed (residue number in the gro file). 
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An example parameter file as well as the source code of gro_contacts.sh and gro_contacts-
calc.c is shown in the Appendix (section 9.4.1, 9.4.3 and 9.4.4, respectively). The program is 
started with the command ./gro_contacts.sh. 
5.4.3 Output files 
Two files are generated. In a short summary file (contacts_sum.txt) each line includes the 
tabular information of a specific interaction between two residues (Figure 5.8). The first two 
columns contain the residue numbers and the third one the fraction of time points in which 
the contact between the corresponding residues is below the cut-off value given in the 
parameter file (var-cutoff). The detailed file (contacts.txt) additionally contains the distance of 
two residues at every time point analyzed. For distances greater than 1.0 nm, a value of 2.0 
is assigned. This can be modified in line 168 of gro_contacts-calc.c. 
 
 
Figure 5.8: Hydrophobic contact analysis 
Minimum distance between the side chains of 
Leu28
1.42
 and Leu72
2.58
 in the MD simulation of 
hH2Ri (chapter 4). The red line indicates the 
cut-off (0.5 nm) for assigning a contact 
between residues. In 24.1% of the 8,000 time 
points analyzed the distance was below that 
limit. In no frame the distance was larger than 
1.0 nm. 
 
 
5.4.4 Performance 
The 80 ns MD simulation of the hH2Ri embedded in a DPPC bilayer and solubilized with 
water molecules (chapter 4) was used for testing the analysis of hydrophobic contacts with 
gro_contacts. The contact map produced with the command g_mdmat of GROMACS which 
was used as input for the C program gro_contacts-calc contained about 672 million data 
points (when analyzing 8,000 time points), each representing the shortest distance between 
two atoms of two residues in alphabetic letters. The complete program runs 31 minutes, 
whereas the analysis of the contact map with gro_contacts-calc needed only 6 minutes. 
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5.5 Structure validation of molecular dynamics simulations: 
gro_validation 
5.5.1 Skills of the program 
This structure validation tool for MD simulations performed with the simulation package 
GROMACS (Van Der Spoel et al., 2005) searches for proper stereochemical configurations 
at Cα atoms of amino acids, checks the planarity of aromatic side chains (His, Phe, Trp, and 
Tyr) and delocalized π-electron systems in side chains of Arg, Asn, Asp, Gln and Glu, and 
controls the planarity of the peptide bond. It further calculates the backbone Φ/Ψ distribution 
(Ramachandran analysis) and compares the side chain rotamers with a dataset obtained 
from crystalized proteins (Lovell et al., 2003; Lovell et al., 2000). All dihedral angles were 
calculated with subprograms of GROMACS (g_angle, g_chi, g_rama). Summarization of 
angles and comparison to experimental values were performed with gro_validation.sh and 
gro_validation-calc. 
5.5.1.1 Chirality check 
The dihedral angle defined by the atoms Cα, N, C and Cβ represents the rotation about the 
virtual bond N-C. It checks the stereochemistry of an amino acid at the Cα atom and 
distinguishes L- from D-stereoisomers (Morris et al., 1992). In an ideal tetrahedral 
arrangement of the four atoms around the Cα atom of L-amino acids, the angle between the 
planes Cα-N-C and N-C-Cβ is about 35° (Figure 5.9). A correct stereochemistry is assumed if 
the dihedral angle Cα-N-C-Cβ is between 0° and 70°. These cut-off values can easily be 
modified by adjusting line 229 of gro_validation-calc.c (section 9.5.3). 
 
 
Figure 5.9: Dihedral angle definition for checking the stereochemisty of amino acids 
Plane N-C-Cβ 
Plane Cα-N-C 
Dihedral angle Cα-N-C-Cβ 
Cα 
Cβ 
C 
N 
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The torsion angle Cα-N-C-Cβ is calculated for each amino acid and time point requested by 
the tool g_chi of GROMACS. The data are transferred into and analyzed by the C program 
gro_validation-calc. 
5.5.1.2 Planarity check 
There are different ways to test normally planar moieties of amino acids such as aromatic 
side chains (His, Phe, Trp and Tyr) or polar groups containing a delocalized π-electron 
system (Arg, Asn, Asp, Gln and Glu) for their deviation from planarity. In the structure 
validation tool PROCHECK (Laskowski et al., 1993), checking single protein structures for 
their stereochemical quality, the root mean square distance of atoms to a plane is calculated. 
Another possibility also used in gro_validation is the measurement of dihedral angles defined 
by atoms of the putatively planar substructures (Figure 5.10). Depending on the number of 
atoms in the respective fragments, different numbers of dihedral angles are considered in the 
analysis (Table 5.7). These improper torsion angles are also used by GROMACS to control 
planarity and are defined in the residue topology file (ffG53a6.rtp). Dihedral angles are 
calculated with g_angle and passed to gro_validation-calc to summarize the data. 
 
 
Table 5.7: Number of dihedrals per amino acid used for calculating the deviation from 
planarity 
Amino acid
1
 
Number of 
dihedrals
2
 
 Amino acid
1
 
Number of 
dihedrals
2
 
ARG 4  HISA
6
 9 
ARGN
3
 3  HISB
6
 9 
ASN 2  HISH
6
 10 
ASN1
4
 2  HIS1
6
 9 
ASP 1  HIS2
6
 9 
ASPH
5
 1  PHE 12 
GLN 2  TRP 20 
GLU 1  TYR 12 
GLUH
5
 1    
1
 All amino acids with planar moieties listed in the residue topology file of the GROMOS96  
53a6 force field (ffG53a6.rtp). 
2 
The number of dihedrals were taken from the residue topology file ffG53a6.rtp of GROMACS. 
3 
Neutral arginine. 
4 
Contains another type of N in the side chain compared to ASN. 
5 
Protonated side chain. 
6 
Different protonation states of nitrogen atoms in the side chain of histidine. 
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Figure 5.10: Checking for planarity with dihedral angles 
One of the 12 dihedral angles used to control the planarity of the phenylalanine side chain. The 
angle between the planes CD2-CG-CE2 (red lines) and CG-CE2-HD2 (green lines) is measured. 
For an ideal planar aromatic moiety the angle is 0° and both planes coincide (blue). The atom 
names were adapted from GROMACS. 
 
 
5.5.1.3 Peptide bond analysis 
According to the IUPAC-IUB Commission on Biochemical Nomenclature (CBN) the peptide 
omega (ω) angle of residue i is defined by the atom sequence Cαi-Ci-Ni+1-C
α
i+1, i.e. the angle 
between the planes Cαi-Ci-Ni+1 and Ci-Ni+1-C
α
i+1 (CBN, 1970). Ideally this angle amounts to 
180° (trans configuration of the peptide bond Ci-Ni+1) or 0° (cis configuration), so that the 
atoms Cαi, Ci, Oi, Ni+1, Hi+1 and C
α
i+1 lie in the same plane (Figure 5.11). By contrast, the tool 
g_rama of GROMACS uses the atoms Oi-Ci-Ni+1-Hi+1 for the calculation. For an ideal planar 
geometry and a trans configuration of the atoms, also an angle of 180° results. The data 
received from g_rama are summarized with gro_validation-calc. 
 
 
Figure 5.11: The peptide bond and its atoms located in one plane 
C
α
i 
C
α
i+1 
Ci 
Oi 
Ni+1 
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CG 
CD2 HD2 
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5.5.1.4 Ramachandran analysis 
The protein backbone dihedral angles Φ (phi) and Ψ (psi) of residue i are defined by the 
sequence of atoms Ci-1-Ni-C
α
i-Ci and Ni-C
α
i-Ci-Ni+1, respectively (CBN, 1970). Depending on 
the type of an amino acid, different combinations of Φ/Ψ angles are preferred. A suitable 
classification is the formation of the four groups glycine, proline, pre-proline (amino acids 
preceding proline in the sequence) and ‘general’ amino acids (all remaining amino acids). 
 
  
  
  
Figure 5.12: Ramachandran plots 
A, ‘General’ amino acids (all except the following); B, Glycine; C, Proline; D, Pre-proline (amino 
acids before proline). All plots were created with data obtained from Lovell et al. (2003). Level 
limits between favored (red) and allowed (yellow) and between allowed and disallowed (grey) are 
0.02 and 0.002, respectively. 
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Φ and Ψ angles are calculated with the tool g_rama of GROMACS. Pairs of values are then 
compared to reference data derived from protein crystal structures. Accordingly, each Φ/Ψ 
combination, classified in intervals with an increment of 2°, has a particular ‘probability value’ 
calculated from the probability distribution of the Φ/Ψ torsions in proteins (Lovell et al., 2003; 
Lovell et al., 2000). The dihedral space is divided into three regions. Φ/Ψ angles with a value 
below 0.002 belong to the disallowed region (outlier), values above 0.02 indicate probable, 
favored backbone conformations, and intermediate values are part of the allowed regions 
(Figure 5.12). In the program gro_validation-calc all combinations of Φ and Ψ dihedrals 
received from a  D simulation are assigned to the proper reference Φ/Ψ interval and marked 
as favored, allowed or disallowed due to the ‘probability value’. 
5.5.1.5 Side chain rotamers 
Similar to Φ and Ψ angles, also side chain dihedral angles and their combination in case of 
more than one dihedral angle in the side chain occur with varying frequency, leading to 
different distributions of rotamer states. Databases containing such information could be 
used to compare values obtained from MD simulations with experimental values. The side 
chain dihedral angles are calculated with g_chi of GROMACS and are then transferred to 
gro_validation-calc, which compares the data of simulations with the reference data and 
classifies it in the groups favored, allowed or disallowed. The same cut-off values (0.002 and 
0.02) as for the Ramachandran analysis are used. Figure 5.13 shows the conformational 
space of amino acids with one or two dihedral angles. 
5.5.2 Structure of the program 
The program gro_validation is composed of three files (parameter file, shell script, C 
program) and one folder containing the reference data provided by Lovell et al. (2000), as 
well as files with the definition of dihedral angles adapted from the GROMOS96 53a6 force 
field. The interplay of programs and text files is described in Figure 5.14. 
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Cys Ser Thr 
   
   
Val Asp Phe, Tyr 
   
   
Asn His Ile 
   
   
Leu Trp 
  
 
Figure 5.13: Side chain rotamer probability plots 
The ‘probability values’ of side chain dihedrals obtained from Lovell et al. (2000) are shown for 
Cys, Ser, Thr and Val. The red, yellow and grey background indicates favored, allowed and 
disallowed regions of the conformational space, respectively, as defined in section 5.5.1.5. For 
amino acids with two dihedral angles in the side chain (Asn, Asp, His, lle, Leu, Phe, Trp and Tyr) 
the color coded ‘probability values’ are shown. 
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Figure 5.14: Flowchart for gro_validation 
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5.5.2.1 Parameter file gro_validation-para.txt 
The parameter file gro_validation-para.txt contains information necessary for the shell script 
to access the correct files for a specific MD simulation and allows the user to modify the 
amount of data analyzed. Table 5.8 lists all parameters needed with a description. An 
example parameter file is given in the Appendix (section 9.5.1). 
 
Table 5.8: Content of the parameter file for the protein structure validation 
Parameter name Description 
var-sim Name of the simulation (all output files start with this term). 
var-filename 
Name of the gro, tpr and xtc files which must have the same name. 
Otherwise the respective lines in the shell script have to be changed. 
var-duration The duration of the simulation in picoseconds. 
var-timestep 
The time step of the analysis in picoseconds. E.g., a value of 10 means 
that the analysis is performed every 10
th
 ps. 
var-first 
Residue number of the first amino acid to analyze (residue number in 
the gro file). 
var-last Last amino acid to analyze. 
 
 
5.5.2.2 Shell script gro_validation.sh 
The shell script gro_validation.sh is the core of the program, receiving information from the 
parameter file and transferring computational intensive applications to subprograms of 
GROMACS or to the C program gro_validation-calc described below. The script is divided in 
several sections. Table 5.9 gives a summary of them and a short description of their 
functions. The complete script is listed in the Appendix (section 9.5.2). The program is 
started with the command ./gro_validation.sh. 
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Table 5.9: Sections of the shell script gro_validation.sh 
Section Description 
1 
Variables are extracted from the parameter file, and new variables are calculated. A 
file is created containing amino acid names including sequence number, atom types 
and atom numbers. This file is needed for writing an appropriate index file which 
works with atom numbers. The atom numbers correspond to amino acid atom types 
(provided in the folder reference) defining the dihedral angles for the chirality analysis, 
the control of planarity and side chain rotamers. 
2 
The index file for the chirality check is constructed. The file containing the definition of 
the respective dihedral angles in terms of amino acids and atom types is located in 
the folder reference (chirality-dihedral.txt). 
3 
Generation of the index file for the planarity check. The file containing the definition of 
the respective dihedral angles is also located in the folder reference (impropers.txt). 
4 
Creation of the index file for calculating side chain rotamers. The corresponding 
reference file is stored in the folder reference (dihedrals.txt). 
5 
Dihedral angles are calculated using the GROMACS tool g_angle and the index files 
written in section 2 to 4. 
6 
Chirality check. With the command line argument 1, the corresponding subfunction of 
gro_validation-calc is started which controls the dihedral angle defining the chirality of 
Cα atoms. The respective values are extracted from the file created in section 5. The 
output file chirality.txt is written. 
7 
Checks aromatic side chains and polar groups with π-electron systems for planarity 
(subfunction 2 of gro_validation-calc). A part of the file produced in section 5 contains 
the dihedrals needed. One file (planarity.txt) is generated. 
8 
Checks backbone ω angles. The dihedrals are calculated with g_chi of GROMACS. 
The subprogram 4 of gro_validation-calc controls for planarity of ω angels. The output 
file omega.txt is created. 
9 
Compares the side chain rotamers with experimental values (subfunction 3 of 
gro_validation-calc). The file which is produced with g_angle in section 5 contains the 
side chain dihedrals. Three files (rotamer-regions.txt, rotamer-time.txt, rotamer-
graph.txt) are written. 
10 
Backbone Φ/Ψ dihedrals (Ramachandran plot) are compared to experimentally 
determined values using the subfunction 5 of gro_validation-calc. The tool g_rama of 
GRO ACS is used to calculate the Φ and Ψ angles. Four output files 
(rama-regions.txt, rama-data.txt, rama-time.txt, rama-graph.txt) are printed. 
 
 
5.5.2.3 C-Program gro_validation-calc 
Computational challenging tasks which could not be solved with subprograms of GROMACS 
are transferred to the C program gro_validation-calc. It is divided in several sections 
addressed with the variable angtype (Table 5.10). For a detailed description, refer to the 
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comments included in the source code presented in the Appendix (section 9.5.3). In lines 12 
to 26 variables determine the range and increment of the frequency distributions of dihedral 
angles. In the variable AAname (line 46 ff) all amino acid names are stored, and no_def_res 
contains the number of residues (line 11). In order to add additional amino acids not present 
in the analysis, these lines have to be modified. So far all standard amino acids of 
GROMACS, present in the residue topology file ffG53a6.rtp are integrated, including ACE 
(acetyl moiety to block the N-terminus) and NH2 (for C-terminal ends of proteins). 
 
Table 5.10: Sections of the C-program gro_validation-calc 
Section 
(angtype) 
Description 
1 
Controls the stereochemistry. In AAcode (line 113) it is stored whether a residue 
contains a chiral Cα atom. The sequence is equal to AAname (line 46 ff). 
2 
Check planarity in side chain elements. AAcode (line 294) contains the number of 
dihedrals per residue in the same sequence as AAname (line 46 ff). 
3 Summarizes data of the peptide dihedral angle. 
4 
Compares side chain torsions with an experimentally determined dataset. In lines 
550 and 551, the variables cutoff_mf (default value 0.02) and cutoff_dis (default 
value 0.002) separate the regions favored, allowed and disallowed (see section 
5.5.2.4) of the conformational space. The variable AAcode (line 577) contains the 
number of dihedrals per side chain, the first line of the respective residue in the 
reference file lovell-rotamer.data, and the ranges and increments of the respective 
torsion angles (Table 5.11). 
5 
Compares Φ/Ψ pairs with experimental values. In line 813 and 814 the variables 
cutoff_mf (default value 0.02) and cutoff_dis (default value 0.002) separate the 
regions favored, allowed and disallowed. 
 
 
5.5.2.4 Reference data 
Dihedral angle definition 
The definition of dihedral angles needed for checking the stereochemistry at Cα atoms, 
planarity of side chain elements and the calculation of side chain rotamers are deposited in 
the files chirality-dihedral.txt, impropers.txt and dihedrals.txt, respectively, all stored in the 
folder reference. Each line contains a residue and atom name. Starting at the beginning of 
each file, four consecutive lines define one dihedral angle. An example for the side chain 
torsions of arginine is given in Figure 5.15. 
190  5.5 Structure validation of molecular dynamics simulations: gro_validation 
ARG N 
ARG CA 
ARG CB 
ARG CG 
ARG CA 
ARG CB 
ARG CG 
ARG CD 
ARG CB 
ARG CG 
ARG CD 
ARG NE 
ARG CG 
ARG CD 
ARG NE 
ARG CZ 
Chi1: N-CA-CB-CG 
 
Chi2: CA-CB-CG-CD 
Chi3: CB-CG-CD-NE 
Chi4: CG-CD-NE-CZ 
Figure 5.15: Definition of the four side chain dihedral angles of arginine in dihedrals.txt 
The definition of the side chain dihedral angles of arginine in dihedrals.txt is shown on the left. 
Four consecutive lines, each containing the residue name and an atom name, define one dihedral 
angle. The dihedral angle definition is equivalent in chirality-dihedral.txt and impropers.txt. 
 
 
Preparation of the library with Φ and Ψ dihedral angles 
The experimental reference data specifying the frequency of a special Φ/Ψ combination were 
taken from the website of the Richardson Laboratory of the Duke University (Durham, UK). A 
zip folder of the ‘(son of) Penultimate Rotamer Library’ is provided there, containing the 
Ramachandran density traces in 2° increments ranging from -179°/-179° to 179°/179° (Lovell 
et al., 2003; Lovell et al., 2000). Φ and Ψ angles as well as the corresponding frequency 
value are listed in columns one to three. The files rama500-general.data, rama500-gly-
sym.data, rama500-pro.data and rama500-prepro.data of the folder pct/rama were combined 
to one file in this sequence (reference/lovell-rama.data), resulting in 129,600 data points. 
Preparation of the rotamer library 
Accordingly, data with most probable side chain conformations were received from the folder 
pct/rota. Respective files were combined to one file (reference/lovell-rotamer.data) in the 
sequence given in Table 5.11. The step size and the range of the dihedral angles depend on 
the individual residue. If present, dihedral angles 1 to 4 are listed in column one to four. 
The frequency value is in the last column. All in all, 3,620,601 data points are summarized in 
that file. 
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Table 5.11: Side chain rotames 
Residue No
a
 
 Angle range from 0° to 
b
  Step size [°]
b
 
 Chi1 Chi2 Chi3 Chi4  Chi1 Chi2 Chi3 Chi4 
Arg 4  360 360 360 360  10 10 10 10 
Asn 2  360 360    5 5   
Asp 2  360 180    5 5   
Cys 1  360     1    
Gln 3  360 360 360   8 8 8  
Glu 3  360 360 180   8 8 7.8
c
  
His 2  360 360    5 5   
Ile 2  360 360    5 5   
Leu 2  360 360    5 5   
Lys 4  360 360 360 360  10 10 10 10 
Met 3  360 360 360   8 8 8  
Phe, Tyr 2  360 180    5 5   
Ser 1  360     1    
Thr 1  360     1    
Trp 2  360 360    5 5   
Val 1  360     1    
a
 Number of side chain dihedrals of the respective amino acid. 
b
 The angle range and step size was determined by the reference data obtained from the  
Richardson Laboratory (Duke University, Durham, UK). 
c
 23 values ranging from 0° to 180° were provided, corresponding to an increment of ~ 7.8°.  
 
 
5.5.3 Output files 
5.5.3.1 Chirality check 
One file is saved in the result folder (output). In each line the information for one amino acid 
is stored, namely the residue number, residue name, the mean angle, the standard deviation 
and a number (zero or one) expressing if all dihedral angles measured were within the limits 
(± 35°) around the reference angle of 35° or not, respectively. Additionally the values for a 
frequency distribution are given, covering values of 10° to 60° of the dihedral angle at the Cα 
atom. An example is given in Figure 5.16. 
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Figure 5.16: Distribution of the mean dihedral angle at Cα atoms and probability 
distribution of one dihedral angle 
A, Mean dihedral angle (black points) of each residue of the MD simulation of the hH2Ri (chapter 
4). The standard deviation is shown in grey bars. B, Probability distribution of the dihedral angle 
defining the chirality at the Cα atom of Asn36
1.50
 during the 80 ns MD simulation of hH2Ri (chapter 
4). Every 10
th
 frame was analyzed (8,000 in total). 
 
 
5.5.3.2 Planarity check 
The file planarity.txt contains all measured dihedral angles with the amino acid number and 
name, the mean, standard deviation and the fraction of values within the interval of two 
standard deviations around the mean. The frequency distribution of the angles ranging 
from  -30° to 30° (a dihedral angle of 0° represents ideal planarity) with an increment of 2° 
can be used to create a probability distribution. Furthermore, means and histogram data of 
dihedral angles defining the planarity of one special residue are summarized (Figure 5.17).  
5.5.3.3 Peptide bond analysis 
In the output file (omega.txt) for each amino acid, the residue number, the mean ω angle, the 
standard deviation and the percentage of values within the interval of two standard 
deviations around the mean are given. Furthermore a frequency distribution ranging from 
100° to 260° is provided (Figure 5.18). Ideal planarity is achieved at a dihedral angle of 180°. 
 
 
 
0
10
20
30
40
50
15 65 115 165 215 265
M
e
a
n
 d
ih
e
d
ra
l 
[ 
]
Residue number
0.00
0.04
0.08
0.12
15 25 35 45
F
re
q
u
e
n
c
y
Dihedral angle[ ]   A                                                        B 
 Chapter 5: Computational tools for MD simulations 193 
   
 
  
Figure 5.17: Planarity control 
A, Mean dihedral angle of each residue containing an aromatic or normally planar polar side 
chain moiety, including all dihedral angles used to define planarity for the respective residue. B, 
Distribution of the two dihedral angles defining the planarity of Asn36
1.50
. C, Mean of each single 
dihedral angle measured. The data are taken from the simulation of hH2Ri described in chapter 
4, analyzing every 10
th
 frame (8,000 in total). 
 
 
   
Figure 5.18: Analysis of the backbone omega angles 
A, Mean omega angle (black point) of each residue and its standard deviation (grey bar). B, The 
frequency distribution is shown for Ile31
1.45
. The data are taken from the simulation of the hH2Ri 
described in chapter 4, analyzing every 10
th
 frame (8,000 in total). 
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5.5.3.4 Ramachandran analysis 
Four files are created. For a description see Table 5.12. 
 
Table 5.12: Output files of the Ramachandran analysis 
File name  Description 
rama-regions.txt For each amino acid the fraction of favored, allowed and disallowed Φ/Ψ 
combinations are given. Figure 5.19 was generated from these data. 
rama-data.txt The file contains all single Φ/Ψ values calculated for each amino acid. 
Figure 5.20 shows four examples of its usage. 
rama-time.txt Each line starts with the amino acid number and contains a character for 
every time point analyzed (f, favored; a, allowed; d, disallowed). With the 
script rama-time.sh presented in the Appendix (section 9.6) a time-
resolved analysis can be performed (Figure 5.21). 
rama-graph.txt For each residue a 180 x 180 matrix is deposited in this file, containing Φ 
dihedrals in columns and Ψ values in lines. The Φ/Ψ pairs are 
categorized in 2° increments, ranging from -180° to 180°. The values 
represent the percentage of dihedrals being in a special interval (in total 
100%). The data are used to create a surface plot (Figure 5.22). 
 
 
 
 
Figure 5.19: Ramachandran analysis 
For each residue the fraction of Φ/Ψ dihedral combinations located in favored (blue), allowed 
(yellow) and disallowed (red) regions of the ramachandran plot is indicated. The data were taken 
from the MD simulation of the hH2Ri described in chapter 4. Every 10
th
 frame was analyzed. 
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Figure 5.20: Ramachandran plots 
Ramachandran plots (grey points) for Asp98
3.32
 (A), Gly183
5.39
 (B), Pro194
5.50
 (C) and Leu193
5.49
 
(D) from the MD simulation of the hH2Ri (chapter 4), analyzing 8,000 time points (time step 10 
ps). In the background the Ramachandran plots for ‘general’ amino acids (A; all amino acids 
except glycine, proline and amino acids preceding proline), glycine (B), proline (C) and pre-
proline (D; amino acids preceding proline) created from the reference data of Lovell et al. (2000) 
and defined in section 5.5.1.4 are shown. 
 
 
 
 
Figure 5.21: Time resolution of a Φ/Ψ dihedral combination 
The graph shows the occurrence of favored, allowed and disallowed Φ/Ψ dihedrals of Lys88
3.22
 
from the MD simulation of the hH2Ri described in chapter 4, indicated by a red, yellow and grey 
line, respectively. In 56% of the simulation the Φ/Ψ combination adopted a disallowed value. 
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Figure 5.22: 3D probability Ramachandran graph  
The distribution is shown for Asp98
3.32
 from the MD simulation of the hH2Ri described in chapter 
4. 8,000 frames were analyzed. 
 
5.5.3.5 Side chain rotamers 
For the analysis of the side chain rotamers three files are produced. Table 5.13 gives an 
overview with a short description of the contents. Figure 5.23 to Figure 5.25 show examples 
of the usage. 
 
Table 5.13: Output files for rotamer analysis 
File name  Description 
rotamer-regions.txt For each amino acid the fraction of favored, allowed and disallowed side 
chain dihedral combinations are given. Figure 5.23 was generated from 
these data. 
rama-time.txt Each line starts with the amino acid number and contains a character for 
every time point analyzed (f, favored; a, allowed; d, disallowed). With the 
script rama-time.sh presented in the Appendix (section 9.6) a time-
resolved analysis can be performed (Figure 5.24). 
rama-graph.txt For residues with one side chain dihedral angle (Cys, Ser, Thr, Val) the 
frequency distribution is given in one line. For amino acids with two or 
more dihedral angles a 2-dimensional matrix is deposited, containing the 
1 and 2 dihedrals in lines and columns, respectively. The increment 
depends on the reference data used (see section 5.5.2.4). The values 
represent the percentage of dihedral angles within a special interval (in 
total 100%). The data can be used to create a surface plot (Figure 5.25). 
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Figure 5.23: Side chain rotamer analysis 
For each proteinogenic amino acid except Ala, Gly and Pro the fraction of side chain dihedral 
angles located in favored (blue), allowed (yellow) and disallowed (red) regions as defined in 
section 5.5.2.4 is indicated. The data were taken from the MD simulation of the hH2Ri described 
in chapter 4. Every 10
th
 frame was analyzed (8,000 in total). 
 
 
 
 
 
Figure 5.24: Time resolution of a side chain dihedral angle 
The graph shows the occurrence of favored, allowed and disallowed side chain conformations of 
His230
6.31
 from the simulation of the hH2Ri described in chapter 4, indicated by a red, yellow and 
grey line, respectively. In 26.2% of the 8,000 time points analyzed, the conformation adopted a 
disallowed combination of 1 and 2 dihedrals. 
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Figure 5.25: Frequency distribution of side chain rotamers and comparison to reference 
values 
A, Distribution of the dihedral angle of Val43
1.57
 from the MD simulation of the hH2Ri (chapter 4). 
In the background the favored, allowed and disallowed regions are shown in red, yellow and 
grey, respectively. 78.5% of the dihedrals were in favored, 12.4% in allowed and 9.1% in 
disallowed regions. B, Occurrence of the dihedral angles 1 and 2 of Trp84
ECL1
 from the MD 
simulation of the hH2Ri (chapter 4). In the background the favored, allowed and disallowed 
regions are shown in red, yellow and grey, respectively. 73.7% of the dihedrals were in favored, 
9.9% in allowed and 16.5% in disallowed regions. A, B, The analysis was performed every 10
th
 
time point (8,000 frames in total). 
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5.5.4 Performance 
The MD simulation of the hH2Ri embedded in a DPPC bilayer and solubilized with water 
molecules (chapter 4) was used for testing this structure validation tool. The simulation 
system contained about 40,000 atoms and ran for 80 ns. Every 10th coordinate file saved to 
hard disc was analyzed, corresponding to every 10th picosecond or 8,000 frames in total, 
respectively. All in all, more than 15.4 million dihedral angles were measured and compared 
to more than 3.7 million reference values. The calculation time was 32 minutes. When 
analyzing all frames (80,000), more than 154.4 million dihedral angles were measured and 
compared to the reference data, lasting 1:41 hours. 
5.6 Summary and conclusion 
Three programs were written in order to systematically analyze direct and water mediated H-
bonds (gro_hbonds) and van der Waals contacts (gro_contacts) occurring in MD simulation 
systems and in order to verify the quality of a MD simulation by calculating stereochemical 
parameters of proteins and compare them to experimentally derived reverence values 
(gro_validation).  
GROMACS provides opportunities to calculate H-bonds and contacts between residues, but 
several disadvantages are associated with these tools (g_hbond and g_mdmat, 
respectively). The program g_hbond is rather suitable to analyze single H-bonds. A 
systematic analysis is not possible without additional tools. Furthermore, g_hbond is much 
more time-consuming compared to the C program gro_hbonds-calc. The crucial accelerating 
element in the program is the introduction of a code for each amino acid (Figure 5.2). The 
analysis of water mediated H-bonds is not possible with g_hbond without additional scripts. A 
further advantage of gro_hbonds is the user-friendly handling. In general, only the parameter 
file gro_hbonds-para.txt (containing eight variables) has to be edited and the complete 
analysis of all possible H-bonds - direct and water mediated - is performed in less than four 
hours (in case of a 80 ns MD simulation described in chapter 4). The format of the output 
files allows a comfortable extraction of individual interactions as well as a transformation to 
spreadsheet applications (tabulator-separated values). Finally, the calculation method of H-
bonds in gro_hbonds was adjusted to different molecular modeling packages (cf. Figure 5.1). 
The analysis of residue contacts with g_mdmat works quite well in GROMACS. However, 
depending on the number of contacts to be investigated, the creation of an appropriate index 
file which defines the residues and atoms to be considered in the calculation may be time-
consuming for the user. Furthermore, the output of g_mdmat is inappropriate for easy 
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analysis (Figure 5.7). Thus, gro_contacts provides the opportunity to analyze all possible 
contacts in a MD simulation system (in about 30 min. for the 80 ns simulation of hH2Ri 
described in chapter 4). In general, only the parameter file gro_contacts-para.txt (six 
variables) has to be adjusted. The output can be scanned for individual interactions and 
transferred to spreadsheet applications. Since both programs (gro_hbonds and 
gro_contacts) calculate all possible interactions, a MD simulation can be completely 
analyzed without losing any contacts. 
The analysis of homology models with programs like PROCHECK (Laskowski et al., 1993) is 
a standard procedure to probe their stereochemical quality. To verify the quality of MD 
simulations, a program is necessary which may handle thousands of coordinate sets and 
compare the measured stereochemical parameters with experimental values. The calculation 
of dihedral angles within gro_validation is performed by tools of GROMACS (g_angle, g_chi 
and g_rama). However, appropriate index files created in gro_validation.sh from reference 
files (chirality-dihedral.txt, impropers.txt and dihedrals.txt) are necessary to identify the 
proper dihedral angles. The C program gro_validation-calc performs the calculation of these 
angles and their comparison with reference values. The rapid assignment of the measured 
backbone dihedrals Φ and Ψ and of the side chain rotamers to the corresponding reference 
values in the files lovell-rama.data and lovell-rotamer.data, respectively, is enabled by direct 
conversion of the value of a dihedral angle into the proper line in the reference files. The 
complete structure validation of a 80 ns MD simulation as described in chapter 4 is 
performed in about 30 minutes. Again, in general only a parameter file (gro_validation-
para.txt with six variables) has to be modified by the user. The output of the program is 
provided in a user-friendly format and can be transferred into spreadsheet applications to 
analyze and visualize the data. 
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Chapter 6 
6 Point Mutation in the Orthosteric Binding Site of 
the Human Histamine H2 Receptor: the Role of 
Tyr182 in TM5 
6.1 Introduction 
In the early 1990s the first site-directed mutagenesis studies were performed at the 
histamine H2 receptor to identify amino acids which contribute to ligand binding (Gantz et al., 
1992). Accordingly, Asp983.32 in TM3 is necessary for H2R binding and agonism of histamine. 
This highly conserved amino acid was also found to be important in several other aminergic 
GPCRs, e.g. the β2-adrenergic receptor, where mutation of the respective amino acid 
resulted in lower affinities of agonists and antagonists (Strader et al., 1988), as well as in the 
dopamine D2 receptor (Mansour et al., 1992) and the muscarinic acetylcholine receptor M2 
(Schwarz et al., 1995). Replacing Asp1865.42 in TM5 of the H2R caused the loss of binding of 
radiolabeled tiotidine, but retained the cAMP generation upon stimulation with histamine. 
However, the cAMP content was reduced compared to the wild-type receptor, and the 
histamine-stimulated cAMP production was only partially inhibited by cimetidine. The authors 
concluded that Asp1865.42 in TM5 must be present as a hydrogen bond acceptor for the 
interaction with the imidazole moiety of histamine in order to produce full response to ligand 
binding. In other GPCRs this residue was shown to play a role in ligand binding and receptor 
activation as well, e.g. in α-adrenergic and dopaminergic receptors (Liapakis et al., 2000). 
The exchange of Thr1905.46 in the H2R by alanine or cysteine resulted in a receptor mutant 
still able to bind radiolabeled tiotidine, but with an altered cAMP response to histamine 
stimulation (Gantz et al., 1992). Based on these results, a three site interaction model for 
histamine at the H2 receptor was proposed, consisting of Asp98
3.32 in TM3 and the couple 
Asp1865.42/Thr1905.46 in TM5, interacting with the protonated amine function and the 
heterocycle, respectively (Figure 6.1 A). By contrast, Nederkoorn et al. (1996a; 1996b) 
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suggested the couple Tyr1825.38/Asp1865.42 in TM5 to interact with the heterocycle of H2R 
ligands (Figure 6.1 B). This conclusion was drawn from molecular mechanics and ab initio 
data at an oligopeptide, mimicking a part of the fifth transmembrane alpha helix, and the fact 
that the mutation of Thr1905.46 does not completely abolish the cAMP response to agonist 
stimulation. In the meantime, either Tyr1825.38 or Thr1905.46 was preferred for the docking of 
H2R ligands (Kelley et al., 2001; Sun et al., 2011).  
 
 
 
Figure 6.1: Docking modes of histamine in the orthosteric binding pocket of an hH2R 
homology model 
A, Histamine in the N
π
H tautomeric form interacting with the couple Asp186
5.42
/Thr190
5.46
. B, 
Histamine in the N
τ
H tautomeric form interacting with Asp186
5.42
/Tyr182
5.38
. Hydrogen bonds are 
indicated with yellow dashed lines. ECL3 is omitted for reasons of clarity. The homology model is 
based on the crystal structure of the nanobody-stabilized active state of the β2-adrenoceptor 
(PDB ID 3P0G;(Rasmussen et al., 2011) described in chapter 3. 
 
 
Since the relevance of Tyr1825.38 was solely investigated with theoretical methods, the 
objective of this study was to analyze the role of this residue with pharmacological methods 
by constructing a Tyr182→Phe182 hH2R mutant. To explore the impact of Tyr182
5.38 on 
ligands varying in their heterocyclic moiety and the distance between the side chain 
amine/guanidine moiety and the heterocycle, structurally diverse ligands were investigated in 
the GTPase activity assay and the [35S]GTPγS binding assay (Figure 6.2). 
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Figure 6.2: Structures of H2R agonists and antagonists 
 
6.2 Materials and methods 
6.2.1 Materials 
The generation of pGEM-3Z-SF-hH2R-His6-GsαS was described previously (Kelley et al., 
2001). The DNA primers for polymerase chain reaction (PCR) were synthesized by Eurofins 
MWG Operon (Ebersberg, Germany). Pfu Ultra II Fusion HS DNA Polymerase was obtained 
from Agilent Technologies (Böblingen, Germany). Restriction enzymes and T4 DNA ligase 
were from New England Biolabs (Ipswich, MA, USA). The monoclonal anti-FLAG M1 
antibody (F3040) and the anti-mouse IgG-peroxidase antibody (A0168) were purchased from 
Sigma-Aldrich (Taufkirchen, Germany). [γ-33P]GTP was synthesized using guanosine 5’-
diphosphate and [γ-33P]Pi (3,000 Ci/mmol orthophosphoric acid) by analogy to the synthesis 
of [γ-32P]GTP described before (Walseth and Johnson, 1979). [γ-33P]Pi and [
35S]GTPγS (≥ 
1000 Ci/mmol, radiochemical purity > 95%) were from Hartmann Analytic (Braunschweig, 
Germany). GF/C filters were from Perkin Elmer (Rodgau, Germany). Histamine, amthamine, 
dimaprit and tiotidine were purchased from Tocris (Avonmouth, Bristol, UK). Cimetidine, 
famotidine and ranitidine were from Sigma-Aldrich. Impromidine (Durant et al., 1978) was 
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synthesized as described (Durant et al., 1985). Burimamide was from W. Schunack (Free 
University of Berlin, Germany). UR-AK51, UR-AK471 and UR-BIT24 were synthesized as 
described (Kraus et al., 2009). Stock solutions were prepared with Millipore water. All other 
reagents were from standard suppliers and of the highest purity available. 
6.2.2 Construction of the cDNA encoding the hH2R-Y182F-GsαS fusion protein 
To generate the cDNA for hH2R-Y182F-GsαS, pGEM-3Z-SF-hH2R-His6-GsαS was used as 
template. As a point mutation of only one amino acid was intended, a method deviated from 
the QuikChange™ Site-Directed Mutagenesis Kit (Stratagene Cloning Systems, La Jolla, CA, 
USA) was used. Two complementary primers, 5’-CCCATCCACCAGCCC-
GAACACTTCATTGACCTG and 5’-CAGGTCAATGAAGTGTTCGGGCTGGTGGATGGG 
(mismatching base pairs underlined), both containing a single mismatch for the 
Tyr182→Phe182 exchange, annealed with the template DNA in a PCR. The product was 
treated with Dpn I endonuclease (target sequence 5’-Gm6ATC), which is specific for 
methylated and hemimethylated DNA and is used to digest the parental DNA template. This 
originates from E. coli and is therefore susceptible to Dpn I digestion. Transformation into 
competent E. coli Top10 cells, single clone selection and plasmid preparation led to the 
desired hH2R-Y182F-GsαS sequence in the pGEM vector. After double-digestion with Sac I 
and Xba I and cloning into the pVL1392-SF-gpH2R-His6-GsαS plasmid digested with the same 
enzymes, the generated DNA sequence of pVL1392-SF-hH2R-Y182F-His6-GsαS was 
confirmed by agarose gel electrophoresis and sequencing (Entelechon, Regensburg, 
Germany). 
6.2.3 Cell culture, generation of recombinant baculoviruses and membrane 
preparation 
As described recently (Schnell et al., 2010), Sf9 insect cells were cultured in 250 ml 
disposable Erlenmeyer flasks at 28 °C under rotation at 150 rpm in Insect-Xpress medium 
(Lonza, Walkersville, MD, USA), supplemented with 5% (v/v) fetal calf serum (Biochrom, 
Berlin, Germany) and 0.1 mg/ml gentamicin (Cambrex Bio Science, Walkersville, MD, USA). 
Cells were maintained at a density of 0.5 to 4.0 x 106 cells/ml. Baculoviruses encoding 
recombinant proteins were generated in Sf9 cells using the BaculoGOLD transfection kit (BD 
Biosciences, San Diego, CA, USA) according to the manufacturer’s instructions. After initial 
transfection with the pVL1392 plasmid containing the DNA sequence of the hH2R-Y182F-
GsαS mutant and the linearized baculovirus DNA, high-titer virus stocks were generated by 
two sequential virus amplifications. In the first step, cells were seeded at 2.0 x 106 cells/ml 
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and infected with a 1:50 dilution of the supernatant from the initial transfection. Cells were 
cultured for 7 days, resulting in the death of virtually the entire cell population. In the second 
amplification, cells were seeded at 3.0 x 106 cells/ml and infected with a 1:20 dilution of the 
supernatant fluid from the first amplification. After 48 h the majority of cells showed signs of 
infections (e.g. altered morphology, viral inclusion bodies), but most of the cells were still 
intact. The supernatant fluid was harvested and stored under light protection at 4 °C. It was 
used as routine virus stock for membrane preparations. Before transfection, Sf9 cells were 
centrifuged, resuspended in fresh medium and seeded at 3.0 x 106 cells/ml. After infection 
with a 1:100 dilution of the high-titer baculovirus stocks, cells were cultured for 48 h and Sf9 
membranes were then prepared as described previously (Seifert et al., 1998), using 1 mM 
EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 10 µg/ml benzamidine and 10 µg/ml leupeptin 
as protease inhibitors. Membranes were suspended in binding buffer (12.5 mM MgCl2, 1 mM 
EDTA and 75 mM Tris-HCl, pH 7.4) and stored at -80 °C until use. 
6.2.4 Immunoblot analysis 
Membrane proteins were diluted in Laemmli buffer and separated on SDS polyacrylamide 
gels containing 12% (w/v) acrylamide. Proteins were then transferred onto 0.2 µm 
Nitrocellulose Blotting-Membrane (Peqlab, Erlangen, Germany). Membranes were reacted 
with the M1 antibody (10 µg/ml) and immunoreactive bands were visualized with the Pierce 
ECL Western Blotting Substrate (Thermo Scientific, Rockford, IL, USA) using goat anti-
mouse IgG coupled to peroxidase. Immunoblots were scanned with a GS-710-calibrated 
imaging densitometer (Bio-Rad Laboratories). 
6.2.5 Steady-state GTPase activity assay 
Steady-state GTPase activity assays, using [γ-33P]GTP as radioligand, were essentially 
performed as already described (Preuss et al., 2007c). Assay tubes contained membranes 
expressing hH2R-Y182F-GsαS fusion protein (10 µg of protein/tube), 1.0 mM MgCl2, 100 µM 
EDTA, 100 µM ATP, 100 nM GTP, 100 µM adenylyl imidodiphosphate, 1.2 mM creatine 
phosphate, 1 µg creatine kinase, 0.2% (w/v) bovine serum albumin in 50 mM Tris/HCl, pH 
7.4, and ligands in various concentrations. For the determination of pKB values histamine 
was added to the reaction mixtures (final concentration of 1 µM). The mixtures (80 µl) were 
incubated for 2 min at 25 °C before the addition of 20 µl of [γ-33P]GTP (0.05 µCi per tube) 
and subsequently allowed to react for 20 min at 25 °C. The reaction was terminated by the 
addition of 900 µl of a slurry consisting of 5% (w/v) activated charcoal (absorbs nucleotides 
but not Pi) and 50 mM NaH2PO4, pH 2.0. Reaction mixtures were centrifuged at room 
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temperature (7 min, 15,000 g). 600 µl of the supernatant were removed and 33Pi was 
determined by liquid scintillation counting using OptiPhase Supermix Cocktail (PerkinElmer, 
Groningen, The Netherlands). Enzyme activities were corrected for spontaneous hydrolysis 
of [γ-33P]GTP determined in tubes containing all components described above plus a high 
concentration of unlabeled GTP (1 mM) to prevent enzymatic cleavage of the labeled 
nucleotides in the presence of Sf9 membranes. Spontaneous [γ-33P]GTP hydrolysis was < 
1% of the total amount of radioactivity added. The experimental conditions chosen ensured 
that not more than 20% of the total amount of added [γ-33P]GTP was converted to 33Pi. 
6.2.6 [35S]GTPγS binding assay 
Membranes were thawed, sedimented by centrifugation at 4 °C and 13,000 g for 10 min, and 
carefully resuspended in binding buffer (12.5 mM MgCl2, 1 mM EDTA and 75 mM Tris/HCl, 
pH 7.4) to remove residual endogenous guanine nucleotides. Experiments were performed in 
96-well plates in a total volume of 100 µL per well, containing 10 µg membrane protein, 1 µM 
GDP, 0.05% (w/v) bovine serum albumin (BSA), 20 nCi of [35S]GTPγS (≥ 0.2 n ) and the 
investigated ligands at various concentrations in binding buffer, added as 10-fold 
concentrated stock solutions. For the determination of KB values of neutral antagonists, 
histamine was added to the reaction mixture at a concentration corresponding to the 10-fold 
EC50 value at the respective receptor (final concentration 1 µM). Nonspecific binding was 
determined in the presence of 10 µ  unlabeled GTPγS. After incubation for 90 min at 25 °C 
and shaking at 200 rpm, bound [35S]GTPγS was separated from free [35S]GTPγS by filtration 
through GF/C filters using a 96-well Brandel harvester (Brandel Inc., Unterföhring, Germany), 
followed by three washes with 2 mL of binding buffer (4 °C). Filters were dried overnight, 
MeltiLex solid scintillator was melted onto the filtermats and luminescence was measured 
with the MicroBeta2 1450 Plate Counter (Perkin Elmer, Rodgau, Germany). 
6.2.7 Miscellaneous 
Protein concentrations were determined using the DC protein assay kit (Bio-Rad, Hercules, 
CA, USA). Analyses of experimental data were performed with the Prism 5.0 software 
(GraphPad Software, San Diego, CA) by nonlinear regression and best fit to sigmoidal 
concentration‐response curves. KB values were calculated using the Cheng-Prusoff equation 
(Cheng and Prusoff, 1973). The intrinsic activity (Emax) is referred to the maximal response to 
histamine (set to 1.0) at the respective receptor. Data are presented as mean of at least 3 
independent experiments ± standard error of the mean (SEM), performed in duplicate or 
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triplicate. Signiﬁcance was calculated using the unpaired two-tailed t-test and a conﬁdence 
interval of 95% (p<0.05) or 99% (p<0.01). 
6.3 Results 
6.3.1 Immunological detection of hH2R-Y182F-GsαS in Sf9 cell membranes 
 
                                                
Figure 6.3: Immunological detection of the expression of hH2R-Y182F-GsαS in Sf9 cells 
Membranes of Sf9 cells expressing hH2R-Y182F-GsαS and membranes of uninfected Sf9 cells 
(control) were prepared, separated by SDS-PAGE on gels containing 12% (w/v) acrylamide, 
transferred onto nitrocellulose membranes and probed with the anti-FLAG (M1) antibody. In each 
lane, 7.5 µg of membrane protein was loaded onto the gel. Labels on the left designate masses 
of marker proteins in kDa. 
 
In Sf9 cells hH2R-Y182F-GsαS was well expressed (Figure 6.3). The calculated mass of the 
non-glycosylated hH2R fusion protein is 87.8 kDa. Bands of fusion proteins separated by 
SDS-PAGE on gels containing 12% (w/v) acrylamide were detected at about 80 kDa 
(Houston et al., 2002; Kelley et al., 2001; Preuss et al., 2007b; c). SDS-PAGE analysis of 
membranes expressing hH2R-Y182F-GsαS yielded intense bands at 85-90 kDa recognized by 
the anti-FLAG antibody. This is in good agreement with the result obtained previously. A 
slight band observed in uninfected Sf9 membranes at 80-85 kDa is also present in 
membranes expressing hH2R-Y182F-GsαS. In the control there is no protein detectable at 85-
90 kDa which could pretend the presence of the fusion protein hH2R-Y182F-GsαS. 
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6.3.2 Agonistic activities at hH2R-GsαS and hH2R-Y182F-GsαS in the GTPase assay 
In comparison to the wild-type (wt) hH2R potencies of HIS, BUR, UR-AK471 and UR-BIT24 
at hH2R-Y182F-GsαS remained nearly unchanged (EC50 ratio of wt and Y182F hH2R 0.7 to 
1.0) (Table 6.1). Although significantly, also pEC50 values of AMT, IMP and UR-AK51 
(p<0.05, respectively) were only slightly changed (EC50 ratios of 0.5 to 1.9). DIM exhibited 
the largest change in potency (3.1 fold increase; p<0.01). For most agonists investigated in 
the GTPase assay a slight decrease of the pEC50 value was observed at the mutant hH2R. 
Only DIM and UR-AK51 were more potent at hH2R-Y182F-GsαS. Intrinsic activities were 
similar at both receptors. A significant increase was measured for AMT (p<0.01; +0.07) and 
DIM (p<0.05; +0.04), a decrease for BUR (p<0.01; -0.06). 
 
 
Table 6.1: Agonistic activities at hH2R-GsαS and hH2R-Y182F-GsαS fusion proteins in the 
GTPase assay  
Cpd. 
hH2R-GsαS 
a
  hH2R-Y182F-GsαS 
pEC50 ± SEM Emax ± SEM
 b
  pEC50 ± SEM
 c
 Emax ± SEM
 b, c
 
HIS 6.00 ± 0.02 1.00  5.92 ± 0.08 1.00 
AMT 6.74 ± 0.07 0.91 ± 0.01  6.47 ± 0.03 * 0.98 ± 0.01 ** 
DIM 6.08 ± 0.09 0.85 ± 0.01  6.57 ± 0.05 ** 0.89 ± 0.02 * 
IMP 6.82 ± 0.06 0.82 ± 0.01  6.57 ± 0.02 * 0.85 ± 0.01 
BUR 5.00 ± 0.25 0.16 ± 0.00  4.87 ± 0.03 0.10 ± 0.00 ** 
UR-AK51 7.00 ± 0.06 0.84 ± 0.03  7.28 ± 0.09 * 0.80 ± 0.01 
UR-AK471 7.63 ± 0.03 0.82 ± 0.02  7.64 ± 0.10 0.85 ± 0.03 
UR-BIT24 7.68 ± 0.12 0.79 ± 0.02  7.55 ± 0.03 0.81 ± 0.01 
GTPase activity on Sf9 membranes was determined as described in section 6.2. Data shown 
are the means ± SEM of three to five experiments performed in duplicate. Intrinsic activities and 
potencies, respectively, of ligands at hH2R-Y182F-GsαS were compared with the corresponding 
parameters at hH2R-GsαS using the t-test. 
a
 Data at the wild-type receptor were taken from Kraus et al. (2009), Preuss et al. (2007a) and  
   Xi et al. (2006). 
b
 Intrinsic activity relative to the maximal response of histamine (Emax = 1.00). 
c Comparison with pEC50 / Emax at hH2R-GsαS; * p<0.05; ** p<0.01. 
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6.3.3 Potencies and intrinsic activities at hH2R-GsαS and hH2R-Y182F-GsαS in the 
[35S]GTPγS binding assay 
In contrast to the GTPase assay, pEC50 values from the [
35S]GTPγS assay surprisingly 
increased for all full and strong partial agonists at hH2R-Y182Y-GsαS (Table 6.2). The ligands 
were 1.5- to 2.9-fold more potent at hH2R-Y182F-GsαS. The increase in potency was 
significant (p<0.05) for DIM, IMP, UR-AK51 and UR-AK471. The weak partial agonist BUR 
was slightly less potent at the mutant compared to the wild-type.  
 
Table 6.2: Histamine H2R agonism and antagonism at hH2R-GsαS and hH2R-Y182F-GsαS 
fusion proteins in the [
35
S]GTPγS assay 
Cpd. 
hH2R-GsαS  hH2R-Y182F-GsαS 
pEC50 or (pKB) 
± SEM 
Emax ± SEM
 a
  
pEC50 or (pKB) 
± SEM 
b
 
Emax ± SEM
 a, b
 
HIS 6.35 ± 0.04 1.00  6.52 ± 0.12 1.00 
AMT 6.89 ± 0.03 1.00 ± 0.07  7.11 ± 0.09 0.96 ± 0.03 
DIM 6.27 ± 0.09 0.95 ± 0.07  6.73 ± 0.05 * 0.91 ± 0.01 
IMP 6.73 ± 0.03 0.73 ± 0.03  6.94 ± 0.04 * 0.91 ± 0.01 ** 
BUR 5.51 ± 0.12 0.14 ± 0.02  5.18 ± 0.38 0.18 ± 0.06 
UR-AK51 7.06 ± 0.05 0.75 ± 0.07  7.31 ± 0.08 * 0.91 ± 0.03 
UR-AK471 7.34 ± 0.02 0.71 ± 0.01  7.70 ± 0.12 * 0.89 ± 0.02 ** 
UR-BIT24 7.86 ± 0.12 0.74 ± 0.06  8.17 ± 0.04 0.84 ± 0.04 
CIM (5.67 ± 0.02) -0.09 ± 0.00  (5.63 ± 0.06) -0.10 ± 0.00 
FAM (7.16 ± 0.01) -0.08 ± 0.01  (7.03 ± 0.03)* -0.10 ± 0.01 
RAN (5.98 ± 0.05) -0.09 ± 0.01  (5.21 ± 0.05)** -0.10 ± 0.01 
TIO (6.96 ± 0.05) -0.09 ± 0.01  (7.01 ± 0.07) -0.10 ± 0.01 
[
35
S]GTPγS binding was determined as described in section 6.2. Data shown are the 
means ± SEM of three to six experiments performed in triplicate. For the determination of KB 
values, reaction mixtures contained membranes of Sf9 cells expressing fusion proteins, 1 µM HA 
as agonist and antagonists at concentrations from 1 nM to 1 µM as appropriate to generate 
saturated competition curves. To determine the intrinsic activities of inverse agonists, the effects 
of antagonists at 100 µM on basal GTPγS binding were assessed and referred to the effect of 
100 µM HA (set to Emax = 1.00). Intrinsic activities and potencies/pKB values, respectively, of 
ligands at hH2R-Y182F-GsαS were compared with the corresponding parameters at hH2R-GsαS 
using the t-test. 
a
 Intrinsic activity relative to the maximal response of histamine (Emax = 1.00). 
b
 Comparison with pEC50/pKB / Emax at hH2R-GsαS; * p<0.05; ** p<0.01. 
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Except for AMT and DIM, Emax values of all ligands were increased at the mutant hH2R; this 
was significant (p<0.01) for IMP and UR-AK471 (Table 6.2). Intrinsic activities of partial 
inverse agonists remained unaffected by the mutation Tyr182→Phe182. Respective pKB 
values obtained in competition experiments with 1 µM histamine remained unchanged for 
CIM and TIO, and decreased slightly for FAM (p<0.05). Remarkably, the KB value of RAN 
decreased to a larger extent (6-fold) at hH2R-Y182F-GsαS (p<0.01). 
 
6.3.4 Comparison of data obtained in the GTPase and [35S]GTPγS assay  
 
 
 
  
 
Figure 6.4: Potency ratio and Emax shift of wild-type and mutated hH2R 
Ratio EC50 (hH2R) / EC50 (Y182F) (A) and difference of Emax values (B) of mutated and wild-type 
hH2R, obtained in the GTPase assay (black) and the [
35
S]GTPγS assay (grey). Emax changes and 
potency ratios, respectively, of ligands at hH2R-Y182F-GsαS were compared with the 
corresponding parameters at hH2R-GsαS using the t-test (* p<0.05; ** p<0.01). 
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Potencies increased upon Tyr182→Phe182 mutation in both assays for DIM and UR-AK51 
(Figure 6.4 A). UR-AK471 exhibited an unchanged (GTPase) and an increased (GTPγS 
assay) pEC50 value. BUR was less potent in both assays at the mutated receptor. For the 
remaining ligands (HIS, AMT, IMP and UR-BIT24) contrary tendencies were observed: a 
decrease in potency in the GTPase and an increase in the GTPγS assay at the mutated 
hH2R. In most cases only minor changes of intrinsic activities (± 0.1) upon mutation of 
Tyr1825.38 were observed. However, in the GTPγS assay, greater increases of Emax values 
resulted for IMP, UR-AK51 and UR-AK471 (Figure 6.4 B). 
 
 
Figure 6.5: Intrinsic activities and potencies obtained in the GTPase assay in comparison 
to the [
35
S]GTPγS assay 
Potencies at hH2R-GsαS (A) and hH2R-Y182F-GsαS (B) as well as intrinsic activities at hH2R-GsαS 
(C) and hH2R-Y182F-GsαS (D) as determined in the GTPase assay and the [
35
S]GTPγS assay. 
The dotted lines represent the line of identity. Emax and pEC50 (pKB in case of partial inverse 
agonists CIM, FAM and RAN) values, respectively, of ligands determined in the GTPγS assay 
were compared with the corresponding parameters determined in the GTPase assay using the t-
test (* p<0.05; ** p<0.01). 
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In principle, for various GPCR systems the GTPase and [35S]GTPγS binding assays can be 
used interchangeably to assess the potencies and intrinsic activities of agonists and inverse 
agonists (Wieland and Seifert, 2006). In the case of the hH2R-GsαS and hH2R-Y182F-GsαS, all 
ligands exhibited higher pEC50 or pKB values in the [
35S]GTPγS assay than in the GTPase 
assay except for UR-AK471 (p<0.01) and IMP at the wild-type receptor (Figure 6.5 A). 
Whereas in most cases a minor difference appeared, for HIS (wt and Y182F), AMT (Y182F), 
IMP (Y182F), UR-BIT24 (Y182F) (p<0.01) and BUR (wt and Y182F) a 2- to 4-fold increase in 
the pEC50 value was obtained, respectively. Intrinsic activities were comparable for both 
assays and no general trend was detected (Figure 6.5 B). 
6.4 Discussion 
Nederkoorn et al. (1996a; 1996b) suggested that Tyr1825.38 in TM5 of the H2R contributes to 
ligand binding via a hydrogen bond of the phenolic hydroxyl group. To test this hypothesis, a 
Tyr182→Phe182 mutation at the hH2R was performed in the present work. Structurally 
different ligands were investigated in the GTPase and [35S]GTPγS assay. However, for the 
majority of these compounds a contribution of Tyr1825.38 was not obvious. Only the weak 
partial agonist burimamide exhibited slightly, but not significantly (significance level 0.05) 
reduced pEC50 values in both assays. Moreover, contrary to expectations, dimaprit and UR-
AK51 showed increased potencies. The decrease in pKB value was most pronounced in case 
of ranitidine. In contrast to the other partial inverse agonists CIM, FAM and TIO, ranitidine 
differs in its physicochemical properties. Whereas the amidine and guanidine moieties of all 
four inverse agonists have a pKa value smaller than 2.7 due to an electron withdrawing 
substitution (Carey et al., 1981; Durant et al., 1977), the tertiary amine of RAN possesses a 
pKa value of about 8.2 (Carey et al., 1981). For the corresponding substructures in CIM, FAM 
and TIO (imidazole, 2-guanidinothiazole) pKa values of 6.8 to 7.1 were reported (Button et 
al., 1985; Islam and Narurkar, 1993; Shankley et al., 1988; Vochten et al., 1980). 
Accordingly, the fraction of charged molecules at a physiological pH of 7.4 is about 86% for 
RAN and only 20% to 33% for the remaining ones. Possibly, the amine moiety of RAN 
interacts with the hydroxyl group of Tyr1825.38 via a charge assisted hydrogen bond in the 
wild-type hH2R. Elimination of this interaction by Tyr182→Phe182 mutation results in 
decreased affinity. Furthermore, Tyr1825.38 is able to form a hydrogen bond to the side chain 
of Asp1865.42, potentially stabilizing the latter in a favored position. Asp1865.42 was shown to 
be important for ligand binding in the H2R (Gantz et al., 1992). Besides the removal of a 
direct interaction between Tyr1825.38 and some ligands, the loss of the attachment of 
Asp1865.42 to Tyr1825.38 could be a reason for a decrease (BUR, RAN) or increase in potency 
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(DIM, UR-AK51). Nevertheless, Tyr1825.38 has only minor effects on binding of a few ligands 
at the human H2R. 
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7 The Role of Acidic Amino Acids in the Third 
Extracellular Loop of the Guinea Pig Histamine H2 
Receptor 
7.1 Introduction 
The three extracellular loops in G-protein coupled receptors, ECL1, ECL2 and ECL3, are 
very different regarding sequence and length (Wheatley et al., 2012), and belong to the most 
flexible elements in GPCRs (Peeters et al., 2011). For example, in the crystal structures of 
the human adenosine A2A receptor (Jaakola et al., 2008), despite the presence of three 
restricting disulfide linkages between ECL2 and ECL1, the second extracellular loop is not 
completely resolved due to weak electron density. Figure 7.1 shows the crystallographic 
temperature factors (B-factors) of an active GPCR conformation of the hβ2AR (PDB ID 
3P0G;(Rasmussen et al., 2011a). Besides the N- and C-terminus, the extra- and intracellular 
loops possess the highest flexibility. With the recent success in GPCR crystallization, NMR 
spectroscopy (Tikhonova and Costanzi, 2009), and indirect methods like site-directed 
mutagenesis (Hawtin et al., 2006) or the substituted cysteine accessibility method (SCAM) 
(Shi and Javitch, 2004), it has become clear that not only the ligand binding transmembrane 
domains and the intracellular loops, interacting with downstream effectors, are important for 
receptor activation. Several amino acids in the extracellular loops were identified to be 
important for ligand binding and the activation mechanism of class A GPCRs (Wheatley et 
al., 2012). This is also supported by the fact that some mutations in the extracellular part of 
GPCRs are associated with diseases (Schöneberg et al., 2004; Thompson et al., 2008). 
Whereas ECL2 is best investigated and seems to play a major role in receptor activation, 
ECL3 is probably the most neglected loop (Peeters et al., 2011). Nevertheless, ECL3 is 
involved in GPCR function, e.g. signal transduction and G-protein activation (Claus et al., 
2005), cell surface expression (Hawtin et al., 2006) and ligand binding (Harterich et al., 
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2008). However, most reports on the loop region are concerned with peptidergic GPCRs, 
whereas corresponding information on aminergic GPCRs is scarce (Lawson and Wheatley, 
2004; Peeters et al., 2012; Wheatley et al., 2007; Wheatley et al., 2012). ECL3 is part of an 
allosteric site in muscarinic acetylcholine receptors (Gregory et al., 2010; Huang et al., 1999; 
Jager et al., 2007; Nawaratne et al., 2010) and contributes to ligand binding in the adenosine 
A2A receptor (Jaakola et al., 2008; Peeters et al., 2012). A hybrid β2AR, integrating the ECL3 
of the α1AAR, exhibited higher binding affinity for agonists and a higher agonist-independent 
basal (constitutive) adenylyl cyclase activity than the wild-type β2AR (Zhao et al., 1998). 
 
 
Figure 7.1: B-factors of backbone heavy atoms of the crystal structure of an active hβ2AR 
conformation 
* The more flexible an atom the larger is the displacement from the mean position, expressed as 
temperature factors or B-factors. B-factors were taken from PDB entry 3P0G (Rasmussen et 
al., 2011a). 
 
 
To study the third extracellular loop, a multiple sequence alignment analysis of 340 aminergic 
GPCRs was performed (section 7.3.2). The results revealed that the ECL3 in the gpH2R is 
exceptional due to a high percentage of negatively charged amino acids. Furthermore, amino 
acids which potentially interact with the basic acylguanidine moiety of the second 
pharmacophore of bivalent acylguanidine-type agonists were identified in ECL3 of the H2R 
(section 7.3.1). Physicochemical properties and the location of this loop relative to the 
orthosteric binding site might explain the high potency of bivalent compounds compared to 
monovalent ones, as well as their dependence on spacer length (chapter 1). 
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Thus, to investigate the importance of acidic amino acids in ECL3 for ligand binding, ligand 
attraction and receptor activation, as well as their capability to compose a second binding 
site for bivalent H2R agonists, in a first gpH2R mutant Asp262, Asp263, Glu267 and Glu270 
were replaced by serine. Serine was selected to preserve the polar properties of ECL3, able 
to form hydrogen bonds with the solvent or ligands, but without the possibility of forming 
strong ionic interactions. Standard H2R ligands (histamine, amthamine and dimaprit), 
monovalent (acyl-)guanidines (impromidine and UR-BIT24) and bivalent acylguanidines (UR-
AK381, UR-BIT106) (Figure 7.2) were tested at the wild-type and the mutant gpH2R in the 
[35S]GTPγS binding assay and in the GTPase activity assay (HIS, AMT, DIM). Based on 
these results, two additional receptor mutants were generated. In the first one, Asp262, 
Asp263 and Glu267 were replaced by serine, and in the second one, the single point 
mutation Glu270→Ser270 was created. Ligands mentioned above were again investigated in 
the [35S]GTPγS binding assay. 
 
 
Figure 7.2: Structures of H2R agonists 
 
7.2 Materials and methods 
7.2.1 Materials 
The construction of the gpH2R-GsαS plasmid was described previously (Kelley et al., 2001). 
Phusion High-Fidelity DNA Polymerase was from New England Biolabs (Ipswich, MA, USA). 
Histamine, amthamine and dimaprit were purchased from Tocris (Avonmouth, Bristol, UK). 
UR-AK381, UR-BIT24 and UR-BIT106 were synthesized as described (Birnkammer et al., 
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2012; Kraus et al., 2009). Impromidine (Durant et al., 1978) was synthesized as described 
(Durant et al., 1985). UR-AK381 and UR-BIT106 (1 mM) were dissolved in 15% (v/v) 
dimethyl sulfoxide (DMSO) and dilutions were prepared in DMSO in order to attain a final 
DMSO concentration of 1.5% (v/v) in each assay tube. All other stock solutions were 
prepared with Millipore water. Other materials are described in section 6.2. 
7.2.2 Construction of the cDNA for gpH2R-D262S-D263S-E267S-E270S-GsαS 
The cDNA for gpH2R-D262S-D263S-E267S-E270S-GsαS (gpH2R-ECL3-4Ser-GsαS) was 
generated by sequential overlap-extension PCR, using pVL1392-SF-gpH2R-His6-GsαS as 
template. In PCR 1A, the DNA region encoding the cleavable signal peptide from influenza 
hemagglutinin (S), the FLAG epitope (F) recognized by the M1 monoclonal antibody, and the 
N-terminal portion of the gpH2R were amplified. The sense primer annealed with 27 base 
pairs (bp) of pVL1392-SF-gpH2R-His6-GsαS in front of the 5’-end of SF, containing a Sac I 
restriction site. The antisense primer encoded the sequence 
5’-TGAAAACACCGAATTCACAGCACTACTCCCTTTCAGCCCACGGTAAACAAAAAC 
(mismatching base pairs underlined) to generate the Asp262→Ser262, Asp263→Ser263, 
Glu267→Ser267 and Glu270→Ser270 exchange, and a new Eco RI restriction site 
(CTTAAG). In PCR 1B, the DNA sequence of the remaining C-terminal part of the gpH2R, a 
hexahistidine tag, and the entire sequence of GsαS were amplified using pVL1392-SF-gpH2R-
His6-GsαS as template. The sense primer encoded the sequence 
5’-AGTAGTGCTGTGAATTCGGTGTTTTCAGATGTTGTTCTGTGGCTGGGC- TATGCC to 
generate the Asp262→Ser262, Asp263→Ser263, Glu267→Ser267 and Glu270→Ser270 
exchange, and a new Eco RI restriction site. The antisense primer annealed with 27 bp of the 
cDNA behind the C-terminus of GsαS and the stop codon, containing the Xba I restriction site. 
In PCR 2 the products of PCR 1A and 1B annealed in the region encoding the newly created 
mutations and the new Eco RI restriction site. Here, the sense primer of PCR 1A and the 
antisense primer of PCR 1B were used. In that way, the complete cDNA for the gpH2R-
D262S-D263S-E267S-E270S-GsαS fusion protein was amplified. The product of PCR 2 was 
double-digested with Sac I and Xba I and cloned into the pVL1392-SF-gpH2R-His6-GsαS 
plasmid digested with the same enzymes. The PCR-generated DNA sequence was verified 
by agarose gel electrophoresis, restriction enzyme analysis and sequencing (Entelechon, 
Regensburg, Germany). 
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7.2.3 Construction of the cDNA for gpH2R-D262S-D263S-E267S-GsαS and 
gpH2R-E270S-GsαS 
To generate the cDNA for gpH2R-D262S-D263S-E267S-GsαS (gpH2R-ECL3-3Ser-GsαS) and 
gpH2R-E270S-GsαS, the pVL1392 vector containing gpH2R-D262S-D263S-E267S-E270S-
GsαS and pVL1392-SF-gpH2R-His6-GsαS, respectively, was used as template. As in both cases 
a point mutation of one amino acid was sufficient, the constructs were prepared by analogy 
with a protocol known from the QuikChange™ Site-Directed Mutagenesis Kit (Stratagene 
Cloning Systems, La Jolla, CA, USA). Two complementary primers, 
5’-GCTGTGAATTCGGTGTTTGAAGATGTTGTTCTGTGGCTG and 5’-CAGCC-
ACAGAACAACATCTTCAAACACCGAATTCACAGC, both containing two mismatches for 
the Ser270→Glu270 exchange, respectively, annealed with the template DNA encoding the 
gpH2R-D262S-D263S-E267S-E270S-GsαS receptor mutant. In the same way, two 
complementary primers, 5’-GCTGTCAATGAGGTGTTTTCAGATGTT-GTTCTGTGGCTG and 
5’-CAGCCACAGAACAACATCTGAAAACAC CTCATTGACAGC, both containing two 
mismatches for the Glu270→Ser270 exchange, respectively, annealed with the template 
pVL1392-SF-gpH2R-His6-GsαS. Both products were treated with Dpn I endonuclease (target 
sequence 5’-Gm6ATC), respectively, which is specific for methylated and hemimethylated 
DNA and is used to digest the parental DNA template, originating from E. coli and therefore 
susceptible to Dpn I digestion. Transformation into competent E. coli Top10 cells, single 
clone selection and plasmid preparation led to the desired gpH2R-D262S-D263S-E267S-GsαS 
and gpH2R-E270S-GsαS sequences in the pVL1392 vector, respectively. Both DNA 
sequences were confirmed by agarose gel electrophoresis and sequencing (Entelechon, 
Regensburg, Germany). 
7.2.4 Cell culture, generation of recombinant baculoviruses and membrane 
preparation 
Described in section 6.2. 
7.2.5 Immunoblot analysis 
Described in section 6.2. 
7.2.6 Steady‐state GTPase activity assay 
Described in section 6.2. 
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7.2.7  [35S]GTPγS binding assay 
Described in section 6.2. 
7.2.8 Multiple sequence alignment 
Sequences of the aminergic class A rhodopsin-like GPCRs as listed in the GPCRDB 
database (Vroling et al., 2011), i.e. muscarinic acetylcholine, adrenergic, dopamine, 
histamine, serotonin, octopamine and trace amine receptors, which were classified as 
reviewed in the UniProt Knowledgebase (UniProtKB;(Consortium, 2012), were taken from 
the latter database and aligned with ClustalW2 (Goujon et al., 2010; Larkin et al., 2007). 
7.2.9 Homology model of the gpH2R 
The homology model of the gpH2R was constructed using hH2Ra1 as template (chapter 3), 
which is based on the crystal structures of the β1-adrenergic receptor (PDB ID 2VT4, chain 
B;(Warne et al., 2008) and opsin in its G-protein-interacting conformation (PDB ID 
3DQB;(Scheerer et al., 2008). Side chain conformations of those amino acids which are 
identical in both H2R species were retained unchanged. Deviating amino acids were mutated 
to the correct residue in the gpH2R and conformations were adjusted as described in section 
3.2.2.3. Further structural refinements were performed as described in section 3.2.2.3. 
7.2.10 Miscellaneous 
See section 6.2. 
7.3 Results 
7.3.1 Selection of a putative accessory binding site for bivalent H2R agonists 
The H2R agonistic effects of bivalent N
G-acylated hetarylpropylguanidines synthesized in our 
group (Birnkammer et al., 2012; Kraus et al., 2009) were shown to be inhibited by H2R 
antagonists like famotidine. The resulting KB values for famotidine were comparable to those 
obtained when histamine was used as the agonist (Birnkammer et al., 2012). This suggests 
that the bivalent compounds interact with the orthosteric binding site of the H2R within TM3 
and TM5. As a common binding mode of imidazole- and aminothiazole-type H2R agonists, 
the heterocycle was suggested to interact with Asp1865.42 (Kraus et al., 2009). At 
physiological pH (7.4) the acylguanidine moiety (pKa = 7-8;(Ghorai et al., 2008; Rewinkel and 
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Adang, 1999; Schmuck and Lex, 1999) occurs in its protonated state predestinated for 
interaction with the negatively charged Asp983.32. This highly conserved residue was 
suggested to interact with the positively charged side chain nitrogen of histamine in the H2R 
(Gantz et al., 1992), by analogy with other biogenic amines and their corresponding GPCR, 
e.g. in the β2-adrenergic receptor (Strader et al., 1988), the dopamine D2 receptor (Mansour 
et al., 1992) and the muscarinic acetylcholine receptor M2 (Schwarz et al., 1995). This strong 
interaction of the acylguanidine moiety of the first pharmacophore with Asp983.32 reduces the 
degrees of freedom for interactions of the second pharmacophore, which also contains an 
acylguanidine. A simultaneous occupation of two orthosteric binding sites in H2R dimers was 
excluded because of insufficient spacer lengths in the most potent acylguanidines. Bivalent 
compounds theoretically capable of bridging dimerizing H2R protomers (necessary spacer 
length of about 20 CH2 groups) are nearly inactive (Birnkammer, 2011; Birnkammer et al., 
2012).  
To test the hypothesis that the second acylguanidine moiety interacts with acidic amino acids 
like in the orthosteric binding site, the receptor surface was screened for appropriate 
residues. Seven and ten acidic amino acids are located in the extracellular region of the 
hH2R and the gpH2R, respectively (Figure 7.3 and Table 7.1). These amino acids were 
considered potential candidates for a contribution to a second interaction site at the H2R, 
explaining higher potencies of bivalent agonists compared to their monovalent congeners. 
Furthermore, this recognition site has to keep a suitable distance from the anchoring point 
Asp983.32 related to spacer-dependent potencies of bivalent agonists. In the most potent 
bivalent acylguanidines, containing eight methylene groups as spacer, both pharmacophores 
are separated by 16 Å (distance between both carbon atoms of the guanidine moieties, 
extended conformation). In addition, Asp983.32 is partially masked by other residues. For 
most residues at the extracellular surface it is impossible to bridge Asp983.32 via the direct 
and shortest path, denoting that a distance of 16 Å between Asp983.32 and a putative second 
interaction site is in most cases too large. 
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Figure 7.3: Snake representation of the guinea pig H2R 
Acidic residues at the extracellular part of the receptor are indicated with red balls, remaining 
ones with purple balls. Most conserved amino acids in each TM are shown in cyan. The N- and 
C-terminus (including one aspartic acid and four glutamic acids) are not shown for reasons of 
clarity. The disulfide bond between Cys91
3.25
 and Cys174
5.28
 in ECL2 is highlighted with dashed 
lines. 
 
 
Table 7.1: Acidic amino acids in the human and guinea pig H2 receptor 
Amino 
acid 
hH2R gpH2R Position 
 Amino 
acid 
hH2R gpH2R Position 
Asp13 x x N-term  Asp262 x x ECL3 
Asp64
2.50
 x x core  Asp263 x x ECL3 
Asp98
3.32
 x x OBS  Glu267 x x ECL3 
Asp115
3.49
 x x core/intrac  Glu270
7.35
 x x ECL3/TM7 
Asp122 x x ICL2  Asp271
7.36
  x OBS 
Glu163 x x ECL2  Asp294 x x TM7/H8 
Asp167  x ECL2  Glu314  x H8 
Asp169  x ECL2  Glu331 x x C-term 
Glu180
5.36
 x x ECL2/TM5  Glu336 x x C-term 
Asp186
5.42
 x x OBS  Asp337 x x C-term 
Glu211
5.67
 x x intrac  Glu349 x x C-term 
Glu229
6.30
 x x intrac  Asp358 x  C-term 
An x indicates the presence of the respective residue in the hH2R and the gpH2R, respectively. 
Amino acids at the extracellular surface of the receptor are highlighted with a grey background.  
C-term, C-terminus; core, core of the receptor; N-term, N-terminus; intrac, intracellular side of the 
receptor; OBS, orthosteric binding site. 
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Asp13 resides in the N-terminus of both the human and guinea pig H2R. In a recent study the 
N-terminus of the hH2R was replaced by the corresponding amino acids in the gpH2R 
(Birnkammer et al., 2012; Brunskole, 2011). Only for one of six bivalent NG-acylguanidines 
investigated at the hybrid, H2R potency and intrinsic activity were shifted towards the gpH2R. 
It was speculated about an interaction between the N-terminus and two or more extracellular 
loops. Asp13 of the H2R is located in close proximity to the top of TM1 (Cys17
1.31 in the 
hH2R, Tyr17
1.31 in the gpH2R). The direct distance between Asp98
3.32 and Cys/Tyr171.31 (~ 26 
Å, distance between Cα atoms) is too far for bridging Asp98
3.32 in TM3 and Asp13 in the N-
terminus with the most potent bivalent ligands. 
The extracellular loop 2 of the human and guinea pig H2R differ by four amino acids (Figure 
7.4), including Asp167 and Asp169, which are only present in ECL2 of the gpH2R. To explore 
the influence of ECL2 on the receptor orthologue selectivity of guanidine-type agonists, in a 
previous study (Preuss et al., 2007c) the respective four amino acids in the hH2R were 
replaced by the corresponding four amino acids of the gpH2R (hH2RgpE2-GsαS) and vice-versa 
(gpH2RhE2-GsαS). Functional analysis of N-[3-(1H-imidazol-4-yl)propyl]guanidines and N
G-
acylated analogues indicated that ECL2 does not contribute to preference of monovalent H2R 
agonists for the guinea pig H2R orthologue. Recently, selected bivalent acylguanidines were 
investigated at these reciprocal mutants as well (Birnkammer et al., 2012). All compounds 
showed similar potencies and intrinsic activities at the hH2RgpE2-GsαS and the wild-type 
hH2R-GsαS fusion proteins, indicating that the inserted acidic amino acids Asp167 and 
Asp169 are not involved in bivalent ligand binding. At the gpH2RhE2-GsαS mutant the intrinsic 
activities of the compounds were comparable to those at the wild-type gpH2R-GsαS. However, 
three of eight investigated ligands exhibited significantly reduced pEC50 values at the mutant 
gpH2R (by 0.5−0.9 logarithmic units).  
 
 
2              160        170 
2               |         | 
hH2R, ECL2  LGWNSRNETSKGNHTTSKCKVQVN  
gpH2R, ECL2 LGWNSRNETSKDNDTIVKCKVQVN  
2           *********** * *  ******* 
Figure 7.4: Sequence alignment of ECL2 of the human and guinea pig H2R 
An asterisk indicates corresponding amino acids in both species. Negatively 
charged amino acids are highlighted with a grey background  
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Although these inconsistent results do not suggest the mutated residues to be directly 
involved in ligand-receptor interactions, the integrity of ECL2 in the gpH2R seems to be 
necessary for high-affinity binding of some bivalent acylguanidines (Birnkammer et al., 2012). 
Hence, Asp167 and Asp169 in the gpH2R were not considered promising candidates for an 
accessory binding site. 
Glu163, present in both H2R orthologues, is situated in the part of ECL2 farthest from the 
orthosteric binding site. The distance to the anchoring residue Asp983.32 is about 24 Å 
(distance between Cα atoms). However, loops are among the most flexible regions in 
GPCRs, and there is some uncertainty about the orientation of ECL2 in the H2R model. The 
outmost position of that part of ECL2 is comparable to the location in crystal structures of the 
tβ1AR (Warne et al., 2008), the hβ2AR (Cherezov et al., 2007; Rasmussen et al., 2011a), the 
hA2AAR (Jaakola et al., 2008), the hH1R (Shimamura et al., 2011), the hD3R (Chien et al., 
2010), the hmAChRM2 (Haga et al., 2012), the rmAChRM3 (Kruse et al., 2012) and the 
hCXCR4 (Wu et al., 2010), suggesting that it is a general characteristic of some GPCRs. All 
in all, the contribution of Glu163 cannot be excluded but seems unlikely. 
 
 
Table 7.2: Distance between Cα atoms of amino acids 3.32 and 5.36 in selected crystal 
structures of GPCRs 
GPCR PDB ID Resolution 
[Å] 
Amino 
acid 3.32 
Amino 
acid 5.36 
Distance 
[Å] 
gpH2R model - - Asp98 Glu180 19.3 
tβ1AR
1
 2VT4 2.7 Asp121 Arg205 19.3 
tβ1AR
2
 2Y00 2.5 Asp121 Arg205 18.8 
hβ2AR
3
 2RH1 2.4 Asp113 Gln197 19.1 
hβ2AR
4
 3P0G 3.5 Asp113 Gln197 19.0 
hD3R
5
 3PBL 2.9 Asp110 Pro186 19.0 
hH1R
6
 3RZE 3.1 Asp107 Thr188 19.1 
Opsin
7
 3DQB 3.2 Ala117 Glu201 21.1 
bovine Rhodopsin
8
 1U19 2.2 Ala117 Glu201 20.6 
1
(Warne et al., 2008), chain B;  
2
(Warne et al., 2011), chain B; 
 3
(Cherezov et al., 2007); 
4 
(Rasmussen et al., 2011a); 
5
(Chien et al., 2010); 
6
(Shimamura et al., 2011); 
7
(Scheerer et al., 
2008); 
8
(Okada et al., 2004) 
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Glu1805.36, present in the human and guinea pig H2R, is a further candidate potentially 
interacting with the acylguanidine moiety of the second pharmacophore since it is located at 
the extracellular end of TM5. In the homology model of the gpH2R the distance between 
Asp983.32 and Glu1805.36 (about 20 Å; measured between Cα atoms) is equal to the distance 
of the corresponding amino acids in GPCR crystal structures (Table 7.2) and thus too large 
to enable an interaction of the second acylguanidine group with Glu1805.36. However, the 
heterocycle connected to this acyguanidine moiety can definitely adopt a position in close 
proximity to Glu1805.36 (Figure 7.5).  
A further amino acid which was previously investigated in more detail is Asp/Ala2717.36 of the 
H2R (Ala in the hH2R, Asp in the gpH2R). To study the species selectivity of guanidine-type 
agonists, a single and a double hH2R mutant (Ala271->Asp271, 
Cys17/Ala271->Tyr17/Asp271, respectively) was generated (Kelley et al., 2001; Preuss et 
al., 2007b). The insertion of the gpH2R amino acids Asp and Tyr in positions 1.31 and 7.35, 
respectively, of the human receptor resulted in a change of the pEC50 values towards those 
determined at the gpH2R. The same tendency was observed for bivalent compounds tested 
recently at this hH2R mutant (Birnkammer et al., 2012). It was speculated about a direct or 
water-mediated hydrogen bond between Tyr171.31 and Asp2717.35 in the gpH2R, stabilizing 
the receptor in an active conformation. The absence of amino acids capable of forming an 
H-bond in the wild-type hH2R could explain higher potencies at the gpH2R and the hH2R 
Ala271->Asp271 mutant. Nevertheless, Asp2717.35 is in close vicinity to the orthosteric 
binding site. Hence, a direct or at least an indirect interaction with ligands cannot be 
excluded, but an interaction with the second pharmacophore of bivalent agonists is unlikely. 
Remaining acidic amino acids at the extracellular surface of the H2R are located in ECL3 and 
the junction of ECL3 and TM7. Asp262, Asp263, Glu267 and Glu270 are present in both, the 
human and guinea pig H2R. These amino acids are in a suitable distance to the orthosteric 
binding site to potentially explain the dependency of pEC50 values of bivalent ligands on 
spacer length. Consequently, as a working hypothesis, these four acidic residues in ECL3 
were considered the most promising candidates for an accessory binding site. Figure 7.5 
shows a possible docking mode of UR-AK381 in the gpH2R homology model. The first 
pharmacophore is hydrogen bonded to Asp983.32 and Asp1865.42 in TM3 and TM5, 
respectively. The second acylguanidine moiety forms hydrogen bonds with Asp262, Asp263 
and Glu267 in ECL3. Additionally, the heterocycle of the second pharmacophoric unit is able 
to interact with Val178ECL2 and Glu1805.36. 
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Figure 7.5: Possible binding mode of UR-AK381 in the gpH2R homology model 
View from the extracellular side at the gpH2R. The surface of the receptor except ECL2 (ribbon 
and tube in dark grey) is shown with a grey transparent surface. Amino acids (carbon atoms in 
orange) close to the ligand UR-AK381 (carbon atoms in green) are shown. Hydrogen bonds 
are indicated with yellow dashed lines. The ligand was manually docked into the binding site. 
The binding mode of the second pharmacophore is based on physicochemical properties as 
well as the certain distance between the aspartate/glutamate residues of ECL3 and the anchor 
residue Asp98
3.32
. 
 
 
7.3.2 Multiple sequence alignment analysis of the third extracellular loop of 
aminergic GPCRs 
The analysis of 340 aminergic GPCRs revealed a similar length of ECL3 with almost 80% of 
the receptors comprising 34 to 36 amino acids between the highly conserved prolines in TM6 
and TM7. However, due to high sequence diversity, a common structural motif could not be 
identified (Table 7.3). Most conserved are residues Cys6.61 (46%), Ser6.64 (31%), Cys6.65 
(80%), Pro7.31 (43%), Leu7.34 (46%) and Phe7.35 (40%). Sorting amino acids according to 
structural and physicochemical properties allowed the detection of further conserved sites. 
Charged amino acids are preferred in position 6.62, 6.63, 7.32 and 7.36 (38%, 45%, 32% 
and 48%, respectively). Furthermore, in position 6.64 tiny residues (49%), in position 7.34 
hydrophobic amino acids (87%), especially aliphatic ones (77%) and in position 7.35 
aromatic residues (59%) are favored.  
ECL2
D262
D263
E267
E270
K260
V99
D98
D186
E180
R161
V178
UR-AK381
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Table 7.3: Sequence analysis of the extracellular loop 3 of 340 aminergic GPCRs
1
 
Position
2
6
.6
1
6
.6
2
6
.6
3
6
.6
4
6
.6
5
7
.2
7
7
.2
8
7
.2
9
7
.3
0
7
.3
1
7
.3
2
7
.3
3
7
.3
4
7
.3
5
7
.3
6
hH2R R G D  -  - - D A I N E V L E A
gpH2R K G D  -  - - D A V N E V F E D
Amino acids
3 97 90 62 46 44 47 90 94 95 79 80 96 96 94 81
hydrophobic
4 39 31 23 30 4 40 52 53 57 66 47 51 87 67 24
polar
4 61 69 77 70 96 60 48 47 43 34 53 49 13 33 76
small
4 54 67 58 70 89 59 62 46 57 69 46 52 34 23 61
proline 0 11 7 4 1 4 16 15 13 43 10 4 0 0 0
tiny
4 6 23 22 49 6 8 7 8 5 12 18 25 5 15 22
aliphatic
4 12 0 2 8 2 24 21 28 34 19 7 17 77 12 15
aromatic
4 22 4 2 13 1 12 19 12 12 13 18 15 6 59 0
positive
4 6 19 13 8 1 12 2 12 3 1 6 8 2 2 15
negative
4 1 19 32 6 7 9 9 10 5 7 27 9 2 5 33
charged
4 7 38 45 13 8 21 11 22 8 8 32 17 3 8 48
Ala 1 3 8 15 1 3 0 2 1 1 7 13 3 1 7
Arg 4 9 2 4 1 2 0 1 3 1 0 5 2 0 3
Asn 1 4 1 4 1 19 6 3 0 3 1 3 0 2 11
Asp 1 12 20 5 1 8 5 4 2 5 9 1 0 0 22
Cys 46 15 2 3 80 9 15 7 0 0 0 0 1 0 0
Gln 2 3 13 1 1 3 3 1 1 0 3 2 1 1 2
Glu 0 8 11 1 5 1 4 6 3 2 18 8 1 5 11
Gly 5 17 4 3 0 1 0 1 0 0 6 9 0 13 1
His 3 4 0 10 1 4 1 4 6 8 4 2 0 1 0
Ile 3 0 1 3 0 12 5 11 16 5 1 5 10 2 5
Leu 8 0 0 4 2 1 5 12 3 7 6 5 46 8 4
Lys 2 9 11 4 0 10 2 11 0 0 6 3 0 2 12
Met 4 0 0 0 1 0 1 0 4 2 2 5 1 0 1
Phe 18 0 1 0 0 8 13 0 5 1 0 0 4 40 0
Pro 0 11 7 4 1 4 16 15 13 43 10 4 0 0 0
Ser 1 4 10 31 5 4 6 5 4 11 5 3 2 0 14
Thr 0 1 5 4 1 1 1 4 22 0 7 12 6 4 1
Trp 0 0 0 0 0 0 1 7 0 0 15 2 2 1 0
Tyr 1 0 0 3 0 0 4 0 0 3 0 10 0 18 0
Val 1 0 0 0 0 11 12 4 15 6 1 7 22 3 5
 
1
 Aminergic receptors of class A rhodopsin-like GPCRs (muscarinic actylcholine, adrenergic, 
dopamine, histamine, serotonin, octopamine and trace amine receptors).  
2
 Residues are named according to the Ballesteros/Weinstein nomenclature (Ballesteros and 
Weinstein, 1995). Between position 6.65 and 7.27, seven positions of the alignment are missing. 
230  7.3 Results 
They are only present in 2-8% of the analyzed GPCRs, having a longer e3 loop. The borders of 
ECL3 were defined according to the transmembrane domains 6 and 7 in GPCR crystal structures 
and the presence of hydrophobic amino acids. 
3  
Percentage of amino acids in the respective position of the alignment. 
4
 Classification of amino acids according to Livingstone et al. (1993), i.e. small (Ala, Asn, Asp, Cys, 
Gly, Pro, Ser, Thr, Val), tiny (Ala, Gly, Ser), aliphatic (Ile, Leu, Val), aromatic (His, Phe, Trp, Tyr) 
and negatively charged (Asp, Glu) amino acids. Additionally, residues were classified as 
hydrophobic (Ala, Gly, Ile, Leu, Met, Phe, Pro, Trp, Val), polar (Arg, Asn, Asp, Cys, Gln, Glu, His, 
Lys, Ser, Thr, Tyr), positively charged (Arg, Lys) and charged (Arg, Asp, Glu, Lys). 
 
 
Most GPCRs contain 40% to 60% polar residues in ECL3 (Figure 7.6 A). Less than 20% of 
this loop are charged residues in the majority of GPCRs. However, there are extreme 
examples at both sides. Whereas in some aminergic GPCRs ECL3 consists only of 
hydrophobic amino acids, there are GPCRs containing a high number of charged residues. 
Considering that aminergic GPCRs bind to ligands which are positively charged at 
physiological pH, such as catecholamines, histamine and 5-hydroxytryptamine, it is 
remarkable that the third extracellular loops differ strongly in the content of negatively 
charged amino acids (Figure 7.6 B). The gpH2R, which is among the GPCRs with the highest 
amount (42%) of acidic residues in ECL3, was selected to explore the importance of these 
negatively charged amino acids for ligand attraction, ligand binding and receptor activation. 
 
  
Figure 7.6: Hydrophobic, polar and charged amino acids in ECL3 of aminergic GPCRs 
Shown is the percentage of 340 GPCRs that possess 0-10% to 90-100% (A) hydrophobic (black) 
and polar (grey) amino acids, or (B) negatively (black) and positively (grey) charged amino acids. 
The classification of amino acids is described in Table 7.3. 
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7.3.3 Immunological detection of recombinant proteins in Sf9 cell membranes 
 
                                  
 
Figure 7.7: Immunological detection of the expression of recombinant proteins in Sf9 cells 
Membranes of Sf9 cells expressing the three gpH2R-GsαS mutants and membranes of uninfected Sf9 
cells (control) were prepared, separated by SDS-PAGE on gels containing 12% (w/v) acrylamide, 
transferred onto nitrocellulose membranes and probed with the anti-FLAG (M1) antibody. In each lane, 
7.5 µg of membrane protein was loaded onto the gel. Labels on the left designate masses of marker 
proteins in kDa. 
 
The mutant receptors gpH2R-ECL3-4Ser-GsαS and gpH2R-E270S-GsαS were well expressed 
in Sf9 cells (Figure 7.7). The band for gpH2R-ECL3-3Ser-GsαS appears weaker, possibly 
because of a lower amount of receptor protein in the membranes. The calculated molecular 
mass of the gpH2R fusion protein is 88.2 kDa, neglecting the glycosylation of the protein. 
Bands for fusion proteins separated by SDS-PAGE on gels containing 12% (w/v) acrylamide 
were detected at about 80kDa (Houston et al., 2002; Kelley et al., 2001; Preuss et al., 2007b; 
c). SDS-PAGE analysis of membranes expressing the gpH2R-GsαS mutants yielded intense 
bands at 85-90 kDa, recognized by the anti-FLAG antibody. This is in good agreement with 
the result obtained previously. A slight band observed in uninfected Sf9 membranes at 80-85 
kDa is also present in membranes containing the recombinant gpH2R-GsαS proteins. In the 
control there is no protein detectable at 85-90 kDa, which could pretend the presence of the 
fusion proteins. 
120
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50
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7.3.4 Intrinsic activities and potencies at the wild-type and mutant gpH2Rs 
Standard H2R ligands (HIS, AMT, DIM, IMP), mono- (BIT24) and bivalent (UR-AK381, 
UR-BIT106) NG-acylated 3-(2-aminothiazol-5-yl)propylguanidines were tested in the 
[35S]GTPγS binding assay at the wild-type and the three mutated gpH2Rs (Table 7.4 and 
Figure 7.8).  
 
 
Table 7.4: Intrinsic activities (Emax) and potencies at wild-type and three mutated gpH2Rs in 
the [
35
S]GTPγS assay 
Cpd. 
gpH2R-GsαS 
 gpH2R-ECL3-
4Ser-GsαS 
b
 
 gpH2R-ECL3-
3Ser-GsαS 
b
 
 gpH2R-E270S-
GsαS 
b
 
pEC50  
± SEM 
Emax  
± SEM
 a
 
 pEC50 
± SEM 
Emax 
± SEM 
a
 
 pEC50 
± SEM 
Emax 
± SEM
 a
 
 pEC50 
± SEM 
Emax 
± SEM
 a
 
HIS 
6.12 ± 
0.01 
1.00 
 
4.14 ± 
0.06 ** 
1.00 
 
5.37 ± 
0.08 ** 
1.00 
 
6.03 ± 
0.02 * 
1.00 
AMT 
6.84 ± 
0.06 
0.99 ± 
0.03 
 
4.76 ± 
0.12 ** 
0.98 ± 
0.04 
 
5.78 ± 
0.09 ** 
1.02 ± 
0.04 
 
6.61 ± 
0.05 * 
1.00 ± 
0.01 
DIM 
6.25 ± 
0.02 
0.94 ± 
0.03 
 
4.76 ± 
0.12 ** 
0.45 ± 
0.02 ** 
 
5.40 ± 
0.05 ** 
0.76 ± 
0.02 ** 
 
5.68 ± 
0.02 ** 
0.87 ± 
0.02 
IMP 
7.35 ± 
0.07 
0.93 ± 
0.00 
 
6.04 ± 
0.03 ** 
0.93 ± 
0.01 
 
6.54 ± 
0.05 ** 
0.96 ± 
0.05 
 
7.73 ± 
0.05 * 
1.03 ± 
0.03 * 
UR-
BIT24 
8.33 ± 
0.12 
0.83 ± 
0.02 
 
7.14 ± 
0.06 ** 
0.78 ± 
0.02 
 
7.98 ± 
0.06 
0.79 ± 
0.03 
 
8.45 ± 
0.05 
0.94 ± 
0.03 * 
UR-
AK381 
9.29 ± 
0.10 
0.84 ± 
0.05 
 
7.84 ± 
0.03 ** 
1.05 ± 
0.02 * 
 
8.86 ± 
0.03 * 
0.93 ± 
0.02 
 
9.15 ± 
0.06 
1.06 ± 
0.02 * 
UR-
BIT106 
8.90 ± 
0.04 
0.89 ± 
0.03 
 
7.87 ± 
0.08 ** 
1.09 ± 
0.02 ** 
 
8.78 ± 
0.03 
0.94 ± 
0.01 
 
9.24 ± 
0.11 * 
1.03 ± 
0.04 * 
[
35
S]GTPγS binding was determined as described in section 6.2. Data shown are the 
means ± SEM of three to five experiments performed in triplicate. Intrinsic activities and 
potencies, respectively, of ligands at the mutated gpH2Rs were compared to the corresponding 
parameters at gpH2R-GsαS, using the t-test.  
a
 Intrinsic activity relative to the maximal response of histamine (Emax = 1.00). 
b
 Comparison with pEC50/Emax at gpH2R-GsαS; * p<0.05; ** p<0.01. 
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Compared to the wild-type gpH2R, exchanging the four acidic amino acids Asp262, Asp263, 
Glu267 and Glu270 by serine, resulted in a strong decrease in potencies of all ligands tested 
(p<0.01). Most pronounced decreases were observed for histamine and amthamine (96- and 
120-fold, respectively), whereas the remaining ligands exhibited a 10- to 30-fold decrease.  
To confirm the results obtained in the [35S]GTPγS binding assay, histamine, amthamine and 
dimaprit were also investigated in the steady state GTPase assay at the mutant receptor 
(Table 7.5). No difference between both assays was observed for wild-type and mutant 
receptors, respectively. Compared to the wild-type gpH2R-GsαS, pEC50 values at the gpH2R-
ECL3-3Ser-GsαS were significantly reduced for standard H2R ligands (p<0.01) and UR-AK381 
(p<0.05). Potencies for UR-BIT24 and UR-BIT106 were reduced, though not significantly. 
Strikingly, EC50 ratios of mutant to wild-type receptor were lowest for acylguanidines (1.3 to 
2.7 compared to 5.6 to 11.4 for the remaining ligands). The mutation Glu270→Ser270 had 
only marginal effects on pEC50 values (potency ratios 0.5 to 1.7) for all ligands except in the 
case of dimaprit (3.8-fold decrease, p<0.01). IMP (p<0.05), UR-BIT24 and UR-BIT106 
(p<0.05) showed slightly increased pEC50 values compared to the wild-type receptor.  
 
Table 7.5: Intrinsic activities (Emax) and potencies at gpH2R-GsαS and gpH2R-ECL3-4Ser-
GsαS in the GTPase assay and comparison to the [
35
S]GTPγS assay 
 GTPase activity assay 
 
[
35
S]GTPγS assay 
Cpd. 
gpH2R-GsαS 
a
 
 gpH2R-ECL3-
4Ser-GsαS 
c
 
 
gpH2R-GsαS 
c
 
 gpH2R-ECL3-
4Ser-GsαS 
d,e
 
pEC50 
± SEM 
Emax 
± SEM
 b
 
 pEC50 
± SEM 
Emax 
± SEM
 b
 
 pEC50 
± SEM 
Emax 
± SEM
 b
 
 pEC50 
± SEM 
Emax 
± SEM
 b
 
HIS 
6.10 ± 
0.08 
1.00 
 
4.26 ± 
0.04 **  
1.00 
 
6.12 ± 
0.01 
1.00 
 
4.14 ± 
0.06 
##
 
1.00 
AMT 
6.74 ± 
0.06 
1.04 ± 
0.00 
 
4.71 ± 
0.05 ** 
1.07 ± 
0.05 
 
6.84 ± 
0.06 
0.99 ± 
0.03 
 
4.76 ± 
0.12 
##
 
0.98 ± 
0.04 
DIM 
6.16 ± 
0.10 
0.94 ± 
0.03 
 
4.92 ± 
0.05 ** 
0.44 ± 
0.02 ** 
 
6.25 ± 
0.02 
0.94 ± 
0.03 
 
4.76 ± 
0.12 
##
 
0.45 ± 
0.02 
##
 
GTPase assay: GTPase activity in Sf9 membranes was determined as described in section 6.2. 
Data shown are the means ± SEM of three to five experiments performed in duplicate. GTPγS 
assay: see Table 7.4. Comparisons of pEC50 and Emax, respectively, were performed by t-tests. 
a
 Data at gpH2R-GsαS in the GTPase assay were taken from Preuss et al. (2007a). 
b
 Intrinsic activity relative to the maximal response of histamine (Emax = 1.00). 
c
 Comparison with pEC50/Emax at gpH2R-GsαS (GTPase assay); * p<0.05; ** p<0.01. 
d
 Comparison with pEC50/Emax at gpH2R-ECL3-4Ser-GsαS (GTPase assay); 
+
 p<0.05; 
++
 p<0.01. 
e Comparison with pEC50/Emax at gpH2R-GsαS (GTPγS assay); 
#
 p<0.05; 
##
 p<0.01. 
234  7.3 Results 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: Concentration-response curves obtained in [
35
S]GTPγS binding assays 
[
35
S]GTPγS binding in membranes of Sf9 cells expressing gpH2R-GsαS (), gpH2R-ECL3-4Ser-GsαS 
(), gpH2R-ECL3-3Ser-GsαS () and gpH2R-E270S-GsαS () was determined as described in section 
6.2. Reaction mixtures contained membranes (10 µg of protein/well) of Sf9 cells expressing fusion 
proteins and the respective ligand at concentrations indicated on the abscissa. Data shown are the 
means ± SEM of three to five independent experiments performed in triplicates, expressed as 
percentage of [
35
S]GTPγS binding relative to the maximum effect induced by histamine (set to 100%). 
Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentration-response 
curves. 
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Significant (p<0.01) decreases in intrinsic activity were only observed for dimaprit at 
gpH2R-ECL3-4Ser-GsαS and gpH2R-ECL3-3Ser-GsαS. At the gpH2R-E270S-GsαS the intrinsic 
activities of all (acyl-)guanidines were increased (p<0.05). The bivalent agonists UR-AK381 
and UR-BIT106 showed also significantly increased Emax values at gpH2R-ECL3-4Ser-GsαS 
(p<0.05 and p<0.01, respectively). 
7.4 Discussion 
7.4.1 Second binding site for bivalent acylguanidine-type agonists and the role of 
Glu270 in the gpH2R 
Replacing four acidic amino acids by serine residues in ECL3 of the gpH2R-GsαS resulted in 
reduced pEC50 values of all investigated agonists. The decrease was most pronounced for 
HIS and AMT. No significant differences were observed between mono- and bivalent 
compounds. Molecular modeling studies revealed that Glu2707.35, which was previously 
supposed to be part of the extracellular surface of ECL3 (Figure 7.5), is able to rotate 
towards the orthosteric binding site. The closest distance from the heteroatoms in the 
Glu2707.35 side chain to the acylguanidine moiety of the first pharmacophore and to Asp983.32 
is reduced from 6.7 Å to 3.8 Å, and from 10 Å to 8 Å, respectively. Hence, a contribution of 
Glu2707.35 to ligand binding within the orthosteric binding site cannot be excluded. In case of 
the β2AR, mutation of Tyr
7.35 to alanine revealed a contribution of this residue to high affinity 
binding of agonists (Isogaya et al., 1998; Kikkawa et al., 1998). Furthermore, in crystal 
structures of the β2AR (Cherezov et al., 2007; Rasmussen et al., 2011b) the complexed 
ligands are in proximity to Tyr7.35. To explore if the reduced potencies of standard H2R 
agonists were caused by the missing glutamate in position 7.35, and if the accessory binding 
site of bivalent acylguanidines is composed only of Asp262, Asp263 and Glu267, two further 
gpH2R-GsαS mutants were generated. The bivalent agonists as well as the monovalent ligand 
UR-BIT24 were similarly potent at the gpH2R-ECL3-3Ser-GsαS and the wild-type receptor. 
Again the potency of the standard H2R agonists histamine, dimaprit, amthamine and 
impromidine was significantly lower than at the wild-type gpH2R-GsαS. However, the pEC50 
values decreased only about midway compared to the reductions in the case of the 4-Ser 
mutant. The results do not support the hypothesis that negatively charged residues in ECL3 
form an accessory binding site for bivalent acylguanidine-type agonists. Alternatively, 
investigating Glu163 in ECL2 may be worthwhile. However, the prediction of a second 
binding site is complicated by the uncertain impact of the highly flexible N-terminus as part of 
the extracellular surface. In addition, the second pharmacophore of various bivalent 
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acylguanidines possibly stabilizes different conformations of the extracellular surface by 
interacting with distinct regions. This ligand specific behavior was partly observed at gpH2R 
mutants with an altered N-terminus or ECL2 (Birnkammer et al., 2012; Brunskole, 2011). 
Last but not least, supposing that depot formation of a lipophilic ligand in the lipid bilayer 
occurs as suggested by Portoghese (2001), the agonist concentration close to the 
extracellular surface of the receptor and therefore near the entrance to the binding site could 
be raised compared to the aqueous phase. For long acting β2-adrenoceptor agonists 
including a lipophilic moiety such as salmeterol, the existence of a specific 'exosite' or a 
membrane deposition (micro-kinetic theory) of the ligands is discussed (Coleman et al., 
1996; Patel et al., 2011). 
Contrary to the initial assumption, the replacement of Glu2707.35 did not affect receptor 
activation of the gpH2R in general. Only the potency of DIM was sensitive to this mutation. 
DIM is an outlier in the present series since about 87% of the molecules are twofold 
positively charged at pH 7.4 (Durant et al., 1977). Possibly, the high affinity of DIM at the 
wild-type gpH2R-GsαS depends on the negatively charged residue in position 7.35, situated at 
the entrance of the binding pocket and close to the highly conserved Asp983.32, well known to 
interact with positively charged moieties of ligands. 
7.4.2 Integrity of the orthosteric binding site 
Amino acids in ECL3 are able to interact with the facing e2 loop. In the β2AR crystal 
structures, close contacts between Lys3057.32 in ECL3 and Asp192ECL2 or Phe193ECL2, 
respectively, were observed (Cherezov et al., 2007; Rasmussen et al., 2011a). Likewise, in 
the β1AR Arg317
ECL3 interacts with Thr203ECL2 (Warne et al., 2011; Warne et al., 2008). 
Replacement of charged amino acids in ECL3, changing its electrostatic potential (Figure 
7.9), could affect the contact to ECL2 and therefore alter the ECL2 conformation. ECL2 is in 
close contact to the orthosteric binding site and part of the binding pocket in several GPCRs 
(Peeters et al., 2011). Furthermore, ECL3 constrains the extracellular parts of TM6 and 7. In 
a previous study on the delta opioid receptor, amino acids in ECL3 were suggested to 
restrain motions of TM6 and 7 on the extracellular side. Mutations may weaken this structural 
constraint and thereby affect the activation mechanism (Decaillot et al., 2003). Moreover, 
amino acids of TM6 are part of the ligand binding site of several GPCRs, presumably 
including the H2R (chapter 3). Therefore, the decreased potency of the ligands at the 4-Ser 
and 3-Ser mutants could result from a distorted orthosteric binding pocket, in particular from 
an altered distance between the aspartates in TM3 and TM5. The contraction of the binding 
site is discussed to be one of the most important roles of agonists in the activation process, 
observed in the β1- and β2-adrenoceptor (Rasmussen et al., 2011a; Warne et al., 2011). In 
 Chapter 7: Acidic amino acids in ECL3 of the gpH2R  237 
an extended conformation, the distance (6.1 Å and 7.7 Å) between the two polar centers in 
HIS and AMT, i.e. the heterocyclic nitrogen and the positively charged side chain amino 
group, is the smallest among all ligands. Strikingly, the greatest decrease in potency at the 
mutant compared to the wild-type H2R was observed for histamine and amthamine. The 
distance between the basic centers is larger for IMP and the three acylguanidines 
UR-AK381, UR-BIT24 and UR-BIT106 (~ 10.0 Å). Possibly, these compounds tolerate a 
certain degree of ‘deformation’ of the binding site. In the case of DIM, the maximal distance 
between the polar heteroatoms (about 7.8 Å) is similar to HIS and AMT. However, DIM is the 
ligand that carries the highest charge per molecule. At pH 7.4, 87% of DIM is present as the 
dication and 5% as the monocation (Durant et al., 1977). Possibly, the ability to form ionic 
interactions with both Asp983.32 and Asp1865.42 allows a specific binding mode between TM3 
and TM5. In line with this idea, acidic amino acids in ECL3 of the gpH2R are necessary for a 
proper folding of the binding pocket. The decrease in potency at the gpH2R-ECL3-3Ser-GsαS 
and the gpH2R-ECL3-4Ser-GsαS mutants compared to the wild-type receptor-GsαS fusion 
protein appears to reflect the deformation of the binding site, depending on the number of 
replaced negatively charged residues. 
7.4.3 Path of the ligand into the binding site 
A further possible reason for reduced potencies at the modified gpH2Rs is an altered 
recognition process of the ligands. Acidic amino acids in ECL3 potentially line the path of the 
ligand into the binding pocket. Asp300 in the e3 loop of the β2AR, which corresponds to 
Asp262 in the gpH2R, was shown to form a salt bridge to the ammonium group of alprenolol 
during its route into the binding pocket of the β2AR in an unbiased molecular dynamic 
simulation on a microsecond timescale (Dror et al., 2011). Glu448 in ECL3 of the gpH1R, 
equivalent to Ala264 in the gpH2R next to the mutated aspartates 262 and 263, was 
suggested to be relevant as a structure-recognition system for histaprodifen (Straßer and 
Wittmann, 2007). Acylguanidines, exhibiting a pKa value of 7 to 8 (Ghorai et al., 2008; 
Rewinkel and Adang, 1999; Schmuck and Lex, 1999), are only partly protonated at 
physiological pH. Remarkably, these compounds revealed the least decrease in potency at 
gpH2R-ECL3-4Ser-GsαS and gpH2R-ECL3-3Ser-GsαS. Obviously, these H2R agonists tolerate 
the replacement of acidic amino acids better than the other ligands, which are charged at a 
higher percentage at pH 7.4. DIM is mainly twofold positively charged (87%). The 
predominant ionic species of IMP is likely to be the monocation (65%). Also the dication 
(33%) and trication (2%) are present in equilibrium (Durant et al., 1985). At pH 7.4 the 
predominant form (almost 100%) of HIS and AMT is the monocation (Eriks et al., 1993). 
Possibly, the route of these ligands into the binding pocket of the wild-type gpH2R-GsαS is 
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more strongly dependent on ionic interactions with the extracellular receptor surface (Figure 
7.9). In contrast, the dependence on negatively charged residues at the extracellular surface 
is less pronounced for acylguanidines. Furthermore, larger molecules such as acylguanidine-
type H2R agonists can form additional contacts apart from ionic interactions.  
 
 
Figure 7.9 Surface of the gpH2R and gpH2R-ECL3-4Ser with the electrostatic potential 
View from the extracellular side at the surfaces of the wild-type gpH2R (A) and gpH2R-ECL3-4Ser 
(B). The surface is colored according to the electrostatic potential, ranging from red (most 
positive) to purple (most negative). The electrostatic potential was calculated with the program 
MOLCAD (MOLecular Computer Aided Design), included in the modeling suite SYBYL X1.3 
(Tripos, St. Louis, MO, USA). 
 
 
7.4.4 Summary and conclusion 
The aim of this study was to investigate the role of the negatively charged amino acids in the 
third extracellular loop of the gpH2R regarding their general function in receptor activation 
and their potential to provide an accessory binding site for bivalent acylguanidine-type 
agonists. Three receptor mutants, gpH2R-ECL3-4Ser-GsαS, gpH2R-ECL3-3Ser-GsαS and 
gpH2R-E270S-GsαS, were generated, and standard H2R agonists, mono- and bivalent 
(NG-acylated) hetarylpropylguanidines were characterized in the [35S]GTPγS binding assay. 
The suggested second binding site located at ECL3 and composed of negatively charged 
residues was not confirmed. However, these residues are possibly responsible for the 
integrity of the orthosteric binding site and/or for the route of some ligands into the binding 
pocket. The particularly high percentage of negatively charged amino acids in ECL3 of the 
gpH2R seems not to be generally needed for a proper function of the receptor. Some ligands 
(UR-BIT24, UR-BIT106) even tolerated the removal of three acidic residues. However, for all 
tested compounds the presence of at least one negatively charged amino acid in ECL3 
proved to be essential to retain high agonistic potency. Further site directed mutagenesis 
studies on ECL3 of the gpH2R may help to unveil the role of this loop in aminergic GPCRs. 
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8 Summary 
G-protein coupled receptors (GPCR) are the most important drug target family in humans. In 
the last decades, our knowledge about GPCR structure, conformational states, activation 
and their role in signal transduction has substantially increased. A huge number of novel 
agonists, antagonists and inverse agonists, including bivalent and functionally selective 
ligands, has been developed. More recently, crystal structures of about 20 GPCRs have 
been resolved. Structures of inactive and active receptor states are available now which 
allow invaluable insights into GPCR activation. The histamine H2 receptor (H2R) belongs to 
the majority of GPCRs with unknown 3D structure. However, its relatedness to the β-
adrenoceptors (βAR) with resolved structures of both states makes the H2R an interesting 
target for structural analysis. 
The aim of this thesis was to investigate differences between inactive and active human (h) 
H2R states with in-silico methods like homology modeling and molecular dynamics (MD) 
simulations. To improve and extend tools provided by the MD package GROMACS for 
analyzing structures and interactions, novel routines were written. Furthermore, in-vitro site-
directed mutagenesis studies should answer open questions on the role of specific amino 
acids in the H2R. Tyr182
5.38 residing in the orthosteric binding site of the hH2R was replaced 
by Phe. In a second approach, guinea pig (gp) H2R mutants were generated replacing acidic 
amino acids in the third extracellular loop (ECL3) in order to investigate the possibility that 
they belong to a second binding site for bivalent hetarylpropylguanidine-type agonists with 
higher potency than their monovalent analogs. Moreover, the question was whether the high 
number of acidic amino acids in ECL3 of the gpH2R compared to other aminergic GPCRs is 
of importance at all. 
Homology models of inactive and active hH2R states were constructed using the structures of 
the β1AR (inactive) and β2AR (active) as templates. With the intention to compare different 
models of active hH2R states with respect to reliability and to select the ‘best’ model, another 
active hH2R state variant was generated, using the templates tβ1AR and opsin. Both active 
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state models were complexed with a C-terminal Gsα-protein fragment. The resulting models 
were embedded in a natural environment consisting of a 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine bilayer and water molecules as solvent. The models were subjected to 80 ns 
MD simulations performed with GROMACS. The analysis of the results was improved by 
novel routines for the systematic calculation of direct and water mediated H-bonds and of 
van der Waals contacts. Additionally, a structure validation tool for proteins in MD simulation 
systems was written, probing the stereochemistry at Cα atoms and the planarity of aromatic 
side chains, delocalized π-electron systems and peptide bonds. Furthermore, backbone Φ/Ψ 
dihedral angles (Ramachandran analysis) as well as side chain torsion were measured and 
compared to experimental reference values. 
The quality of the homology models before and during the MD simulations in terms of 
backbone and side chain conformations was in very good agreement to experimental protein 
data. Crucial rearrangements between the inactive and the active hH2R state especially in 
the cytoplasmic domain were similar to changes observed at crystal structures. All molecular 
switches suggested to be essential for receptor activation were connected to the pronounced 
outward move of TM6 upon receptor activation: the parallel rearrangement of TM5 and TM6, 
the cleavage of the ionic lock, the disruption of a hydrophobic barrier in the center of the TM 
bundle, the inward move of TM7 including the highly conserved NPxxY(x)5,6F motif, the 
rearrangement of the H-bond network around TM7, and alterations at the bottom of the 
binding site. As key amino acids for the hH2R activation Arg116
3.50, Tyr2025.58, Glu2296.30, 
Phe2436.44, Asn2807.45 and Tyr2887.53 were identified. 
Site-directed mutagenesis experiments were based on the expression of mutant cDNA in Sf9 
cells using bacculoviruses. Membranes containing the recombinant proteins were prepared. 
The H2R mutants were characterized by testing H2R agonists and antagonists in the GTPase 
and GTPγS assay. 
Pharmacological investigations with the Tyr182Phe mutant of the hH2R revealed that, unlike 
previously expected, the hydroxyl group of Tyr1825.38 has only a minor effect on ligand 
binding. Most ligands tested exhibited a similar potency (pEC50) and intrinsic activity as at the 
wild-type hH2R. The suggested second binding site in ECL3 for bivalent agonists was not 
confirmed by results on three gpH2R mutants in which acidic amino acids were replaced by 
serines. However, acidic residues in ECL3 are possibly responsible for the integrity of the 
orthosteric binding site and/or for the pathway of some ligands into the binding pocket. The 
exceptionally high number of negatively charged amino acids in ECL3 of the gpH2R seems 
not to be generally necessary for proper receptor function. 
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The theoretical analysis of hH2R states contributes to the understanding of GPCR states and 
their differences. In particular, results from MD simulations indicate that GPCR activation is 
based on a concerted interaction of molecular switches and rearrangements of 
transmembrane and cytoplasmic domains. Computational tools have been introduced which 
allow an improved and extended analysis of MD simulations as well as a validation of 
simulated proteins. The pharmacological investigations do not verify hypotheses about a 
possible contribution of Tyr1825.38 to hH2R ligand binding and about the putative role of acidic 
amino acids in ECL3 of the gpH2R. 
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9 Appendix 
9.1 Parameters for MD simulations in GROMACS 
Parameter Value Description
1
 
   
RUN CONTROL PARAMETERS: 
integrator md 
A leap-frog algorithm for integrating 
Newton’s equations of motion. 
tinit 0 Starting time of the simulation [ps]. 
dt 0.002 Time step for integration [ps]. 
nsteps 40000000 
Maximum number of steps to 
integrate. 
comm-mode Linear Remove center of mass translation. 
nstcomm 1 
Frequency for center of mass 
motion removal [steps]. 
comm-grps Protein_DPPC SOL_CL 
Groups for center of mass motion 
removal. 
   
OUTPUT CONTROL: 
nstxout 500 
Frequency to write coordinates to 
output trajectory ﬁle [steps]. 
nstvout 500 
Frequency to write velocities to 
output trajectory [steps]. 
nstfout 500 
Frequency to write forces to output 
trajectory [steps]. 
nstlog 500 
Frequency to write energies to log 
ﬁle [steps]. 
nstenergy 500 
Frequency to write energies to 
energy ﬁle [steps]. 
nstxtcout 500 
Frequency to write coordinates to 
xtc trajectory [steps]. 
xtc-precision 1000 Precision to write to xtc trajectory. 
energygrps Protein_DPPC SOL_CL Groups to write to energy ﬁle. 
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NEIGHBOR SEARCHING: 
nstlist 10 
Frequency to update the neighbor 
list [steps]. 
ns_type grid 
Make a grid in the box and only 
check atoms in neighboring grid 
cells when constructing a new 
neighbor list every nstlist steps. 
pbc xyz 
Use periodic boundary conditions 
(pbc) in all directions. 
rlist 1.4 
Cut-off distance for the short-range 
neighbor list [nm]. 
   
ELECTROSTATICS AND VAN DER WAALS: 
coulombtype PME 
Use Particle-Mesh Ewald (PME) 
electrostatics to calculate long-
range electrostatic interactions. 
rcoulomb 1.4 
Distance for the Coulomb cut-off 
[nm]. 
vdw-type Cut-off 
Apply twin-range cut-offs for van der 
Waals interactions. 
rvdw 1.4 
Distance for the Lennard-Jones cut-
off [nm]. 
DispCorr EnerPres 
Apply long range dispersion 
corrections for energy and pressure. 
fourierspacing 0.12 
Maximum grid spacing for the Fast  
Fourier Transform (FFT) grid when 
using PME [nm]. 
pme_order 4 
Interpolation order for PME. Four 
equals cubic interpolation. 
ewald_rtol 1.00E-05 
The relative strength of the Ewald-
shifted direct potential. 
ewald_geometry 3d 
The Ewald sum is performed in all 
three dimensions. 
optimize_fft yes 
Calculate the optimal FFT plan for 
the grid at startup. This saves a few 
percent for long simulations. 
   
TEMPERATURE AND PRESSURE COUPLING: 
tcoupl berendsen 
Temperature coupling with a 
Berendsen-thermostat. 
tc-grps Protein DPPC SOL_CL 
Groups to couple separately to 
temperature bath. 
tau-t 0.1 0.1 0.1 
Time constant for coupling (one for 
each group in tc_grps) [ps]. 
ref-t 323 323 323 
Reference temperature for coupling 
(one for each group in tc_grps) [K]. 
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pcoupl berendsen 
Exponential relaxation pressure 
coupling. 
pcoupltype semiisotropic 
Pressure coupling which is isotropic 
in the x and y direction, but different 
in the z direction. Useful for 
membrane simulations. 
tau-p 2 Time constant for coupling [ps]. 
compressibility 4.5 E-05 4.5 E-05 
Compressibility [1/bar]. For water at 
1 atm and 300 K the compressibility 
is 4.5e-5 bar
-1
. 
ref-p 1 1 Reference pressure for coupling. 
   
GENERATE VELOCITIES FOR STARTUP RUN: 
gen-vel no 
Generate velocities in grompp 
according to a Maxwell distribution 
at temperature gen_temp, with 
random seed gen_seed. This is only 
used at the beginning of the 
equilibration. 
gen-temp 323 
Temperature for Maxwell distribution 
[K]. 
gen-seed 1982 
Used to initialize random generator 
for random velocities. 
   
BONDS: 
constraints all-bonds Convert all bonds to constraints. 
constraint-algorithm Lincs 
LINear Constraint Solver. Allow the 
usage of a time step for integration 
of 2 fs. 
lincs-order 4 
Highest order in the expansion of 
the constraint coupling matrix. For 
‘normal’ MD simulations an order of 
4 usually sufﬁces. 
lincs-warnangle 30 
Maximum angle that a bond can 
rotate before LINCS will complain 
[°]. 
morse no 
Bonds are represented by a 
harmonic potential. 
   
NMR REFINEMENT: 
disre simple 
Simple (per-molecule) distance 
restraints. 
disre-weighting equal 
Divide the restraint force equally 
over all atom pairs in the restraint. 
disre-fc 1000 
Force constant for distance 
restraints [kJ mol
-1
 nm
-2
]. 
1
 The description of parameters was adapted from the GROMACS User Manual 4.5.6 (Hess et al., 
2008; Van Der Spoel et al., 2005). 
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9.2 GROMOS96 53a6 force field parameters for histamine 
 
 
 
Histamine with atom names 
 
Atoms 
 
 
Atom Charge group Charge Mass 
    
C3 1 0 12.011 
H3 1 0.14 1.008 
N1 1 -0.05 14.0067 
H12 1 0.31 1.008 
C1 1 0 12.011 
H1 1 0.14 1.008 
N2 1 -0.54 14.0067 
C2 1 0 12.011 
C8 2 0 14.027 
C10 3 0.127 14.027 
N11 3 0.129 14.0067 
H84 3 0.248 1.008 
H85 3 0.248 1.008 
H11 3 0.248 1.008 
 
Bonds 
 
 
Atom 1 Atom 2 Parameter 
a
 
   
C3 H3 gb_3 
C3 N1 gb_10 
C2 C3 gb_10 
N1 H12 gb_2 
N1 C1 gb_10 
C1 H1 gb_3 
C1 N2 gb_10 
C2 N2 gb_10 
C2 C8 gb_27 
C8 C10 gb_27 
C10 N11 gb_21 
N11 H84 gb_2 
N11 H85 gb_2 
N11 H11 gb_2 
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Angles 
 
 
Atom 1 Atom 2 Atom 3 Parameter 
a
 Function 
b
 
     
H3 C3 N1 ga_36 2 
H3 C3 C2 ga_36 2 
N1 C3 C2 ga_7 2 
C3 N1 H12 ga_36 2 
C3 N1 C1 ga_7 2 
H12 N1 C1 ga_36 2 
N1 C1 H1 ga_36 2 
N1 C1 N2 ga_7 2 
H1 C1 N2 ga_36 2 
C1 N2 C2 ga_7 2 
C3 C2 N2 ga_7 2 
C3 C2 C8 ga_37 2 
N2 C2 C8 ga_37 2 
C2 C8 C10 ga_15 2 
C8 C10 N11 ga_15 2 
C10 N11 H84 ga_11 2 
C10 N11 H85 ga_11 2 
C10 N11 H11 ga_11 2 
H84 N11 H85 ga_10 2 
H84 N11 H11 ga_10 2 
H85 N11 H11 ga_10 2 
 
Dihedral angles 
 
 
Atom 1 Atom 2 Atom 3 Atom 4 Parameter 
a
 Function 
b
 
      
C10 C8 C2 C3 gd_40 1 
N11 C10 C8 C2 gd_34 1 
C8 C10 N11 H11 gd_29 1 
 
Improper dihedral angles 
c
 
 
 
Atom 1 Atom 2 Atom 3 Atom 4 Parameter 
a
 Function 
b
 
      
C3 C2 N1 H3 gi_1 2 
N1 C1 H12 C3 gi_1 2 
C1 N1 N2 H1 gi_1 2 
C2 C8 N2 C3 gi_1 2 
C3 N1 C1 N2 gi_1 2 
N1 C1 N2 C2 gi_1 2 
C1 N2 C2 C3 gi_1 2 
N2 C2 C3 N1 gi_1 2 
C2 C3 N1 C1 gi_1 2 
 
a
 Parameters as defined in the topology file ffG53a6bon.itp of the GROMOS 53a6 force field 
included in GROMACS 4.0.7. 
b
 Function used for the calculation. 
c
 Improper dihedrals are meant to keep planar groups (e.g. aromatic rings) planar, or to prevent 
molecules from ﬂipping over to their mirror images.
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9.3 Systematic calculation of hydrogen bonds: gro_hbonds 
9.3.1 Parameter file gro_hbonds-para.txt 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
# PLEASE ENTER: name of the simulation 
var-sim=inact-md1-2 
 
# PLEASE ENTER: name of the gro-file (also xtc and tpr files must have this  
# name; otherwise change respective lines in gro_hbonds.sh) 
var-filename=../../hH2R_inactive_2VT4_md1_2 
 
# PLEASE ENTER: duration of the simulation in picoseconds 
var-duration=80000 
 
# PLEASE ENTER: time step for analysis 
var-timestep=10 
 
# PLEASE ENTER: the number of amino acids, lipids and ligands in the coordinate 
# file (has to be in one sequence) 
var-residues=412 
 
# PLEASE ENTER: cut-off for heteroatom1-heteroatom2 distance for H-bonds in  
# picometer; natural number 
var-cutoffdist=350 
 
# PLEASE ENTER: cut-off for heteroatom1-H-heteroatom2 angle for H-bonds in degree;  
# natural number 
var-cutoffang=120 
 
# PLEASE ENTER: number of data points the average in the output files should be  
# calculated (division of duration/timestep/histo has to be possible without a  
# rest) 
var-histo=50 
 
 
9.3.2 Shell script gro_hbonds.sh 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
#!/bin/bash 
 
################################################################################## 
### Content: 
#   Systematic calculation of direct and water mediated H-bonds 
#   Helix analysis 
#   Analysis of buried unsatisfied hydrogen bond donors and acceptors 
#   Detailed information (distance and angle) of a specific H-bond during the  
#      entire simulation 
#   Picture (.jpg) of the existence of an H-bond over time 
 
 
################################################################################## 
#### Section 1 
################################################################################## 
 
# Compilation of the C program gro_hbonds-calc 
gcc gro_hbonds-calc.c /usr/lib64/libm.a -o gro_hbonds-calc 
 
# Storage of the result files 
mkdir output_detail 
mkdir output_sum 
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24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
 
63 
64 
65 
66 
67 
68 
 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
 
83 
84 
85 
86 
87 
 
88 
89 
 
90 
91 
92 
93 
# Extract variables from gro_hbonds-para.txt 
descr=gro_hbonds-para.txt 
 
sim=`sed -n /var-sim=/p $descr | cut -d= -f2` 
filename=`sed -n /var-filename=/p $descr | cut -d= -f2` 
duration=`sed -n /var-duration=/p $descr | cut -d= -f2` 
timestep=`sed -n /var-timestep=/p $descr | cut -d= -f2` 
residues=`sed -n /var-residues=/p $descr | cut -d= -f2` 
cutoffdist=`sed -n /var-cutoffdist=/p $descr | cut -d= -f2` 
cutoffang=`sed -n /var-cutoffang=/p $descr | cut -d= -f2` 
histo=`sed -n /var-histo=/p $descr | cut -d= -f2` 
 
# Extract the number of atoms/sites from the coordinate file (.gro) 
coordline=`sed -n '2p' $filename.gro` 
# Create a list with residue numbers and names 
cut -c1-9 $filename.gro | sed -n '1,2!p' | sed '$d' | sort -n -u | cut -c6-9 | sed 
's/ //g' > aa-name.txt 
# Determine number of residues 
resline=`wc -l aa-name.txt | cut -d \  -f 1` 
# Total number of time points to analyze 
frames=`expr $duration / $timestep` 
 
 
################################################################################## 
#### Section 2: Calculate H-bonds 
################################################################################## 
 
# The program works with slices of 1000 frames 
slice=1000  
# Number of trjconv runs 
parts=0  
# Beginning and end of one slice (in ps) 
begin=$(echo "scale=2; $timestep-0.5" |bc) 
end=$(echo "scale=2; $slice*$timestep+0.5" |bc) 
start=$timestep 
 
while [ $start -le $duration ]; do 
 
# Create coordinate file with trjconv 
echo 0 | trjconv -f $filename.xtc -s $filename.tpr -o frame_$begin-$end.gro -pbc 
mol -dt $timestep -b $begin -e $end >> trjconv-result.txt 2>&1 
 
# Combine sequence and coordinates 
cat aa-name.txt frame_$begin-$end.gro > input_frame_$begin-$end.txt 
rm -f frame_$begin-$end.gro 
 
./gro_hbonds-calc 1 $resline $coordline $slice $residues $start $cutoffdist 
$cutoffang $timestep < input_frame_$begin-$end.txt >> out_h-bonds_int_all.txt 
 
rm -f input_frame_$begin-$end.txt 
 
parts=`expr $parts + 1` 
begin=$(echo "scale=2; $parts*$slice*$timestep+$timestep-0.5" |bc) 
end=$(echo "scale=2; ($parts+1)*$timestep*$slice+0.5" |bc) 
start=`echo $(echo "scale=2; $begin+0.5" |bc) | cut -d\. -f1` 
done 
 
rm -f aa-name.txt 
rm -f trjconv-result.txt 
 
# Sort the output; necessary for the subprogram arg1=2 
sort -n -t- -k 1,1 -k 2,2 -k 5,5 -k 6,6 -k 9,9 out_h-bonds_int_all.txt > out_h-
bonds_int_all_sort.txt 
rm -f out_h-bonds_int_all.txt 
# Summarize all single H-bond files; the data for a heteroatom1-heteroatom2  
# interaction is combined over the whole simulation 
minus=`grep -o - out_h-bonds_int_all_sort.txt | wc -l` 
./gro_hbonds-calc 2 $minus 0 0 0 0 0 0 0 < out_h-bonds_int_all_sort.txt > 
output_detail/$sim-h-bond-all-int-Het_.txt 
rm -f out_h-bonds_int_all_sort.txt 
sort -n -t- -k 1,1 -k 2,2 -k 3,3 -k 4,4 -k 5,5 -k 6,6 output_detail/$sim-h-bond-
all-int-Het_.txt > output_detail/$sim-hbond-Het_int.txt 
rm -f output_detail/$sim-h-bond-all-int-Het_.txt 
# Create summarized output: Heteroatom-based interactions without water  
# interactions 
sed -n '/^[0-9]*-[0-9]*-[0-9]*-[012356]-/p' output_detail/$sim-hbond-Het_int.txt > 
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94 
95 
 
96 
97 
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99 
 
100 
101 
 
102 
103 
 
104 
105 
106 
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108 
 
109 
110 
 
111 
112 
 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
 
125 
126 
127 
128 
129 
130 
 
131 
132 
133 
134 
 
135 
136 
137 
138 
139 
 
140 
141 
 
142 
143 
144 
 
145 
146 
147 
148 
 
149 
150 
 
151 
152 
output_detail/$sim-hbond-Het_int_-SOL.txt 
minus=`grep -o - output_detail/$sim-hbond-Het_int_-SOL.txt | wc -l` 
./gro_hbonds-calc 7 $minus 8 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-Het_int_-SOL.txt > output_sum/$sim-hbond-Het_-SOL.txt 
 
# Interactions: type-based (e.g. bb, sc, terminus) without water interactions 
minus=`grep -o - output_detail/$sim-hbond-Het_int.txt | wc -l` 
./gro_hbonds-calc 4 $minus 1 0 0 0 0 0 0 < output_detail/$sim-hbond-Het_int.txt > 
output_detail/$sim-hbond-type_int.txt 
minus=`grep -o - output_detail/$sim-hbond-type_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 4 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-type_int.txt > output_sum/$sim-hbond-type.txt 
sed -n 1p output_sum/$sim-hbond-type.txt > output_sum/$sim-hbond-type_-SOL.txt 
sed -n '/^[0-9]*\t[0-9]*\t[0-9]*\t[012356]\t/p' output_sum/$sim-hbond-type.txt >> 
output_sum/$sim-hbond-type_-SOL.txt 
 
# Interactions: residue-based without water interactions 
minus=`grep -o - output_detail/$sim-hbond-Het_int.txt | wc -l` 
./gro_hbonds-calc 4 $minus 2 0 0 0 0 0 0 < output_detail/$sim-hbond-Het_int.txt > 
output_detail/$sim-hbond-res_int.txt 
sed -n '/^[0-9]*-[0-9]*-[0-9]*-[012356]-/p' output_detail/$sim-hbond-Het_int.txt > 
output_detail/$sim-hbond-Het_int_-SOL.txt 
minus=`grep -o - output_detail/$sim-hbond-Het_int_-SOL.txt | wc -l` 
./gro_hbonds-calc 4 $minus 2 0 0 0 0 0 0 < output_detail/$sim-hbond-Het_int_-
SOL.txt > output_detail/$sim-hbond-res_int_-SOL.txt 
minus=`grep -o - output_detail/$sim-hbond-res_int_-SOL.txt | wc -l` 
./gro_hbonds-calc 7 $minus 2 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-res_int_-SOL.txt > output_sum/$sim-hbond-res_-SOL.txt 
 
rm -f output_sum/$sim-hbond-type.txt 
rm -f output_detail/$sim-hbond-Het_int_-SOL.txt 
rm -f output_detail/$sim-hbond-res_int_-SOL.txt 
 
 
################################################################################## 
#### Section 3: Calculate water mediated H-bonds 
################################################################################## 
 
# Extract all lines where a water molecule is present: code X-X-X-4-X-X-X-X 
sed -n '/^[0-9]*-[0-9]*-[0-9]*-4-*/p' output_detail/$sim-hbond-Het_int.txt > 
water_hbonds.txt 
# Sort water molecules 
sort -n -t- -k 2,2 -k 1,1 -k 5,5 water_hbonds.txt > water_hbonds_sort.txt 
rm -f water_hbonds.txt 
minus=`grep -o - water_hbonds_sort.txt | wc -l` 
 
./gro_hbonds-calc 3 $minus 1 0 0 0 0 0 0 < water_hbonds_sort.txt > $sim-SOL-
mediated-hbond-int_.txt 
rm -f water_hbonds_sort.txt 
 
# Sort the output according to the residue numbers 
sort -t- -k 1,1 -k 2,2 -k 3,3 -k 4,4 -k 5,5 -k 6,6 -n $sim-SOL-mediated-hbond-
int_.txt > $sim-SOL-mediated-hbond-int-sort.txt 
rm -f $sim-SOL-mediated-hbond-int_.txt 
 
# Generate a detailed file (each atom separate): Het-based 
minus=`grep -o - $sim-SOL-mediated-hbond-int-sort.txt | wc -l` 
./gro_hbonds-calc 3 $minus 2 0 0 0 0 0 0 < $sim-SOL-mediated-hbond-int-sort.txt > 
output_detail/$sim-SOL-mediated-hbond-int-Het_.txt 
rm -f $sim-SOL-mediated-hbond-int-sort.txt 
sort -n -t- -k 1,1 -k 2,2 -k 3,3 -k 4,4 -k 5,5 -k 6,6 output_detail/$sim-SOL-
mediated-hbond-int-Het_.txt > output_detail/$sim-hbond_SOL-Het_int.txt 
rm -f output_detail/$sim-SOL-mediated-hbond-int-Het_.txt 
minus=`grep -o - output_detail/$sim-hbond_SOL-Het_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 8 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond_SOL-Het_int.txt > output_sum/$sim-hbond_SOL-Het.txt 
 
# Generate a summarized file: type-based (e.g. bb, sc, terminus) 
minus=`grep -o - output_detail/$sim-hbond_SOL-Het_int.txt | wc -l` 
./gro_hbonds-calc 4 $minus 1 0 0 0 0 0 0 < output_detail/$sim-hbond_SOL-
Het_int.txt > output_detail/$sim-hbond_SOL-type_int.txt 
minus=`grep -o - output_detail/$sim-hbond_SOL-type_int.txt| wc -l` 
./gro_hbonds-calc 7 $minus 4 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond_SOL-type_int.txt > output_sum/$sim-hbond_SOL-type.txt 
 
# Generate a summarized file: residue-based 
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165 
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175 
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185 
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192 
193 
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195 
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197 
198 
 
199 
200 
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202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
minus=`grep -o - output_detail/$sim-hbond_SOL-Het_int.txt | wc -l` 
./gro_hbonds-calc 4 $minus 2 0 0 0 0 0 0 < output_detail/$sim-hbond_SOL-
Het_int.txt > output_detail/$sim-hbond_SOL-res_int.txt 
minus=`grep -o - output_detail/$sim-hbond_SOL-res_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 2 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond_SOL-res_int.txt > output_sum/$sim-hbond_SOL-res.txt 
 
 
################################################################################## 
#### Section 4: Calculate bb1-3, bb1-4 and bb1-5 interactions for helicity-ckeck  
################################################################################## 
 
# bb-bb interactions: Het-based 
sed -n /^[0-9]*-[0-9]*-0-0-[0-9]*-[0-9]*-*/p output_detail/$sim-hbond-Het_int.txt 
> output_detail/$sim-hbond-bb-int-Het.txt 
minus1=`grep -o - output_detail/$sim-hbond-bb-int-Het.txt | wc -l` 
 
# bb-bb-interactions-1-3 
./gro_hbonds-calc 5 3 $minus1 $frames $residues 2 0 0 0 < output_detail/$sim-
hbond-bb-int-Het.txt > output_detail/$sim-hbond-helix-1-3-res_int.txt 
minus=`grep -o - output_detail/$sim-hbond-helix-1-3-res_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 2 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-helix-1-3-res_int.txt > output_sum/$sim-hbond-helix-1-3-res.txt 
 
# bb-bb-interactions-1-4 
./gro_hbonds-calc 5 4 $minus1 $frames $residues 2 0 0 0 < output_detail/$sim-
hbond-bb-int-Het.txt > output_detail/$sim-hbond-helix-1-4-res_int.txt 
minus=`grep -o - output_detail/$sim-hbond-helix-1-4-res_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 2 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-helix-1-4-res_int.txt > output_sum/$sim-hbond-helix-1-4-res.txt 
 
# bb-bb-interactions-1-5 
./gro_hbonds-calc 5 5 $minus1 $frames $residues 2 0 0 0 < output_detail/$sim-
hbond-bb-int-Het.txt > output_detail/$sim-hbond-helix-1-5-res_int.txt 
minus=`grep -o - output_detail/$sim-hbond-helix-1-5-res_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 2 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbond-helix-1-5-res_int.txt > output_sum/$sim-hbond-helix-1-5-res.txt 
 
rm -f output_detail/$sim-hbond-bb-int-Het.txt 
 
 
################################################################################## 
#### Section 5: Calculate percentage of frames where heteroatoms are hydrogen  
#### bonded (structure validation) 
################################################################################## 
 
# Get a list of the amino acid sequence 
cut -c1-9 $filename.gro | sed -n 1,2'!'p | sort -u -n | sed -n 1,"$residues"p | 
cut -c 6-9 | sed 's/ \+//g' > aa-list.txt 
minus=`grep -o - output_detail/$sim-hbond-Het_int.txt | wc -l` 
cat aa-list.txt output_detail/$sim-hbond-Het_int.txt > $sim-input-str-val-h-
bonds.txt 
 
# Output with all frames where H-bonds occur 
./gro_hbonds-calc 6 0 $minus $frames $residues 0 0 0 0 < $sim-input-str-val-h-
bonds.txt > $sim-str-val-h-bonds-sum-int.txt 
 
cut -f1,3,4,6- $sim-str-val-h-bonds-sum-int.txt | sed -n 1'!'p | sed 's/\t/-/g' > 
output_detail/$sim-hbonds-amount_int.txt 
 
minus=`grep -o - output_detail/$sim-hbonds-amount_int.txt | wc -l` 
./gro_hbonds-calc 7 $minus 3 $frames $timestep $histo 0 0 0 < output_detail/$sim-
hbonds-amount_int.txt > output_sum/$sim-hbonds-amount.txt 
 
rm -f $sim-input-str-val-h-bonds.txt 
rm -f $sim-str-val-h-bonds-sum-int.txt 
rm -f aa-list.txt 
 
 
################################################################################## 
#### Section 6: detailed output for one special H-bond (heteroatom1 - hydrogen – 
#### heteroatom2) 
################################################################################## 
 
# Atom numbers in the gro-file (example) 
het1=228 
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215 
216 
217 
218 
219 
220 
221 
222 
223 
 
224 
225 
226 
227 
228 
229 
230 
231 
232 
233 
234 
 
235 
236 
 
237 
238 
239 
240 
241 
242 
243 
244 
245 
246 
247 
248 
 
249 
250 
251 
252 
253 
254 
het2=212 
H=229 
 
echo \[ hbond\ \] > index-$het1-$het2-$H.ndx 
echo $het1 $het2 $H >> index-$het1-$het2-$H.ndx 
 
begin=$(echo "scale=2; $timestep-0.5" |bc) 
end=$(echo "scale=2; $duration+0.5" |bc) 
trjconv -f $filename.xtc -s $filename.tpr -o hbond-$het1-$het2-$H.gro -n index-
$het1-$het2-$H.ndx -b $begin -e $end -dt $timestep >> trjconv-result.txt 2>&1 
rm -f trjconv-result.txt 
rm -f index-$het1-$het2-$H.ndx 
 
sed -n '/[0-9]\.[0-9][0-9][0-9]$/p' hbond-$het1-$het2-$H.gro > tmp1.txt 
rm -f hbond-$het1-$het2-$H.gro 
cut -c21-44 tmp1.txt > tmp2.txt 
rm -f tmp1.txt 
 
lines=`wc -l tmp2.txt | cut -d\  -f1` 
 
echo -e time\[ps\]\\tdistance\[nm\]\\tangle\[°\]\\thbond > hbond-dist-ang-$het1-
$het2-$H.txt 
 
./gro_hbonds-calc 8 $lines $timestep 0 0 0 $cutoffdist $cutoffang 0 < tmp2.txt >> 
hbond-dist-ang-$het1-$het2-$H.txt 
 
rm -f tmp2.txt 
 
 
################################################################################## 
#### Section 7: jpg-picture for one H-bond (for line 1 in output_detail/$sim- 
#### hbond-Het_int.txt) 
################################################################################## 
 
sed -n 1p output_detail/$sim-hbond-Het_int.txt > interaction.txt 
 
./gro_hbonds-calc 9 8 $frames $timestep 0 0 0 0 0 < interaction.txt > interaction-
pic.xpm 
 
convert -density 300 interaction-pic.xpm hbond-existance_example.jpg 
 
rm -f interaction.txt 
rm -f interaction-pic.xpm 
rm -f gro_hbonds-calc 
 
 
9.3.3 C program gro_hbonds-calc.c 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
#include <stdio.h> 
#include <stdlib.h> 
#include <string.h> 
#include <math.h>  
 
// Compile with: 
// gcc gro_hbonds-calc.c /usr/lib64/libm.a -o gro_hbonds-calc 
 
// Number of residues which are defined by the AAcode in this program  
// (charge_termini) 
#define no_def_res 40  
 
int main(int argc, char *argv[]) { 
 
int arg1, arg2, arg3, arg4, arg5, arg6, arg7, arg8, arg9; 
 
// With parameters in the shell script the following variables are defined 
arg1 = strtol(argv[1], NULL, 10); 
arg2 = strtol(argv[2], NULL, 10);  
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arg3 = strtol(argv[3], NULL, 10);  
arg4 = strtol(argv[4], NULL, 10);  
arg5 = strtol(argv[5], NULL, 10);  
arg6 = strtol(argv[6], NULL, 10); 
arg7 = strtol(argv[7], NULL, 10); 
arg8 = strtol(argv[8], NULL, 10); 
arg9 = strtol(argv[9], NULL, 10); 
 
float cutoffdist = ((float) arg7)/1000; 
float cutoffang = ((float) arg8)/1; 
 
// This number (> duration of the MD) is always at the end of a line/section;  
int endline=9999999;  
 
// (charge_termini) for every charged terminal residue; also change "no_def_res"  
// if necessary 
// int terminus1aa=319; // residue number 
// int terminus1code=39; // position in AAcode 
 
// In AAname the amino acid name is stored and compared to the amino acid sequence  
// which is read in; all listed standard amino acids of GROMACS (ffG53a6.rtp) are  
// included (+ ACE and NH2), except HYP (hydroxyproline); additionally: DPPC, SOL,  
// SOLc, CL-, HAH 
char AAname[no_def_res][5]={  
            {'A','C','E'}, // 0 
            {'N','H','2'}, // 1 
            {'A','L','A'}, // 2 
            {'A','R','G'}, // 3 
            {'A','R','G','N'}, // 4 
            {'A','S','N'}, // 5 
            {'A','S','N','1'}, // 6 
            {'A','S','P'}, // 7 
            {'A','S','P','H'}, // 8 
            {'C','Y','S'}, // 9 
            {'C','Y','S','H'}, // 10 
            {'C','Y','S','1'}, // 11 
            {'C','Y','S','2'}, // 12 
            {'G','L','N'}, // 13 
            {'G','L','U'}, // 14 
            {'G','L','U','H'}, // 15 
            {'G','L','Y'}, // 16 
            {'H','I','S','A'}, // 17 
            {'H','I','S','B'}, // 18 
            {'H','I','S','H'}, // 19 
            {'H','I','S','1'}, // 20 
            {'H','I','S','2'}, // 21 
            {'I','L','E'}, // 22 
            {'L','E','U'}, // 23 
            {'L','Y','S'}, // 24 
            {'L','Y','S','H'}, // 25 
            {'M','E','T'}, // 26 
            {'P','H','E'}, // 27 
            {'P','R','O'}, // 28 
            {'S','E','R'}, // 29 
            {'T','H','R'}, // 30 
            {'T','R','P'}, // 31 
            {'T','Y','R'}, // 32 
            {'V','A','L'}, // 33 
            {'D','P','P','C'}, // 34 
            {'S','O','L'}, // 35 
            {'S','O','L','c'}, // 36 
            {'C','L','-'}, // 37 
            {'H','A','H'} // 38 
            }; 
 
// For each amino acid a code necessary for calculating the H-bonds is stored; the  
// sequence of the code has to be the same as the amino acid sequence in AAname 
int AAcode[no_def_res][18]={ 
            {3,1,2,0}, // 0-ACE 
            {3,1,0,2}, // 1-NH2 
            {6,2,0,1,5,0}, // 2-ALA 
            {17,5,0,1,6,1,9,2,12,2,16,0}, // 3-ARG 
            {16,5,0,1,6,1,9,1,11,2,15,0}, // 4-ARGN 
            {11,4,0,1,5,0,6,2,10,0}, // 5-ASN 
            {11,4,0,1,5,0,6,2,10,0}, // 6-ASN1 
            {9,4,0,1,5,0,6,0,8,0}, // 7-ASP 
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            {10,4,0,1,5,0,6,1,9,0}, // 8-ASPH 
            {7,3,0,1,4,0,6,0}, // 9-CYS 
            {8,3,0,1,4,1,7,0}, // 10-CYSH 
            {7,3,0,1,4,0,6,0}, // 11-CYS1 
            {7,3,0,1,4,0,6,0}, // 12-CYS2 
            {12,4,0,1,6,0,7,2,11,0}, // 13-GLN 
            {10,4,0,1,6,0,7,0,9,0}, // 14-GLU 
            {11,4,0,1,6,0,7,1,10,0}, // 15-GLUH 
            {5,2,0,1,4,0}, // 16-GLY 
            {14,4,0,1,5,1,11,0,13,0}, // 17-HISA 
            {14,4,0,1,5,0,10,1,13,0}, // 18-HISB 
            {15,4,0,1,5,1,11,1,14,0}, // 19-HISH 
            {14,4,0,1,5,1,11,0,13,0}, // 20-HIS1 
            {14,4,0,1,5,1,11,0,13,0}, // 21-HIS2 
            {9,2,0,1,8,0}, // 22-ILE 
            {9,2,0,1,8,0}, // 23-LEU 
            {12,3,0,1,7,2,11,0}, // 24-LYS 
            {13,3,0,1,7,3,12,0}, // 25-LYSH 
            {9,3,0,1,5,0,8,0}, // 26-MET 
            {17,2,0,1,16,0}, // 27-PHE 
            {7,2,0,0,6,0}, // 28-PRO 
            {8,3,0,1,4,1,7,0}, // 29-SER 
            {9,3,0,1,4,1,8,0}, // 30-THR 
            {21,3,0,1,8,1,20,0}, // 31-TRP 
            {18,3,0,1,14,1,17,0}, // 32-TYR 
            {8,2,0,1,7,0}, // 33-VAL 
            {50,8,6,0,8,0,9,0,10,0,13,0,15,0,32,0,34,0}, // 34-DPPC 
            {3,1,0,2}, // 35-SOL 
            {3,1,0,2}, // 36-SOLc 
            {1,1,0,0}, // 37-CL- 
            {14,3,2,1,6,0,10,3}, // 38-HAH 
            {10,3,0,1,8,0,9,0} // (charge_termini) 39-terminal aa of GaCT is LEU 
                               // and charged (ends with -COO) 
            }; 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 1: Calculate H-bonds: need arg1, arg2, arg3, arg4, arg5, arg6, arg7, 
// arg8, arg9 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==1) 
{ 
 
int a,b,e,f,k,l,i,j,t,u,v,x,y,z,cmp;  
int lineaa1, lineaa2, lineH, begaa1, begaa2, aa1fr, aa2fr, aa1, aa2, type1, type2;  
char w; 
float d; 
float alphab, alphaw, cosalphab; 
float pi=3.14159; 
 
// In matrixres the amino acid sequence is stored 
char matrixres[arg2][5]; 
 
// Initialize matrixres with NULL 
for (i=0; i<arg2; i++) {for (j=0; j<5; j++) matrixres[i][j]=0;} 
 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[arg2]; 
 
// Get memory from RAM for matrixcoord where all coordinates are stored 
float ** matrixcoord; 
matrixcoord = malloc((arg4*arg3) * sizeof(float *)); 
if(NULL == matrixcoord) 
{ 
printf("NO RAM for matrixcoord 1!"); 
return EXIT_FAILURE; 
} 
for(i=0; i<(arg4*arg3); i++) 
{ 
matrixcoord[i] = malloc(3 * sizeof(float)); 
if(NULL == matrixcoord[i]) 
{ 
printf("NO RAM for matrixcoord 2!"); 
return EXIT_FAILURE; 
} 
 Chapter 9: Appendix 259 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
200 
201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
238 
239 
240 
241 
242 
243 
244 
245 
246 
247 
} 
 
// Interactions per residue 
int resultlines=100000; 
// In intresulttable 8 integers describing both residues are stored 
int intresulttable[resultlines][8]; 
 
// Get memory from RAM for resulttable -> here it is stored if there is an  
// interaction at a specific time point 
char ** resulttable; 
resulttable = malloc((resultlines) * sizeof(char *)); 
if(NULL == resulttable) 
{ 
printf("NO RAM for resulttable 1!"); 
return EXIT_FAILURE; 
} 
for(i=0; i<(resultlines); i++) 
{ 
resulttable[i] = malloc((arg4) * sizeof(char)); 
if(NULL == resulttable[i]) 
{ 
printf("NO RAM for resulttable 2!"); 
return EXIT_FAILURE; 
} 
} 
 
// Read amino acid sequence 
for(i=0; i<arg2; i++) 
{ 
for(j=0; ; j++) 
{ 
scanf("%c", &matrixres[i][j]); 
if(matrixres[i][j]=='\n'){matrixres[i][j]=0; break;} 
} 
} 
 
// Convert amino acids to numbers 
for(i=0; i<arg2; i++) 
{ 
for(j=0;j<no_def_res;j++) 
{ 
if((cmp=strcmp(matrixres[i], AAname[j]))==0) {arrayres[i]=j; break;} 
} 
} 
 
// Read coordinates 
for(i=0; i<(arg4*arg3); ) 
{ 
for(j=0; ;j++) {scanf("%c", &w); if(w=='\n') break;} 
scanf("%d",&a); 
 
for(a=0;a<arg3;a++) 
{ 
for(j=0; j<21; j++) scanf("%c", &w); 
scanf("%f", &matrixcoord[i][0]); 
scanf("%f", &matrixcoord[i][1]); 
scanf("%f", &matrixcoord[i][2]); 
i++; 
} 
scanf("%c", &w); 
for(j=0; ;j++) {scanf("%c", &w); if(w=='\n') break;} 
 
} 
 
/* control output 
for(i=0;i<arg2;i++) 
printf("%s - %d\n", matrixres[i], arrayres[i]); 
for(i=0;i<100;i++) 
printf("%f %f %f\n", matrixcoord[i][0], matrixcoord[i][1], matrixcoord[i][2]); 
*/ 
 
// Start the H-bond calculation 
// x is the first amino acid, arg5 the number of residues which should be analyzed 
for(x=0; x<arg5;x++)  
{ 
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// Initialize intresulttable with 0 
for (i=0; i<resultlines; i++) {for(j=0; j<8; j++) intresulttable[i][j]=0;} 
 
// Initialize resulttable with SPACE 
for (i=0; i<resultlines; i++) {for(j=0; j<arg4; j++) resulttable[i][j]=' ';} 
 
// Count the number of result lines of amino acid no x (in intresulttable and  
// resulttable) 
u=0;  
 
// First line of the first amino acid (x) 
begaa1=0;  
for(i=0;i<x;i++) 
{j=arrayres[i]; begaa1+=AAcode[j][0];} 
 
// Amino acid type (as integer code) of the first amino acid (x) 
aa1=arrayres[x]; 
 
// (charge_termini) if there is more than one charged termini add corresponding  
// lines 
// if(x==terminus1aa-1) aa1=terminus1code; 
// if(x>terminus1aa-1) begaa1++; 
 
// Only interactions to residues having a higher sequence number are calculated 
for(y=x;y<arg2;y++)  
{ 
// First line of the second amino acid (y) 
begaa2=0;  
for(i=0;i<y;i++) 
{j=arrayres[i]; begaa2+=AAcode[j][0];} 
 
// Amino acid type (as integer code) of the second amino acid (y) 
aa2=arrayres[y];  
 
// (charge_termini) if there is more than one charged termini add corresponding  
// lines 
// if(y==terminus1aa-1) aa2=terminus1code; 
// if(y>terminus1aa-1) begaa2++;        
 
// Control output: printf("%d_%d_%d_%d ", x, begaa1, y, begaa2); 
 
for(z=0;z<arg4;z++) 
{ 
aa1fr=begaa1+z*arg3; 
aa2fr=begaa2+z*arg3; 
 
// Check if the first atoms of the first and second amino acid has a greater 
// distance than 3 nm (critical for lipids) 
d=sqrt((matrixcoord[aa1fr][0]-matrixcoord[aa2fr][0])*(matrixcoord[aa1fr][0]-
matrixcoord[aa2fr][0])+(matrixcoord[aa1fr][1]-
matrixcoord[aa2fr][1])*(matrixcoord[aa1fr][1]-
matrixcoord[aa2fr][1])+(matrixcoord[aa1fr][2]-
matrixcoord[aa2fr][2])*(matrixcoord[aa1fr][2]-matrixcoord[aa2fr][2])); 
if(d<=3.0) 
{ 
for(a=2, b=0; b<AAcode[aa1][1];a+=2,b++)  
// heteroatom in the first amino acid/residue 
{ 
for(e=2,f=0;f<AAcode[aa2][1];e+=2,f++)  
// heteroatom of the second amino acid/residue 
{ 
 
lineaa1=aa1fr+AAcode[aa1][a]; 
lineaa2=aa2fr+AAcode[aa2][e]; 
 
if(lineaa1<lineaa2) 
{ 
 
d=sqrt((matrixcoord[lineaa1][0]-matrixcoord[lineaa2][0])*(matrixcoord[lineaa1][0]-
matrixcoord[lineaa2][0])+(matrixcoord[lineaa1][1]-
matrixcoord[lineaa2][1])*(matrixcoord[lineaa1][1]-
matrixcoord[lineaa2][1])+(matrixcoord[lineaa1][2]-
matrixcoord[lineaa2][2])*(matrixcoord[lineaa1][2]-matrixcoord[lineaa2][2])); 
 
// check if the distance is below the cutoff and if there is at least one hydrogen 
// connected to the heteroatoms 
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if(d<=cutoffdist && ( AAcode[aa1][a+1]!=0 || AAcode[aa2][e+1]!=0) )  
{ 
 
// Code for interacting heteroatoms: 0 backbone, 1 side chain, 2 termini (ACE,  
// NH2), 3 DPPC, 4 SOL und SOLc, 5 CL-, 6 ligand 
if(aa1==0 || aa1==1) type1=2; //0: ACE; 1: NH2 
else if(aa1==34) type1=3; // DPPC 
else if(aa1==35 || aa1==36) type1=4; // SOL and SOLc 
else if(aa1==37) type1=5; // chloride 
else if(aa1==38) type1=6; // ligand 
else if(AAcode[aa1][1]==2) type1=0; // if there are only two heteroatoms in the 
// remaining residues than this must be a aa without heteroatoms in the side chain 
else if( (AAcode[aa1][1]>2) && ((a==2) || (a==(2*AAcode[aa1][1])) ) ) type1=0;  
// if there are more than 2 heteroatoms and it is the first (a=2) or the last in 
// the AAcode definition 
else type1=1; // remaining: side chain 
if(aa2==0 || aa2==1) type2=2; //0: ACE; 1: NH2 
else if(aa2==34) type2=3; // DPPC 
else if(aa2==35 || aa2==36) type2=4; // SOL and SOLc 
else if(aa2==37) type2=5; // chloride 
else if(aa2==38) type2=6; // ligand 
else if(AAcode[aa2][1]==2) type2=0; // if there are only two heteroatoms in the  
// remaining residues than this must be a aa without heteroatoms in the side chain 
else if( (AAcode[aa2][1]>2) && ((e==2) || (e==(2*AAcode[aa2][1])) ) ) type2=0;  
// if there are more than 2 heteroatoms and it is the first (a=2) or the last in  
// the AAcode definition 
else type2=1; // remaining: side chain 
 
for(k=1, l=0; l<AAcode[aa1][a+1]; k++, l++) 
{ 
lineH=lineaa1+k; 
 
cosalphab=((matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa2][2]-
matrixcoord[lineH][2]))/((sqrt((matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2]))*sqrt((matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa2][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa2][2]-matrixcoord[lineH][2])))); 
alphab=acos( cosalphab ); 
alphaw=alphab*180/pi; 
 
if(alphaw>=cutoffang)  
{   
v=0; 
for(t=0;t<u;t++) 
{ 
// Check if these amino acids interacted over another hydrogen before or were  
// present at an earlier time point 
if( (intresulttable[t][1]==x+1) && (intresulttable[t][2]==b+1) && 
(intresulttable[t][5]==y+1) && (intresulttable[t][6]==f+1) ) 
{resulttable[t][z]='1'; v=1; break;} 
} 
if(v==0) 
{ 
// 0:amino acid name 1; 1:amino acid number 1; 2: number of heteroatom in amino 
// acid number 1; 3:type of heteroatom in amino acid 1 (backbone etc.); 4:amino  
// acid name 1; 5:amino acid number 1; 6: number of heteroatom in amino acid 
// number 1; 7:type of heteroatom in amino acid 1 (backbone etc.) 
intresulttable[u][0]=(lineaa1-z*arg3)+1; 
intresulttable[u][1]=x+1;     
intresulttable[u][2]=b+1; 
intresulttable[u][3]=type1; 
intresulttable[u][4]=(lineaa2-z*arg3)+1; 
intresulttable[u][5]=y+1; 
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intresulttable[u][6]=f+1; 
intresulttable[u][7]=type2; 
resulttable[u][z]='1'; 
u++; 
} 
} 
} 
 
for(k=1, l=0; l<AAcode[aa2][e+1]; k++, l++) 
{ 
lineH=lineaa2+k; 
 
cosalphab=((matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa2][2]-
matrixcoord[lineH][2]))/((sqrt((matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa1][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa1][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa1][2]-
matrixcoord[lineH][2]))*sqrt((matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])*(matrixcoord[lineaa2][0]-
matrixcoord[lineH][0])+(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])*(matrixcoord[lineaa2][1]-
matrixcoord[lineH][1])+(matrixcoord[lineaa2][2]-
matrixcoord[lineH][2])*(matrixcoord[lineaa2][2]-matrixcoord[lineH][2])))); 
alphab=acos( cosalphab ); 
alphaw=alphab*180/pi; 
 
if(alphaw>=cutoffang)  
{ 
v=0; 
for(t=0;t<u;t++) 
{ 
// Check if these amino acids interacted over another hydrogen before or were  
// present at an earlier time point 
if( (intresulttable[t][1]==x+1) && (intresulttable[t][2]==b+1) && 
(intresulttable[t][5]==y+1) && (intresulttable[t][6]==f+1) ) 
{resulttable[t][z]='1'; v=1; break;} 
} 
if(v==0) 
{ 
// 0:amino acid name 1; 1:amino acid number 1; 2: number of heteroatom in amino 
// acid number 1; 3:type of heteroatom in amino acid 1 (backbone etc.); 4:amino  
// acid name 1; 5:amino acid number 1; 6: number of heteroatom in amino acid  
// number 1; 7:type of heteroatom in amino acid 1 (backbone etc.) 
intresulttable[u][0]=(lineaa1-z*arg3)+1; 
intresulttable[u][1]=x+1;     
intresulttable[u][2]=b+1; 
intresulttable[u][3]=type1; 
intresulttable[u][4]=(lineaa2-z*arg3)+1; 
intresulttable[u][5]=y+1; 
intresulttable[u][6]=f+1; 
intresulttable[u][7]=type2; 
resulttable[u][z]='1'; 
u++; 
} 
} 
} 
} 
} 
} 
} 
} 
} 
} 
 
// Output: aa1-no, aa2-no, type1, type2, Het1, Het2, atomNo1, atomNo2 
for(i=0;i<u;i++) 
{ 
printf("%d-", intresulttable[i][1]); 
printf("%d-", intresulttable[i][5]); 
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printf("%d-", intresulttable[i][3]); 
printf("%d-", intresulttable[i][7]); 
printf("%d-", intresulttable[i][2]); 
printf("%d-", intresulttable[i][6]); 
printf("%d-", intresulttable[i][0]); 
printf("%d-", intresulttable[i][4]); 
for(j=0;j<arg4;j++) {if(resulttable[i][j]=='1') printf("%d-", arg6+j*arg9);} 
printf("%d-\n", endline); 
} 
 
} 
 
// Free memory 
for(i = 0; i < (arg4*arg3); i++) 
free(matrixcoord[i]); 
free(matrixcoord); 
 
for(i = 0; i < (resultlines); i++) 
free(resulttable[i]); 
free(resulttable); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 2: Calculate summary of h-bonds: need arg1, arg2; not: arg3, arg4,  
// arg5, arg6 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==2) 
{ 
 
int a,i,j; 
int tmp [8]; 
for(i=0;i<8;i++) tmp[i]=0; 
int tmp1[8]; 
 
// In intall all values are stored 
int *intall = malloc(arg2 * sizeof(int)); 
if(intall == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<arg2;i++) 
scanf("%d-", &intall[i]); 
 
for(i=0;i<arg2;i++) 
{ 
 
a=i; 
for(j=0;j<8;j++,a++) tmp1[j]=intall[a]; 
 
if( tmp[0]==tmp1[0] && tmp[1]==tmp1[1] && tmp[4]==tmp1[4] && tmp[5]==tmp1[5] ) 
i+=8; 
else {if(i!=0) printf("%d-\n", endline);} 
 
for(j=0; ;j++) 
{ 
if(intall[i]==endline) {for(a=0;a<8;a++) tmp[a]=tmp1[a]; break;} 
printf("%d-",intall[i]); 
i++; 
} 
} 
 
printf("%d-\n", endline); 
 
// Free memory 
free(intall); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 3: Calculate water mediated h-bonds: need arg1, arg2, arg3 
////////////////////////////////////////////////////////////////////////////////// 
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if(arg1==3) 
{ 
 
int a,b,i,j,t,v; 
 
// In intall all integer values of the input are stored 
int *intall = malloc(arg2 * sizeof(int)); 
if(intall == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// In result summarized data is stored 
int *result = malloc(arg2 * sizeof(int)); 
if(result == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<arg2;i++) 
scanf("%d-", &intall[i]); 
 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg3==1) 
{ 
 
t=0; 
for(i=0;i<arg2;i++) 
{ 
 
j=i; 
for( ; ; ) 
{ 
 
for( ;j<arg2;j++) 
{ 
if(intall[j]==endline) {j++; break;} 
} 
 
if(j>=arg2) break; 
 
if(intall[i+1]==intall[j+1]) 
{ 
 
v=0; 
for(a=0;intall[i+8+a]!=endline; a++) 
{ 
for(b=0;intall[j+8+b]!=endline;b++) 
{ 
if(intall[i+8+a]==intall[j+8+b]) 
{ 
if(v==0) 
{ 
result[t]=intall[i];t++; 
result[t]=intall[j];t++; 
result[t]=intall[i+2]; t++; 
result[t]=intall[j+2]; t++; 
result[t]=intall[i+4]; t++; 
result[t]=intall[j+4]; t++; 
result[t]=intall[i+6]; t++; 
result[t]=intall[j+6]; t++; 
} 
result[t]=intall[j+8+b]; t++; 
v++; 
} 
} 
} 
if(v!=0) {result[t]=endline; t++;} 
} 
 
else // for if(intall[i+1]==intall[j+1]) 
{ 
for( ; ;i++) 
{ 
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if(intall[i]==endline) break; 
} 
break; 
} 
}  
} 
 
// Output 
for(i=0;i<t;i++) 
{ 
printf("%d-", result[i]); 
if(result[i]==endline) printf("\n"); 
} 
 
} 
 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg3==2) 
{ 
 
for(i=0;i<arg2; ) 
{ 
 
printf("%d-%d-%d-%d-%d-%d-%d-%d-", intall[i], intall[i+1], intall[i+2], 
intall[i+3], intall[i+4], intall[i+5], intall[i+6], intall[i+7]); 
t=0; 
for(j=i+8;j<arg2;j++,t++) 
{ 
if(intall[j]==endline) {break;} 
result[t]=intall[j]; 
} 
 
j=i; 
for( ;j<arg2 ; ) 
{ 
 
for( ;j<arg2;j++) 
{ 
if(intall[j]==endline) {j++; break;} 
} 
 
if(intall[i]==intall[j] && intall[i+1]==intall[j+1] && intall[i+4]==intall[j+4] && 
intall[i+5]==intall[j+5]) 
{ 
for( ;intall[j+8]!=endline;t++,j++) result[t]=intall[j+8]; 
} 
 
else  
{ 
result[t]=endline; 
 
for(a=0;result[a]!=endline;a++) 
{ 
for(b=a+1;result[b]!=endline;b++) 
{ 
 
for( ;result[b]!=endline; ) 
{ 
if(result[a]==result[b]) { for(v=b+1; result[v-1]!=endline; v++) result[v-
1]=result[v]; } 
else break; 
} 
 
if(result[b]<result[a]) 
{ 
v=result[a]; 
result[a]=result[b]; 
result[b]=v; 
} 
} 
} 
 
for(v=0;result[v]!=endline;v++) printf("%d-", result[v]); 
printf("%d-\n",endline); 
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i=j; 
break; 
} 
} 
} 
} 
 
// Free memory 
free(intall); 
free(result); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 4: Summarize code- and residue-based interactions from Het-based input 
// file: need arg1, arg2, arg3 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==4) 
{ 
 
int a,b,i,j,t,v; 
 
// In intall all integer values of the input are stored 
int *intall = malloc(arg2 * sizeof(int)); 
if(intall == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// In result summarized data is stored 
int *result = malloc(arg2 * sizeof(int)); 
if(result == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<arg2;i++) 
scanf("%d-", &intall[i]); 
 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg3==1) 
{ 
 
for(i=0;i<arg2; ) 
{ 
 
printf("%d-%d-%d-%d-", intall[i], intall[i+1], intall[i+2], intall[i+3]); 
t=0; 
for(j=i+8;j<arg2;j++,t++) 
{ 
if(intall[j]==endline) {break;} 
result[t]=intall[j]; 
} 
 
j=i; 
for( ;j<arg2 ; ) 
{ 
 
for( ;j<arg2;j++) 
{ 
if(intall[j]==endline) {j++; break;} 
} 
 
if((intall[i]==intall[j] && intall[i+1]==intall[j+1] && intall[i+2]==intall[j+2] 
&& intall[i+3]==intall[j+3])) 
{ 
for( ;intall[j+8]!=endline;t++,j++) result[t]=intall[j+8]; 
} 
 
else  
{ 
result[t]=endline; 
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for(a=0;result[a]!=endline;a++) 
{ 
for(b=a+1;result[b]!=endline;b++) 
{ 
 
for( ;result[b]!=endline; ) 
{ 
if(result[a]==result[b]) { for(v=b+1; result[v-1]!=endline; v++) result[v-
1]=result[v]; } 
else break; 
} 
 
if(result[b]<result[a]) 
{ 
v=result[a]; 
result[a]=result[b]; 
result[b]=v; 
} 
} 
} 
 
for(v=0;result[v]!=endline;v++) printf("%d-", result[v]); 
printf("%d-\n",endline); 
 
i=j; 
break; 
} // for else ... 
} // for for( ;j<arg2 ; ) 
} // for for(i=0;i<arg2; ) 
} // for if(arg3==1) 
 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg3==2) 
{ 
 
for(i=0;i<arg2; ) 
{ 
 
printf("%d-%d-", intall[i], intall[i+1]); 
t=0; 
for(j=i+8;j<arg2;j++,t++) 
{ 
if(intall[j]==endline) {break;} 
result[t]=intall[j]; 
} 
 
j=i; 
for( ;j<arg2 ; ) 
{ 
 
for( ;j<arg2;j++) 
{ 
if(intall[j]==endline) {j++; break;} 
} 
 
if(intall[i]==intall[j] && intall[i+1]==intall[j+1]) 
{ 
for( ;intall[j+8]!=endline;t++,j++) result[t]=intall[j+8]; 
} 
 
else  
{ 
result[t]=endline; 
 
for(a=0;result[a]!=endline;a++) 
{ 
for(b=a+1;result[b]!=endline;b++) 
{ 
 
for( ;result[b]!=endline; ) 
{ 
if(result[a]==result[b]) { for(v=b+1; result[v-1]!=endline; v++) result[v-
1]=result[v]; } 
else break; 
} 
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if(result[b]<result[a]) 
{ 
v=result[a]; 
result[a]=result[b]; 
result[b]=v; 
} 
} 
} 
 
for(v=0;result[v]!=endline;v++) printf("%d-", result[v]); 
printf("%d-\n",endline); 
 
i=j; 
break; 
} // for else ... 
} // for for( ;j<arg2 ; ) 
} // for for(i=0;i<arg2; ) 
} // for if(arg3==2) 
 
////////////////////////////////////////////////////////////////////////////////// 
 
// Free memory 
free(intall); 
free(result); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 5: Calculate bb-interactions for helicity-check: need arg1, arg2,  
// arg3, arg4, arg5, arg6 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==5) 
{ 
 
int a,b,i,j; 
float contact; 
 
// In alldata the input is stored 
int *alldata = malloc(arg3 * sizeof(int)); 
if(alldata == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<arg3;i++) scanf("%d-",&alldata[i]); 
 
// Check if there are 1-arg2 interactions (alpha-helix) and if so count the number 
// of interactions 
 
for(i=0, a=1 ;i<arg3; i++) 
{ 
 
if(a==arg5-arg2) break; 
 
if(alldata[i]==a) 
{ 
 
// check if there are 1-4 interactions and if the first heteroatom (oxygen) has a 
// bigger Het-no than the second (nitrogen) 
if( (alldata[i]==(alldata[i+1]-arg2)) && (alldata[i+4]>alldata[i+5]) )  
{ 
 
for(j=i+8,b=0; ;j++,b++) 
{ 
if(alldata[j]==endline)  
{ 
contact=1.0*(float)b/(float)arg4;  
if(arg6==1) printf("%d\t%d\t%.3f\n", alldata[i], alldata[i+1], contact);  
if(arg6==2) printf("%d-%d-", alldata[i], alldata[i+1]);  
break; 
} 
} 
if(arg6==2) 
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{ 
for(j=i+8; ;j++) 
{ 
printf("%d-", alldata[j]); 
if(alldata[j]==endline) {printf("\n"); break;} 
} 
} 
 
a++; 
 
} 
 
for( ; ; i++) {if(alldata[i]==endline) break;} 
 
} 
 
else if(alldata[i]<a) 
{ 
for( ; ; i++) {if(alldata[i]==endline) break;} 
} 
 
else  
{ 
if(arg6==1) printf("%d\t%d\t0.000\n", a, a+arg2); 
if(arg6==2) printf("%d-%d-%d-\n", a, a+arg2, endline); 
a++; 
i--; 
} 
} 
 
// Free memory 
free(alldata); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 6: Calculate percentage of frames where heteroatoms are hydrogen 
// bonded: need arg1, arg3, arg4, arg5 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==6) 
{ 
 
int a,b,i,j,k,t,u,v,y,z; 
int cmp, code; 
 
// In matrixres the amino acid sequence is stored 
char matrixres[arg5][5]; 
// Initialize matrixres with NULL 
for (i=0; i<arg5; i++) {for (j=0; j<5; j++) matrixres[i][j]=0;} 
 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[arg5]; 
 
// In intall all values are stored 
int *intall = malloc(arg3 * sizeof(int)); 
if(intall == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// In result summarized data is stored; *2 if there are double interactions at the 
// same time point analyzed 
int *result = malloc((arg4*2) * sizeof(int)); 
if(result == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read amino acid sequence 
for(i=0; i<arg5; i++) 
{ 
for(j=0; ; j++) 
{ 
scanf("%c", &matrixres[i][j]); 
if(matrixres[i][j]=='\n'){matrixres[i][j]=0; break;} 
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} 
} 
 
// Convert amino acids to numbers 
for(i=0; i<arg5; i++) 
{ 
for(j=0;j<no_def_res;j++) 
{ 
if((cmp=strcmp(matrixres[i], AAname[j]))==0) {arrayres[i]=j; break;} 
} 
} 
 
// Read the data 
for(i=0;i<arg3;i++) 
scanf("%d-", &intall[i]); 
 
printf("aa-no\taa-name\tHet-no\ttype\th-bonded\n"); 
 
for(i=0;i<arg5;i++) 
{ 
 
j=arrayres[i]; 
// (charge_termini) if there is more than one charged termini add corresponding  
// lines 
// if(i==terminus1aa-1) j=arrayres[terminus1code]; 
 
// Check all heteroatoms 
for(k=0; k<AAcode[j][1]; k++)  
{ 
 
for(z=0;z<2*arg4;z++) result[z]=0; 
 
u=0; 
for(y=0; y<arg3; y++) 
{ 
if( (intall[y]==i+1 && intall[y+4]==k+1) || (intall[y+1]==i+1 && intall[y+5]==k+1) 
) 
{ 
for(t=y+8; ;u++, t++) 
{ 
if(intall[t]==endline) break; 
result[u]=intall[t]; 
} 
 
} //if( (intall[y]==j & 
 
for( ; ; y++) 
{ 
if(intall[y]==endline) break; 
} 
 
} //for(y=0; y<arg3; y++) 
 
if(j==0 || j==1) code=2; //0: ACE; 1: NH2 
else if(j==34) code=3; // DPPC 
else if(j==35 || j==36) code=4; // SOL and SOLc 
else if(j==37) code=5; // chloride 
else if(j==38) code=6; // ligand 
else if(AAcode[j][1]==2) code=0; 
else if( (AAcode[j][1]>2) && ((k==0) || (k==AAcode[j][1]-1) )  ) code=0; 
else code=1; // remaining: side chain 
 
if(u==0) printf("%d\t%s\t%d\t%d\t0.000\t%d-\n", i+1, matrixres[i],k+1, code, 
endline); 
else 
{ 
 
result[u]=endline; 
for(t=0;t<u-1;t++) 
{ 
for(b=t+1;b<u;b++) 
{ 
 
if(result[b]==result[t]) { for(v=b+1; result[v-1]!=endline; v++) {result[v-
1]=result[v];} u--; } 
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if(result[b]<result[t]) 
{ 
v=result[t]; 
result[t]=result[b]; 
result[b]=v; 
} 
} 
} // else 
 
printf("%d\t%s\t%d\t%d\t%.3f\t", i+1, matrixres[i],k+1, code, (float)(u-
1)/(float)arg4); // (float)(u-1)/(float)arg4 
for(z=0;z<u;z++) printf("%d-", result[z]);  
printf("%d-\n", endline); 
 
} //else 
} //for(k=0; k<AAcode[j][1]; k++) // check all heteroatoms 
} //for(i=0;i<arg5; ) 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 7: Analyze H-bond data: need arg1, arg2, arg3, arg4, arg5 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==7) 
{ 
 
// Time step (in picoseconds) used for H-bond calculation for the final output 
int timestep = arg5; 
int a,b,c,i,j; 
int histo[arg4/arg6]; 
 
// In intall all values are stored 
int *intall = malloc(arg2 * sizeof(int)); 
if(intall == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<arg2;i++) 
scanf("%d-", &intall[i]); 
 
if(arg3==2) printf("aa1\taa2\tinteractions\t"); 
if(arg3==3) printf("aa\tHet\tcode\th-bonded\t"); 
if(arg3==4) printf("aa1\taa2\tc1\tc2\tinteractions\t"); 
if(arg3==8) 
printf("aa1\taa2\tc1\tc2\tHet1\tHet2\tatomNo1\tatomNo2\tinteractions\t"); 
 
for(i=0;i<(arg4/arg6);i++) printf("%d\t", timestep*((i+1)*arg6-(arg6/2))); 
printf("\n"); 
 
for(i=0;i<arg2;i++) 
{ 
for(j=0;j<(arg4/arg6);j++) histo[j]=0; 
 
for(j=i;j<i+arg3;j++) printf("%d\t", intall[j]); 
a=0; 
for(j=i+arg3; ;j++,a++) 
{ 
for(b=timestep,c=0; b<arg4*timestep; b+=arg6*timestep,c++) 
{ 
if(intall[j]>=b && intall[j]<(b+arg6*timestep)) {histo[c]++; break;} 
} 
if(intall[j]==endline) break; 
} 
printf("%.3f\t", (float)a/(float)arg4); 
for(j=0;j<(arg4/arg6);j++) printf("%.3f\t", (float)histo[j]/(float)arg6); 
printf("\n"); 
for(;;i++) if(intall[i]==endline) break; 
 
} 
 
free(intall); 
} 
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////////////////////////////////////////////////////////////////////////////////// 
// Section 8: Calculate a single H-bond: distance and angle values 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==8) 
{ 
 
int i,j; 
 
float d; 
float alphab, alphaw, cosalphab; 
float pi=3.14159; 
 
// Get memory from RAM for matrixcoord were all coordinates are stored 
float ** matrixcoord; 
matrixcoord = malloc(arg2 * sizeof(float *)); 
if(NULL == matrixcoord) 
{ 
printf("NO RAM for matrixcoord 1!"); 
return EXIT_FAILURE; 
} 
for(i=0; i<arg2; i++) 
{ 
matrixcoord[i] = malloc(3 * sizeof(float)); 
if(NULL == matrixcoord[i]) 
{ 
printf("NO RAM for matrixcoord 2!"); 
return EXIT_FAILURE; 
} 
} 
 
// Read coordinates 
for(i=0; i<arg2; i++) 
{ 
scanf("%f", &matrixcoord[i][0]); 
scanf("%f", &matrixcoord[i][1]); 
scanf("%f", &matrixcoord[i][2]); 
} 
 
// Calculate distance and angle 
for(i=0; i<arg2; i+=3) 
{ 
d=sqrt((matrixcoord[i][0]-matrixcoord[i+1][0])*(matrixcoord[i][0]-
matrixcoord[i+1][0])+(matrixcoord[i][1]-matrixcoord[i+1][1])*(matrixcoord[i][1]-
matrixcoord[i+1][1])+(matrixcoord[i][2]-matrixcoord[i+1][2])*(matrixcoord[i][2]-
matrixcoord[i+1][2])); 
 
cosalphab=((matrixcoord[i][0]-matrixcoord[i+2][0])*(matrixcoord[i+1][0]-
matrixcoord[i+2][0])+(matrixcoord[i][1]-matrixcoord[i+2][1])*(matrixcoord[i+1][1]-
matrixcoord[i+2][1])+(matrixcoord[i][2]-matrixcoord[i+2][2])*(matrixcoord[i+1][2]-
matrixcoord[i+2][2]))/((sqrt((matrixcoord[i][0]-
matrixcoord[i+2][0])*(matrixcoord[i][0]-matrixcoord[i+2][0])+(matrixcoord[i][1]-
matrixcoord[i+2][1])*(matrixcoord[i][1]-matrixcoord[i+2][1])+(matrixcoord[i][2]-
matrixcoord[i+2][2])*(matrixcoord[i][2]-
matrixcoord[i+2][2]))*sqrt((matrixcoord[i+1][0]-
matrixcoord[i+2][0])*(matrixcoord[i+1][0]-
matrixcoord[i+2][0])+(matrixcoord[i+1][1]-
matrixcoord[i+2][1])*(matrixcoord[i+1][1]-
matrixcoord[i+2][1])+(matrixcoord[i+1][2]-
matrixcoord[i+2][2])*(matrixcoord[i+1][2]-matrixcoord[i+2][2])))); 
alphab=acos( cosalphab ); 
alphaw=alphab*180/pi; 
 
if(d<=cutoffdist && alphaw>=cutoffang) j=1; else j=0; 
 
printf("%d\t%.3f\t%.3f\t%d\n", i/3*arg3+arg3, d, alphaw, j); 
 
} 
 
// Free memory 
for(i=0; i<arg2; i++) 
free(matrixcoord[i]); 
free(matrixcoord); 
} 
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1169 
1170 
1171 
1172 
1173 
1174 
1175 
1176 
1177 
1178 
1179 
1180 
1181 
1182 
1183 
1184 
1185 
1186 
1187 
1188 
1189 
1190 
1191 
1192 
1193 
1194 
1195 
1196 
1197 
1198 
1199 
1200 
1201 
1202 
1203 
1204 
1205 
1206 
1207 
1208 
1209 
1210 
1211 
1212 
1213 
1214 
1215 
1216 
1217 
 
////////////////////////////////////////////////////////////////////////////////// 
// Section 9: Generate a xpm picture for one hydrogen bonding interaction 
////////////////////////////////////////////////////////////////////////////////// 
 
if(arg1==9) 
{ 
 
int d,i,j; 
 
// In alldata the input is stored 
int *alldata = malloc((arg2+arg3) * sizeof(int)); 
if(alldata == NULL) 
{printf("NO RAM\n"); 
return EXIT_FAILURE; 
} 
 
// Read the data 
for(i=0;i<(arg2+arg3);i++)  
{ 
scanf("%d-",&alldata[i]); 
if (alldata[i]==endline) break; 
} 
 
// Print header 
printf("/* XPM */\n"); 
printf("static char * pic_xpm[] = {\n"); 
printf("\"%d %d 3 1\",\n", arg3, arg3/20); 
printf("\" \tc None\",\n"); 
printf("\"0\tc #FFFFFF\",\n"); 
printf("\"1\tc #000000\",\n"); 
 
// Print the data 
 
for(j=0; j<arg3/20; j++) // Height of the image is 1/20 of ist width 
{ 
 
printf("\""); 
for(i=arg2, d=1 ;d<arg3+1; d++) 
{ 
if(alldata[i]/arg4==d) {printf("1"); i++;} 
else printf("0"); 
} 
if(j==(arg3/20)-1) printf("\"}"); else printf("\","); 
printf("\n"); 
} 
 
// Free memory 
free(alldata); 
} 
 
return EXIT_SUCCESS; 
} 
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9.4 Calculation of hydrophobic contacts: gro_contacts 
9.4.1 Parameter file gro_contacts-para.txt 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
# PLEASE ENTER: name of the simulation 
var-sim=inact-md1-2 
 
# PLEASE ENTER: name of the gro-file (also xtc and tpr files must have this  
# name; otherwise change respective lines in gro_contacts.sh) 
var-filename=../../hH2R_inactive_2VT4_md1_2 
 
# PLEASE ENTER: duration of the simulation in picoseconds 
var-duration=80000 
 
# PLEASE ENTER: time step for analysis 
var-timestep=10 
 
# PLEASE ENTER: cut-off value for contacts in picometer (the number has to be  
# divided by 10 without a rest) 
var-cutoff=500 
 
# PLEASE ENTER: the number of amino acids, lipids and ligands in the coordinate  
# file (has to be in one sequence) 
var-last=412 
 
 
9.4.2 Reference file contacts-atoms.txt 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
ALA CB 
ARG CB 
ARG CG 
ARG CD 
ARGN CB 
ARGN CG 
ARGN CD 
ASN CB 
ASN1 CB 
ASP CB 
ASPH CB 
CYS CB 
CYSH CB 
CYS1 CB 
CYS1 SG 
CYS2 CB 
CYS2 SG 
GLN CB 
GLN CG 
GLU CB 
GLU CG 
GLUH CB 
GLUH CG 
GLY CA 
HISA CB 
HISA CG 
HISA CD2 
HISA CE1 
HISB CB 
HISB CG 
HISB CD2 
HISB CE1 
HISH CB 
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34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
HISH CG 
HISH CD2 
HISH CE1 
HIS1 CB 
HIS1 CG 
HIS1 CD2 
HIS1 CE1 
HIS2 CB 
HIS2 CG 
HIS2 CD2 
HIS2 CE1 
ILE CB 
ILE CG1 
ILE CG2 
ILE CD 
LEU CB 
LEU CG 
LEU CD1 
LEU CD2 
LYS CB 
LYS CG 
LYS CD 
LYS CE 
LYSH CB 
LYSH CG 
LYSH CD 
LYSH CE 
MET CB 
MET CG 
MET CE 
PHE CB 
PHE CG 
PHE CD1 
PHE HD1 
PHE CD2 
PHE HD2 
PHE CE1 
PHE HE1 
PHE CE2 
PHE HE2 
PHE CZ 
PHE HZ 
PRO CB 
PRO CG 
PRO CD 
SER CB 
THR CB 
THR CG2 
TRP CB 
TRP CG 
TRP CD1 
TRP HD1 
TRP CD2 
TRP CE2 
TRP CE3 
TRP HE3 
TRP CZ2 
TRP HZ2 
TRP CZ3 
TRP HZ3 
TRP CH2 
TRP HH2 
TYR CB 
TYR CG 
TYR CD1 
TYR HD1 
TYR CD2 
TYR HD2 
TYR CE1 
TYR HE1 
TYR CE2 
TYR HE2 
TYR CZ 
VAL CB 
VAL CG1 
VAL CG2 
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110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
DPPC C22 
DPPC C23 
DPPC C24 
DPPC C25 
DPPC C26 
DPPC C27 
DPPC C28 
DPPC C29 
DPPC C210 
DPPC C211 
DPPC C212 
DPPC C213 
DPPC C214 
DPPC C215 
DPPC C216 
DPPC C12 
DPPC C13 
DPPC C14 
DPPC C15 
DPPC C16 
DPPC C17 
DPPC C18 
DPPC C19 
DPPC C110 
DPPC C111 
DPPC C112 
DPPC C113 
DPPC C114 
DPPC C115 
DPPC C116 
HAH C3 
HAH H3 
HAH C1 
HAH H1 
HAH C2 
HAH C8 
HAH C10 
 
9.4.3 Shell script gro_contacts.sh 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
 
25 
26 
27 
#!/bin/bash 
 
################################################################# 
### Content: 
# Calculates contacts between hydrophobic sites 
# A file with atoms should be provided: "contacts-atoms.txt" 
################################################################# 
 
# Compilation of the C program gro_contacts-calc 
gcc gro_contacts-calc.c -o gro_contacts-calc 
 
# Extract variables from parameter.txt 
descr=contacts-para.txt 
 
sim=`sed -n /var-sim=/p $descr | cut -d= -f2` 
filename=`sed -n /var-filename=/p $descr | cut -d= -f2` 
duration=`sed -n /var-duration=/p $descr | cut -d= -f2` 
timestep=`sed -n /var-timestep=/p $descr | cut -d= -f2` 
cutoff=`sed -n /var-cutoff=/p $descr | cut -d= -f2` 
last=`sed -n /var-last=/p $descr | cut -d= -f2` 
histo=`sed -n /var-histo=/p $descr | cut -d= -f2` 
 
# Extract residue name 
cut -c1-9 $filename.gro | sed -n '1,2!p' | sed '$d' | sort -n -u | cut -c6-9 | sed 
's/ //g' | sed -n 1,"$last"p > aa-name.txt 
residues=`wc -l aa-name.txt | cut -d\  -f 1` 
 
# Create index-file for g_mdmat 
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28 
 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
 
62 
63 
64 
65 
66 
67 
 
 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
echo -e "del 10-20 \n \nq\n" | make_ndx -f $filename.gro -o index_contacts.ndx >> 
make_index.txt 2>&1; 
echo \[ contacts \] >> index_contacts.ndx; 
 
# Prepare the gro-file for extracting data 
sed 's/  / /g'  $filename.gro > $filename.txt 
delspace=1 
while [ $delspace -le 10 ]; do 
sed 's/  / /g'  $filename.txt > $filename.txt1 
rm -f $filename.txt 
mv $filename.txt1 $filename.txt 
delspace=`expr $delspace + 1` 
done 
 
# Extract the atom numbers of the atoms out of the modified gro-file 
lineno=`/usr/bin/wc -l contacts-atoms.txt | cut  -d\  -f 1` 
linecount=1 
while [ $linecount -le $lineno ]; do 
var1=`sed -n ''$linecount'p' contacts-atoms.txt` 
sed -n "/$var1\ /p" $filename.txt | cut -d\  -f 4 >> index_contacts_tmp1.ndx 
linecount=`expr $linecount + 1` 
done 
 
# Sort the atom numbers: necessary for g_mdmat 
sort -n index_contacts_tmp1.ndx > index_contacts_tmp2.ndx 
rm -f index_contacts_tmp1.ndx 
 
# Add the atom numbers to the index file 
cat index_contacts.ndx index_contacts_tmp2.ndx > index_contacts_.ndx 
rm -f index_contacts.ndx 
rm -f index_contacts_tmp2.ndx 
mv index_contacts_.ndx index_contacts.ndx 
 
# Resort the index-file (to GROMACS format) 
echo -e "\nq\n" | make_ndx -f $filename.gro -n index_contacts.ndx -o 
index_contacts_.ndx  >> make_index.txt 2>&1; 
rm -f index_contacts.ndx 
mv index_contacts_.ndx index_contacts.ndx 
rm -f make_index.txt 
 
# g_mdmat 
echo 10 | g_mdmat -f $filename.xtc -s $filename.tpr -frames all.xpm -mean 
dm_all.xpm -n index_contacts.ndx -dt $timestep -t 1.0 -nlevels 51 -e $duration >> 
g_mdmat-result_all.txt 2>&1 
 
# Reduction of the output-file to important lines 
sed -e '/yyy/!d' all.xpm > all_reorder.txt 
sed -e 's/,//g' all_reorder.txt > all_reorder_.txt 
rm -f all_reorder.txt 
sed -e 's/"//g' all_reorder_.txt > all_reorder.txt 
rm -f all_reorder_.txt 
 
# Number of lines of the modified output file of g_mdmat 
var2=`/usr/bin/wc -l all_reorder.txt | cut  -d\  -f 1` 
 
# File size of the modified output file of g_mdmat 
bytes=`wc -c all_reorder.txt | cut -d\  -f 1` 
 
# Determine number of frames and number of amino acids: input to C-program 
frames=`sed -n /t=/p all.xpm | wc -l` 
reshydr=`expr $var2 / $frames` 
 
cat aa-name.txt all_reorder.txt > input.txt 
 
./gro_contacts-calc $bytes $frames $reshydr $residues $cutoff < input.txt > $sim-
contacts.txt 
cut -f 1-3 $sim-contacts.txt > $sim-contacts_sum.txt 
 
rm -f aa-name.txt 
rm -f all.xpm 
rm -f dm_all.xpm 
rm -f g_mdmat-result_all.txt 
rm -f all_reorder.txt 
rm -f input.txt 
rm -f index_contacts.ndx 
rm -f gro_contacts-calc 
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9.4.4 C program gro_contacts-calc.c 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
#include <stdio.h> 
#include <stdlib.h> 
#include <string.h> 
 
// Compile with: 
// gcc gro_contacts-calc.c -o gro_contacts-calc 
 
// Number of residues which are defined by the AAcode in this program 
#define no_def_res 39  
 
int main(int argc, char *argv[]) { 
 
int bytes, frames, reshydr, residues, cutoff; 
 
// With parameters in the shell script the following variables are defined 
bytes = strtol(argv[1], NULL, 10); 
frames = strtol(argv[2], NULL, 10); 
reshydr = strtol(argv[3], NULL, 10); 
residues = strtol(argv[4], NULL, 10); 
cutoff = strtol(argv[5], NULL, 10); 
 
 
int a,b,c,i,j,r,s,cmp,amount,count,far,aa1,aa2,aa1temp,aa2temp,aa1print,aa2print; 
float d; 
char *array; 
char aatmp[frames]; 
float aares[frames]; 
float y = ((float) cutoff)/1000; 
 
// In matrixres the amino acid sequence is stored 
char matrixres1[residues][5]; 
// Initialize matrixres with NULL 
for (i=0; i<residues; i++) {for (j=0; j<5; j++) matrixres1[i][j]=0;} 
 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[residues]; 
 
// In matrixres2 the amino acid sequence with hydrophobic atoms as integer code is 
// saved 
int matrixres2[residues]; 
 
 
// Memory for array 
array = calloc(bytes,sizeof(char)); 
if(NULL == array) 
{ 
printf("NO RAM!"); 
return EXIT_FAILURE; 
} 
 
 
char AAname[no_def_res][5]={  
            {'A','C','E'}, // 0 
            {'N','H','2'}, // 1 
            {'A','L','A'}, // 2 
            {'A','R','G'}, // 3 
            {'A','R','G','N'}, // 4 
            {'A','S','N'}, // 5 
            {'A','S','N','1'}, // 6 
            {'A','S','P'}, // 7 
            {'A','S','P','H'}, // 8 
            {'C','Y','S'}, // 9 
            {'C','Y','S','H'}, // 10 
            {'C','Y','S','1'}, // 11 
            {'C','Y','S','2'}, // 12 
            {'G','L','N'}, // 13 
            {'G','L','U'}, // 14 
            {'G','L','U','H'}, // 15 
            {'G','L','Y'}, // 16 
            {'H','I','S','A'}, // 17 
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71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
            {'H','I','S','B'}, // 18 
            {'H','I','S','H'}, // 19 
            {'H','I','S','1'}, // 20 
            {'H','I','S','2'}, // 21 
            {'I','L','E'}, // 22 
            {'L','E','U'}, // 23 
            {'L','Y','S'}, // 24 
            {'L','Y','S','H'}, // 25 
            {'M','E','T'}, // 26 
            {'P','H','E'}, // 27 
            {'P','R','O'}, // 28 
            {'S','E','R'}, // 29 
            {'T','H','R'}, // 30 
            {'T','R','P'}, // 31 
            {'T','Y','R'}, // 32 
            {'V','A','L'}, // 33 
            {'D','P','P','C'}, // 34 
            {'S','O','L'}, // 35 
            {'S','O','L','c'}, // 36 
            {'C','L','-'}, // 37 
            {'H','A','H'} // 38 
            }; 
 
// 0: no hydrophobic atom; 1: hydrophobic atom in residue (sequence according to 
// AAname) 
int AAcode[no_def_res]= 
{0,0,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,1}; 
 
// Read amino acid sequence 
for(i=0; i<residues; i++) 
{ 
for(j=0; ; j++) 
{ 
scanf("%c", &matrixres1[i][j]); 
if(matrixres1[i][j]=='\n'){matrixres1[i][j]=0; break;} 
} 
} 
 
// Convert amino acids to numbers 
for(i=0; i<residues; i++) 
{ 
for(j=0;j<no_def_res;j++) 
{ 
if((cmp=strcmp(matrixres1[i], AAname[j]))==0) {arrayres[i]=j; break;} 
} 
} 
 
// Create the sequence of residues with hydrophobic atoms 
for(i=0, a=0; i<residues; i++) 
{ 
j=arrayres[i]; 
if(AAcode[j]==1) {matrixres2[a]=i+1; a++;} 
} 
 
// Read g_mdmat data 
for(i=0; i<bytes; i++) 
scanf("%c", &array[i]); 
 
// Header for output 
printf("aa1\taa2\tcontacts<cutoff\tcontacts>2.0 nm\t"); 
for(i=0;i<frames; i++) printf("%d\t", i*10); 
printf("\n"); 
 
 
// Analyze 
for(aa1=(reshydr-1),s=1;aa1>0;aa1--,s++) 
{ 
 
for(aa2=s; aa2<reshydr; aa2++) 
{ 
     
    for(i=(reshydr+1)*aa1+aa2, c=0; c<frames; c++, i+=((reshydr+1)*reshydr)) 
    {aatmp[c]=array[i];} 
 
    count=0; 
    for(b=0;b<frames;b++) 
280 9.5 Structure validation of MD simulations: gro_validation 
146 
147 
 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
 
175 
 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
    { 
    if( ((aatmp[b]>64 && aatmp[b]<91) || (aatmp[b]>96 && aatmp[b]<122)) && 
aatmp[b]<(cutoff/10/2)+65 ) count++; 
    } 
 
 
 
    if(count>0) 
    { 
    far=0; 
    for(r=0; r<frames; r++) 
    { 
        for(a = 65; a < 91; a++) 
            { 
            if (aatmp[r] == a)  
            {d = (a-64)*0.02; aares[r]=d;} 
        } 
        for(a = 97; a < 121; a++) 
        { 
            if (aatmp[r] == a)  
                {d = (a-70)*0.02; aares[r]=d;} 
        } 
        if (aatmp[r] == 121)  
            {d = 2.0; aares[r]=d;far++;}  
    } 
 
     
    aa1print=reshydr-aa1-1; 
    aa2print=aa2; 
 if(aa1print>aa2print) {aa1temp=aa2print; aa2temp=aa1print;} else 
{aa1temp=aa1print; aa2temp=aa2print;} 
 printf("%d\t%d\t%.4f\t%.4f\t", matrixres2[aa1temp], matrixres2[aa2temp], 
count*1.0/frames, far*1.0/frames); 
    for(r=0; r<frames; r++) 
    printf("%.2f\t", aares[r]); 
    printf("\n"); 
    } 
} 
} 
 
free(array); 
 
return EXIT_SUCCESS; 
 
} 
 
 
9.5 Structure validation of MD simulations: gro_validation 
9.5.1 Parameter file gro_validation-para.txt 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
# PLEASE ENTER: name of the simulation 
var-sim=inact-md1-2 
 
# PLEASE ENTER: name of the gro file (also xtc and tpr files must have this  
# name; otherwise change respective lines in gro_validation.sh) 
var-filename=../../hH2R_inactive_2VT4_md1_2 
 
# PLEASE ENTER: duration of the simulation in picoseconds 
var-duration=80000 
 
# PLEASE ENTER: time step for analysis 
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12 
13 
14 
15 
16 
17 
18 
19 
var-timestep=10 
 
# PLEASE ENTER: the residue number in the gro file of the FIRST amino acid to  
# analyze 
var-first=1 
 
# PLEASE ENTER: the number of the LAST amino acid to analyze 
var-last=292 
 
 
9.5.2 Shell script gro_validation.sh 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
#!/bin/bash 
 
################################################################################## 
### Content: 
#   Chirality check of amino acids 
#   Check for planarity of aromatic side chains and of polar amino acid side  
#      chains containing a delocalized pi-electron system 
#   Check peptide dihedral angle (peptide bond) for planarity 
#   Compare the side chain rotamers with experimental values of Lovell et al.  
#      (2000) 
#   Make a ramachandran analysis using the data provided by Lovell et al. (2000) 
 
### Reference files (folder: reference) 
#   chirality-dihedral.txt -> contains a list of amino acid atoms which were used  
#      to calculate the dihedral angle at C-alpha atoms to check for proper  
#      chirality 
#   impropers.txt -> contains a list of amino acid atoms to calculate the dihedral  
#      angles for the planarity check 
#   dihedrals.txt -> contains a list of amino acid atoms defining the dihedral  
#      angles of the side chain rotamers 
#   lovell-rotamer.data -> reordered reference data for rotamer analysis  
#      from Lovell et al. (2000) 
#   lovell-rama.data -> reordered reference data for ramachandran analysis from  
#      Lovell et al. (2000) 
 
 
################################################################################## 
#### Section 1 
################################################################################## 
 
# Compilation of the C program gro_validation-calc 
gcc gro_validation-calc.c /usr/lib64/libm.a -o gro_validation-calc 
 
# In ‘output’ all result files are stored 
mkdir output 
 
# Extract variables from parameter.txt 
descr=gro_validation-para.txt  
 
sim=`sed -n /var-sim=/p $descr | cut -d= -f2` 
filename=`sed -n /var-filename=/p $descr | cut -d= -f2` 
duration=`sed -n /var-duration=/p $descr | cut -d= -f2` 
timestep=`sed -n /var-timestep=/p $descr | cut -d= -f2` 
first=`sed -n /var-first=/p $descr | cut -d= -f2` 
last=`sed -n /var-last=/p $descr | cut -d= -f2` 
 
# Number of amino acids 
aminoacids=`expr $last - $first + 1` 
 
# Number of frames to analyze 
frames=`expr $duration / $timestep` 
lastframe=`expr $duration + 1` 
 
# Get a list of the amino acid numbering and sequence 
cut -c1-9 $filename.gro | sed -n 1,2'!'p | sort -u -n | sed -n "$first","$last"p | 
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56 
 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
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74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
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105 
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107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
cut -c 1-5 | sed 's/ \+//g' > aa-no.txt 
cut -c1-9 $filename.gro | sed -n 1,2'!'p | sort -u -n | sed -n "$first","$last"p | 
cut -c 6-9 | sed 's/ \+//g' > aa-list.txt 
 
# Generate a modified gro file 
paste -d- aa-no.txt aa-list.txt | sed -n 's/-//p' > aa-no_list.txt 
number=1 
while [ $number -le $aminoacids ]; do 
var=`sed -n ''$number'p' aa-no_list.txt` 
sed -n /[\ ^]"$var"/p  $filename.gro |  sed 's/ \+/ /g' >> gro-file-mod_.txt 
number=`expr $number + 1` 
done 
cut -d\  -f1-4 gro-file-mod_.txt > gro-file-mod.txt 
rm -f gro-file-mod_.txt 
 
 
################################################################################## 
### Section 2: Get the atom numbers for the chirality check 
################################################################################## 
 
end=`wc -l reference/chirality-dihedral.txt | cut -d\  -f 1` 
 
l1=1 
while [ $l1 -le $end ]; do 
 
var=`sed -n "$l1"p reference/chirality-dihedral.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 > atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/chirality-dihedral.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/chirality-dihedral.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/chirality-dihedral.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
 
l2=`wc -l atom-numbers_0.txt | cut -d\  -f 1` 
if [ $l2 -gt 1 ]; then 
 
step=`expr $l2 / 4` 
a1=1 
while [ $a1 -le $step ]; do 
 
a2=`expr $a1 + $step` 
a3=`expr $a1 + $step + $step` 
a4=`expr $a1 + $step + $step + $step` 
sed -n "$a1"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a2"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a3"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a4"p atom-numbers_0.txt >> atom-numbers_1.txt 
 
a1=`expr $a1 + 1` 
 
done 
 
cat atom-numbers_1.txt | tr "\n" " " > atom-numbers_2.txt 
rm -f atom-numbers_1.txt 
l3=1 
while [ $l3 -le $l2 ]; do 
 
l4=`expr $l3 + 3` 
cut -d\  -f "$l3"-"$l4" atom-numbers_2.txt >> atom-numbers_3.txt 
l3=`expr $l3 + 4` 
 
done 
 
else  
echo > noaa.txt 
fi  
 
done 
 
sort -n atom-numbers_3.txt >> atom-numbers_final-chirality.txt 
rm -f atom-numbers_0.txt 
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rm -f atom-numbers_1.txt 
rm -f atom-numbers_2.txt 
rm -f atom-numbers_3.txt 
rm -f noaa.txt 
 
 
################################################################################## 
### Section 3: Get the atom numbers for the planarity check 
################################################################################## 
 
end=`wc -l reference/impropers.txt | cut -d\  -f 1` 
l1=1 
while [ $l1 -le $end ]; do 
 
var=`sed -n "$l1"p reference/impropers.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 > atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/impropers.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/impropers.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/impropers.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
 
l2=`wc -l atom-numbers_0.txt | cut -d\  -f 1` 
if [ $l2 -gt 1 ]; then 
 
step=`expr $l2 / 4` 
a1=1 
while [ $a1 -le $step ]; do 
 
a2=`expr $a1 + $step` 
a3=`expr $a1 + $step + $step` 
a4=`expr $a1 + $step + $step + $step` 
sed -n "$a1"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a2"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a3"p atom-numbers_0.txt >> atom-numbers_1.txt 
sed -n "$a4"p atom-numbers_0.txt >> atom-numbers_1.txt 
 
a1=`expr $a1 + 1` 
done 
 
cat atom-numbers_1.txt | tr "\n" " " > atom-numbers_2.txt 
rm -f atom-numbers_1.txt 
l3=1 
while [ $l3 -le $l2 ]; do 
 
l4=`expr $l3 + 3` 
cut -d\  -f "$l3"-"$l4" atom-numbers_2.txt >> atom-numbers_3.txt 
l3=`expr $l3 + 4` 
 
done 
 
else  
echo > noaa.txt 
fi  
 
done 
 
sort -n atom-numbers_3.txt >> atom-numbers_final-impropers.txt 
rm -f atom-numbers_0.txt 
rm -f atom-numbers_1.txt 
rm -f atom-numbers_2.txt 
rm -f atom-numbers_3.txt 
rm -f noaa.txt 
 
 
################################################################################## 
### Section 4: Get the atom numbers for the side chain rotamers 
################################################################################## 
 
line=`wc -l reference/dihedrals.txt | cut -d\  -f 1` 
l1=2 
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while [ $l1 -le $line ]; do 
 
var=`sed -n "$l1"p reference/dihedrals.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 > atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/dihedrals.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/dihedrals.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
var=`sed -n "$l1"p reference/dihedrals.txt` 
sed -n /"$var"\ /p gro-file-mod.txt | cut -d\  -f 4 >> atom-numbers_0.txt 
l1=`expr $l1 + 1` 
 
sort -n atom-numbers_0.txt > atom-numbers_1.txt 
end=`wc -l atom-numbers_1.txt | cut -d\  -f 1` 
cat atom-numbers_1.txt | tr "\n" " " > atom-numbers_2.txt 
l2=1 
while [ $l2 -le $end ]; do 
 
l3=`expr $l2 + 3` 
cut -d\  -f "$l2"-"$l3" atom-numbers_2.txt >> atom-numbers_3.txt 
l2=`expr $l2 + 4` 
 
done 
 
done 
 
sort -n atom-numbers_3.txt >> atom-numbers_final-rotamer.txt 
rm -f atom-numbers_0.txt 
rm -f atom-numbers_1.txt 
rm -f atom-numbers_2.txt 
rm -f atom-numbers_3.txt 
 
 
################################################################################## 
### Section 5: Measure dihedrals for chirality, planarity and rotamers 
################################################################################## 
 
echo \[ dihedrals \] > atom-numbers_final-chirality-planarity-rotamer.ndx 
cat atom-numbers_final-chirality.txt atom-numbers_final-impropers.txt atom-
numbers_final-rotamer.txt >> atom-numbers_final-chirality-planarity-rotamer.ndx 
 
# Measure all dihedrals in protein side chain 
g_angle -f $filename.xtc -b 1 -e $lastframe -dt $timestep -all -n atom-
numbers_final-chirality-planarity-rotamer.ndx -type dihedral -od $sim-dihedrals-
angdist.xvg -ov $sim-dihedrals-angaver.xvg > g_angle-result.txt 2>&1 
 
# Extract important columns from the output of g_angle 
sed -n '/[\#@]/!p' $sim-dihedrals-angaver.xvg | sed 's/^ \+//g' | sed 's/ \+/ /g' 
| cut -d\  -f 3- > $sim-dihedrals-angaver-imp.txt 
 
 
################################################################################## 
### Section 6: Chirality check 
################################################################################## 
 
beg=1 
end=`wc -l atom-numbers_final-chirality.txt | cut -d\  -f 1` 
cut -d\  -f $beg-$end $sim-dihedrals-angaver-imp.txt > $sim-chirality-protein-
angaver-imp.txt 
# Generate input file from aa-no, aa-list and measured angles 
cat aa-no.txt aa-list.txt $sim-chirality-protein-angaver-imp.txt > input-
chirality.txt 
# Number of impropers 
intangles=`wc -l atom-numbers_final-chirality.txt | cut -d\  -f 1` 
 
./gro_validation-calc 1 $aminoacids $frames $intangles 0 0 < input-chirality.txt > 
output/$sim-chirality.txt 
 
 
################################################################################## 
### Section 7: Planarity check 
################################################################################## 
 
 Chapter 9: Appendix 285 
275 
276 
277 
278 
279 
 
280 
281 
 
282 
283 
284 
285 
286 
 
287 
288 
289 
290 
291 
292 
293 
294 
295 
296 
297 
298 
 
299 
300 
301 
302 
 
303 
304 
305 
306 
307 
308 
309 
310 
311 
312 
313 
314 
315 
316 
 
317 
 
318 
319 
320 
321 
322 
323 
324 
325 
326 
327 
328 
329 
330 
331 
 
332 
333 
 
334 
335 
336 
337 
338 
339 
 
340 
beg=`expr $end + 1` 
end=`wc -l atom-numbers_final-impropers.txt | cut -d\  -f 1` 
end=`expr $beg + $end` 
end=`expr $end - 1` 
cut -d\  -f $beg-$end $sim-dihedrals-angaver-imp.txt > $sim-impropers-protein-
angaver-imp.txt 
# Generate input file from aa-no, aa-list and measured angles 
cat aa-no.txt aa-list.txt $sim-impropers-protein-angaver-imp.txt > input-
planarity.txt 
# Number of impropers in protein side chain 
intangles=`wc -l atom-numbers_final-impropers.txt | cut -d\  -f 1` 
# Complete output with all single impropers (mean, SD, and values within 2*SD  
# interval, histogram) incl. residue based mean and histogram 
./gro_validation-calc 2 $aminoacids $frames $intangles 0 0 < input-planarity.txt > 
output/$sim-planarity.txt 
 
 
################################################################################## 
### Section 8: Check peptide dihedral angle 
################################################################################## 
 
# In g_chi the output files of g_chi are stored; in resid the modified files 
mkdir g_chi-omega 
mkdir resid-omega 
 
cd g_chi-omega 
g_chi -f ../$filename.xtc -s ../$filename.tpr -omega -all -dt $timestep -b 0 -e 
$lastframe >> ../g_chi.txt 2>&1 
cd .. 
 
# List of aa without ACE and NH2 
paste -d- aa-list.txt aa-no.txt | sed -n /ACE/'!'p | sed -n /NH2/'!'p > aa-
no_list-omega.txt 
aminoacidsomega=`wc -l aa-no_list-omega.txt | cut -d\  -f 1` 
 
cut -d- -f 1 aa-no_list-omega.txt > omega-aa-list.txt 
cut -d- -f 2 aa-no_list-omega.txt > omega-aa-no.txt 
 
# Print header 
./gro_validation-calc 3 1 $frames 0 0 0 > output/$sim-omega.txt 
 
number=1 
while [ $number -le $aminoacidsomega ]; do 
 
no=`sed -n ''$number'p' omega-aa-no.txt` 
aa=`sed -n ''$number'p' omega-aa-list.txt` 
sed '/[#@]/d' g_chi-omega/omega$aa$no.xvg | cut -c13- | sed 's/ *//g' | sed -n 
1'!'p > resid-omega/resid$no.txt 
./gro_validation-calc 3 $no $frames 0 1 0 < resid-omega/resid$no.txt >> 
output/$sim-omega.txt 
 
number=`expr $number + 1` 
done 
 
 
################################################################################## 
### Section 9: Compare the rotamers with experimental values 
################################################################################## 
 
beg=`expr $end + 1` 
end=`wc -l atom-numbers_final-rotamer.txt | cut -d\  -f 1` 
end=`expr $beg + $end` 
end=`expr $end - 1` 
cut -d\  -f $beg-$end $sim-dihedrals-angaver-imp.txt > $sim-dihedrals-protein-
angaver-imp.txt 
# Generate input file from aa-no, aa-list, reference angles and measured angles 
cat aa-no.txt aa-list.txt reference/lovell-rotamer.data $sim-dihedrals-protein-
angaver-imp.txt > input-rotamer.txt 
# Number of reference dihedrals 
reflines=`wc -l reference/lovell-rotamer.data | cut -d\  -f 1` 
# Number of dihedrals in protein side chain 
intangles=`wc -l atom-numbers_final-rotamer.txt | cut -d\  -f 1` 
# Rotamer location (favored, allowed, disallowed) for every amino acid 
./gro_validation-calc 4 $aminoacids $frames $intangles 1 $reflines < input-
rotamer.txt > output/$sim-rotamer-regions.txt 
# Matrices for generating a surface graph (Residues with one and two rotamers;  
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# more than 2 rotamers: only chi1 and chi2) 
./gro_validation-calc 4 $aminoacids $frames $intangles 2 $reflines < input-
rotamer.txt > output/$sim-rotamer-graph.txt 
# Time resolution of side chain rotamers 
./gro_validation-calc 4 $aminoacids $frames $intangles 3 $reflines < input-
rotamer.txt > output/$sim-rotamer-time.txt 
 
 
################################################################################## 
### Section 10: Backbone phi/psi dihedrals: ramachandran plot 
################################################################################## 
 
# g_rama 
g_rama -f $filename.xtc -s $filename.tpr -o phi-psi.xvg -b 1 -dt $timestep -e 
$lastframe >> rama-result.txt 2>&1 
 
sed -e '/[#@]/d' phi-psi.xvg > phi-psi_header.txt 
sed -n 's/  / /pg' phi-psi_header.txt > phi-psi_space.txt 
 
# Number the lines of the file 
nl phi-psi_space.txt | sed -n 's/\t/ /p' > phi-psi_space_no.txt 
 
# List of aa without ACE and NH2 
paste -d- aa-list.txt aa-no.txt | sed -n /ACE/'!'p | sed -n /NH2/'!'p > aa-
no_list-rama.txt 
aminoacidsrama=`wc -l aa-no_list-rama.txt | cut -d\  -f 1` 
 
# Extract the right angles of the complete xvg-file 
number=1 
while [ $number -le $aminoacidsrama ]; do 
var=`sed -n "$number"p aa-no_list-rama.txt` 
sed -n /"$var"$/p phi-psi_space_no.txt >> phi-psi_.txt 
number=`expr $number + 1` 
done 
 
# Reduce the output of g_rama to couple of phi/psi values 
sed 's/^[ ]\+//p' phi-psi_.txt | sort -n -u -t\  -k 1,1 | cut -d\  -f 2,3 > phi-
psi_in.txt 
 
intangle=`wc -l phi-psi_in.txt | cut -d\  -f 1` 
 
cut -d- -f 1 aa-no_list-rama.txt > rama-aa-list.txt 
cut -d- -f 2 aa-no_list-rama.txt > rama-aa-no.txt 
 
# Combine the sequence, reference data, and the measured phi/psi values to one  
# file 
cat rama-aa-no.txt rama-aa-list.txt reference/lovell-rama.data phi-psi_in.txt > 
rama-input.txt 
 
reflines=`wc -l reference/lovell-rama.data | cut -d\  -f 1` 
 
# Ramachandran values for every amino acid 
./gro_validation-calc 5 $aminoacidsrama $frames $intangle 1 $reflines < rama-
input.txt > output/$sim-rama-regions.txt 
# List of phi and psi values, tab-separated 
./gro_validation-calc 5 $aminoacidsrama $frames $intangle 2 $reflines < rama-
input.txt > output/$sim-rama-data.txt 
# 180x180 matrix for generating a surface graph 
./gro_validation-calc 5 $aminoacidsrama $frames $intangle 3 $reflines < rama-
input.txt > output/$sim-rama-graph.txt 
# Time resolution of ramachandran values 
./gro_validation-calc 5 $aminoacidsrama $frames $intangle 4 $reflines < rama-
input.txt > output/$sim-rama-time.txt 
 
 
################################################################################## 
### Clean directory 
 
rm -f aa-no.txt 
rm -f aa-no_list.txt 
rm -f aa-list.txt 
rm -f gro-file-mod.txt 
rm -f g_angle-result.txt 
rm -f omega-aa-no.txt 
rm -f omega-aa-list.txt 
rm -f g_chi.txt 
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rm -rf g_chi-omega 
rm -f aa-no_list-omega.txt 
rm -rf resid-omega 
rm -f rama-result.txt    
rm -f phi-psi_space_no.txt  
rm -f aa-no_list-rama.txt 
rm -f phi-psi_.txt 
rm -f rama-aa-no.txt 
rm -f rama-aa-list.txt 
rm -f phi-psi_in.txt 
rm -f rama-input.txt 
rm -f atom-numbers_final-chirality.txt  
rm -f atom-numbers_final-impropers.txt  
rm -f atom-numbers_final-rotamer.txt 
rm -f atom-numbers_final-chirality-planarity-rotamer.ndx 
rm -f input-chirality.txt 
rm -f input-planarity.txt 
rm -f input-rotamer.txt 
rm -f $sim-dihedrals-angdist.xvg  
rm -f $sim-dihedrals-angaver.xvg 
rm -f $sim-chirality-protein-angaver-imp.txt 
rm -f $sim-impropers-protein-angaver-imp.txt 
rm -f $sim-dihedrals-protein-angaver-imp.txt 
rm -f $sim-dihedrals-angaver-imp.txt 
rm -f CA.txt 
rm -f phi-psi.xvg 
rm -f phi-psi_header.txt 
rm -f phi-psi_space.txt 
rm -f gro_dihedrals 
rm -f gro_validation-calc 
 
 
9.5.3 C program gro_validation-calc.c 
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10 
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#include <stdio.h> 
#include <stdlib.h> 
#include <string.h> 
#include <math.h>  
 
// Compile with: 
// gcc gro_validation-calc.c /usr/lib64/libm.a –o gro_validation-calc 
 
// Definition of constants 
// Number of residues which are defined by the variable AAcode in this program 
#define no_def_res 34 
// Number of bars in histogram for chirality (even number) 
#define histono_chir 52 
// Width of the bars for chirality 
#define z_chir 1 
// Mean dihedral angle for chirality 
#define imprref 35 
// Number of bars in histogram for planarity check (even number) 
#define histono_imp 32 
// Width of the bars for planarity 
#define z_imp 2 
// Number of bars in histogram for peptide dihedral angle distribution (even  
// number) 
#define histono_omega 34 
// Width of the bars for peptide bond 
#define z_omega 5 
 
int main(int argc, char *argv[]) { 
 
int angtype, aminoacids, frames, intangles, selection, reflines; 
 
// With parameters in the shell script the following variables are defined  
angtype = strtol(argv[1], NULL, 10); 
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aminoacids = strtol(argv[2], NULL, 10); 
frames = strtol(argv[3], NULL, 10); 
intangles = strtol(argv[4], NULL, 10); 
selection = strtol(argv[5], NULL, 10); 
reflines = strtol(argv[6], NULL, 10); 
int datsize;  
datsize=frames*intangles; 
 
// In AAname the amino acid name is stored and compared to the amino acid sequence  
// which is read in; all listed standard amino acids of GROMACS (ffG53a6.rtp) are  
// included, incl. ACE and NH2, except HYP (hydroxyproline) 
 
char AAname[no_def_res][5]= 
            {    
            {'A','C','E'}, // 0 
            {'N','H','2'}, // 1 
            {'A','L','A'}, // 2 
            {'A','R','G'}, // 3 
            {'A','R','G','N'}, // 4 
            {'A','S','N'}, // 5 
            {'A','S','N','1'}, // 6 
            {'A','S','P'}, // 7 
            {'A','S','P','H'}, // 8 
            {'C','Y','S'}, // 9 
            {'C','Y','S','H'}, // 10 
            {'C','Y','S','1'}, // 11 
            {'C','Y','S','2'}, // 12 
            {'G','L','N'}, // 13 
            {'G','L','U'}, // 14 
            {'G','L','U','H'}, // 15 
            {'G','L','Y'}, // 16 
            {'H','I','S','A'}, // 17 
            {'H','I','S','B'}, // 18 
            {'H','I','S','H'}, // 19 
            {'H','I','S','1'}, // 20 
            {'H','I','S','2'}, // 21 
            {'I','L','E'}, // 22 
            {'L','E','U'}, // 23 
            {'L','Y','S'}, // 24 
            {'L','Y','S','H'}, // 25 
            {'M','E','T'}, // 26 
            {'P','H','E'}, // 27 
            {'P','R','O'}, // 28 
            {'S','E','R'}, // 29 
            {'T','H','R'}, // 30 
            {'T','R','P'}, // 31 
            {'T','Y','R'}, // 32 
            {'V','A','L'} // 33 
            }; 
 
////////////////////////////////////////////////////////////////////////////////// 
// Chirality check: needs angtype, aminoacids, datsize (-> frames, intangles) 
////////////////////////////////////////////////////////////////////////////////// 
 
if(angtype==1) 
{ 
 
int a,d,i,j,k,x,y; 
int cmp;  
int SD2spann; 
int check; 
float ang; 
float mean; 
float SD; 
float histofl[histono_chir]; 
float checkfl; 
 
// In matrixres the amino acid sequence is stored 
char matrixres[aminoacids][5]; 
// Initialize matrixres with NULL 
for (i=0; i<aminoacids; i++)  
{   for (j=0; j<5; j++) 
    matrixres[i][j]=0; 
} 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[aminoacids]; 
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// In matrixno the amino acid numbers are stored 
int matrixno[aminoacids]; 
// Each amino with a chiral center at the C-alpha atom contains one 
int AAcode[no_def_res][1]= 
            { 
            {0}, // 0 
            {0}, // 1 
            {1}, // 2 
            {1}, // 3 
            {1}, // 4 
            {1}, // 5 
            {1}, // 6 
            {1}, // 7 
            {1}, // 8 
            {1}, // 9 
            {1}, // 10 
            {1}, // 11 
            {1}, // 12 
            {1}, // 13 
            {1}, // 14 
            {1}, // 15 
            {0}, // 16 
            {1}, // 17 
            {1}, // 18 
            {1}, // 19 
            {1}, // 20 
            {1}, // 21 
            {1}, // 22 
            {1}, // 23 
            {1}, // 24 
            {1}, // 25 
            {1}, // 26 
            {1}, // 27 
            {1}, // 28 
            {1}, // 29 
            {1}, // 30 
            {1}, // 31 
            {1}, // 32 
            {1} // 33 
            }; 
 
// In dihedraldata the angle data is stored 
float *dihedraldata = malloc((datsize) * sizeof(float)); 
if(dihedraldata == NULL) 
{   printf("NO RAM\n"); 
    return EXIT_FAILURE; 
} 
 
// Read amino acid numbers 
for(i=0; i<aminoacids; i++)  
scanf("%d", &matrixno[i]); 
 
// Read amino acid sequence 
scanf("%c", &matrixres[0][0]); 
for(i=0; i<aminoacids; i++) 
{   for(j=0; ; j++) 
    {   scanf("%c", &matrixres[i][j]); 
        if(matrixres[i][j]=='\n') 
        {   matrixres[i][j]=0; 
            break; 
        } 
    } 
} 
 
// Convert amino acid sequence to numbers 
for(i=0; i<aminoacids; i++) 
{   for(j=0;j<no_def_res;j++) 
    {   if((cmp=strcmp(matrixres[i], AAname[j]))==0)     
        {   arrayres[i]=j; 
            break; 
        } 
    } 
} 
 
// Read the measured dihedrals 
for(i=0; i<datsize; i++)  
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scanf("%f", &dihedraldata[i]); 
 
// Print header for histogram 
printf("AS-no\tAS\tmean\tSD\tchiralityOK\t"); 
printf("<%.1f\t", imprref-(1.0)*((histono_chir-2)/2)*z_chir); 
for(y=0, ang=imprref-(1.0)*((histono_chir-2)/2)*z_chir; y<histono_chir-2; y++, 
ang+=z_chir) 
printf("%.1f-%.1f\t", ang, ang+z_chir); 
printf(">%.1f\n", imprref+((histono_chir-2.0)/2)*z_chir); 
 
// Calculate dihedral angles 
for(i=0; i<aminoacids ; i++) 
{ 
 
mean=0.0; 
SD=0.0; 
 
// Determine the starting point of the measured angles 
k=0; 
for(d=0;d<i;d++)  
{   a=arrayres[d]; 
    k+=AAcode[a][0]; 
} 
a=arrayres[i]; 
 
if(AAcode[a][0]>0) 
{ 
 
check=0; 
for(d=0;d<histono_chir;d++)  
histofl[d]=0.0; 
 
// Calculate mean, histogram and perform chirality-check 
x=k; 
for(d=0;d<frames; d++, x+=intangles) 
{   mean+=dihedraldata[x]; 
    for(y=0, ang=imprref-(1.0)*((histono_chir-2)/2)*z_chir; y<histono_chir-2; y++, 
ang+=z_chir) 
    {   if(dihedraldata[x]>=ang && dihedraldata[x]<ang+z_chir) 
        histofl[y+1]+=1.0/frames; 
    } 
    if(dihedraldata[x]<imprref-(1.0)*((histono_chir-2)/2)*z_chir) 
    histofl[0]+=1.0/frames; 
    if(dihedraldata[x]>=imprref+((histono_chir-2)/2)*z_chir) 
    histofl[histono_chir-1]+=1.0/frames; 
    if(dihedraldata[x] <0 || dihedraldata[x] > 70) 
    check++;  
// 0 and 70: +-35 degree of the reference of 35 degree 
} 
 
mean/=frames; 
checkfl=(float)check/(float)frames; 
 
// Calculate standard deviation SD 
x=k; 
for(d=0; d<frames; d++, x+=intangles)  
SD+=(dihedraldata[x]-mean)*(dihedraldata[x]-mean); 
 
SD=sqrt(SD/(frames-1)); 
 
// Calculate fraction of values within 2*SD 
x=k; 
SD2spann=0; 
for(d=0; d<frames; d++, x+=intangles) 
{   if(dihedraldata[x]>(mean-2*SD) && dihedraldata[x]<(mean+2*SD))  
    SD2spann++; 
} 
printf("%d\t%s\t\%.3f\t%.3f\t%.3f\t", matrixno[i], matrixres[i], mean, SD, 1.0-
checkfl); 
for(d=0; d<histono_chir; d++) printf("%.3f\t", histofl[d]); 
printf("\n"); 
} 
} 
 
// Free memory 
free(dihedraldata); 
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} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Check for planarity: needs angtype, aminoacids, datsize (-> frames, intangles) 
////////////////////////////////////////////////////////////////////////////////// 
 
if(angtype==2) 
{ 
 
int a,d,i,j,k,x,y; 
int cmp;  
float ang; 
float meansum; 
float SDsum; 
float SD2spannsum; 
int SD2spann[20]; // Max 20 impropers per residue (TRP) 
float mean[20]; 
float SD[20]; 
float histofl[20][histono_imp]; 
float histoflsum[histono_imp]; 
 
// In matrixres the amino acid sequence is stored 
char matrixres[aminoacids][5]; 
// Initialize matrixres with NULL 
for (i=0; i<aminoacids; i++) 
{   for (j=0; j<5; j++) 
    matrixres[i][j]=0; 
} 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[aminoacids]; 
// In matrixno the amino acid numbers are stored 
int matrixno[aminoacids]; 
// In AAcode for each residue the amount of dihedral angles used for the planarity 
// control is stored 
int AAcode[no_def_res][1]= 
            { 
            {0}, // 0 
            {0}, // 1 
            {0}, // 2 
            {4}, // 3 
            {3}, // 4 
            {2}, // 5 
            {2}, // 6 
            {1}, // 7 
            {1}, // 8 
            {0}, // 9 
            {0}, // 10 
            {0}, // 11 
            {0}, // 12 
            {2}, // 13 
            {1}, // 14 
            {1}, // 15 
            {0}, // 16 
            {9}, // 17 
            {9}, // 18 
            {10}, // 19 
            {9}, // 20 
            {9}, // 21 
            {0}, // 22 
            {0}, // 23 
            {0}, // 24 
            {0}, // 25 
            {0}, // 26 
            {12}, // 27 
            {0}, // 28 
            {0}, // 29 
            {0}, // 30 
            {20}, // 31 
            {12}, // 32 
            {0} // 33 
            }; 
 
// In dihedraldata the angle data is stored 
float *dihedraldata = malloc((datsize) * sizeof(float)); 
if(dihedraldata == NULL) 
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{   printf("NO RAM\n"); 
    return EXIT_FAILURE; 
} 
 
// Read amino acid numbers 
for(i=0; i<aminoacids; i++) 
scanf("%d", &matrixno[i]); 
 
// Read amino acid sequence 
scanf("%c", &matrixres[0][0]);  
for(i=0; i<aminoacids; i++) 
{   for(j=0; ; j++) 
    {   scanf("%c", &matrixres[i][j]); 
        if(matrixres[i][j]=='\n'){matrixres[i][j]=0; break;} 
    } 
} 
 
// Convert amino acid sequence to numbers 
for(i=0; i<aminoacids; i++) 
{   for(j=0;j<no_def_res;j++) 
        {   if((cmp=strcmp(matrixres[i], AAname[j]))==0) 
            {   arrayres[i]=j; 
                break; 
            } 
        } 
} 
 
// Read the measured dihedrals 
for(i=0; i<datsize; i++) 
scanf("%f", &dihedraldata[i]); 
 
// Print header for histogram 
printf("AS-no\tAS\tmean-sum\tSD-sum\t2SD-interval\t"); 
printf("<%.1f\t", (-1.0)*((histono_imp-2)/2)*z_imp); 
for(y=0, ang=(-1)*((histono_imp-2)/2)*z_imp; y<histono_imp-2; y++, ang+=z_imp) 
printf("%.1f-%.1f\t", ang, ang+z_imp); 
printf(">%.1f\n", ((histono_imp-2.0)/2)*z_imp); 
 
// Calculate impropers 
for(i=0; i<aminoacids ; i++) 
{ 
 
for(j=0; j<20; j++) 
{   mean[j]=0.0; 
    SD[j]=0.0; 
} 
 
// Determine the starting point of the measured angles 
k=0; 
for(d=0;d<i;d++)  
{   a=arrayres[d]; 
    k+=AAcode[a][0]; 
} 
 
a=arrayres[i]; 
 
if(AAcode[a][0]>0) 
{ 
 
for(j=0; j<20; j++) 
{   for(d=0;d<histono_imp;d++)  
    histofl[j][d]=0.0; 
} 
 
for(d=0; d<histono_imp; d++) 
histoflsum[d]=0.0; 
for(j=0; j<AAcode[a][0]; j++, k++) 
{ 
 
// Calculate mean and histogram 
x=k; 
for(d=0;d<frames; d++, x+=intangles) 
{   mean[j]+=dihedraldata[x]; 
    for(y=0, ang=(-1)*((histono_imp-2)/2)*z_imp; y<histono_imp-2; y++, ang+=z_imp) 
    {   if(dihedraldata[x]>=ang && dihedraldata[x]<ang+z_imp) 
        histofl[j][y+1]+=1.0/frames; 
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    } 
    if(dihedraldata[x]<(-1)*((histono_imp-2)/2)*z_imp) 
    histofl[j][0]+=1.0/frames; 
    if(dihedraldata[x]>=((histono_imp-2)/2)*z_imp) 
    histofl[j][histono_imp-1]+=1.0/frames; 
} 
mean[j]/=frames; 
 
// Calculate SD 
x=k; 
for(d=0; d<frames; d++, x+=intangles) 
SD[j]+=(dihedraldata[x]-mean[j])*(dihedraldata[x]-mean[j]); 
 
SD[j]=sqrt(SD[j]/(frames-1)); 
 
// Calculate fraction of values within 2*SD 
x=k; 
SD2spann[j]=0; 
for(d=0; d<frames; d++, x+=intangles) 
{   if(dihedraldata[x]>(mean[j]-2*SD[j]) && dihedraldata[x]<(mean[j]+2*SD[j])) 
    SD2spann[j]++; 
} 
} 
 
for(d=0;d<histono_imp;d++) 
{   for(j=0; j<AAcode[a][0]; j++)  
    histoflsum[d]+=histofl[j][d]; 
    histoflsum[d]/=AAcode[a][0]; 
} 
 
meansum=0.0; 
for(j=0; j<AAcode[a][0]; j++)  
meansum+=mean[j]; 
meansum/=AAcode[a][0]; 
printf("%d\t%s\tsummary\t%.4f\t-\t-\t", matrixno[i], matrixres[i], meansum); 
for(d=0; d<histono_imp; d++)  
printf("%.4f\t", histoflsum[d]); 
printf("\n"); 
for(j=0; j<AAcode[a][0]; j++) 
{   printf("%d\t%s\t%d\t%.4f\t%.4f\t%.4f\t", matrixno[i], 
matrixres[i],j+1,mean[j],SD[j], (float)SD2spann[j]/frames); 
    for(d=0; d<histono_imp; d++) 
    printf("%.4f\t", histofl[j][d]); 
    printf("\n"); 
} 
} 
} 
 
// Free memory 
free(dihedraldata); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Calculate omega backbone angle: needs angtype, aminoacids, frames, selection 
////////////////////////////////////////////////////////////////////////////////// 
 
if(angtype==3) 
{ 
 
int i,k,y; 
float ang; 
float mean, SD, k_SD; 
float histofl[histono_omega]; 
float values[frames]; 
 
// Print header 
if(selection==0) 
{   printf("aa-no\tmean\tSD\t2SDinterval\t"); 
    printf("<%.1f\t", 180-((histono_omega-2.0)/2)*z_omega); 
    for(y=0, ang=180.0-((histono_omega-2)/2)*z_omega; y<histono_omega-2; y++, 
ang+=z_omega) 
    printf("%.1f-%.1f\t", ang, ang+z_omega); 
    printf(">%.1f\n", 180+((histono_omega-2.0)/2)*z_omega); 
} 
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if(selection==1) 
{ 
 
// Read data 
for(i=0; i<frames; i++) 
scanf("%f\n", &values[i]); 
 
// Convert data 
for(i=0; i<frames; i++)  
{   if(values[i]<0)  
    values[i]+=360.0;  
} 
 
// Calculation of the mean 
mean=0.0; 
for(i=0;i<frames;i++) 
mean+=values[i]; 
mean=mean/frames; 
 
// Standard deviation 
SD=0.0; 
for(i=0;i<frames;i++) 
SD+=(values[i]-mean)*(values[i]-mean); 
SD=sqrt(SD/(frames-1)); 
 
// Interval +- 2*SD 
k=0; 
for(i=0;i<frames;i++) 
{   if(values[i]>(mean - 2*SD) && values[i]<(mean + 2*SD)) 
    k++; 
} 
k_SD = (float) k/ (float) (frames); 
 
// Histogram 
for(i=0;i<histono_omega;i++) 
histofl[i]=0.0; 
for(i=0;i<frames;i++) 
{   for(y=0, ang=180.0-(((histono_omega-2)/2)*z_omega); y<histono_omega-2; y++, 
ang+=z_omega) 
    {   if(values[i]>=ang && values[i]<ang+z_omega) 
        histofl[y+1]+=1.0/frames; 
    } 
    if(values[i]<180.0-(((histono_omega-2)/2)*z_omega)) 
    histofl[0]+=1.0/frames; 
    if(values[i]>=180.0+((histono_omega-2)/2)*z_omega) 
    histofl[histono_omega-1]+=1.0/frames; 
} 
 
// Output 
printf("%d\t%.3f\t%.3f\t%.3f\t",aminoacids,mean,SD,k_SD); 
for(i=0;i<histono_omega;i++) 
printf("%.3f\t", histofl[i]); 
printf("\n"); 
} 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Compare side chain dihedrals with Lovell values: needs angtype, aminoacids,  
// datsize (-> frames, intangles), selection, reflines 
////////////////////////////////////////////////////////////////////////////////// 
 
if(angtype==4) 
{ 
 
// Cut-off values for favored, allowed, and disallowed 
float cutoff_mf=0.02; 
float cutoff_dis=0.002; 
 
int a,d,i,j,k,x,y,z; 
int cmp, place, tmp, mata, matb; 
float mat[360][360]; 
float ang[4]; 
int angint[4]; 
int mf, al, dis; 
float mf_f, al_f, dis_f; 
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char timeres[frames]; 
 
// In matrixres the amino acid sequence is stored 
char matrixres[aminoacids][5]; 
// Initialize matrixres with NULL 
for (i=0; i<aminoacids; i++) 
{   for (j=0; j<5; j++) 
    matrixres[i][j]=0; 
} 
// In arrayres the amino acid sequence as integer code is saved 
int arrayres[aminoacids]; 
// In matrixno the amino acid numbers are stored 
int matrixno[aminoacids]; 
// In AAcode for each amino acid the data of dihedrals is stored; Position 1:  
// number of dihedrals in the side chain; Position 2: start of the reference  
// values in the respective reference file; Position 3 and further: step size for  
// each dihedral  
int AAcode[no_def_res][18]=  
            { 
            {0}, // 0 
            {0}, // 1 
            {0}, // 2 
            {4,0,10,360,10,360,10,360,10,360}, // 3 
            {4,0,10,360,10,360,10,360,10,360}, // 4 
            {2,1679616,5,360,5,360}, // 5 
            {2,1679616,5,360,5,360}, // 6 
            {2,1684800,5,360,5,180}, // 7 
            {2,1684800,5,360,5,180}, // 8 
            {1,1687392,1,360}, // 9 
            {1,1687392,1,360}, // 10 
            {1,1687392,1,360}, // 11 
            {1,1687392,1,360}, // 12 
            {3,1687752,8,360,8,360,8,360}, // 13 
            {3,1778877,8,360,8,360,8,180}, // 14 
            {3,1778877,8,360,8,360,8,180}, // 15 
            {0}, // 16 
            {2,1825452,5,360,5,360}, // 17 
            {2,1825452,5,360,5,360}, // 18 
            {2,1825452,5,360,5,360}, // 19 
            {2,1825452,5,360,5,360}, // 20 
            {2,1825452,5,360,5,360}, // 21 
            {2,1830636,5,360,5,360}, // 22 
            {2,1835820,5,360,5,360}, // 23 
            {4,1841004,10,360,10,360,10,360,10,360}, // 24 
            {4,1841004,10,360,10,360,10,360,10,360}, // 25 
            {3,3520620,8,360,8,360,8,360}, // 26 
            {2,3611745,5,360,5,180}, // 27 
            {0}, // 28 
            {1,3614337,1,360}, // 29 
            {1,3614697,1,360}, // 30 
            {2,3615057,5,360,5,360}, // 31 
            {2,3611745,5,360,5,180}, // 32 
            {1,3620241,1,360} // 33 
            }; 
 
// In angleref the angle data is stored 
float *angleref = malloc((reflines) * sizeof(float)); 
if(angleref == NULL) 
{   printf("NO RAM\n"); 
    return EXIT_FAILURE; 
} 
 
// In dihedraldata the angle data is stored 
float *dihedraldata = malloc((datsize) * sizeof(float)); 
if(dihedraldata == NULL) 
{   printf("NO RAM\n"); 
    return EXIT_FAILURE; 
} 
 
// Read amino acid numbers 
for(i=0; i<aminoacids; i++) 
scanf("%d", &matrixno[i]); 
 
// Read amino acid sequence 
scanf("%c", &matrixres[0][0]);  
// New line character after amino acid numbers 
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for(i=0; i<aminoacids; i++) 
{   for(j=0; ; j++) 
    {   scanf("%c", &matrixres[i][j]); 
        if(matrixres[i][j]=='\n') 
        {   matrixres[i][j]=0; 
            break; 
        } 
    } 
} 
 
// Convert amino acid sequence to numbers 
for(i=0; i<aminoacids; i++) 
{   for(j=0;j<no_def_res;j++) 
    {   if((cmp=strcmp(matrixres[i], AAname[j]))==0)  
        {   arrayres[i]=j; 
            break; 
        } 
    } 
} 
 
// Read the reference data in the order: arg-asn-asp-cys-gln-glu-his-ile-leu-lys- 
// met-phetyr-ser-thr-trp-val 
for(i=0; i<reflines; i++) 
scanf("%f", &angleref[i]); 
 
// Read the measured dihedrals 
for(i=0; i<datsize; i++) 
{   scanf("%f", &dihedraldata[i]);  
    if(dihedraldata[i]<0) 
    dihedraldata[i]=360.0+dihedraldata[i]; 
} 
 
// Compare dihedrals 
for(i=0; i<aminoacids ; i++) 
{ 
 
if(selection==2) 
{   for(mata=0;mata<360;mata++)  
    {   for(matb=0;matb<360;matb++) 
        mat[mata][matb]=0.0; 
    } 
} 
 
// Determine the starting point of the measured angles 
k=0; 
for(d=0;d<i;d++)  
{   a=arrayres[d]; 
    k+=AAcode[a][0]; 
} 
a=arrayres[i]; 
 
if(AAcode[a][0]>0) 
{ 
 
mf=0; 
al=0; 
dis=0; 
x=k; 
 
for(d=0;d<frames; d++, x=x-AAcode[a][0]+intangles) 
{ 
 
place=0; mata=0; matb=0; 
// Determine the reference value (the right line) 
for(j=0, y=2 ;j<AAcode[a][0];j++, y+=2)  
{ 
 
if( (a==7 || a==8 || a==14 || a==15 || a==27 || a==32) &&  (j==(AAcode[a][0]-1)) 
&& (dihedraldata[x]>180.0))  
dihedraldata[x]-=180.0;  
// The last angle for ASP, GLU, PHE and TYR has only a range of 180 degrees in the  
// reference data 
if(selection==0) 
printf("%f\t", dihedraldata[x]); 
 
// Special treatment of GLU and GLUH 
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if(a==14 || a==15)  
{ 
 
if(selection==2) 
{   if(j==0) {mata=(int)(dihedraldata[x]/8);} 
    if(j==1) {matb=(int)(dihedraldata[x]/8);} 
} 
if(j==0 ) {angint[j]=((int)(dihedraldata[x]/8)*45*23);} 
else if(j==1) {angint[j]=((int)(dihedraldata[x]/8)*23);} 
else if(j==2) {angint[j]=((int)(dihedraldata[x]/(180.0/23)));} 
if(selection==0) printf("%d\t",angint[j]); // Control 
} 
 
else 
{ 
// The angle is divided by the step size of the angle in the reference data 
ang[j]=dihedraldata[x]/AAcode[a][y];  
// The integer of this new angle is used 
angint[j]=(int)ang[j];  
if(selection==2) 
{   if(j==0) {mata=(int)(dihedraldata[x]/AAcode[a][y]);} 
    if(j==1) {matb=(int)(dihedraldata[x]/AAcode[a][y]);} 
} 
tmp=1; 
for(z=y+2;z<AAcode[a][0]*2+1;z+=2)  
tmp*=(AAcode[a][z+1]/AAcode[a][z]);  
 
angint[j]*=tmp; 
if(selection==0) printf("%d\t",angint[j]); 
} 
 
place+=angint[j]; 
x++; 
} 
 
place+=AAcode[a][1]; 
if(selection==0)  
printf("%d\t%d\t%f\t\n", place, place-AAcode[a][1],angleref[place]); 
if(selection==2)  
mat[mata][matb]+=1.0/frames; 
if(angleref[place]>cutoff_mf)  
{   mf++; 
    timeres[d]='f'; 
} 
else if(angleref[place]<=cutoff_mf && angleref[place]>=cutoff_dis)  
{       al++; 
        timeres[d]='a'; 
} 
else if(angleref[place]<cutoff_dis) 
{       dis++; 
        timeres[d]='d'; 
} 
} 
 
// Print the data 
mf_f=(float)mf/frames; 
al_f=(float)al/frames; 
dis_f=(float)dis/frames; 
if(selection==1)  
printf("%d\t%s\t%.3f\t%.3f\t%.3f\n", matrixno[i], matrixres[i], mf_f, al_f, 
dis_f); 
if(selection==2)  
{   j=(AAcode[a][3]/AAcode[a][2]); 
    if(AAcode[a][0]==1) 
    {   printf("%s-%d\n", matrixres[i], matrixno[i]); 
        for(mata=0;mata<j;mata++) 
        printf("%f\t", mat[mata][0]); 
        printf("\n"); 
    } 
    else if (AAcode[a][0]>1) 
    {       d=(AAcode[a][5]/AAcode[a][4]); 
            printf("%s-%d\n", matrixres[i], matrixno[i]); 
            for(mata=0;mata<j;mata++) 
            {   for(matb=0;matb<d;matb++) 
                printf("%f\t", mat[mata][matb]); 
                printf("\n"); 
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            } 
    } 
} 
if(selection==3) 
{   printf("%d\t", matrixno[i]); 
    for(z=0;z<frames;z++) 
    printf("%c", timeres[z]); 
    printf("\n"); 
} 
} 
} 
 
// Free memory 
free(dihedraldata); 
free(angleref); 
} 
 
 
////////////////////////////////////////////////////////////////////////////////// 
// Ramachandran plot: compares phi and psi combinations with experimental values  
// from Lovell: needs angtype, aminoacids, frames, intangles, selection, reflines 
////////////////////////////////////////////////////////////////////////////////// 
 
if(angtype==5) 
{ 
 
// Cut-off values for favored, allowed, and disallowed 
float cutoff_mf=0.02; 
float cutoff_dis=0.002; 
 
int mf, al, dis; 
float mf_f, al_f, dis_f; 
reflines=2*reflines; 
int ramaref1[reflines]; // There are 180*180*2 phi and psi values 
int ramaref2[reflines]; 
int ramaref3[reflines]; 
int ramaref4[reflines]; 
reflines=reflines/2; 
float ramavalue1[reflines]; // There are 180*180 values 
float ramavalue2[reflines]; 
float ramavalue3[reflines]; 
float ramavalue4[reflines]; 
int phi[frames]; 
int psi[frames]; 
int a,b,d,i,j,f,k; 
int ang; 
float matr1[359][359];  
float matr2[359][359]; 
float matr3[359][359]; 
float matr4[359][359]; 
char timeres[frames]; 
 
// Initialize with zero 
for(i=0;i<359;i++) 
{   for(j=0;j<359;j++)  
    {   matr1[i][j]=0.0; 
        matr2[i][j]=0.0; 
        matr3[i][j]=0.0; 
        matr4[i][j]=0.0; 
    } 
} 
 
// Matrix where temporarily the reference data are stored depending on the current  
// amino acid 
float matref[359][359];  
// Store fraction of angles 
float mat[359][359];  
// In ramadat the angle data is stored 
float *ramadat = malloc((2*intangles) * sizeof(int)); 
if(ramadat == NULL) 
{   printf("NO RAM\n"); 
    return EXIT_FAILURE; 
} 
// In matrixres the amino acid sequence is stored 
char matrixres[aminoacids][5]; 
// Initialize matrixres with NULL 
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for (i=0; i<aminoacids; i++) 
{   for (j=0; j<5; j++) 
    matrixres[i][j]=0; 
} 
// In matrixno the amino acid numbers are stored 
int matrixno[aminoacids]; 
// For GLY, PRO, and pre-PRO other reference values are used 
char AAname[2][4]=  {   {'P','R','O','\0'}, 
                        {'G','L','Y','\0'}  
                    }; 
 
// Read amino acid numbers 
for(i=0; i<aminoacids; i++)  
scanf("%d", &matrixno[i]); 
 
// Read amino acid sequence 
scanf("%c", &matrixres[0][0]);  
for(i=0; i<aminoacids; i++) 
{   for(j=0; ; j++) 
    {   scanf("%c", &matrixres[i][j]); 
        if(matrixres[i][j]=='\n') 
        {   matrixres[i][j]=0; 
            break; 
        } 
    } 
} 
 
// Read the reference data in the order: general, glycine, pro, pre-pro 
for(i=0, j=0;j<reflines/4;i+=2,j++) 
{   scanf("%d", &ramaref1[i]); 
    scanf("%d", &ramaref1[i+1]); 
    scanf("%f", &ramavalue1[j]); 
} 
 
for(i=0, j=0;j<reflines/4;i+=2,j++) 
{   scanf("%d", &ramaref2[i]); 
    scanf("%d", &ramaref2[i+1]); 
    scanf("%f", &ramavalue2[j]); 
} 
 
for(i=0, j=0;j<reflines/4;i+=2,j++) 
{   scanf("%d", &ramaref3[i]); 
    scanf("%d", &ramaref3[i+1]); 
    scanf("%f", &ramavalue3[j]); 
} 
 
for(i=0, j=0;j<reflines/4;i+=2,j++) 
{   scanf("%d", &ramaref4[i]); 
    scanf("%d", &ramaref4[i+1]); 
    scanf("%f", &ramavalue4[j]); 
} 
 
// Convert the reference data 
for(i=0, j=0; j<reflines/4; i+=2,j++) 
{   a=ramaref1[i]+179; b=ramaref1[i+1]+179; 
    matr1[a][b]=ramavalue1[j]; 
    a=ramaref2[i]+179; b=ramaref2[i+1]+179; 
    matr2[a][b]=ramavalue2[j]; 
    a=ramaref3[i]+179; b=ramaref3[i+1]+179; 
    matr3[a][b]=ramavalue3[j]; 
    a=ramaref4[i]+179; b=ramaref4[i+1]+179; 
    matr4[a][b]=ramavalue4[j]; 
} 
 
// Read the angle data 
for(i=0;i<(2*intangles);i++) 
scanf("%f", &ramadat[i]); 
 
// Ramachandran plot 
for(f=0,d=0; d<aminoacids; f+=2,d++) 
{ 
 
if ((a=strcmp(matrixres[d],AAname[0]))==0) // Check if PRO 
{   for(i=0;i<359;i++)  
    {   for(j=0;j<359;j++)  
        matref[i][j]=matr3[i][j]; 
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    } 
} 
else if ((a=strcmp(matrixres[d+1],AAname[0]))==0 && d!=aminoacids-1)  
// Check if pre-PRO until second to last amino acid 
{       for(i=0;i<359;i++)  
        {   for(j=0;j<359;j++) 
            matref[i][j]= matr4[i][j]; 
        } 
} 
else if ((a=strcmp(matrixres[d],AAname[1]))==0) // Check if GLY 
{       for(i=0;i<359;i++) 
        {   for(j=0;j<359;j++) 
            matref[i][j]= matr2[i][j]; 
        } 
} 
else 
{   for(i=0;i<359;i++)  
    {   for(j=0;j<359;j++) 
        matref[i][j]= matr1[i][j]; 
    } // Else: "general" 
} 
if(selection==2) 
printf("%s-%d\n", matrixres[d], matrixno[d]); 
if(selection==3) 
{   printf("%s-%d\n", matrixres[d], matrixno[d]); 
    for(i=0;i<359;i++) 
    {   for(j=0;j<359;j++) 
        mat[i][j]=0.0; 
    } 
} 
for(i=f, j=0; j<frames; i+=(2*aminoacids), j++) 
{   ang=(int)(ramadat[i]);  
    if ((ang%2) == 0) 
    {   if (ramadat[i]<0) ang--; 
        else ang++; 
    } 
    phi[j]=ang; 
    if(selection==2) printf("%.4f\t", ramadat[i]); 
    ang=(int)(ramadat[i+1]); 
    if ((ang%2) == 0)  
    {   if (ramadat[i+1]<0) ang--;  
        else ang++; 
    } 
    psi[j]=ang; 
    if(selection==2)  
    printf("%.4f\n", ramadat[i+1]); 
    a=phi[j]+179; b=psi[j]+179; 
    mat[a][b]+=(100*(1/(float)frames)); 
} 
if(selection==3) 
{   for(i=0;i<360;i+=2,k++) 
    {   for(j=0;j<360;j+=2) 
        printf("%f\t", mat[i][j]); 
        printf("\n"); 
    } 
} 
if(selection==1 || selection==4)  
{ 
 
mf=0; 
al=0; 
dis=0; 
for(j=0;j<frames;j++) 
{   a=phi[j]+179; b=psi[j]+179; 
    if(matref[a][b]>cutoff_mf) 
    {   mf++; 
        timeres[j]='f'; 
    } 
    else if(matref[a][b]<=cutoff_mf && matref[a][b]>=cutoff_dis)  
    {       al++; 
            timeres[j]='a'; 
    } 
    else if(matref[a][b]<cutoff_dis) 
    {       dis++; 
            timeres[j]='d'; 
    } 
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} 
mf_f=(float)mf/frames; 
al_f=(float)al/frames; 
dis_f=(float)dis/frames; 
if(selection==1)  
printf("%d\t%s\t%.3f\t%.3f\t%.3f\n", matrixno[d], matrixres[d], mf_f, al_f, 
dis_f); 
if(selection==4)  
{   printf("%d\t", matrixno[d]); 
    for(j=0;j<frames;j++) 
    printf("%c", timeres[j]); 
    printf("\n"); 
} 
} 
} 
 
// Free memory 
free(ramadat); 
} 
 
return EXIT_SUCCESS; 
} 
 
 
9.6 Time resolved Ramachandran analysis: rama_time.sh 
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#!/bin/bash 
 
 
### PLEASE ENTER ################# 
file=inact-md1-2-rama-time  #example 
residue=74                  #example 
frames=8000                 #example 
################################## 
 
sed -n '/^#C#/p' test.sh | cut -c4- > rama-xpm-file.c 
 
gcc rama-xpm-file.c -o rama-xpm-file 
 
sed -n /^$residue\\t/p $file.txt | cut -f2 > $residue.txt 
./rama-xpm-file $frames < $residue.txt > $residue.xpm 
 
convert -density 300 $residue.xpm $residue.jpg 
 
rm -f $residue.txt 
rm -f $residue.xpm 
rm -f rama-xpm-file.c 
rm -f rama-xpm-file 
 
### C program rama-xpm-file 
#C#  
#C# ///////////////////////////////////////////////////////////////// 
#C# // Generate an xpm picture for one residue containing the time  
#C# // resolved ramachandran analysis 
#C# ///////////////////////////////////////////////////////////////// 
#C#  
#C# #include <stdio.h> 
#C# #include <stdlib.h> 
#C# #include <string.h> 
#C#  
#C# int main(int argc, char *argv[]) { 
#C#  
#C# int frames; 
#C# frames = strtol(argv[1], NULL, 10); 
#C#  
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#C# int i,j; 
#C#  
#C# // In alldata the input is stored 
#C# char alldata[frames]; 
#C#  
#C# // Read the data 
#C# for(i=0;i<frames;i++)  
#C# { 
#C# scanf("%c",&alldata[i]); 
#C# } 
#C#  
#C# // Print header 
#C# printf("/* XPM */\n"); 
#C# printf("static char * pic_xpm[] = {\n"); 
#C# printf("\"%d %d 5 1\",\n", frames, frames/20); 
#C# printf("\" \tc None\",\n"); 
#C# printf("\"0\tc #FFFFFF\",\n"); 
#C# printf("\"f\tc #FFFFFF\",\n"); // blue: #0101DF 
#C# printf("\"a\tc #FFFFFF\",\n"); // green: #088A08; yellow: #FFFF00 
#C# printf("\"d\tc #FF0000\",\n"); 
#C#  
#C# // Height of the picture is 1/20 of its width 
#C# for(j=0; j<frames/20; j++)  
#C# { 
#C# printf("\""); 
#C# for(i=0 ;i<frames; i++) 
#C# { 
#C# printf("%c", alldata[i]); 
#C# } 
#C# if(j==(frames/20)-1) printf("\"}"); else printf("\","); 
#C# printf("\n"); 
#C# } 
#C#  
#C# return EXIT_SUCCESS; 
#C# } 
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